Submitted URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5p...
Effective URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_h...
Submission: On December 15 via api from DE

Summary

This website contacted 112 IPs in 13 countries across 91 domains to perform 697 HTTP transactions. The main IP is 2a02:26f0:6c00:297::11ae, located in Ascension Island and belongs to AKAMAI-ASN1, EU. The main domain is www.dailymail.co.uk.
TLS certificate: Issued by DigiCert Secure Site ECC CA-1 on April 29th 2020. Valid for: 10 months.
This is the only time www.dailymail.co.uk was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 199.60.103.2 209242 (CLOUDFLAR...)
98 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
4 2a00:1450:400... 15169 (GOOGLE)
4 2a00:1450:400... 15169 (GOOGLE)
4 5 18.196.214.144 16509 (AMAZON-02)
6 2600:9000:210... 16509 (AMAZON-02)
4 65.9.68.93 16509 (AMAZON-02)
13 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
2 2 15.237.76.117 16509 (AMAZON-02)
1 2 104.111.238.139 16625 (AKAMAI-AS)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 2 34.250.60.119 16509 (AMAZON-02)
1 99.84.89.98 16509 (AMAZON-02)
22 99.84.88.20 16509 (AMAZON-02)
29 151.101.13.44 54113 (FASTLY)
1 1 185.94.180.128 35220 (SPOTX-AMS)
1 2.21.36.138 20940 (AKAMAI-ASN1)
1 2600:9000:20e... 16509 (AMAZON-02)
1 2a02:26f0:eb:... 20940 (AKAMAI-ASN1)
1 1 134.209.131.220 14061 (DIGITALOC...)
3 54.225.161.250 14618 (AMAZON-AES)
2 104.19.149.54 13335 (CLOUDFLAR...)
1 2a04:4e42:3::621 54113 (FASTLY)
9 37.252.161.190 29990 (ASN-APPNEX)
6 178.250.0.165 44788 (ASN-CRITE...)
11 104.111.215.135 16625 (AKAMAI-AS)
1 35.159.48.82 16509 (AMAZON-02)
19 34.98.64.218 15169 (GOOGLE)
3 52.28.106.210 16509 (AMAZON-02)
2 17 185.33.220.242 29990 (ASN-APPNEX)
4 2.18.232.7 16625 (AKAMAI-AS)
4 69.173.144.143 26667 (RUBICONPR...)
10 52.28.203.152 16509 (AMAZON-02)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a03:2880:f02... 32934 (FACEBOOK)
45 172.217.22.2 15169 (GOOGLE)
4 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
5 6 54.93.211.166 16509 (AMAZON-02)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a03:2880:f12... 32934 (FACEBOOK)
1 151.139.128.11 20446 (HIGHWINDS3)
1 2a00:1450:400... 15169 (GOOGLE)
3 6 185.94.180.125 35220 (SPOTX-AMS)
7 52.28.189.33 16509 (AMAZON-02)
3 12 2.21.37.92 20940 (AKAMAI-ASN1)
12 15 51.89.20.87 16276 (OVH)
4 4 52.57.190.156 16509 (AMAZON-02)
5 6 34.245.253.34 16509 (AMAZON-02)
4 4 35.227.248.159 15169 (GOOGLE)
6 6 34.240.2.137 16509 (AMAZON-02)
1 2a02:26f0:eb:... 20940 (AKAMAI-ASN1)
1 1 2a00:1288:110... 34010 (YAHOO-IRD)
3 35.201.67.47 15169 (GOOGLE)
2 35.190.91.160 15169 (GOOGLE)
1 2 35.190.59.101 15169 (GOOGLE)
4 2600:9000:210... 16509 (AMAZON-02)
5 65.9.73.91 16509 (AMAZON-02)
2 2600:9000:210... 16509 (AMAZON-02)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
2 52.1.33.51 14618 (AMAZON-AES)
3 30 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
78 2a00:1450:400... 15169 (GOOGLE)
2 2 18.185.197.81 16509 (AMAZON-02)
2 18 141.226.228.48 200478 (TABOOLA-AS)
13 151.101.113.44 54113 (FASTLY)
1 2 198.148.27.139 19189 (PULSEPOINT)
1 104.111.246.202 16625 (AKAMAI-AS)
2 2606:4700:10:... 13335 (CLOUDFLAR...)
1 34.98.67.61 15169 (GOOGLE)
1 1 52.29.85.133 16509 (AMAZON-02)
2 2 54.80.202.86 14618 (AMAZON-AES)
1 2600:1f18:444... 14618 (AMAZON-AES)
2 3 51.210.112.66 16276 (OVH)
7 9 52.50.156.162 16509 (AMAZON-02)
2 2 172.217.23.162 15169 (GOOGLE)
2 3 185.64.190.80 62713 (AS-PUBMATIC)
1 2 52.18.215.87 16509 (AMAZON-02)
2 2 34.120.207.148 15169 (GOOGLE)
1 2 72.251.249.9 29791 (VOXEL-DOT...)
1 1 34.213.170.153 16509 (AMAZON-02)
1 185.86.139.115 201081 (SMARTADSE...)
1 174.137.133.49 27257 (WEBAIR-IN...)
1 18.195.155.181 16509 (AMAZON-02)
1 2 88.99.214.77 24940 (HETZNER-AS)
1 2 147.75.102.200 54825 (PACKET)
1 1 178.250.2.151 44788 (ASN-CRITE...)
1 1 139.162.84.221 63949 (LINODE-AP...)
10 12 3.124.119.192 16509 (AMAZON-02)
6 11 18.156.0.31 16509 (AMAZON-02)
1 192.132.33.46 18568 (BIDTELLECT)
1 141.226.224.32 200478 (TABOOLA-AS)
1 1 13.227.156.93 16509 (AMAZON-02)
13 34.107.254.252 15169 (GOOGLE)
9 185.94.180.123 35220 (SPOTX-AMS)
23 199.232.57.44 54113 (FASTLY)
7 16 2a00:1450:400... 15169 (GOOGLE)
1 65.9.73.31 16509 (AMAZON-02)
2 2 37.157.3.29 198622 (ADFORM)
1 65.9.73.118 16509 (AMAZON-02)
4 2a02:2638::3 44788 (ASN-CRITE...)
4 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 185.64.189.249 62713 (AS-PUBMATIC)
7 151.101.13.108 54113 (FASTLY)
1 2 52.29.22.19 16509 (AMAZON-02)
2 104.108.50.124 16625 (AKAMAI-AS)
4 4 151.101.114.49 54113 (FASTLY)
1 1 2620:116:800d... 16509 (AMAZON-02)
2 2a02:26f0:170... 20940 (AKAMAI-ASN1)
3 2.21.38.40 20940 (AKAMAI-ASN1)
8 2a02:26f0:170... 20940 (AKAMAI-ASN1)
3 2a02:26f0:10c... 20940 (AKAMAI-ASN1)
8 3.81.198.99 14618 (AMAZON-AES)
2 2a00:1450:401... 15169 (GOOGLE)
1 35.171.145.49 14618 (AMAZON-AES)
4 213.174.135.1 39572 (ADVANCEDH...)
6 23.227.137.155 55081 (24SHELLS)
2 185.64.189.112 62713 (AS-PUBMATIC)
1 109.206.182.43 50245 (SERVEREL-AS)
1 1 2a0c:5c81:516... 55081 (24SHELLS)
1 62.149.0.72 15497 (COLOCALL ...)
1 2a00:1450:400... 15169 (GOOGLE)
4 10 2.18.234.233 16625 (AKAMAI-AS)
2 54.239.17.112 16509 (AMAZON-02)
1 2001:4de0:ac1... 20446 (HIGHWINDS3)
1 54.195.94.143 16509 (AMAZON-02)
2 2a00:1288:f03... 10310 (YAHOO-1)
5 35.157.226.24 16509 (AMAZON-02)
1 2.21.37.33 20940 (AKAMAI-ASN1)
1 35.156.233.67 16509 (AMAZON-02)
697 112
Apex Domain
Subdomains
Transfer
117 dailymail.co.uk
www.dailymail.co.uk
i.dailymail.co.uk
scripts.dailymail.co.uk
ted.dailymail.co.uk
t.dailymail.co.uk
secured.dailymail.co.uk
crta.dailymail.co.uk
fff.dailymail.co.uk
creative.dailymail.co.uk
video.dailymail.co.uk
4 MB
84 taboola.com
cdn.taboola.com
trc.taboola.com
15.taboola.com
sync.taboola.com
match.taboola.com
sync-t1.taboola.com
cds.taboola.com
trc-events.taboola.com
images.taboola.com
vidstat.taboola.com
imprammp.taboola.com
am-match.taboola.com
am-vid-events.taboola.com
wf.taboola.com
c3.taboola.com
2 MB
61 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
cm.g.doubleclick.net
googleads.g.doubleclick.net
412 KB
55 googlesyndication.com
45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com
tpc.googlesyndication.com
pagead2.googlesyndication.com
ee12f6ec35b2c173a5233b824c7d979b.safeframe.googlesyndication.com
806 KB
35 ampproject.org
cdn.ampproject.org
677 KB
33 adnxs.com
prebid.adnxs.com
ib.adnxs.com
acdn.adnxs.com
18 KB
24 amazon-adsystem.com
c.amazon-adsystem.com
s.amazon-adsystem.com
41 KB
22 yahoo.com
c2shb.ssp.yahoo.com
pr-bh.ybp.yahoo.com
ups.analytics.yahoo.com
14 KB
19 advertising.com
ads.adaptv.advertising.com
pixel.advertising.com
7 KB
19 openx.net
mailonline-uk-d.openx.net
u.openx.net
eu-u.openx.net
select-d.openx.net
4 KB
18 google.com
adservice.google.com
www.google.com
666 B
16 casalemedia.com
htlb.casalemedia.com
ssum-sec.casalemedia.com
ssum.casalemedia.com
6 KB
15 id5-sync.com
id5-sync.com
21 KB
15 spotxchange.com
sync.search.spotxchange.com
search.spotxchange.com
8 KB
15 permutive.com
cdn.permutive.com
api.permutive.com
googlesync.permutive.com
211 KB
13 selectmedia.asia
play.selectmedia.asia
player.hb.selectmedia.asia
hb.hb.selectmedia.asia
167 KB
12 aniview.com
player.aniview.com
track1.aniview.com
go1.aniview.com
183 KB
12 userreport.com
sak.userreport.com
cdn.userreport.com
visitanalytics.userreport.com
tag.userreport.com
relay.userreport.com
cdw-dcl.userreport.com
audex.userreport.com
92 KB
11 stickyadstv.com
cdn.stickyadstv.com Failed
ads.stickyadstv.com
120 KB
10 newzit.com
www.newzit.com
i.newzit.com
94 KB
9 adsrvr.org
match.adsrvr.org
4 KB
9 googletagservices.com
www.googletagservices.com
252 KB
8 vidible.tv
acds.prod.vidible.tv
cdn-ssl.vidible.tv
trk.vidible.tv
112 KB
8 skimresources.com
s.skimresources.com
t.skimresources.com
p.skimresources.com
r.skimresources.com
24 KB
7 indexww.com
js-sec.indexww.com
7 pubmatic.com
simage2.pubmatic.com
image2.pubmatic.com
aud.pubmatic.com
hbopenbid.pubmatic.com
ads.pubmatic.com
2 KB
7 rubiconproject.com
fastlane.rubiconproject.com
pixel.rubiconproject.com Failed
eus.rubiconproject.com
prebid-server.rubiconproject.com Failed
18 KB
7 criteo.com
bidder.criteo.com
dis.criteo.com
1 KB
6 crwdcntrl.net
sync.crwdcntrl.net
2 KB
6 bidswitch.net
x.bidswitch.net
2 KB
6 cloudfront.net
d3tsytm1wtjqo2.cloudfront.net
14 KB
5 iris.tv
ovp.iris.tv
context.iris.tv
7 KB
5 creative-serving.com
ads.creative-serving.com
3 KB
4 everesttech.net
sync-tm.everesttech.net
965 B
4 criteo.net
static.criteo.net
50 KB
4 avct.cloud
ads.avct.cloud
2 KB
4 tapad.com
pixel.tapad.com
2 KB
4 360yield.com
ice.360yield.com
2 KB
4 teads.tv
a.teads.tv
1 KB
4 dotmetrics.net
uk-script.dotmetrics.net
39 KB
4 googleapis.com
imasdk.googleapis.com
128 KB
3 moatads.com
z.moatads.com
px.moatads.com
146 KB
3 onaudience.com
pixel.onaudience.com
1 KB
3 liadm.com
i.liadm.com
i6.liadm.com
1 KB
3 justpremium.com
pre.ads.justpremium.com
507 B
3 3lift.com
tlx.3lift.com
eb2.3lift.com
705 B
3 inskinad.com
mfad.inskinad.com
2 KB
2 gstatic.com
csi.gstatic.com
108 B
2 adform.net
dmp.adform.net
673 B
2 exelator.com
loadm.exelator.com
3 KB
2 1dmp.io
sync.1dmp.io
825 B
2 lijit.com
ce.lijit.com
1018 B
2 rlcdn.com
idsync.rlcdn.com
799 B
2 ml314.com
ml314.com
884 B
2 zeotap.com
mwzeom.zeotap.com
958 B
2 contextweb.com
bh.contextweb.com
819 B
2 mfadsrvr.com
rtb.mfadsrvr.com
1 KB
2 avocet.io
ads.avocet.io
452 B
2 google-analytics.com
google-analytics.com
ssl.google-analytics.com
18 KB
2 go-mpulse.net
s.go-mpulse.net
c.go-mpulse.net
51 KB
2 smartclip.net
sync.sxp.smartclip.net
931 B
2 scorecardresearch.com
sb.scorecardresearch.com
1 KB
2 and.co.uk
swa.and.co.uk
2 KB
2 silobreaker.com
info.silobreaker.com
3 KB
1 google.pl
adservice.google.pl
803 B
1 152media.com
sync.ads.152media.com
532 B
1 adtelli.com
s.adtelli.com
397 B
1 admanmedia.com
pub.admanmedia.com
276 B
1 adtelligent.com
player.adtelligent.com
12 KB
1 quantserve.com
pixel.quantserve.com
519 B
1 smadex.com
cm.smadex.com
527 B
1 bttrack.com
bttrack.com
380 B
1 appier.net
s.c.appier.net
362 B
1 emxdgt.com
e1.emxdgt.com
124 B
1 adkernel.com
dsp.adkernel.com
233 B
1 smartadserver.com
rtb-csync.smartadserver.com
697 B
1 storygize.net
www.storygize.net
431 B
1 agkn.com
aa.agkn.com
333 B
1 mookie1.com
odr.mookie1.com
324 B
1 bluekai.com
tags.bluekai.com
329 B
1 google.de
adservice.google.de
803 B
1 2mdn.net
s0.2mdn.net
11 KB
1 facebook.com
www.facebook.com
376 B
1 facebook.net
connect.facebook.net
3 KB
1 jsdelivr.net
cdn.jsdelivr.net
1 KB
1 serverbid.com
e.serverbid.com
284 B
1 spotxcdn.com
aka.spotxcdn.com
155 KB
1 spotx.tv
js.spotx.tv
590 B
1 anm.co.uk
hulkprod.anm.co.uk
12 KB
0 creativecdn.com Failed
prebid-eu.creativecdn.com Failed
0 consensu.org Failed
api.skimlinks.mgr.consensu.org Failed
697 91
Domain Requested by
54 i.dailymail.co.uk www.dailymail.co.uk
45 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.dailymail.co.uk
info.silobreaker.com
43 tpc.googlesyndication.com securepubads.g.doubleclick.net
www.dailymail.co.uk
tpc.googlesyndication.com
cdn.ampproject.org
39 www.dailymail.co.uk info.silobreaker.com
www.dailymail.co.uk
scripts.dailymail.co.uk
35 cdn.ampproject.org securepubads.g.doubleclick.net
22 images.taboola.com www.dailymail.co.uk
22 c.amazon-adsystem.com www.dailymail.co.uk
c.amazon-adsystem.com
17 ib.adnxs.com 2 redirects www.dailymail.co.uk
cdn.permutive.com
player.hb.selectmedia.asia
player.aniview.com
17 cdn.taboola.com www.dailymail.co.uk
cdn.taboola.com
securepubads.g.doubleclick.net
16 www.google.com 7 redirects www.dailymail.co.uk
securepubads.g.doubleclick.net
15 id5-sync.com 12 redirects www.dailymail.co.uk
12 api.permutive.com cdn.permutive.com
12 pixel.advertising.com 10 redirects www.dailymail.co.uk
11 ups.analytics.yahoo.com 6 redirects www.dailymail.co.uk
11 htlb.casalemedia.com www.dailymail.co.uk
player.hb.selectmedia.asia
player.aniview.com
10 ads.stickyadstv.com 4 redirects player.aniview.com
www.dailymail.co.uk
cdn.stickyadstv.com
10 c2shb.ssp.yahoo.com www.dailymail.co.uk
9 search.spotxchange.com js.spotx.tv
player.aniview.com
9 match.adsrvr.org 7 redirects www.dailymail.co.uk
player.aniview.com
9 crta.dailymail.co.uk www.dailymail.co.uk
scripts.dailymail.co.uk
9 trc.taboola.com cdn.taboola.com
www.dailymail.co.uk
9 prebid.adnxs.com www.dailymail.co.uk
9 www.googletagservices.com www.dailymail.co.uk
securepubads.g.doubleclick.net
8 track1.aniview.com www.dailymail.co.uk
player.aniview.com
8 i.newzit.com www.dailymail.co.uk
8 pagead2.googlesyndication.com www.dailymail.co.uk
securepubads.g.doubleclick.net
8 vidstat.taboola.com cdn.taboola.com
vidstat.taboola.com
8 cm.g.doubleclick.net 5 redirects www.dailymail.co.uk
8 mailonline-uk-d.openx.net www.dailymail.co.uk
7 js-sec.indexww.com www.dailymail.co.uk
player.aniview.com
7 acdn.adnxs.com www.dailymail.co.uk
player.aniview.com
7 googleads.g.doubleclick.net www.dailymail.co.uk
7 ads.adaptv.advertising.com www.dailymail.co.uk
player.aniview.com
cdn-ssl.vidible.tv
6 hb.hb.selectmedia.asia player.hb.selectmedia.asia
www.dailymail.co.uk
6 trc-events.taboola.com www.dailymail.co.uk
cdn.taboola.com
6 sync.crwdcntrl.net 5 redirects www.dailymail.co.uk
6 sync.search.spotxchange.com 3 redirects www.dailymail.co.uk
6 x.bidswitch.net 5 redirects www.dailymail.co.uk
6 bidder.criteo.com www.dailymail.co.uk
static.criteo.net
6 d3tsytm1wtjqo2.cloudfront.net www.dailymail.co.uk
5 trk.vidible.tv www.dailymail.co.uk
5 sync.taboola.com 2 redirects www.dailymail.co.uk
5 ads.creative-serving.com 4 redirects www.dailymail.co.uk
4 select-d.openx.net player.hb.selectmedia.asia
player.aniview.com
4 sync-tm.everesttech.net 4 redirects
4 u.openx.net www.dailymail.co.uk
player.aniview.com
4 play.selectmedia.asia securepubads.g.doubleclick.net
player.aniview.com
www.dailymail.co.uk
4 static.criteo.net www.dailymail.co.uk
static.criteo.net
4 context.iris.tv ovp.iris.tv
4 cdn.userreport.com sak.userreport.com
cdn.userreport.com
4 ads.avct.cloud 4 redirects
4 pixel.tapad.com 4 redirects
4 ice.360yield.com 4 redirects
4 ssum-sec.casalemedia.com 2 redirects www.dailymail.co.uk
4 fastlane.rubiconproject.com www.dailymail.co.uk
player.hb.selectmedia.asia
4 a.teads.tv www.dailymail.co.uk
4 uk-script.dotmetrics.net www.dailymail.co.uk
uk-script.dotmetrics.net
4 scripts.dailymail.co.uk www.dailymail.co.uk
securepubads.g.doubleclick.net
scripts.dailymail.co.uk
4 imasdk.googleapis.com www.dailymail.co.uk
imasdk.googleapis.com
3 player.hb.selectmedia.asia info.silobreaker.com
player.hb.selectmedia.asia
3 player.aniview.com play.selectmedia.asia
player.aniview.com
3 am-match.taboola.com vidstat.taboola.com
3 imprammp.taboola.com vidstat.taboola.com
info.silobreaker.com
3 eu-u.openx.net www.dailymail.co.uk
3 pixel.onaudience.com 2 redirects www.dailymail.co.uk
3 15.taboola.com cdn.taboola.com
3 45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com securepubads.g.doubleclick.net
3 t.skimresources.com www.dailymail.co.uk
s.skimresources.com
3 fff.dailymail.co.uk www.dailymail.co.uk
3 pre.ads.justpremium.com www.dailymail.co.uk
3 mfad.inskinad.com www.dailymail.co.uk
2 cdn-ssl.vidible.tv acds.prod.vidible.tv
player.aniview.com
2 s.amazon-adsystem.com www.dailymail.co.uk
2 hbopenbid.pubmatic.com player.hb.selectmedia.asia
player.aniview.com
2 csi.gstatic.com securepubads.g.doubleclick.net
2 am-vid-events.taboola.com www.dailymail.co.uk
2 z.moatads.com www.dailymail.co.uk
cdn-ssl.vidible.tv
2 www.newzit.com scripts.dailymail.co.uk
2 video.dailymail.co.uk www.dailymail.co.uk
2 eus.rubiconproject.com www.dailymail.co.uk
player.aniview.com
2 eb2.3lift.com 1 redirects www.dailymail.co.uk
2 image2.pubmatic.com 2 redirects
2 dmp.adform.net 2 redirects
2 sync-t1.taboola.com www.dailymail.co.uk
2 loadm.exelator.com 1 redirects www.dailymail.co.uk
2 sync.1dmp.io 1 redirects www.dailymail.co.uk
2 ce.lijit.com 1 redirects www.dailymail.co.uk
2 idsync.rlcdn.com 2 redirects
2 ml314.com 1 redirects www.dailymail.co.uk
2 i.liadm.com 2 redirects
2 mwzeom.zeotap.com www.dailymail.co.uk
2 bh.contextweb.com 1 redirects www.dailymail.co.uk
2 rtb.mfadsrvr.com 2 redirects
2 adservice.google.com securepubads.g.doubleclick.net
2 relay.userreport.com sak.userreport.com
2 tag.userreport.com sak.userreport.com
cdn.userreport.com
2 r.skimresources.com 1 redirects www.dailymail.co.uk
2 p.skimresources.com www.dailymail.co.uk
2 ads.avocet.io 2 redirects
2 cdn.permutive.com www.dailymail.co.uk
cdn.permutive.com
2 sync.sxp.smartclip.net 1 redirects www.dailymail.co.uk
2 sb.scorecardresearch.com 1 redirects www.dailymail.co.uk
2 swa.and.co.uk 2 redirects
2 t.dailymail.co.uk www.dailymail.co.uk
2 ted.dailymail.co.uk www.dailymail.co.uk
2 info.silobreaker.com 1 redirects
1 px.moatads.com www.dailymail.co.uk
1 ads.pubmatic.com player.aniview.com
1 acds.prod.vidible.tv player.aniview.com
1 prebid-server.rubiconproject.com player.aniview.com
1 ee12f6ec35b2c173a5233b824c7d979b.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 adservice.google.pl securepubads.g.doubleclick.net
1 sync.ads.152media.com www.dailymail.co.uk
1 s.adtelli.com 1 redirects
1 pub.admanmedia.com player.hb.selectmedia.asia
1 player.adtelligent.com player.hb.selectmedia.asia
1 c3.taboola.com www.dailymail.co.uk
1 go1.aniview.com player.aniview.com
1 wf.taboola.com vidstat.taboola.com
1 cdn.stickyadstv.com imasdk.googleapis.com
player.aniview.com
cdn.stickyadstv.com
1 pixel.quantserve.com 1 redirects
1 ssum.casalemedia.com 1 redirects
1 aud.pubmatic.com www.dailymail.co.uk
1 googlesync.permutive.com www.dailymail.co.uk
1 audex.userreport.com www.dailymail.co.uk
1 cdw-dcl.userreport.com www.dailymail.co.uk
1 cm.smadex.com 1 redirects
1 cds.taboola.com www.dailymail.co.uk
1 bttrack.com www.dailymail.co.uk
1 s.c.appier.net 1 redirects
1 dis.criteo.com 1 redirects
1 e1.emxdgt.com www.dailymail.co.uk
1 dsp.adkernel.com www.dailymail.co.uk
1 rtb-csync.smartadserver.com www.dailymail.co.uk
1 www.storygize.net 1 redirects
1 simage2.pubmatic.com www.dailymail.co.uk
1 i6.liadm.com www.dailymail.co.uk
1 aa.agkn.com 1 redirects
1 odr.mookie1.com www.dailymail.co.uk
1 tags.bluekai.com www.dailymail.co.uk
1 match.taboola.com www.dailymail.co.uk
1 adservice.google.de securepubads.g.doubleclick.net
1 c.go-mpulse.net s.go-mpulse.net
1 visitanalytics.userreport.com www.dailymail.co.uk
1 pr-bh.ybp.yahoo.com 1 redirects
1 creative.dailymail.co.uk www.dailymail.co.uk
1 s0.2mdn.net imasdk.googleapis.com
1 s.skimresources.com www.dailymail.co.uk
1 www.facebook.com www.dailymail.co.uk
1 stats.g.doubleclick.net www.dailymail.co.uk
1 ssl.google-analytics.com 1 redirects
1 connect.facebook.net www.dailymail.co.uk
1 google-analytics.com www.dailymail.co.uk
1 s.go-mpulse.net www.dailymail.co.uk
1 tlx.3lift.com www.dailymail.co.uk
1 cdn.jsdelivr.net www.dailymail.co.uk
1 e.serverbid.com 1 redirects
1 secured.dailymail.co.uk www.dailymail.co.uk
1 ovp.iris.tv www.dailymail.co.uk
1 aka.spotxcdn.com www.dailymail.co.uk
1 js.spotx.tv 1 redirects
1 sak.userreport.com www.dailymail.co.uk
1 hulkprod.anm.co.uk www.dailymail.co.uk
0 prebid-eu.creativecdn.com Failed player.hb.selectmedia.asia
0 api.skimlinks.mgr.consensu.org Failed s.skimresources.com
0 pixel.rubiconproject.com Failed www.dailymail.co.uk
697 166
Subject Issuer Validity Valid
info.silobreaker.com
Cloudflare Inc ECC CA-3
2020-06-30 -
2021-06-30
a year crt.sh
secured.dailymail.co.uk
DigiCert Secure Site ECC CA-1
2020-04-29 -
2021-02-18
10 months crt.sh
*.g.doubleclick.net
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
upload.video.google.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.creative-serving.com
Sectigo RSA Domain Validation Secure Server CA
2019-03-27 -
2021-04-02
2 years crt.sh
*.cloudfront.net
DigiCert Global CA G2
2020-05-26 -
2021-04-21
a year crt.sh
*.dotmetrics.net
Amazon
2020-11-23 -
2021-12-22
a year crt.sh
*.dailymail.co.uk
DigiCert SHA2 Secure Server CA
2020-12-07 -
2021-12-14
a year crt.sh
sb.scorecardresearch.com
DigiCert Secure Site ECC CA-1
2020-07-17 -
2021-06-02
a year crt.sh
dmgprivacyint.co.uk
Let's Encrypt Authority X3
2020-11-05 -
2021-02-03
3 months crt.sh
*.smartclip.net
Amazon
2020-02-29 -
2021-03-29
a year crt.sh
*.userreport.com
RapidSSL RSA CA 2018
2019-01-10 -
2021-03-10
2 years crt.sh
c.amazon-adsystem.com
Amazon
2020-08-04 -
2021-08-02
a year crt.sh
*.taboola.com
DigiCert TLS RSA SHA256 2020 CA1
2020-11-25 -
2021-12-26
a year crt.sh
cdn.spotxcdn.com
GeoTrust RSA CA 2018
2020-05-21 -
2021-06-20
a year crt.sh
iris.tv
Amazon
2020-10-10 -
2021-11-10
a year crt.sh
mfad.inskinad.com
Amazon
2020-03-28 -
2021-04-28
a year crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2020-06-09 -
2021-06-09
a year crt.sh
f3.shared.global.fastly.net
GlobalSign CloudSSL CA - SHA256 - G3
2020-10-26 -
2021-04-17
6 months crt.sh
prebid.adnxs.com
GeoTrust TLS RSA CA G1
2020-03-29 -
2022-03-29
2 years crt.sh
*.criteo.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2020-11-17 -
2021-02-14
3 months crt.sh
san.casalemedia.com
GeoTrust RSA CA 2018
2020-03-02 -
2021-04-01
a year crt.sh
*.3lift.com
Amazon
2020-07-04 -
2021-08-05
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2020-06-18 -
2021-08-17
a year crt.sh
tracking.justpremium.com
Amazon
2020-11-26 -
2021-12-25
a year crt.sh
*.adnxs.com
DigiCert ECC Secure Server CA
2019-01-23 -
2021-03-08
2 years crt.sh
teads.tv
Let's Encrypt Authority X3
2020-11-19 -
2021-02-17
3 months crt.sh
*.rubiconproject.com
DigiCert SHA2 Secure Server CA
2019-01-10 -
2021-01-14
2 years crt.sh
web.ssp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2020-09-18 -
2021-03-17
6 months crt.sh
akstat.io
DigiCert Secure Site ECC CA-1
2020-05-06 -
2021-08-05
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2020-11-02 -
2021-01-30
3 months crt.sh
*.skimresources.com
DigiCert SHA2 Secure Server CA
2020-09-10 -
2021-10-12
a year crt.sh
*.doubleclick.net
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.search.spotxchange.com
GeoTrust RSA CA 2018
2019-03-20 -
2021-04-21
2 years crt.sh
*.v.ssp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2020-07-29 -
2021-01-25
6 months crt.sh
*.id5-sync.com
Let's Encrypt Authority X3
2020-09-27 -
2020-12-26
3 months crt.sh
*.google.de
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.google.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2
2019-06-13 -
2021-06-28
2 years crt.sh
odc-prod-01.oracle.com
DigiCert Secure Site ECC CA-1
2020-10-15 -
2021-04-09
6 months crt.sh
*.mookie1.com
DigiCert SHA2 Secure Server CA
2020-02-21 -
2021-03-22
a year crt.sh
*.liadm.com
Amazon
2020-11-30 -
2021-12-29
a year crt.sh
*.onaudience.com
Certyfikat SSL
2020-05-28 -
2021-05-28
a year crt.sh
*.pubmatic.com
Sectigo RSA Organization Validation Secure Server CA
2019-02-22 -
2021-02-21
2 years crt.sh
*.ml314.com
Amazon
2020-02-17 -
2021-03-17
a year crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2020-03-11 -
2021-05-10
a year crt.sh
*.contextweb.com
DigiCert SHA2 Secure Server CA
2020-05-07 -
2022-05-12
2 years crt.sh
*.smartadserver.com
DigiCert Global CA G2
2020-02-03 -
2022-02-03
2 years crt.sh
*.adkernel.com
COMODO RSA Domain Validation Secure Server CA
2017-11-17 -
2021-01-05
3 years crt.sh
*.emxdgt.com
Go Daddy Secure Certificate Authority - G2
2020-05-18 -
2021-07-17
a year crt.sh
sync.1dmp.io
Let's Encrypt Authority X3
2020-11-03 -
2021-02-01
3 months crt.sh
*.exelator.com
Go Daddy Secure Certificate Authority - G2
2019-05-17 -
2021-06-25
2 years crt.sh
ups.analytics.yahoo.com
DigiCert SHA2 High Assurance Server CA
2020-10-24 -
2021-04-20
6 months crt.sh
*.bttrack.com
Sectigo RSA Domain Validation Secure Server CA
2019-03-19 -
2021-04-13
2 years crt.sh
api.permutive.com
Let's Encrypt Authority X3
2020-10-24 -
2021-01-22
3 months crt.sh
*.spotxchange.com
GeoTrust RSA CA 2018
2019-03-18 -
2021-03-17
2 years crt.sh
misc-sni.google.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
*.criteo.net
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2020-11-17 -
2021-02-14
3 months crt.sh
wl.aniview.com
R3
2020-12-11 -
2021-03-11
3 months crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1
2019-03-07 -
2021-04-19
2 years crt.sh
cdn.adnxs.com
GlobalSign CloudSSL CA - SHA256 - G3
2020-10-29 -
2021-04-14
5 months crt.sh
pixel.advertising.com
DigiCert SHA2 High Assurance Server CA
2020-10-04 -
2021-03-31
6 months crt.sh
*.bidswitch.net
Sectigo RSA Domain Validation Secure Server CA
2020-04-23 -
2022-05-04
2 years crt.sh
newzit.com
Let's Encrypt Authority X3
2020-11-20 -
2021-02-18
3 months crt.sh
moatads.com
DigiCert SHA2 Secure Server CA
2020-01-17 -
2021-03-17
a year crt.sh
*.aniview.com
DigiCert SHA2 Secure Server CA
2020-01-22 -
2021-04-22
a year crt.sh
*.gstatic.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
player.hb.selectmedia.asia
Let's Encrypt Authority X3
2020-11-09 -
2021-02-07
3 months crt.sh
hb.hb.selectmedia.asia
Let's Encrypt Authority X3
2020-11-22 -
2021-02-20
3 months crt.sh
*.adtelligent.com
Sectigo RSA Domain Validation Secure Server CA
2020-10-28 -
2021-11-27
a year crt.sh
*.admanmedia.com
Go Daddy Secure Certificate Authority - G2
2020-04-20 -
2021-06-19
a year crt.sh
sync.ads.152media.com
Let's Encrypt Authority X3
2020-11-29 -
2021-02-27
3 months crt.sh
*.google.pl
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
www.google.com
GTS CA 1O1
2020-11-10 -
2021-02-02
3 months crt.sh
ads.stickyadstv.com
DigiCert TLS RSA SHA256 2020 CA1
2020-11-13 -
2021-11-17
a year crt.sh
s.amazon-adsystem.com
Amazon
2020-08-28 -
2021-08-20
a year crt.sh
*.stickyadstv.com
DigiCert SHA2 High Assurance Server CA
2019-11-25 -
2022-02-18
2 years crt.sh
acds.prod.vidible.tv
DigiCert SHA2 High Assurance Server CA
2018-01-24 -
2021-01-28
3 years crt.sh
cdn-ycs.vidible.tv
DigiCert SHA2 High Assurance Server CA
2020-07-22 -
2021-01-18
6 months crt.sh
trk.vidible.tv
DigiCert SHA2 High Assurance Server CA
2018-02-21 -
2021-02-25
3 years crt.sh

This page contains 65 frames:

Primary Page: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Frame ID: A43EA2C152FE8D174176D6FFDCE0517E
Requests: 449 HTTP requests in this frame

Frame: https://imasdk.googleapis.com/js/core/bridge3.431.1_en.html
Frame ID: 8B9B676F48171B9DAC9BA61B22FF7C8B
Requests: 1 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Frame ID: 1DF2C8117DA47A81B3DB0E413FC21B65
Requests: 1 HTTP requests in this frame

Frame: https://t.skimresources.com/api/v2/robots.txt?__skimjs_preflight__please_ignore__=true&rnd=0.4568768790418434
Frame ID: F2673590F844F6240006182703C8F2FB
Requests: 1 HTTP requests in this frame

Frame: https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Frame ID: 49FE244E034753F59228DA9EDBB0409D
Requests: 32 HTTP requests in this frame

Frame: https://imasdk.googleapis.com/js/core/bridge3.431.1_en.html
Frame ID: 7AA98E8D483A34F6E3CBB9EC12BB1297
Requests: 1 HTTP requests in this frame

Frame: https://tag.userreport.com/server.html
Frame ID: 57BF379F689EBB0474D90B10AC1A803F
Requests: 1 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 1CE41CCEFDCD5D246BCE0E2B6D29728B
Requests: 13 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstCVRFTGDauQdHqrCWQbKtpGOrOEbmCcM6DFf6_udvYlzfJPewn0DiLTS-dFhMXfuJeVV21avqojKHU595--2mgCdJJhu73xXQQK9N4lrSIOq02PYIBehYIZYF5KuD8iNU1UKc3Iwkz1iw7EfK1dc7ACN8om4U_5d8LCiMGUMkyrt_Z4Dr4cm2-nJzrR9gBkKTvEgXhZwH2ewV8xi28q8wGhtVOdsJElg6rCYm65i93EgHxbthbaZfvloHLYAlE6xr_zaNCfPpV7Mb1SXJkLXRYYG4e5wfPifAH9PZMO5AOVys_BCUfKrbheHYNr_-QU5TbAyrF&sai=AMfl-YT_GgTE73f22JEuwZ-GFjbv0gODaDI8JMbaxeV2v8qm5MVDHZCdXCbJnCQKn4Ui3Li4KpQhLNHhhb6waG9hhnaJ6HcyD_O0JG1l1DibtlSJ5B_wwOqtuQkw1_JIWP4j&sig=Cg0ArKJSzO8H0wXtLuNVEAE&adurl=
Frame ID: 19E7BDE6C0AFF41F5C2A707F69D914F2
Requests: 11 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstolr8H42Ka-9i_jvkbQIigHL_feb0LCM41TJaDHRHmnAciWdCCsWRV9d22smgr01lFT84OZ6oVlwtL1mMsIOJ52YS3UnvZc0Z9T5xlubTxGnM4uBiyMKhoB6Fo3iaFBv9Uta99dWUcR4Wb9gMmvXSThI3BTK5PPER3FEZ9QGwmfxH4VuN_n9wNKPrYUudY-hpgj3RKT-WtQZSeznWw8c90AM2Nero7vIQH4hGk5Ht8UXi4adMFnm4FB2GkrT6Ata6QnW2IuX1sS9EZlRiLmdlbA2iBAmvVK3Al-LlA8_KEtdbtZa3Z4I-ahCeFK0OoRClr2D25tZs&sai=AMfl-YTuh16fbMMKe4eSrwXJHaQVdFuVvaYVjOPwiC4XPucGvC1vsc3B_i9WBFeOW7YImjABgjcZOGdM7abuOTu31Yt1A_f8SsGLHFUPHMUgL_dBWQ5z0PP8JjZNG0TGomHJ&sig=Cg0ArKJSzPY4oc-5O6ALEAE&adurl=
Frame ID: 80B47E8B65158950541C245AB9320CFC
Requests: 7 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssIJrIZLo7ii-rCKBzWrXCVYeYtMZBAVFg1_RUKWrL0ymIHDfdJVSY0ey-v-iNrdyojS45W0QdKaM_gKiPkqgekXYIDItyyiFgF4Oapu9_rAGDqbQ2GwrEJ4YdTZ68Sxfp4TKhvq68zBm_7VrCMnKgcYdM9P7RqlM6RvbiU7FcwyX7ubEQsA8YbfEKKDGg2ArQRXDfnhLf8ohyYSJc3BKzfFGAHQzR_xhqp1UEx2dUh7sXhaud6LcS0cnXDctLi85dM0pX5ZEoYNmUkKPefCOyU7tAXay97JdKv7izzbPiN6cdw4XWN5aqt6SGjS67wOBdrX_-p2Pit64tX&sai=AMfl-YR8BF-L1Old-uLWihMgRujvwp_HSMfcoY_NxBakrPBwuagIE00p8SYHdxrwrLDrvK5j3yhSZrvveqHuw2wSRn47_lxNDtmz8675dwRQkKuqP5wfhdeAk85JhBS7XEI&sig=Cg0ArKJSzCgzclF5vGImEAE&urlfix=1&adurl=
Frame ID: 507C63E6D4C0685FEB29D51479DBF303
Requests: 6 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvwM-2qXEz67vG1vKHi2oTDHS_AqNmdcVt-eKclTpPtc2mdaRJ4JqY4r1BKsMJPW7zLLsO5hNaviNQQXb0UfiAYLtCRf5m18II4kn5So3FFXUxcCLpl6LaL5AOyHVo4AOTU48-VyNCu9tAiIXBh3xHsgsXNBqQzXxMXaqvjYrfzo58BcxJ-Ln5UehnTxu7f-KE_BSfSi8qhpPd0YoYXZg7AvwcdWAHVDXSP6B3mQP7X8US1qTb5WiXQlGAnPuL84uXz69t_m-p_NwD8aHMDPZejD9bVkg0W_Ka99OkMbco3lrBqq38tyk3c9WiNN9JjtuHeqW8P&sai=AMfl-YQ04QpMesqhvehAPHpzDgXOUnuqL79jJTr9RBlUevo3pHcs8RqVA0tyyLpiFtQY-iafoZVx-L9gn1QSFfrE_VllS-PcyPS5om83UNgVACXwjIsTMng-e6GjMzHLbH8&sig=Cg0ArKJSzDfAIQgD0qNfEAE&adurl=
Frame ID: DBCC5CB145E21D603C5AC7BC90F2E866
Requests: 8 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 661955F76CBE076B26D1D1A88AEA0FA1
Requests: 14 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/pd
Frame ID: 98DBD4FADC1544914DC6F3AD009DDF04
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: FAA9BA1DE314EB6BA4887A5D7235DF82
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 0507C33601A196B859953FCEF074B220
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: 74C1A0E8047CEFD87E7A87E0D005854D
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: CC1649B471460E2F35396B9B7C1380F0
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 07E57EDF7BF66283D23E30ACF9F5C408
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: A63D212A844910BD2BDB169B9F83763E
Requests: 1 HTTP requests in this frame

Frame: https://pre.ads.justpremium.com/v/1.0/t/sync?_c=aqsy8qr1608036524841
Frame ID: 7A2012E1C0CC8BFD01D2039CB4DE9CBD
Requests: 1 HTTP requests in this frame

Frame: https://eb2.3lift.com/sync?&ld=1
Frame ID: 6CF62A34E2A28B882ACAE150FFFFA149
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html
Frame ID: 7197B91DEFB0E455088D933C1D1902FC
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 0B3BE089DFEF9A8927539F2C28EA5540
Requests: 1 HTTP requests in this frame

Frame: https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Frame ID: F9DDA1C169CA237F64448AEA91FAC7AE
Requests: 1 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/pd
Frame ID: 0C4CC4A0F5D8D097DC1621BED7EA3DD9
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Frame ID: CB027541C1D421DA7D6FE31589F32C74
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Frame ID: 47B787F7D298906DF20924DED63E2D43
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: D22FC4E7A4A8A09C1B82362DC5F04EEC
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: 8E9FD35AE378876CC8CBBC8D23CDBE2F
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Frame ID: 626718A79DA5CD5F74341C483B6C718E
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: FEC9CF6632DC91041C053BDFB15FABDB
Requests: 1 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 2D4A4BEB55A4A438C4B5A21A6FC77484
Requests: 13 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss7jbowWmnGemZR_x3VRSUwwwKahINab3XnmHU0uYEmy-9cOGGx1xFLgyB0f-jo0sOOloTrv1zqzP0AJoWmAD_furwo8sghxjWSlI0ZRSAGqZy9wMXZ7Hr212vBfMMaNyFbZY5h3V32KDzr_t_7hg9UJR49ZRbDQAFidJtkGWRyMDkCKRNYiojqcin2i0_QvtTPcbxlhIVQna1ruTS_dkOIAAYAThV4HDFSxC9F2H95UEJiw44D99pLCHB4-pPWVlbX2hZsmmDiijm1f5-x3KY7pv4N-dlAdtjTtxCNxVTeD9l3AvwW_NQN_MZG0r7ahJnXeItzYcMXS2pNfbZ7DMpZzgXIk7H7sp4fExN33jLYYeE&sai=AMfl-YQwGUmKf2e8bxjAQuE4VNoQrvoLINu0mK5pevWwj2qOdKunM0xQIpbcQxBkWa7apOYacbx3tTZRWHu1CgGe8Ub9uvKz1FLvQv9Q36Imt4vZcJ7Qz5P6V07l6H8bykvJ&sig=Cg0ArKJSzE6cibwlZ8PUEAE&urlfix=1&adurl=
Frame ID: D53FA5AD569D2F686D0AE8E47C68F6E8
Requests: 14 HTTP requests in this frame

Frame: https://45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: D31C307B7339C412C274F25E47AFCB17
Requests: 1 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 6F27EFB66DE72A5BA63C6A442D04E715
Requests: 12 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssyvsSJ3OINZ3ZriS2SJkM5J9NFvBeAY1LFo2GKEo9GzEpeKb9FbKrQaCwipNS6AkXYuPAReFwrm-hWjJ82UrG1-1qQquq_-A1cWNf_swA_-I0bezvLFw9wOY0EMmvrRlGxCqu7dXzIbDAA8Rl4n2JzhBBCK5lNW8x1YYVkUFOIKedcV8oX8hKxJqetKwgXPyAT2oMckYD8qXnIXi8EkQ5TKRZefTjt5OD6a94H828jd_eTDwaZS1W3BFuXApRtXHa_O3qrMmX8_Or_IdHAIrgMiN6pIeQp3lNWlrSLh3kPKDtOdzZ5XfeIZM5OcE9ZuilOCeJuww&sai=AMfl-YRBRRRUsLGE-qj7eWPh5NNGid0k5uAw7O87FEO5X8lXlS9ntiq6m2l8vcBhV1QjmfO4Esv4M0Sd6s6wWIiInewMP2KYg1yeJ4FC1jDJuG_capVlwUhfOGuXnpNziWNM&sig=Cg0ArKJSzGatvCiFk8FxEAE&urlfix=1&adurl=
Frame ID: 37E40FBC3EC71B655CE458CF7E080D1D
Requests: 4 HTTP requests in this frame

Frame: https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
Frame ID: 1FE6991BD8200ED4386A28B615C15649
Requests: 15 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 4A357D97F3EAEB47AA9CB5468BB62738
Requests: 12 HTTP requests in this frame

Frame: https://www.newzit.com/setABframe.html
Frame ID: F1DF975FB1407CADAB50C25402CCC7F0
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssxYG8aFou-EVCY1QktXzCww_QFLSSL_rFBKDfn9AhvmPzznDVc3pDQi6WE0Bxz-Fn6eI8frMRWhax_4rPzDH3KubLgD843T4r_epP2f7-f-5a_fe2eeRCHG7u8iA7BRixA_F6n4SnMQ09Jp1UEmERrEMhzKHplkZUToo1wRHk3dDbuUN9H7-sR34pQHVUD9XfOOz_r2eUz9z6ucO7x0PGy6091d9nCpFu2VNeDgjlhHp6t1FHoZtX7lTma5YBUg4v31kE5X2nFGjVwZyI8F_cgQEnBrvncvoMh2M3vgmkuZvTXDWKSfsbM1hMeSQp4CB0&sig=Cg0ArKJSzCNOM_wDsa5gEAE&adurl=
Frame ID: 861FA8E3AF7E5CCADD1AC7AFB9624673
Requests: 9 HTTP requests in this frame

Frame: https://imasdk.googleapis.com/js/sdkloader/loader.js
Frame ID: 709A727763E8B6FFD18A8927B00CC882
Requests: 2 HTTP requests in this frame

Frame: https://imprammp.taboola.com/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4901665&dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&cmcv=&pix=undefined&cb=1608036533064&uv=2853&tms=1608036533064&abt=expn_vJ!heavyc_vA!lapams_vA!rev_vG!spa2_vB!t45!ufm_vE&ft=0&su=6&unm=FEED_MANAGER&aure=false&agl=1&cirid=68B45114834771126741973585882&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
Frame ID: 086761EF8D92EF56E413DC5FC4DA72FD
Requests: 1 HTTP requests in this frame

Frame: https://am-match.taboola.com/sync?dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&excid=22&docw=0&cijs=1&nlb=true
Frame ID: E3DD48F2018BA0E868D92B3D15AE8B8E
Requests: 1 HTTP requests in this frame

Frame: https://imprammp.taboola.com/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7BqQCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBuIHGzhYLVYTxmw2W-02i81uNZpsBsvlcjNaDoEDB6vFasKYzWar3Wax2a02i91kMlttFrPlFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ABQ5TBYy8Pr9_0DAOChAAQAYECBBGBA7agEQEIh8QQAAAAAAAAAgOX___8_BkCP_1cG4EKuvwfgwQfggaggsYgRAAAAgPBY2tjRpE6oLKoAAAjSrQCuAAAC7MzkUq7CAAAABsYW6GHx-80Ou8bvdhkAAAAAAAAAgNn_2T-aEFIUe1qQZ_2w2i8gAMDaLyAAAJu6AQC8CcAFHUErBoPVDdBkMTsAAACAu____389kLJtBpOVY-bYDBbL5WKwcC53K9twMNsYJqvdcuY9XVgzz3WrDrw-DmGZ_b6DgnJ6eswug6joelvsDqfZc5DMTfabsMVoNZlslsPZcjEZDEfD0Wh_ArgZ4AQNh4PFbrDYLRbDyWIyGiwHCxSIwQQnZDjaTFaj3Wo3WQ4no9FsM9kgRatWs9FmMFzNJrPdbjUcDJejEVK0ZjGbTBaz0XK3GSwno8FwMhwiTI1cG4vNMXMrNjbXWjSY2dbKwWDk1i1GLs9kYTMsFp616PUx3UaWzWyy8aJgQNleBBfpRORwmp1vh9Pslvx9F7FEc7JIJ7LLvmXbDCYrx8yxGSyWy8Vg4VzuVrbhYLYxTFa75czfGrk2Fptj5lZsbK61aDCzrZWDwcitW4xcnsnCZlgsPGvR62O6jSyb2WTjb8wGw8Fmtpqs9o3ZYDjYzFaT1b5DZ_iuPmejLdo9d3wij3kmtM1MB4XLYPQuPxdpt_i5GX3O8EuYGi4jn4lV6Pf7_X6_3-_3-70bs8FjMBh-Lttx-DEv15rT46CIJYLTRToRvYyni1gieVqkE9FqMbKsbIbZbrGxjWw2x8Jkce1Gvs3MNpgNZyuLWKI0XaQTvebjdNk9LtPLY_QrLKenx-xyKwerwXCy2EtebpPL87Q9LW-Jy-6yOT1Oh9kteJieLrvp8xb5Paa_5fOWvGwvh9kuNL3NFvUfG2I5miuXc8VgNVcuVwkAAAAAAAAAYAlz5k0AAAAATgOZbIaL1XIBHoz2dH8c7cjUQEePdl2wOdkuz4xMihs_biCH0-x8O5xmt-TvuzLAg9Ed82bPBLFWq2UNAABAgA0AABDArZu3QExGDg!&cmcv=&pix=undefined&cb=1608036533249&uv=2853&tms=1608036533249&abt=expn_vJ!heavyc_vA!rev_vG!spa2_vB!t45!ufm_vA&ft=0&su=0&unm=WIDGET_ITEM&aure=false&cirid=80515B166657313754230999349&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
Frame ID: 3F36FA7F36BA5F14D9FEF26255DD0DFD
Requests: 1 HTTP requests in this frame

Frame: https://am-match.taboola.com/sync?dast=V7BqQCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBuIHGzhYLVYTxmw2W-02i81uNZpsBsvlcjNaDoEDB6vFasKYzWar3Wax2a02i91kMlttFrPlFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ABQ5TBYy8Pr9_0DAOChAAQAYECBBGBA7agEQEIh8QQAAAAAAAAAgOX___8_BkCP_1cG4EKuvwfgwQfggaggsYgRAAAAgPBY2tjRpE6oLKoAAAjSrQCuAAAC7MzkUq7CAAAABsYW6GHx-80Ou8bvdhkAAAAAAAAAgNn_2T-aEFIUe1qQZ_2w2i8gAMDaLyAAAJu6AQC8CcAFHUErBoPVDdBkMTsAAACAu____389kLJtBpOVY-bYDBbL5WKwcC53K9twMNsYJqvdcuY9XVgzz3WrDrw-DmGZ_b6DgnJ6eswug6joelvsDqfZc5DMTfabsMVoNZlslsPZcjEZDEfD0Wh_ArgZ4AQNh4PFbrDYLRbDyWIyGiwHCxSIwQQnZDjaTFaj3Wo3WQ4no9FsM9kgRatWs9FmMFzNJrPdbjUcDJejEVK0ZjGbTBaz0XK3GSwno8FwMhwiTI1cG4vNMXMrNjbXWjSY2dbKwWDk1i1GLs9kYTMsFp616PUx3UaWzWyy8aJgQNleBBfpRORwmp1vh9Pslvx9F7FEc7JIJ7LLvmXbDCYrx8yxGSyWy8Vg4VzuVrbhYLYxTFa75czfGrk2Fptj5lZsbK61aDCzrZWDwcitW4xcnsnCZlgsPGvR62O6jSyb2WTjb8wGw8Fmtpqs9o3ZYDjYzFaT1b5DZ_iuPmejLdo9d3wij3kmtM1MB4XLYPQuPxdpt_i5GX3O8EuYGi4jn4lV6Pf7_X6_3-_3-70bs8FjMBh-Lttx-DEv15rT46CIJYLTRToRvYyni1gieVqkE9FqMbKsbIbZbrGxjWw2x8Jkce1Gvs3MNpgNZyuLWKI0XaQTvebjdNk9LtPLY_QrLKenx-xyKwerwXCy2EtebpPL87Q9LW-Jy-6yOT1Oh9kteJieLrvp8xb5Paa_5fOWvGwvh9kuNL3NFvUfG2I5miuXc8VgNVcuVwkAAAAAAAAAYAlz5k0AAAAATgOZbIaL1XIBHoz2dH8c7cjUQEePdl2wOdkuz4xMihs_biCH0-x8O5xmt-TvuzLAg9Ed82bPBLFWq2UNAABAgA0AABDArZu3QExGDg!&excid=22&docw=0&cijs=1&nlb=true
Frame ID: 97C487F73E6008F88A2FE07602C69EB3
Requests: 1 HTTP requests in this frame

Frame: https://imprammp.taboola.com/st?cipid=7991117&ttype=0&cirid=F9D93BEDAA57331901705257486&cicmp=1337627&cijs=1&dast=V7PIoCFgPB1fY8sSPvsQTB1fY8sSPvsQUAAAAGBugHHMYcMTcTFonBYO02m8VyMFgsJ6vFaLObTKZgsIXP6e5uQ6A-mk6Hz3Wv1_1-d5HDaXa-HU6zXeO3q75-zcfpsntcppfH6FdYTk-P2eVWDlaD4WSxl7TcJpfnaXta3hKX3WVzepwOs1vwMD1ddtPnLfJ7TH_L5y152V4Os11oepv9-6Ln7XQPh8vdaDcazfRFz8vucQ8uCzrjdH2rJSynr2y6DedmnpPJaVUWN17bQrEeDUsL03khPod0Esuz4lc6XtKV9SXszi5rrWI3Ta9vFpvvofuZLsqO7-isjmO-18jgPVuW2XFufR1rZ7euyKK6tXzDqexamJ67m2Xm2ZjmAAAAAPAAQNQSDbHj29AeAQAAACDBM3KtQBFQ8W8hcAEAAACAAUAgFq4BoMphsJaH1-_7BwDAQwEIAMCAAgmAQGJhCYDD3eIJAADAQZ3M0zbL____fwxA3nuTDABF2saNQQ_Agw_AgxAAAMDFEDuO7Ht6eGYfUYFiESMAAAAA4bG0saNJnVBZVP3___9bAVwBAATYmcn9-GXdnBSzhgEAAAyMLdDD4vebHXaN3-2y_________3-z_zMANCGkKPa0IM_6YTWekWuFtV9AAAC2dwMAeBOAizkAOwAAAIC7_____zwAAICSPUq212o8e5T1PoMtfE53d_0mbDFaTSab5XC2XEwGw9FwNNqfAG4GOEHD4WCxGyx2i8VwspiMBsvBAgViMMEJGY42k9Vot9pNlsPJaDTbTDZI0arVbLQZDFezyWy3Ww0Hw-VohBStWcwmk8VstNxtBsvJaDCcDIcIYxbjzLWY7NayhW-yFi1GrrVwsFq4ZQubcbGcmQwbh8sten1Mt5FlM9ts9tgQy9FcuZwrBqu5crlKAAAAAAAAAABLmDJvAgAAAHAaxGw22e1W3HizZ4JYq9WyBgAAAODWjRw!&excid=22&tst=1&docw=0&cs=false
Frame ID: FD0C3CC4EF3E0E453ACEC5D6249A1B8E
Requests: 1 HTTP requests in this frame

Frame: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Frame ID: A12807386BB513C68ACA2D72662CCFA0
Requests: 2 HTTP requests in this frame

Frame: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Frame ID: DF1E9E74BF1DBF4875423AB6D7456254
Requests: 28 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 0113F0BED72C2B0E24475AA05FBEE441
Requests: 15 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html
Frame ID: 58BD5C9F416961CD68A2C7AA2E30E4AF
Requests: 1 HTTP requests in this frame

Frame: https://45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: C252690775EB8014FAA1015774C631AD
Requests: 1 HTTP requests in this frame

Frame: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Frame ID: 089D1E99087C4D1F9FB0F56FF3D287C9
Requests: 4 HTTP requests in this frame

Frame: https://acds.prod.vidible.tv/o2shim?companionId=&cpmPassback=&placementId=1206795&orgId=28230&injectCompanionDummy=&pauseOnClick=&d.vw=&d.app=&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vrid=2f180f54-42c7-4d69-ab74-0c70596da56b&pblob=
Frame ID: 3F16CFC240FC9B07C5CB4337EB635896
Requests: 8 HTTP requests in this frame

Frame: https://cdn-ssl.vidible.tv/prod/player/ad-time/local-storage.html
Frame ID: C0B1A4FF55FA28FB3B7C378836FE7058
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/showad.js
Frame ID: D5CA8BE2EA7BDF5344C24CE802CDA7B9
Requests: 1 HTTP requests in this frame

Frame: https://js-sec.indexww.com/um/ixmatch.html
Frame ID: E22FD322782CE7266F7D7788EBDBF9D4
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: 8B07D3CC23FFEA8620EF99D5CADBBB50
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/dmp/async_usersync.html
Frame ID: CA922828AAFB3EC44ABB000F7052C150
Requests: 1 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/pd
Frame ID: 9EC8FF82BA887674DC7717360E692D01
Requests: 1 HTTP requests in this frame

Frame: https://u.openx.net/w/1.0/pd
Frame ID: 36589326B2AFEEA9E7FD97EF8B24B6CD
Requests: 1 HTTP requests in this frame

Frame: https://eus.rubiconproject.com/usync.html
Frame ID: 0C50150FFEB9C199E5B1634C79DBC8B8
Requests: 1 HTTP requests in this frame

Frame: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Frame ID: 4D49A5F3E5F025F690C0CEFE28E93938
Requests: 17 HTTP requests in this frame

Frame: https://am-match.taboola.com/sync?dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&excid=22&docw=0&cijs=1&nlb=true
Frame ID: 8047034EFD331E2E2EB7BB5700BCC962
Requests: 1 HTTP requests in this frame

Frame: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Frame ID: 4B1C1F83A9BE5A4624AE0D67FC2F926E
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14... Page URL
  2. https://info.silobreaker.com/events/public/v1/track/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV... HTTP 307
    https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.ht... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers server /^cloudflare$/i

Page Statistics

697
Requests

97 %
HTTPS

30 %
IPv6

91
Domains

166
Subdomains

112
IPs

13
Countries

9794 kB
Transfer

23195 kB
Size

0
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1 Page URL
  2. https://info.silobreaker.com/events/public/v1/track/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1?_ud=5f6272a9-6c89-4b09-8fe1-389470d4ad85&_ch=p&_pr2=p&_pl=0&_lg=en-US&_dr=b&_ts=p HTTP 307
    https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 23
  • https://ads.creative-serving.com/pixel?id=3140889 HTTP 302
  • https://ads.creative-serving.com/ul_cb/pixel?id=3140889
Request Chain 54
  • https://swa.and.co.uk/b/ss/anddailymailprod/1/JS-2.9.0/s2574234187497?AQB=1&ndh=1&pf=1&t=15%2F11%2F2020%2013%3A48%3A44%202%20-60&fid=37E040AF18157E12-1449A94B1F36F652&ce=iso-8859-1&ns=associatednorthcliffedigital&cdp=3&pageName=%2Fsciencetech%2Farticle&g=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&c.&gunther=17.14.0&fesbv=5.9.0&feabv=6.18.1&vbv=6.11.0-pr-503.2312&tag=fe_abv_vbv_test_desktop&pushNotificationStatus=not_supported&.c&ch=dailymail.co.uk&events=event108%2Cevent2%2Cevent25&c1=%2Fsciencetech&v1=D%3Dc1&c2=%2Fsciencetech&v2=D%3Dc2&h2=dailymail.co.uk%2Fsciencetech&l3=coronavirus&c4=article&v4=D%3Dc4&c5=remdesivir%20could%20be%20beneficial%20for%20some%20patients%2C%20doctors%20reveal%C2%A0&v5=D%3Dc5&c6=9050821&v6=D%3Dc6&c11=Logged%20Out&v11=D%3DpageName&v12=D%3Dch&c13=%2Fsciencetech%2Farticle&c14=New&v14=New&c15=%2Fsciencetech%2Farticle&v21=D%3Dc23&v22=D%3Dc24&c23=2020-12-14&v23=D%3Dc25&c24=12&c25=Joe%20Pinkstone%20For%20Mailonline&v25=D%3Dc27&v26=D%3Dc28&c27=2020-12-15&v27=D%3Dc29&c28=13&c29=direct&v31=D%3Dc33&c33=%2Fsciencetech%2Farticle&c37=DE&c38=%2Fsciencetech%2Farticle&v38=D%3Dc38&c44=D%3Dg&c46=17.14.0&c47=adBlocker%20off&v49=%21-%21EXT%21-%21&v50=D%3Dg&c51=Clicked%20a%20link%20or%20entered%20a%20URL&c53=direct%5Edirect%5Edirect&v54=NoInstart&c57=62517997&v57=D%3Dc57&v58=Guest&c59=1%5E1%5E1&v59=D%3Dc59&c65=Desktop&v65=Desktop&v67=faf613d9-2aa3-41b8-ae83-31ee727de10e&v70=default&v96=1651%3A1560%3A27%3A9%3A9%3A23%3A23&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&AQE=1 HTTP 302
  • https://swa.and.co.uk/b/ss/anddailymailprod/1/JS-2.9.0/s2574234187497?AQB=1&pccr=true&vidn=2FEC58560515CE45-40000666530440B3&ndh=1&pf=1&t=15%2F11%2F2020%2013%3A48%3A44%202%20-60&fid=37E040AF18157E12-1449A94B1F36F652&ce=iso-8859-1&ns=associatednorthcliffedigital&cdp=3&pageName=%2Fsciencetech%2Farticle&g=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&c.&gunther=17.14.0&fesbv=5.9.0&feabv=6.18.1&vbv=6.11.0-pr-503.2312&tag=fe_abv_vbv_test_desktop&pushNotificationStatus=not_supported&.c&ch=dailymail.co.uk&events=event108%2Cevent2%2Cevent25&c1=%2Fsciencetech&v1=D%3Dc1&c2=%2Fsciencetech&v2=D%3Dc2&h2=dailymail.co.uk%2Fsciencetech&l3=coronavirus&c4=article&v4=D%3Dc4&c5=remdesivir%20could%20be%20beneficial%20for%20some%20patients%2C%20doctors%20reveal%C2%A0&v5=D%3Dc5&c6=9050821&v6=D%3Dc6&c11=Logged%20Out&v11=D%3DpageName&v12=D%3Dch&c13=%2Fsciencetech%2Farticle&c14=New&v14=New&c15=%2Fsciencetech%2Farticle&v21=D%3Dc23&v22=D%3Dc24&c23=2020-12-14&v23=D%3Dc25&c24=12&c25=Joe%20Pinkstone%20For%20Mailonline&v25=D%3Dc27&v26=D%3Dc28&c27=2020-12-15&v27=D%3Dc29&c28=13&c29=direct&v31=D%3Dc33&c33=%2Fsciencetech%2Farticle&c37=DE&c38=%2Fsciencetech%2Farticle&v38=D%3Dc38&c44=D%3Dg&c46=17.14.0&c47=adBlocker%20off&v49=%21-%21EXT%21-%21&v50=D%3Dg&c51=Clicked%20a%20link%20or%20entered%20a%20URL&c53=direct%5Edirect%5Edirect&v54=NoInstart&c57=62517997&v57=D%3Dc57&v58=Guest&c59=1%5E1%5E1&v59=D%3Dc59&c65=Desktop&v65=Desktop&v67=faf613d9-2aa3-41b8-ae83-31ee727de10e&v70=default&v96=1651%3A1560%3A27%3A9%3A9%3A23%3A23&s=1600x1200&c=24&j=1.6&v=N&k=Y&bw=1600&bh=1200&AQE=1 HTTP 302
  • https://sb.scorecardresearch.com/r?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3838634626&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4 HTTP 302
  • https://sb.scorecardresearch.com/r2?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3838634626&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&cs_ak_ss=1
Request Chain 56
  • https://sync.sxp.smartclip.net/sync?type=red&dsp=10 HTTP 302
  • https://sync.sxp.smartclip.net/sync?type=red&dsp=10&ang_testid=1
Request Chain 62
  • https://js.spotx.tv/directsdk/v1/234272.js HTTP 307
  • https://aka.spotxcdn.com/integration/directsdk/v1/directsdk.js
Request Chain 65
  • https://e.serverbid.com/udb/9969/match?redir=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fpool%2Fset%2Fi.gif%3FpoolId%3D9969%26poolKey%3D HTTP 302
  • https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-2aed38e2-3ebc-44e9-8fc5-088ff3e22299
Request Chain 117
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dgrid%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24%7BBSW_UUID%7D?gdpr=0&gdpr_consent=&us_privacy= HTTP 302
  • https://x.bidswitch.net/ul_cb/check_uuid/https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dgrid%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24%7BBSW_UUID%7D?gdpr=0&gdpr_consent=&us_privacy= HTTP 302
  • https://ib.adnxs.com/prebid/setuid?bidder=grid&gdpr=0&gdpr_consent=&uid=f644313d-5c9b-496a-98b0-21d748a69350
Request Chain 136
  • https://ssl.google-analytics.com/r/__utm.gif?utmwv=5.7.2&utms=1&utmn=265532343&utmhn=www.dailymail.co.uk&utmcs=UTF-8&utmsr=1600x1200&utmvp=1600x1200&utmsc=24-bit&utmul=en-us&utmje=0&utmfl=-&utmdt=Remdesivir%20%27could%20be%20beneficial%20for%20some%20patients%27%2C%20doctors%20reveal%C2%A0%20%7C%20Daily%20Mail%20Online&utmhid=1653325603&utmr=-&utmp=%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&utmht=1608036524924&utmac=UA-3639451-1&utmcc=__utma%3D141568423.1453141251.1608036525.1608036525.1608036525.1%3B%2B__utmz%3D141568423.1608036525.1.1.utmcsr%3D(direct)%7Cutmccn%3D(direct)%7Cutmcmd%3D(none)%3B&utmjid=919056266&utmredir=1&utmu=qAAAAAAAAAAAAAAAAAAAAAAE~ HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-3639451-1&cid=1453141251.1608036525&jid=919056266&_v=5.7.2&z=265532343
Request Chain 200
  • https://sync.search.spotxchange.com/partner?source=dados HTTP 302
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=de90a433-3ed3-11eb-a754-15ce3e534d06
Request Chain 211
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D HTTP 302
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Request Chain 212
  • https://id5-sync.com/i/167/9.gif?gdpr=&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/167/0/9/1.gif?gdpr=1&gdpr_consent= HTTP 302
  • https://ice.360yield.com/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMO6tA3QNYViPdwxqXlM7pRwmnB91HmAtL0p2oNRg&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F167%2F124%2F8%2F2.gif%3Fpuid%3D%7BPUB_USER_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://ice.360yield.com/ul_cb/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMO6tA3QNYViPdwxqXlM7pRwmnB91HmAtL0p2oNRg&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F167%2F124%2F8%2F2.gif%3Fpuid%3D%7BPUB_USER_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/cq/167/124/8/2.gif?puid=1d8dd5a5-48ae-4ede-8ff4-0b58c8740c50&gdpr=1&gdpr_consent=&gdpr=1&gdpr_consent= HTTP 302
  • https://sync.crwdcntrl.net/map/c=13953/tp=IDFI/gdpr=1/gdpr_consent=?https://id5-sync.com/c/167/19/7/3.gif?puid=${profile_id}&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/167/19/7/3.gif?puid=b8757e1265bd76128ab1634229ce863a&gdpr=1&gdpr_consent= HTTP 302
  • https://ads.creative-serving.com/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F101%2F6%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/167/101/6/4.gif?puid=c09025a4-3ce0-4ccf-aa9e-425c20b4837e&gdpr=1&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F108%2F5%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F108%2F5%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/167/108/5/5.gif?puid=dfe301f4-3ed3-11eb-a599-e2dd7f45358e&gdpr=1&gdpr_consent= HTTP 302
  • https://ads.avocet.io/getuid?url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F4%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 301
  • https://ads.avct.cloud/getuid?r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F4%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://ads.avct.cloud/getuid?bounce=true&r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F4%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/167/146/4/6.gif?puid=acaaa0c8-2a7a-4890-bbea-931320f979cb&gdpr=1&gdpr_consent=
Request Chain 221
  • https://pr-bh.ybp.yahoo.com/sync/appnexusprebidserver/?gdpr=0&euconsent=&us_privacy=&url=https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dbrightroll%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24UID HTTP 302
  • https://ib.adnxs.com/prebid/setuid?bidder=brightroll&gdpr=0&gdpr_consent=&uid=y-wPf9RO51lxbqnPJgiGb0zMM0bDiELEJLhaAaxcungM9JDgUuJ0BB_.0-
Request Chain 225
  • https://r.skimresources.com/api/ HTTP 307
  • https://r.skimresources.com/api/?xguid=01ESK74ATS6N9SWYC3BV06G4AP&persistence=1&checksum=e4f9793094f15d319101de2a54d6ee9ced3dc890dc276ab94659cec811174d68
Request Chain 262
  • https://sync.crwdcntrl.net/map/c=10924/tp=OOLA/tpid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Request Chain 263
  • https://rtb.mfadsrvr.com/sync?ssp=taboola HTTP 302
  • https://rtb.mfadsrvr.com/ul_cb/sync?ssp=taboola HTTP 302
  • https://sync.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=dfac0f09-7b02-45bd-9865-aa7db649c705 HTTP 302
  • https://match.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=dfac0f09-7b02-45bd-9865-aa7db649c705&tbid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&query=taboola_hm%3Ddfac0f09-7b02-45bd-9865-aa7db649c705&isDirect=0
Request Chain 265
  • https://bh.contextweb.com/bh/rtset?pid=562107&ev=1&rurl=https%3A%2F%2Fsync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=%%VGUID%%&orig=trc HTTP 302
  • https://sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=NF7WK0yOs2i7&ev=1&orig=trc&pid=562107
Request Chain 269
  • https://aa.agkn.com/adscores/g.pixel?sid=9212237748&puid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c HTTP 302
  • https://trc.taboola.com/sg/neustar/1/cm?taboola_hm=164970703636000653469
Request Chain 270
  • https://i.liadm.com/s/32441?bidder_id=88068&bidder_uuid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c HTTP 303
  • https://i.liadm.com/s/32441?bidder_id=88068&bidder_uuid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_li_chk=true&previous_uuid=7d9ade16903e4d9f9839cf862cb8c597 HTTP 303
  • https://i6.liadm.com/s/32441?bidder_id=88068&bidder_uuid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Request Chain 271
  • https://pixel.onaudience.com/?partner=137085097&mapped=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c HTTP 302
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=xksw9la&ttd_tpi=1 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=xksw9la&ttd_tpi=1 HTTP 302
  • https://pixel.onaudience.com/?partner=147&mapped=756bd07b-da9f-4519-81af-bb93a5ce71b6&icm HTTP 302
  • https://sync.crwdcntrl.net/map/c=8587/tp=CLOD?https%3A%2F%2Fpixel.onaudience.com%2F%3Fpartner%3D104%26icm%26mapped%3D%24%7Bprofile_id%7D HTTP 302
  • https://pixel.onaudience.com/?partner=104&icm&mapped=b8757e1265bd76128ab1634229ce863a
Request Chain 273
  • https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_cm&google_sc HTTP 302
  • https://trc.taboola.com/sg/google-network/1/rtb-h/?taboola_hm=CAESEKbcyJrl95BxMcRtbC_wd94&google_cver=1
Request Chain 275
  • https://ml314.com/utsync.ashx?eid=50077&et=0&fp=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&return=https%3a%2f%2fidsync.rlcdn.com%2f395886.gif%3fpartner_uid%3d%5bPersonID%5d HTTP 302
  • https://idsync.rlcdn.com/395886.gif?partner_uid=3615253859167895625 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTMzYxNTI1Mzg1OTE2Nzg5NTYyNRAAGg0IsOHi_gUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=22a6ad8e161b85079896f268e0670ce6647ddb1005e9c0165d3f112159e41947f4cb09cee1a4f8eb&person_id=3615253859167895625&eid=50082
Request Chain 276
  • https://sync.taboola.com/sg/google-network/1/rtb?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dtaboola_dbm%26google_sc%26gdpr%3D0%26gdpr_consent%3D&orig=trc HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_sc&gdpr=0&gdpr_consent=&google_hm=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Request Chain 277
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=054f32o&ttd_tpi=1 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=054f32o&ttd_tpi=1 HTTP 302
  • https://trc.taboola.com/sg/thetradedesk-network/1/rtb-h/?taboola_hm=756bd07b-da9f-4519-81af-bb93a5ce71b6
Request Chain 278
  • https://ce.lijit.com/merge?pid=42&3pid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&us_privacy=&gdpr=0&gdpr_consent= HTTP 302
  • https://ce.lijit.com/merge?pid=42&3pid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&us_privacy=&gdpr=0&gdpr_consent=&dnr=1
Request Chain 280
  • https://www.storygize.net/ccm/4b560cdd-91f9-422b-adb7-e9dff26bc3ad?u=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c HTTP 302
  • https://sync.taboola.com/sg/storygize-network/1/rtb-h?taboola_hm=37cf273d-6031-4a9e-b4c2-17b86d952301
Request Chain 284
  • https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c HTTP 302
  • https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&cs=1
Request Chain 285
  • https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c HTTP 302
  • https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&xl8blockcheck=1
Request Chain 286
  • https://dis.criteo.com/dis/usersync.aspx?r=29&p=282&cp=taboolaortb&cu=1&url=https%3A%2F%2Fsync-t1.taboola.com%2Fsg%2Fcriteortb-network%2F1%2Frtb-h%2F%3Ftaboola_hm%3D%40%40CRITEO_USERID%40%40 HTTP 302
  • https://sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/?taboola_hm=93d2da82-af3b-4ee8-9308-b0f68c7b854c
Request Chain 288
  • https://id5-sync.com/s/464/9.gif?puid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&gdpr=0&gdpr_consent=&callback=https%3A%2F%2Fsync.taboola.com%2Fsg%2Fid5-network%2F1%2Frtb-h%2F%3Ftaboola_hm%3D%7BID5UID%7D HTTP 302
  • https://id5-sync.com/c/464/464/7/1.gif?puid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&gdpr=1&gdpr_consent= HTTP 302
  • https://ice.360yield.com/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMO5fexWetOj-d8VxjB-SIDrzkh2U9KCoF8riX9QQ&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F464%2F124%2F6%2F2.gif%3Fpuid%3D%7BPUB_USER_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://ice.360yield.com/ul_cb/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMO5fexWetOj-d8VxjB-SIDrzkh2U9KCoF8riX9QQ&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F464%2F124%2F6%2F2.gif%3Fpuid%3D%7BPUB_USER_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/cq/464/124/6/2.gif?puid=32e0a8e4-4532-4c65-a0f9-911fc13b4927&gdpr=1&gdpr_consent=&gdpr=1&gdpr_consent= HTTP 302
  • https://sync.crwdcntrl.net/map/c=13953/tp=IDFI/gdpr=1/gdpr_consent=?https://id5-sync.com/c/464/19/5/3.gif?puid=${profile_id}&gdpr=1&gdpr_consent= HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=13953/tp=IDFI/gdpr=1/gdpr_consent=?https://id5-sync.com/c/464/19/5/3.gif?puid=${profile_id}&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/464/19/5/3.gif?puid=b8757e1265bd76128ab1634229ce863a&gdpr=1&gdpr_consent= HTTP 302
  • https://ads.creative-serving.com/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F101%2F4%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://ads.creative-serving.com/ul_cb/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F101%2F4%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/464/101/4/4.gif?puid=1ffe5f45-8d53-444d-987d-373a6dc53240&gdpr=1&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F108%2F3%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F108%2F3%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_consent= HTTP 302
  • https://id5-sync.com/c/464/108/3/5.gif?puid=e1b37c33-3ed3-11eb-984f-2ace66be1f57&gdpr=1&gdpr_consent= HTTP 302
  • https://ads.avocet.io/getuid?url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F2%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 301
  • https://ads.avct.cloud/getuid?r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F2%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://ads.avct.cloud/getuid?bounce=true&r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F2%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D HTTP 302
  • https://id5-sync.com/c/464/146/2/6.gif?puid=acaaa0c8-2a7a-4890-bbea-931320f979cb&gdpr=1&gdpr_consent=
Request Chain 289
  • https://s.c.appier.net/taboola HTTP 302
  • https://sync.taboola.com/sg/appierrtb-network/1/rtb-h?taboola_hm=w0qjRnFhA4iB9jjds7DYXw
Request Chain 290
  • https://pixel.advertising.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1 HTTP 302
  • https://pixel.advertising.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1&verify=true HTTP 302
  • https://ups.analytics.yahoo.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1&apid=UPe17b2eaa-3ed3-11eb-a111-065bccc7e89e HTTP 302
  • https://ups.analytics.yahoo.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1&apid=UPe17b2eaa-3ed3-11eb-a111-065bccc7e89e&verify=true
Request Chain 293
  • https://x.bidswitch.net/sync?ssp=taboola&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.smadex.com/sync?sm_did=bds&bds_ssp_id=taboola&bds_param=f644313d-5c9b-496a-98b0-21d748a69350 HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=340&user_id=e0d5220c-1391-4c16-872e-57b645103fee&expires=10&ssp=taboola&bsw_param=f644313d-5c9b-496a-98b0-21d748a69350 HTTP 302
  • https://sync-t1.taboola.com/sg/bidswitch-network/1/rtb-h?taboola_hm=f644313d-5c9b-496a-98b0-21d748a69350
Request Chain 331
  • https://sync.search.spotxchange.com/partner?source=dados HTTP 302
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=e2c02f16-3ed3-11eb-a489-1f6fc1874306
Request Chain 351
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 354
  • https://dmp.adform.net/serving/cookie/match/?party=1001&cid=612561e1-b6af-4af8-9302-cfd9ad491e75 HTTP 302
  • https://dmp.adform.net/serving/cookie/match/?CC=1&party=1001&cid=612561e1-b6af-4af8-9302-cfd9ad491e75 HTTP 302
  • https://audex.userreport.com/sync/put/adform?adfusr=2560869188276099566
Request Chain 394
  • https://cm.g.doubleclick.net/pixel?google_nid=permutive_dmp&google_cm&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=8ae168bc-50cf-4fd5-aa08-6b927e71518c HTTP 302
  • https://googlesync.permutive.com/v2.0/px/sync?alias=CAESELhJCqdGkLSnc1gDOhVCFVs&error=&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=8ae168bc-50cf-4fd5-aa08-6b927e71518c&google_cver=1
Request Chain 395
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Faud.pubmatic.com%2FAdServer%2FArtemis%3Fdpid%3D267%26segid%3D10277 HTTP 302
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Faud.pubmatic.com%2FAdServer%2FArtemis%3Fdpid%3D267%26segid%3D10277 HTTP 302
  • https://aud.pubmatic.com/AdServer/Artemis?dpid=267&segid=10277
Request Chain 417
  • https://eb2.3lift.com/sync HTTP 302
  • https://eb2.3lift.com/sync?&ld=1
Request Chain 420
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D HTTP 302
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Request Chain 428
  • https://sync-tm.everesttech.net/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent= HTTP 302
  • https://sync-tm.everesttech.net/ct/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr HTTP 302
  • https://pixel.advertising.com/ups/55986/sync?uid=X9iwtQAAALpUgSzr&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr HTTP 302
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwtQAAALpUgSzr&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86 HTTP 302
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwtQAAALpUgSzr&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86&verify=true
Request Chain 429
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adaptv&ttd_tpi=1 HTTP 302
  • https://pixel.advertising.com/ups/55953/sync?uid=756bd07b-da9f-4519-81af-bb93a5ce71b6&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=756bd07b-da9f-4519-81af-bb93a5ce71b6
Request Chain 430
  • https://ssum.casalemedia.com/usermatchredir?s=185638&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D HTTP 302
  • https://mfad.inskinad.com/udb/9874/sync/i.gif?partnerId=1&userId=X9iws7niHq6YTPQ3bBMqvgAA%261162
Request Chain 431
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true HTTP 302
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&verify=true HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86 HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86&verify=true HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=adaptv_dbm&google_cm&google_hm=VVBlMmY3NmVhYi0zZWQzLTExZWItYTYxMS0wNjljZmQxYjZlODY%3D HTTP 302
  • https://pixel.advertising.com/ups/57304/sync?uid=CAESEHtsl8YElh_NAhXjwjiB5TQ&google_cver=1 HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEHtsl8YElh_NAhXjwjiB5TQ&google_cver=1&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86
Request Chain 432
  • https://x.bidswitch.net/sync?ssp=themediagrid HTTP 302
  • https://pixel.quantserve.com/pixel/p-zLwwakwy-hZw3.gif?idmatch=0&ssp=themediagrid&gdpr=&gdpr_consent= HTTP 302
  • https://x.bidswitch.net/sync?dsp_id=76&user_group=2&ssp=themediagrid&gdpr=1&user_id=EhOoYEVFrmgKR65pEUDhOkMRqm4KR6g5H0bz4jdY
Request Chain 433
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 449
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 468
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 498
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 581
  • https://s.adtelli.com/mc?c=vmuid%3A17522445236a9257&r2=hb.hb.selectmedia.asia HTTP 302
  • https://hb.hb.selectmedia.asia/mcd
Request Chain 582
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.ads.152media.com%2Fcsync%3Ft%3Da%26ep%3D285868%26extuid%3D%24UID HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%253A%252F%252Fsync.ads.152media.com%252Fcsync%253Ft%253Da%2526ep%253D285868%2526extuid%253D%2524UID HTTP 302
  • https://sync.ads.152media.com/csync?t=a&ep=285868&extuid=1434332830242018214
Request Chain 610
  • https://ads.stickyadstv.com/user-matching?id=11 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=MTVkYTFlYmY2NDUxZWJjOWMyN2JkZWY4MWQyYTA2ZQ==&gdpr=0&gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=MTVkYTFlYmY2NDUxZWJjOWMyN2JkZWY4MWQyYTA2ZQ==&gdpr=0&gdpr_consent=&google_tc=
Request Chain 612
  • https://ads.stickyadstv.com/user-matching?id=2545 HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=cd13812ae7acf834110947fcc38a88b&ex=freewheel.tv&gdpr=0&gdpr_consent=
Request Chain 616
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 687
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adaptv&ttd_tpi=1 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=adaptv&ttd_tpi=1 HTTP 302
  • https://pixel.advertising.com/ups/55953/sync?uid=e8feca8b-7df7-47ac-9429-9f6b961e7756&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=e8feca8b-7df7-47ac-9429-9f6b961e7756
Request Chain 688
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true HTTP 302
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&verify=true HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e&verify=true HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=adaptv_dbm&google_cm&google_hm=VVBlYjdmYmE2OS0zZWQzLTExZWItYTExMS0wNjViY2NjN2U4OWU%3D HTTP 302
  • https://pixel.advertising.com/ups/57304/sync?uid=CAESEGMi23x308itW04Onv7Ii9w&google_cver=1 HTTP 302
  • https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEGMi23x308itW04Onv7Ii9w&google_cver=1&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
Request Chain 689
  • https://sync-tm.everesttech.net/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent= HTTP 302
  • https://sync-tm.everesttech.net/ct/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=&_test=X9iwwwAAAIX6IToG HTTP 302
  • https://pixel.advertising.com/ups/55986/sync?uid=X9iwwwAAAIX6IToG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwwwAAAIX6IToG HTTP 302
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwwwAAAIX6IToG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwwwAAAIX6IToG&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
Request Chain 705
  • https://www.google.com/pagead/drt/ui HTTP 302
  • https://googleads.g.doubleclick.net/pagead/drt/si
Request Chain 709
  • https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent= HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDM1ZWZmNzNhODRjYjQwZDc4OWRmZjRmNDg0YWFi&gdpr=0&gdpr_consent=
Request Chain 710
  • https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent= HTTP 302
  • https://s.amazon-adsystem.com/ecm3?id=d35eff73a84cb40d789dff4f484aab&ex=freewheel.tv&gdpr=0&gdpr_consent=
Request Chain 721
  • https://sync.search.spotxchange.com/partner?source=dados HTTP 302
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=eef7087d-3ed3-11eb-a9da-1ce730eb0606

697 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc3...
info.silobreaker.com/e2t/tc/
9 KB
3 KB
Document
General
Full URL
https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.60.103.2 , Canada, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., GB),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

:method
GET
:authority
info.silobreaker.com
:scheme
https
:path
/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-type
text/html;charset=utf-8
set-cookie
__cfduid=d7d7ed22e3c00a9b46d256680949c81cc1608036523; expires=Thu, 14-Jan-21 12:48:43 GMT; path=/; domain=.info.silobreaker.com; HttpOnly; SameSite=Lax __cfruid=465d35eef865c775e4ba9bc7db05c363b187ab91-1608036523; path=/; domain=.info.silobreaker.com; HttpOnly; Secure; SameSite=None
cf-ray
602047cef9790c29-AMS
vary
Accept-Encoding
cf-cache-status
MISS
access-control-allow-credentials
false
cf-request-id
07080b355e00000c297b098000000001
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
referrer-policy
no-referrer
server
cloudflare
content-encoding
br
Primary Request Remdesivir-beneficial-patients-doctors-reveal.html
www.dailymail.co.uk/sciencetech/article-9050821/
Redirect Chain
  • https://info.silobreaker.com/events/public/v1/track/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2Kv...
  • https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzME...
421 KB
83 KB
Document
General
Full URL
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
7e0c9ce526962871dad05e19f9566a433669fb0381deca6e8ca081f99e24b377

Request headers

:method
GET
:authority
www.dailymail.co.uk
:scheme
https
:path
/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1

Response headers

content-type
text/html;charset=UTF-8
set-cookie
x-loc=none; path=/ percent=427318;Max-Age=31536000;path=/;HttpOnly;Secure ak_bmsc=C739AD3B78C300D7D1189485A60499AA0210BA8558510000ABB0D85FBD284268~plGQKl2fgYKrmdglzicp4iQbX0tpOdlj8ZJJ3y+mC7YHXHiy2F9XcqgpxBO83b+1JOPGIwYa8xamZYdXCZu1GaK3Yj3UG+g3VIBCvntkQ9cCF/i9CKkq3LSjIan01wltww1jcdfzkvmcyHLlLB02w+TAVELUGSa8eVtfzu/jgxjawXF4/ahnMpydY/Y9Myi65Doj8lBWGPzESgRqvOkg/1nEnuHdA3W5tUNSZJ0B23jMm0rYdkYHc542yxLMSwbKjr; expires=Tue, 15 Dec 2020 14:48:43 GMT; max-age=7200; path=/; domain=.dailymail.co.uk; HttpOnly AKA_A2=A; expires=Tue, 15-Dec-2020 13:48:43 GMT; path=/; domain=dailymail.co.uk; secure; HttpOnly
x-rs-ctime
240
vary
User-Agent Accept-Encoding
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
edge; dur=1 cdn-cache; desc=HIT
x-graced
false
x-mol-georesp
de
x-rs-time
Tue, 15 Dec 2020 12-45-00 GMT
x-rs-ops
varnish-web-a3-fe:6081
restarts
0
x-rs-ben
cljfe-b10:8181
x-storage
newarticles
x-akamai-transformed
9 426188 0 pmb=mRUM,2
content-encoding
gzip
cache-control
max-age=17
date
Tue, 15 Dec 2020 12:48:43 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:48:43 GMT
location
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
cf-ray
602047cfbb270c29-AMS
link
<https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4>; rel="canonical"
vary
Accept-Encoding
cf-cache-status
MISS
access-control-allow-credentials
false
cf-request-id
07080b35d700000c29d3bce000000001
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
referrer-policy
no-referrer
x-robots-tag
none
server
cloudflare
gpt.js
www.googletagservices.com/tag/js/
54 KB
19 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
678c16283762d2d1a12c9b055cf3e4333ca3c4c6638a95741f1130084882756f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"724 / 783 of 1000 / last-modified: 1608034737"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
18850
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:43 GMT
desktop.css
www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/
152 KB
93 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
8f9584b90be33bd7c46ca2521386b57de0bf7094d3f2a56b5b44111fbd094c85

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
94448
last-modified
Wed, 18 Nov 2020 15:16:49 GMT
server
Akamai Resource Optimizer
etag
"625d215ccc396c317248be2f901b6985:1605708288.604204"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=268151
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Fri, 18 Dec 2020 15:17:54 GMT
articleDefer.css
www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/
337 KB
84 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
2ad40955d26fc1042906d8322388080b9d8270019faf5527b6a4771f606693e9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
85293
last-modified
Thu, 19 Nov 2020 11:13:34 GMT
server
Akamai Resource Optimizer
etag
"580b61c7613c627e32a5ecb1622eb576:1605783253.249572"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=339860
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Sat, 19 Dec 2020 11:13:03 GMT
all--.css
www.dailymail.co.uk/static/gunther/17.14.0/
267 KB
34 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
d43ac5826a74f4e5dcd9435aabe994b89a7e2030babd441463c621e96eec0375

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
34267
last-modified
Sun, 09 Aug 2020 02:32:46 GMT
server
Akamai Resource Optimizer
etag
"e391873d0754fa60110c5299203d6f76:1595000955.065137"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=827075
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Fri, 25 Dec 2020 02:33:18 GMT
all1--.css
www.dailymail.co.uk/static/gunther/17.14.0/
55 KB
10 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.14.0/all1--.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
62e5b5020499d0dbd26922152f199b559ee4922d9132b4242364edf88dc63121

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
10119
last-modified
Wed, 07 Oct 2020 10:21:44 GMT
server
Akamai Resource Optimizer
etag
"2456679cc8c0c996054aec3c292d82d0:1595000965.438073"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=1287343
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Wed, 30 Dec 2020 10:24:26 GMT
mol-adverts.desktop.css
www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/
21 KB
5 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.desktop.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
6ffcbf498d2e35c180533fd7a7147f65d54b32d57e4f515ad6539270fe15f793

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Tue, 15 Dec 2020 10:14:10 GMT
server
Akamai Resource Optimizer
etag
"d5134761ae4c470e63d2d30514182609:1608027086.092035"
vary
User-Agent
content-type
text/css
cache-control
max-age=2582740
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
content-length
4443
expires
Thu, 14 Jan 2021 10:14:23 GMT
registration--.css
www.dailymail.co.uk/static/gunther/17.13.0/
25 KB
5 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.13.0/registration--.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
03482ceb4519a7706406f47e5992b55e9e5974abd56c45af482a7e1a09d836e6

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
4945
last-modified
Thu, 05 Nov 2020 20:02:24 GMT
server
Akamai Resource Optimizer
etag
"1d7a19f1f78591a33d5ec97dd91f96b4:1593164448.110325"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=1494925
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Fri, 01 Jan 2021 20:04:08 GMT
rc-main--.css
www.dailymail.co.uk/static/gunther/17.14.0/
19 KB
5 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
ee80e2de5c026fa3c0786f587eed85d1521d50ba1aba027c2b0714c108c351a6

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
4321
last-modified
Mon, 09 Nov 2020 16:23:48 GMT
server
Akamai Resource Optimizer
etag
"02c739164733a3164294a8737f313c36:1595000956.467317"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=677081
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Wed, 23 Dec 2020 08:53:24 GMT
fff.css
www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/styles/
46 KB
8 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/styles/fff.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
01ae4bee7f4b463778e1e929d83b4eedcaf598d05ae8e748030259b5b5f0b083

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
7921
last-modified
Sat, 24 Oct 2020 12:52:26 GMT
server
Akamai Resource Optimizer
etag
"cf69bb0d655c656383a84adc6fe705c6:1560175753"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=432454
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Sun, 20 Dec 2020 12:56:17 GMT
v-0.56.min.js
www.dailymail.co.uk/rta2/
15 KB
5 KB
Script
General
Full URL
https://www.dailymail.co.uk/rta2/v-0.56.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
7a08a60be43dea8a9d5999a3dac0aa2a72456c2ba1cf11e7763502ac84d99129

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
x-check-cacheable
YES
server
Akamai Resource Optimizer
etag
"59974d80c74b04ca65798afd2166fe6c:1604075542.494144"
vary
User-Agent
content-type
application/x-javascript
cache-control
max-age=1821486
last-modified
Mon, 09 Nov 2020 14:46:45 GMT
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
content-length
5023
expires
Tue, 05 Jan 2021 14:46:49 GMT
desktop.js
www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/
357 KB
89 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
38bd596c19e49a9f4ddf96fe1592220458baf48f4ecb6398c7efa237fefcb917

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:43 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
90729
last-modified
Wed, 18 Nov 2020 15:01:29 GMT
server
Akamai Resource Optimizer
etag
"028ef1f0a228d430a58072914d37cc73:1605708286.990279"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=267160
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Fri, 18 Dec 2020 15:01:23 GMT
mol-adverts.js
www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/
1 MB
321 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
3623b3438c9edda2eb78d592ba39d5e9a62100c2d0d50df2fed3eb2c5649216f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
vary
Accept-Encoding, User-Agent
last-modified
Tue, 15 Dec 2020 10:11:28 GMT
server
AkamaiNetStorage
etag
"b5814f41264682f7e322bc33e37f5c2e:1608027088.487051"
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
content-type
application/x-javascript
cache-control
max-age=794
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
content-length
327643
expires
Tue, 15 Dec 2020 13:01:58 GMT
articleDefer.js
www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle//6.18.1/
501 KB
116 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle//6.18.1/articleDefer.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
91339a18fd1dccf876d2c33a52bbf4913c9bf61c802ff5dea3d2246824d69799

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
117700
last-modified
Thu, 19 Nov 2020 11:11:42 GMT
server
Akamai Resource Optimizer
etag
"5246a0c538708cb10b2613fba743d79c:1605783222.595748"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=340696
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Sat, 19 Dec 2020 11:27:00 GMT
async_bundle--.js
www.dailymail.co.uk/static/gunther/17.14.0/
328 KB
84 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/gunther/17.14.0/async_bundle--.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
0c7912ff68380c2a84d28cf812215fb6d230d5750f9f67b328970e01d0da5a37

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=2
content-length
85559
last-modified
Fri, 18 Sep 2020 02:58:02 GMT
server
Akamai Resource Optimizer
etag
"0620d2935cb03d1451a72e524963ba2d:1595000960.633166"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=1952043
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Thu, 07 Jan 2021 03:02:47 GMT
ima3.js
imasdk.googleapis.com/js/sdkloader/
316 KB
109 KB
Script
General
Full URL
https://imasdk.googleapis.com/js/sdkloader/ima3.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b14abfd75835ce63eab33192177d25b5601c61cf583f5063c793d598e5500282
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
111414
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:44 GMT
mol-fe-videoplayer.min.css
www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/styles/
90 KB
11 KB
Stylesheet
General
Full URL
https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/styles/mol-fe-videoplayer.min.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
c64308e6ed3ab4dc8c78868174040d8d09546ea9e6ab19682285a675897edc98

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
10681
last-modified
Sun, 13 Dec 2020 23:24:47 GMT
server
Akamai Resource Optimizer
etag
"62426632e135cbbb9a89d534c68e342c:1607900148.714095"
vary
User-Agent
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2499366
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Wed, 13 Jan 2021 11:04:50 GMT
mol-fe-videoplayer.min.js
www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/
449 KB
101 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/mol-fe-videoplayer.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
5a21c893e4b3515483af9b313ef5ef75526924e820e0a7e42b307b9d697a739d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
102455
last-modified
Sun, 13 Dec 2020 23:13:37 GMT
server
Akamai Resource Optimizer
etag
"b2b367f122790c9ffa0832b6b0088133:1607900147.197028"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=2456647
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Tue, 12 Jan 2021 23:12:51 GMT
logo_mol.gif
i.dailymail.co.uk/i/sitelogos/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/sitelogos/logo_mol.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
f17cf1cb73dc13f928ef0122375fe550926a471e46d614199bfe8ef69733437a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Tue, 09 Dec 2008 12:49:57 GMT
server
Apache
etag
"258fb3209febe558120d7d564d7422b1:1228827055"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3918
expires
Thu, 14 Jan 2021 12:48:44 GMT
DailyMail.png
i.dailymail.co.uk/i/furniture/facebook/DailyMail/
5 KB
6 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/facebook/DailyMail/DailyMail.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
706822fd264da6a7ad6e9763da53c45c0be08913fc51b77a33bad1b4d572c939

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Sun, 13 Sep 2020 22:57:02 GMT
server
AkamaiNetStorage
etag
"548b0c6a06ae3744bb1f7567824037ac:1600037822.614521"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
5504
expires
Thu, 14 Jan 2021 12:48:44 GMT
btn_add-your-comment.png
i.dailymail.co.uk/i/furniture/comments/articles/
1 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/comments/articles/btn_add-your-comment.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
b6849b99c9da8c60aec9d8fcad58817ef0aabe354e6f9194f24b7e68df71f41a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Mon, 06 Nov 2017 11:57:22 GMT
server
AkamaiNetStorage
etag
"35cf287579c56cfa1b37c7d845558128:1509969442"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
1349
expires
Thu, 14 Jan 2021 12:48:44 GMT
icon_comments_74.png
i.dailymail.co.uk/i/furniture/comments/articles/
517 B
723 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/comments/articles/icon_comments_74.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
10d217fc2d14b793dd2acba83780093ff88896b4433f7eb36bfc4a220f78350f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Tue, 28 Feb 2017 12:52:27 GMT
server
Apache
etag
"a85bf8e29331cd62725b2bb16387eb8d:1488286347"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
517
expires
Thu, 14 Jan 2021 12:48:44 GMT
index.css
scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-vouchercodes/3.1.1/
12 KB
2 KB
Stylesheet
General
Full URL
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-vouchercodes/3.1.1/index.css
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
100b3faacb4f5fc346251921b1eaf802e9948e497f182783af0e35f9961863bc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
last-modified
Thu, 14 May 2020 08:52:39 GMT
server
AkamaiNetStorage
etag
"df0637b2a64b87b6cfd4be29c11c324f:1589446359"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
content-length
1839
expires
Thu, 14 Jan 2021 12:48:44 GMT
pixel
ads.creative-serving.com/ul_cb/
Redirect Chain
  • https://ads.creative-serving.com/pixel?id=3140889
  • https://ads.creative-serving.com/ul_cb/pixel?id=3140889
43 B
589 B
Image
General
Full URL
https://ads.creative-serving.com/ul_cb/pixel?id=3140889
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.196.214.144 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-196-214-144.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Content-Length
43
Content-Type
image/gif

Redirect headers

Location
https://ads.creative-serving.com/ul_cb/pixel?id=3140889
Date
Tue, 15 Dec 2020 12:48:44 GMT
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Length
0
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
wire-36666038-1607567496-261_87x84.jpg
i.dailymail.co.uk/1s/2020/12/10/02/
3 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/10/02/wire-36666038-1607567496-261_87x84.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9ed0d9a45e3ce3a37a3a1fe1470e618951b0d23ed8336659b5be77669641d49e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
ZTPOwFt1PFI_XyuFbZMpT3NKCGUYLzRV
last-modified
Thu, 10 Dec 2020 02:31:38 GMT
server
AmazonS3
x-amz-request-id
BD8B74432BD57F45
etag
"47bece4065442ee10b4718f1c8a1220a"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3439
x-amz-id-2
9Npndf74WUREeItK8LNXQXyixun+KZzJf94JrkA5lrO2COTqlZCjHaywNvWscePgftqBqrO3QyA=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36828172-0-image-a-8_1607963389043.jpg
i.dailymail.co.uk/1s/2020/12/14/16/
5 KB
5 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/16/36828172-0-image-a-8_1607963389043.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
b6c4a7a76de5efeb8579ffe542573f66295ee8f233885bc79e62b9f29b848d32

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
xzINNqTsyAdnp4jKh0qvh0snfjfQfpPL
last-modified
Mon, 14 Dec 2020 16:29:54 GMT
server
AmazonS3
x-amz-request-id
382E610E6F94EFCE
etag
"fa7f26c2294de79dc7e16dd96682233e"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4952
x-amz-id-2
yD4HbHGNPAcTvjs/9ttBaRyCcUlWwsJiuntEwez/T6Y583X00EGd6nemAHwH6hckeRtRoUjIr+0=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36836578-0-image-a-23_1607978667726.jpg
i.dailymail.co.uk/1s/2020/12/14/20/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/20/36836578-0-image-a-23_1607978667726.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
85a792a4e3c1db0df263a1c5bc2b80c091846cacd77dc8cb997af68760081919

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
dvqVMx7DMwTJIzxlDQfCLtwwpcbhIxZC
last-modified
Mon, 14 Dec 2020 20:44:29 GMT
server
AmazonS3
x-amz-request-id
0D7AE6067352E289
etag
"89fc6eeb7888432d387cfe8a25f3c4df"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4208
x-amz-id-2
C1sJSXHarO+IausYutiy5Ixx7wOwSQCozytiUaujHX8yLIXWAiwMYTecDeARTZty1/P99rh5Zgc=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36837444-0-image-a-7_1607977577625.jpg
i.dailymail.co.uk/1s/2020/12/14/20/
5 KB
5 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/20/36837444-0-image-a-7_1607977577625.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
bd05ac1e6cf11ec9d57182c0773eb218ec1983e49eba75f4fbc47a853de3006c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
ECtteOstVZRe3IYCW8F2e2QfWTJryMMu
last-modified
Mon, 14 Dec 2020 20:26:21 GMT
server
AmazonS3
x-amz-request-id
A22B8AB0A64D3321
etag
"66d926836ad0ba945afcc4cca573b0d2"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4638
x-amz-id-2
4VYxIAcIypcQHeuZZT8i2JnEHLxIJOLN+E/Lko+joVejC0Q1lQ+O1S1dUGaXk+4Yg3qQQOtvZ3w=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36830554-0-image-m-29_1607965874299.jpg
i.dailymail.co.uk/1s/2020/12/14/17/
3 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/17/36830554-0-image-m-29_1607965874299.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
cd74edb32efde8fe026b88cc510296e7d7988274d731561c3fd61caebd825e9b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
X5zChIBWsg.rSkYy3Mudm01ly.xdXcDB
last-modified
Mon, 14 Dec 2020 17:11:23 GMT
server
AmazonS3
x-amz-request-id
6FD2E89F01EDDBC3
etag
"ea910fb9bbb9f01970eab6c8e00218e0"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3397
x-amz-id-2
p1lMSitFSLkosr01zo/eox9hAkY8uLIMPNUo35cHxxbL8RA4cBCcb6DBpfroXvovz4ug6PMIEeo=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36831966-0-image-a-16_1607966538962.jpg
i.dailymail.co.uk/1s/2020/12/14/17/
2 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/17/36831966-0-image-a-16_1607966538962.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
23dd4feae622db63eacd52142fbde329e221ddc51b8f6586ba50a98bc3da64c5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
RoQYTbpXMhdolmpqIb1okt.Ga6nu30o.
last-modified
Mon, 14 Dec 2020 17:22:20 GMT
server
AmazonS3
x-amz-request-id
AF29C53BE9412AA6
etag
"f716c05556c5158849b774b16e67ea41"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2085
x-amz-id-2
Dpap/13aEgBJqr1MR1z+Lj1aCf6/5z7SGPUeRU++SI0eo7vBXupPxlXqjlAXriAg7WYxgy4G4Pc=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36822432-0-image-a-7_1607951289791.jpg
i.dailymail.co.uk/1s/2020/12/14/13/
3 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/13/36822432-0-image-a-7_1607951289791.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
e9d3f78a91e7a061e841d8df627f663327abddc894c843efca7136e670f579dc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
hFpJzCMF0ZljmQAIySe0Jt09Awv0MMMV
last-modified
Mon, 14 Dec 2020 13:08:10 GMT
server
AmazonS3
x-amz-request-id
EB4356398E7F98BF
etag
"c749349eec6322d882c52b5a2bec523f"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3228
x-amz-id-2
EXxeXcdp0CmxrDGQAByidMcOwLGtHOWQRtoD/8mcPri+7fy8nn3v2Si5lTCOzwd7riglG2m764U=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36830970-0-image-m-14_1607964912819.jpg
i.dailymail.co.uk/1s/2020/12/14/16/
1 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/16/36830970-0-image-m-14_1607964912819.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
4c3f356fde98236d17b8b57d7fd036f2f8b271380b0b55db958ebc34ef7517be

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
mmwWwDZ1pgKtO.3S0KcosW7o2IgHDz.T
last-modified
Mon, 14 Dec 2020 16:55:18 GMT
server
AmazonS3
x-amz-request-id
C88FAE0C70F273E9
etag
"11ea6fa17b2fd187cb48a1dbd889d430"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
1355
x-amz-id-2
3cmDFLArYtXYkh/WtWHkOIhxyHD9b11WODITOugNl5qOUcrWg7+Mp+ECWSJRuuFfnWWTSo55APM=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36833232-0-image-m-4_1607968512524.jpg
i.dailymail.co.uk/1s/2020/12/14/17/
3 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/17/36833232-0-image-m-4_1607968512524.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
255fedf22da697ef2b26db0b3ab414d109d0b9982135378e925565e69d3bfc5b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
Dtk0j6x9qislDZ.7VYcXxRDy8Kwf.Pkv
last-modified
Mon, 14 Dec 2020 17:55:25 GMT
server
AmazonS3
x-amz-request-id
01C0580D76E527BA
etag
"ba8c705f46322c750604d4e1187e55c8"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3578
x-amz-id-2
iDe/DI8VH8tyGtpMpvDtkTfD2ELSiTyH9hCo+5SyFmvsrWv9RALTH3j4grjffGIREvPgjyP3wRM=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36828788-0-image-m-22_1607961742756.jpg
i.dailymail.co.uk/1s/2020/12/14/16/
2 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/16/36828788-0-image-m-22_1607961742756.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
c503edc50146e501269d073b7bd9c28a31f20be7558c8287a6085c624993ad0a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
.wHFPELWUG6RWF2MpSh0e1Tdn7Pt0Kan
last-modified
Mon, 14 Dec 2020 16:02:29 GMT
server
AmazonS3
x-amz-request-id
9FB86E27FCD68660
etag
"c605f9ae56edf3dda4a0f3140f9b1dbf"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2156
x-amz-id-2
J0BBgLcujOCUOC3rHQCthRc8as5n6zqWO1AUHVFE0e7+agRhXMcht1dHZsuk2tY29QXbExStEtY=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36830310-0-image-a-9_1607964220496.jpg
i.dailymail.co.uk/1s/2020/12/14/16/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/16/36830310-0-image-a-9_1607964220496.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
fb13088df0fc04523af2442780eec3f56cfd8e141ce62bbe36e00a893f2e1372

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
lCo470FfGBn6PJeEJDnTYyHLtvQZTfAo
last-modified
Mon, 14 Dec 2020 16:43:41 GMT
server
AmazonS3
x-amz-request-id
8668EC768BDD88FF
etag
"08ea1d30b95d71e562f3dee374ab493f"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2699
x-amz-id-2
LgrdMuxCXu2iu1DuueZl7qA1GzjiC6sEHf2puU+P4JXUft8WSSGys5rBQuy85y02ASrgri0lZw0=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36820590-0-image-m-9_1607949226305.jpg
i.dailymail.co.uk/1s/2020/12/14/12/
7 KB
7 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/12/36820590-0-image-m-9_1607949226305.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
196bd5161ac3b53b38293d9c18cae0ab1841bc58efe96a1ee28f1d559bed6b89

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
dxWQDDS0uPoTAFopQnZ3qDAHgHmXj_JN
last-modified
Mon, 14 Dec 2020 12:34:00 GMT
server
AmazonS3
x-amz-request-id
1DC0F24F47613B09
etag
"3318823d5ed0ee279e0d2bc715cea61f"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
6865
x-amz-id-2
0gxGiFIoExHiOMKQ8NmJnn9AucNsyBwLZk7s5WwBF7pwM7W/0B+kRMVZOmL7XF3Zoi2YJA1K9RU=
expires
Thu, 14 Jan 2021 12:48:44 GMT
33571772-0-There_was_more_activity_in_the_brains_of_newborn_babies_in_react-m-14_1607953109922.jpg
i.dailymail.co.uk/1s/2020/12/14/13/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/13/33571772-0-There_was_more_activity_in_the_brains_of_newborn_babies_in_react-m-14_1607953109922.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
cfe608e6487da8145e7e48a975cb6f5ebb858b05d5f96f3ffcf499bfba3a7ee9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
EG8U7bz25K5azOVw53OtVqBAndEid4CQ
last-modified
Mon, 14 Dec 2020 13:38:42 GMT
server
AmazonS3
x-amz-request-id
32183099A36BD7A7
etag
"f8a9b170f697b2dbaeac42b696f4030f"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2767
x-amz-id-2
jgkenUhIVCcIiFhuyPHnRJIK45NP3PChsKHAXE40Q5SmVL80rwq6Jv/dQJKzqJk8U3px38tta2w=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36820434-0-image-m-15_1607947303994.jpg
i.dailymail.co.uk/1s/2020/12/14/12/
2 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/12/36820434-0-image-m-15_1607947303994.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5232b69e435e6251aa60156bf9c0ec5b223005ad3f19265fdbc426decae2344c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
x.5g1HGYuzqz8TAGFr00TrBfZqq9O.Fk
last-modified
Mon, 14 Dec 2020 12:01:53 GMT
server
AmazonS3
x-amz-request-id
F747A17DC4A987F9
etag
"41b0f0d3e19cf4af12f8b25683d4e7bd"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2439
x-amz-id-2
/vxpW16B9uX19jdwr7J3Xjhh64n4vzWlSdrjf5KcXuiovEitEdXXbmuMOY2yMTv4rFSrcgTCPjM=
expires
Thu, 14 Jan 2021 12:48:44 GMT
36817660-0-image-m-5_1607942891119.jpg
i.dailymail.co.uk/1s/2020/12/14/10/
2 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/14/10/36817660-0-image-m-5_1607942891119.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
be9bd032888981008418da966f5f6dd986a9b491a54506dd1a7a308c3eaceaed

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
8LBIxNn6avhYU1TmTkCY0FmnU3RkyAwP
last-modified
Mon, 14 Dec 2020 10:48:17 GMT
server
AmazonS3
x-amz-request-id
D264CE7B22D5A034
etag
"15b81fb0232e88f606f8802374d84d29"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2404
x-amz-id-2
Q8wVkh2sOohDu0M6bD7SKS+rok52R5J7h7JLLP33RCN2H8AGLN8NZTvumS8LnWHhHGBfILCGrK0=
expires
Thu, 14 Jan 2021 12:48:44 GMT
iphone_ad_308x111.jpg
i.dailymail.co.uk/i/pix/promoboxes/
18 KB
18 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/promoboxes/iphone_ad_308x111.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
f744634b59058c2fa455853051f7d7cbea03c40a79a2c822e25a22cba5d82316

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Tue, 20 Dec 2011 15:43:09 GMT
server
AkamaiNetStorage
etag
"d0cc3541816686ffa19219c42f0bf076:1324395789"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
18253
expires
Thu, 14 Jan 2021 12:48:44 GMT
ebayUSandGermany_308x111.jpg
i.dailymail.co.uk/i/pix/ebay/
18 KB
18 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/ebay/ebayUSandGermany_308x111.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
19ee7648c66c9ee28c12dda0bf54e77586ca87c7e056d91d17cb7f45f4e11fd5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Tue, 21 Aug 2012 06:55:37 GMT
server
AkamaiNetStorage
etag
"c58f0f4aacc46b045e1aacd3dcbfd38e:1345532137"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
18143
expires
Thu, 14 Jan 2021 12:48:44 GMT
bn_michaelhanlon_308x76.jpg
i.dailymail.co.uk/i/pix/blogs/
14 KB
14 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/blogs/bn_michaelhanlon_308x76.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
aa42e91b61ad52d2fe90951063eb3926346fb39f42fcfd9722c44a0f076995a4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Tue, 15 Feb 2011 16:40:11 GMT
server
Apache
etag
"1f65f9cb53bdf8c92f6261d0c841b26f:1297788011"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
14387
expires
Thu, 14 Jan 2021 12:48:44 GMT
argos_9.png
d3tsytm1wtjqo2.cloudfront.net/180x/images/a/
3 KB
4 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/180x/images/a/argos_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:c000:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
a4d997cd946ba1053d2915c8d762ad2a650705d2b92c7ca4ddfc51337052cc24

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 13:37:44 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
83460
etag
"1d8a85982ac6f5d4058f8157b37565897502b868"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
AMS1-C1
content-length
3342
x-amz-cf-id
3qBzr_S7XNKxTSNZbd568g_hCOksQknyU3bWx5uR1bFCNztLW0wtvw==
expires
Tue, 15 Dec 2020 13:37:44 GMT
AO_9.png
d3tsytm1wtjqo2.cloudfront.net/images/media/72/a/
2 KB
2 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/images/media/72/a/AO_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:c000:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
466597f6c1aceaf97413759997defb334bf5ed7f70244ee967e5c9868ceee094

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 23:59:13 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
46171
etag
"d8c63d90b548f625706c2d42e013fdfdef7749c1"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
AMS1-C1
content-length
1662
x-amz-cf-id
HqPez0u2gaDiAwUoiLZUrhf5Inn_T_SkSQrzYIsJCLlYSoqba-MVpg==
expires
Tue, 15 Dec 2020 23:59:13 GMT
bq-discount-code_9.png
d3tsytm1wtjqo2.cloudfront.net/150x/images/b/
1 KB
2 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/150x/images/b/bq-discount-code_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:c000:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
f99c74752a26095daefffa7a738fc2b0de872c1bc7d302bd43bd208e30123be3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 23:53:57 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
46487
etag
"95906087f2aea3576c071b3539d7445f0c4eab15"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
AMS1-C1
content-length
1226
x-amz-cf-id
R47kPK8VGKRelVxdR0XJXTgCZOrIKf-Bi92SKlE-wOlmvlr3vITAXQ==
expires
Tue, 15 Dec 2020 23:53:57 GMT
ebayJAN2020logo_9.png
d3tsytm1wtjqo2.cloudfront.net/180x/images/e/
2 KB
2 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/180x/images/e/ebayJAN2020logo_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:c000:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
b1f18ada6ab967638a22a5311419ef4418ea1e9e18c848fa0aee688825dc49fa

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 00:14:18 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
45266
etag
"12234a02a53d66bb7be0279ea5c69c26160f2d6c"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
AMS1-C1
content-length
2138
x-amz-cf-id
U_dCUrBO_y1aSd4dRTSA5tAGYlHXRNytAINit4iolaej8A-e0y0X9g==
expires
Wed, 16 Dec 2020 00:14:18 GMT
verylogo_9.png
d3tsytm1wtjqo2.cloudfront.net/150x/images/v/
1 KB
2 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/150x/images/v/verylogo_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:c000:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
0c757241644e8278b2e3643da1277e023aa3189172cde6d36516fe5729247f5e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 23:53:57 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
46487
etag
"3c689fc65fdfb66a4397f98c184c7d09f621656b"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
AMS1-C1
content-length
1412
x-amz-cf-id
oBB5icu_CM2pfPw4lJ_elO4UroPdgpNt74-x9iXZEVdkYClHA9HCbA==
expires
Tue, 15 Dec 2020 23:53:57 GMT
wayfair-discount-code_9.png
d3tsytm1wtjqo2.cloudfront.net/180x/images/w/
2 KB
3 KB
Image
General
Full URL
https://d3tsytm1wtjqo2.cloudfront.net/180x/images/w/wayfair-discount-code_9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:c000:1:91d6:b080:21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.1 /
Resource Hash
f657f517ee764727ecc6e8d119035bb3e750a9680aaf7a533a33f2525cb0284c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 20:18:22 GMT
via
1.1 3ffec0ecfde687fb371812ad42f5cfc2.cloudfront.net (CloudFront)
server
nginx/1.12.1
age
59422
etag
"e2fe3865901182a19a0e804b803c15c5b0fff81f"
vary
Accept
x-cache
Hit from cloudfront
content-type
image/webp
cache-control
max-age=86400,public
x-amz-cf-pop
AMS1-C1
content-length
2452
x-amz-cf-id
LqLiqpnpoe620eMoZpQI232AyOHxURz7vXrRgM9RLMpQsCUC_eabEw==
expires
Tue, 15 Dec 2020 20:18:22 GMT
36801520-0-image-m-47_1607901989700.jpg
i.dailymail.co.uk/1s/2020/12/13/23/
5 KB
5 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/12/13/23/36801520-0-image-m-47_1607901989700.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
7f8d5f84ab7ccf51fcc7b37e0a719ea5bfba9f537b76954dc6c675ce701367c3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
RUwlDQioz8hXUX8JHM9.HhFpA_lQrxmb
last-modified
Sun, 13 Dec 2020 23:27:26 GMT
server
AmazonS3
x-amz-request-id
229587DFF6004005
etag
"3f77c323ea9bc82401859812f367f0b7"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4853
x-amz-id-2
S57XFGytFUtD0mqMC9yAZkWp0yWLWUW+GyduH61Kytklfg5QKgSD4yyMVW/uQ1gssr475AJGNRk=
expires
Thu, 14 Jan 2021 12:48:44 GMT
fff.js
www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/
119 KB
35 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/fff.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
835f1dfc4109c578b77ba1b24a70cf3c07e73440aa65a94c329c29f763423bc5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
35222
last-modified
Mon, 26 Oct 2020 00:49:53 GMT
server
Akamai Resource Optimizer
etag
"eea372bce8ac8e188267c4751ef1d05a:1560175752"
vary
User-Agent
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=561785
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Tue, 22 Dec 2020 00:51:49 GMT
logo_cookie_reg.png
i.dailymail.co.uk/i/furniture/misc/
189 B
394 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/misc/logo_cookie_reg.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
2f59ac8dad7d832c75edc7cf917c512a3788d03ce0862b38c1bfccc54eb01d10

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Mon, 06 Nov 2017 11:54:00 GMT
server
Apache
etag
"2c776973168421488cd8ba0f131ef7f4:1509969240"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
189
expires
Thu, 14 Jan 2021 12:48:44 GMT
door.js
uk-script.dotmetrics.net/
7 KB
3 KB
Script
General
Full URL
https://uk-script.dotmetrics.net/door.js?d=www.dailymail.co.uk&t=sciencetech
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.68.93 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Kestrel /
Resource Hash
7657af92b217ab8d43d7f38ae11642c3bf7f1242529dde1e026935f848f52301

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
br
server
Kestrel
x-amz-cf-pop
FRA56-C1
etag
".www.dailymail.co.uk.sciencetech.175.2020121512"
vary
Accept-Encoding
x-cache
Miss from cloudfront
p3p
policyref="https://uk-script.dotmetrics.net/w3c/p3p.xml", CP="NOI DSP LAW CURa ADMa DEVa PSAa HISa OUR IND STA"
via
1.1 106758604a7f1ae0fa6678cd3d828d62.cloudfront.net (CloudFront)
cache-control
private
content-type
application/javascript
x-amz-cf-id
FKQ9IHFXomcMcKOj1h4rUHH4ar4Lq9fZ6cAJ4KS9BvKrl396yRMjXA==
sa
ted.dailymail.co.uk/s/
229 B
773 B
XHR
General
Full URL
https://ted.dailymail.co.uk/s/sa
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/rta2/v-0.56.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
b23ba1762da79e4ddf97d97464a69f88cf114041971a09f6aa194da005dcbf0b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 12:48:44 GMT
cache-control
private, no-cache, proxy-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, documentReferer
content-length
229
x-rs-ops
rta2-rufus-a1-fe.hsk.mol.dmgt.net:8180
sa
t.dailymail.co.uk/s/
232 B
778 B
XHR
General
Full URL
https://t.dailymail.co.uk/s/sa
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/rta2/v-0.56.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
14c6948ce4efe5559f1979f88bed9d239afb28599c82ad8a20fbf0b28dbe37ea

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 12:48:44 GMT
cache-control
private, no-cache, proxy-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, documentReferer
content-length
232
x-rs-ops
rta2-rufus-c2-fe.rdg.mol.dmgt.net:8180
r2
sb.scorecardresearch.com/
Redirect Chain
  • https://swa.and.co.uk/b/ss/anddailymailprod/1/JS-2.9.0/s2574234187497?AQB=1&ndh=1&pf=1&t=15%2F11%2F2020%2013%3A48%3A44%202%20-60&fid=37E040AF18157E12-1449A94B1F36F652&ce=iso-8859-1&ns=associatednor...
  • https://swa.and.co.uk/b/ss/anddailymailprod/1/JS-2.9.0/s2574234187497?AQB=1&pccr=true&vidn=2FEC58560515CE45-40000666530440B3&ndh=1&pf=1&t=15%2F11%2F2020%2013%3A48%3A44%202%20-60&fid=37E040AF18157E1...
  • https://sb.scorecardresearch.com/r?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3838634626&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-pati...
  • https://sb.scorecardresearch.com/r2?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3838634626&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-pat...
43 B
589 B
Image
General
Full URL
https://sb.scorecardresearch.com/r2?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3838634626&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&cs_ak_ss=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.238.139 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-238-139.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
24e480e4659fbae818853a38f8a3036f529f539024dc3e772c0b594ce02ea9db

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:45 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/r2?c2=6034964&d.c=gif&d.o=anddailymailprod&d.x=3838634626&d.t=page&d.u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&cs_ak_ss=1
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:45 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
register.js
hulkprod.anm.co.uk/api/web-push-notification/v1/static/latest/mol-fe-web-push-browser-register/
55 KB
12 KB
Script
General
Full URL
https://hulkprod.anm.co.uk/api/web-push-notification/v1/static/latest/mol-fe-web-push-browser-register/register.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:bb21 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
0b2cc81f0d413537e2d91883bd3389eb3b6055954cbd6b9b69a71706e7ed6f47

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-rs-ops
mol-fe-web-push-notification-a3-fe:8080
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET, POST, OPTIONS, DELETE, PATCH
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, no-cache
accept-ranges
bytes
access-control-allow-headers
X-Requested-With, X-HTTP-Method-Override, Content-Type, Accept, Authorization
content-length
11443
service-worker-allowed
/
expires
Tue, 15 Dec 2020 12:48:44 GMT
sync
sync.sxp.smartclip.net/
Redirect Chain
  • https://sync.sxp.smartclip.net/sync?type=red&dsp=10
  • https://sync.sxp.smartclip.net/sync?type=red&dsp=10&ang_testid=1
42 B
377 B
XHR
General
Full URL
https://sync.sxp.smartclip.net/sync?type=red&dsp=10&ang_testid=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.250.60.119 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-250-60-119.eu-west-1.compute.amazonaws.com
Software
nginx/1.17.6 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
nginx/1.17.6
P3P
CP="CURa ADMa DEVa PSAo PSDo OUR BUS UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
42

Redirect headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
nginx/1.17.6
Location
https://sync.sxp.smartclip.net/sync?type=red&dsp=10&ang_testid=1
P3P
CP="CURa ADMa DEVa PSAo PSDo OUR BUS UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
edgedata.html
www.dailymail.co.uk/geo/
785 B
1 KB
Fetch
General
Full URL
https://www.dailymail.co.uk/geo/edgedata.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
dfb749c8597c2c8686580548520a1575a8026ed3efda320792bc9f5bc8cd246a

Request headers

pragma
no-cache
cache-control
no-cache
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
vary
User-Agent
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
content-type
text/html
cache-control
max-age=423
server-timing
edge; dur=1, cdn-cache; desc=HIT
content-length
785
x-akamai-transformed
9 785 0 pmb=mRUM,2
launcher.js
sak.userreport.com/mol/
46 KB
15 KB
Script
General
Full URL
https://sak.userreport.com/mol/launcher.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.89.98 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-89-98.muc50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
2a2d04bb04d52ca53c1aaf2f8de8574e929f1136e08c828f36bfe0b03d588835

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
I0zZ8fJjlbBdpU31WSxSwsQh_njKJ8CZ
content-encoding
gzip
last-modified
Mon, 16 Nov 2020 11:54:59 GMT
server
AmazonS3
x-amz-cf-pop
MUC50-C1
etag
"6d509bc807890482e7742fa12a3fdc85"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 e96f95ae91ddaf74bf5c3845501fcac8.cloudfront.net (CloudFront)
cache-control
max-age=7200, s-maxage=60
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-cf-id
fvtWmr5M993jyqbzrqzyUS9O9Ba0lM8XzunVnmcV94QTbae2VPrcNQ==
pubcid.min.js
www.dailymail.co.uk/static/mol-adverts/demo/mol-21682/dist/
57 KB
16 KB
Script
General
Full URL
https://www.dailymail.co.uk/static/mol-adverts/demo/mol-21682/dist/pubcid.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Akamai Resource Optimizer /
Resource Hash
afd2447f77118df6fd4b8710c2b23e7bb4edb557795c643e3d8a7c12df4e6586

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
br
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Wed, 11 Nov 2020 12:39:47 GMT
server
Akamai Resource Optimizer
etag
"c74b87c9a8cadd3463a338a08b3f2cf6:1603291730.298429"
vary
User-Agent
content-type
application/x-javascript
cache-control
max-age=616350
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
content-length
16091
expires
Tue, 22 Dec 2020 16:01:14 GMT
apstag.js
c.amazon-adsystem.com/aax2/
116 KB
30 KB
Script
General
Full URL
https://c.amazon-adsystem.com/aax2/apstag.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
dde5dcb02f349d5cd1f36d6afe709ddfd5713b27129dbae727f456cde6582883

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:34:11 GMT
content-encoding
gzip
server
Server
age
872
etag
089c185b065ebe3e9c21625b16dea242
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
cache-control
public, max-age=900
x-amz-cf-pop
MUC50-C1
accept-ranges
bytes
timing-allow-origin
*
x-amz-version-id
dMDl4v7Re.7jmw9HDy.5O8xRCx.Enz0f
x-amz-cf-id
oujIRD6en7GK2TUTBXDYeATOsnM9e1xy70wZPFPbmYjX3tHeGzCwUg==
tfa.js
cdn.taboola.com/libtrc/unip/1125455/
62 KB
21 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f3b197cbaeccc165326cbcbcafdd7c9b6cbfd9a6e4b491f7e15005d5ae1bc54f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
CWn2XVqOOPHV7d9ufmX_sO4trqOMW86V
content-encoding
gzip
etag
"f307857c217d76ef1a20ffe52928f705"
age
32
x-cache
HIT
x-amz-replication-status
PENDING
content-length
21416
x-amz-id-2
oM0wVJZ/zN+Ec48FN1mHYtugK2s/dviMKyu7xhpO0+9G2RDFQgC/25NySitaoNBEc9iur6l1gGA=
x-served-by
cache-fra19151-FRA
last-modified
Mon, 23 Nov 2020 22:28:02 GMT
server
AmazonS3
x-timer
S1608036525.633634,VS0,VE1
date
Tue, 15 Dec 2020 12:48:44 GMT
vary
Accept-Encoding
x-amz-request-id
9484206517740AAC
via
1.1 varnish
cache-control
private,max-age=14401
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
33
x-cache-hits
1
directsdk.js
aka.spotxcdn.com/integration/directsdk/v1/
Redirect Chain
  • https://js.spotx.tv/directsdk/v1/234272.js
  • https://aka.spotxcdn.com/integration/directsdk/v1/directsdk.js
418 KB
155 KB
Script
General
Full URL
https://aka.spotxcdn.com/integration/directsdk/v1/directsdk.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.36.138 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-36-138.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
d6fa7c39b1d5e288c739c3a225a90d0698798485d5b17c1350dc17925942b841

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Content-Encoding
gzip
Last-Modified
Thu, 10 Sep 2020 19:35:03 UTC
Server
nginx
Access-Control-Allow-Headers
ETag
7112a693437c5fad3aa28033ed1f53f1
Vary
Accept-Encoding
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
text/javascript;charset=UTF-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=269
Connection
keep-alive
Timing-Allow-Origin
*
X-SpotX-Build-Version
1.31.0-20200910.1910
Content-Length
157844

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Last-Modified
Tue, 15 Dec 2020 12:48:44 UTC
Server
nginx
Location
//aka.spotxcdn.com/integration/directsdk/v1/directsdk.js
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
post-check=0, pre-check=0, no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
116
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 GMT
iris-context.min.js
ovp.iris.tv/libs/context/
13 KB
5 KB
Script
General
Full URL
https://ovp.iris.tv/libs/context/iris-context.min.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:20eb:4600:15:d134:4e40:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9710dab6bb3447842cba847209148bd89fb928f55865b045105fa3aefa4fb51f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
5ZdiiNwZl43A.GuGAotRXH1LFI541fXN
content-encoding
gzip
last-modified
Thu, 18 Jun 2020 14:14:19 GMT
server
AmazonS3
age
69151
etag
"1f6dcd0526f7505c7eb84fec71d5e468"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 3aed5a4f89d72775aaf2cc5a5f642386.cloudfront.net (CloudFront)
date
Mon, 14 Dec 2020 17:36:14 GMT
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
DJuiRPPdIyvvff6inpLRUZ4YFkLK0iqy1SXvEDyL2X8K1S6N5nz1eg==
topVideos.json
secured.dailymail.co.uk/feeds/commercial/
137 KB
40 KB
XHR
General
Full URL
https://secured.dailymail.co.uk/feeds/commercial/topVideos.json
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:eb:3b5::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
82b592ee259fdc8334c077d77c4d3febcdd73d5baf02b2804368f168f2964db5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Connection
keep-alive
Content-Length
40327
X-rs-ops
varnish-web-a3-fe:6081
Access-Control-Allow-Headers
X-Requested-With, X-HTTP-Method-Override, Content-Type, Accept, Authorization
x-graced
false
x-rs-time
Tue, 15 Dec 2020 12-47-28 GMT
restarts
0
Access-Control-Allow-Methods
GET, POST, PUT, PATCH, DELETE, OPTIONS
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
private, max-age=1800
Accept-Ranges
bytes
x-rs-ben
video-feed-a2.hsk.mol.dmgt.net:3000
x-storage
other
Expires
Tue, 15 Dec 2020 13:18:44 GMT
i.gif
mfad.inskinad.com/udb/9874/pool/set/
Redirect Chain
  • https://e.serverbid.com/udb/9969/match?redir=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fpool%2Fset%2Fi.gif%3FpoolId%3D9969%26poolKey%3D
  • https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-2aed38e2-3ebc-44e9-8fc5-088ff3e22299
43 B
875 B
Image
General
Full URL
https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-2aed38e2-3ebc-44e9-8fc5-088ff3e22299
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.225.161.250 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-225-161-250.compute-1.amazonaws.com
Software
nginx/1.16.1 / adzerk bifrost/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:08 GMT
ETag
W/"2b-6KwiS6nul+h2cO1vOi8BKLevn+Q"
Server
nginx/1.16.1
x-powered-by
adzerk bifrost/
Access-Control-Allow-Methods
GET, PUT, POST, DELETE, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
undefined
Expires
0
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
Accept, Origin, Content-Type, Content-Length, X-Adzerk-Explain, X-Adzerk-Sdk-Version
Content-Length
43
x-served-by
engine-production-i-08e9e7def57c6c3eb

Redirect headers

location
https://mfad.inskinad.com/udb/9874/pool/set/i.gif?poolId=9969&poolKey=ue1-sb1-2aed38e2-3ebc-44e9-8fc5-088ff3e22299
date
Tue, 15 Dec 2020 12:49:00 GMT
content-length
0
5f42864d-a421-4f37-9478-00266f871d68-web.js
cdn.permutive.com/
811 KB
187 KB
Script
General
Full URL
https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.19.149.54 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ecbaca00d81dee47e105d71a524f5c44ae23dc2866ec1e2f8b3fc53a0342ecef

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
br
cf-cache-status
HIT
age
609
x-guploader-uploadid
ABg5-UwiHoSZkJ7ikphTwyj1qy2vQ8ZS45t_zjoiShEVsDbB7bI1ErLL6E87f_M5CnWgufc1FqLOm9i7HYlKHb9btZQ
x-goog-storage-class
REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
gzip
content-type
application/javascript
cf-request-id
07080b3f0a00000c8da2ac8000000001
last-modified
Tue, 15 Dec 2020 11:38:33 GMT
server
cloudflare
etag
W/"8b58e91b87dd0cb4475fa0402716adc1"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
x-goog-hash
crc32c=li8bRg==, md5=i1jpG4fdDLRHX6BAJxatwQ==
x-goog-generation
1608032313699745
cache-control
public, max-age=300
x-goog-stored-content-length
202637
cf-ray
602047de78390c8d-AMS
expires
Tue, 15 Dec 2020 12:53:45 GMT
latest.json
cdn.jsdelivr.net/gh/prebid/currency-file@1/
1 KB
1 KB
XHR
General
Full URL
https://cdn.jsdelivr.net/gh/prebid/currency-file@1/latest.json
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a04:4e42:3::621 , Ascension Island, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
3cfa4702961c26f4b82c3fa3a80a6de1faa60dc6eee544bf7fd1eb97b81cb655
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
age
37216
x-cache
HIT
cross-origin-resource-policy
cross-origin
content-length
755
etag
W/"53d-3hAsEjuqSPx7l6Hxt7WLqG3cLVY"
x-served-by
cache-fra19161-FRA
date
Tue, 15 Dec 2020 12:48:44 GMT
vary
Accept-Encoding
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
*
cache-control
public, max-age=604800, s-maxage=43200
accept-ranges
bytes
timing-allow-origin
*
cookie_sync
prebid.adnxs.com/pbs/v1/
579 B
741 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/cookie_sync
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
ed46c6ec566f2365d4957732515715a333ea0c15be47f992a94e5e4ac2d6007f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Content-Encoding
gzip
Server
nginx/1.19.0
Vary
Accept-Encoding, Origin
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Transfer-Encoding
chunked
Expires
0
auction
prebid.adnxs.com/pbs/v1/openrtb2/
166 B
515 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
a8774e43c6773974f79dc99e1240ecd50af93b4218989125ba53f1b66c9e5db1

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
166
Expires
0
cdb
bidder.criteo.com/
0
149 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=32&wv=4.13.0-mol-1&cb=69180898455
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:48:44 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
cygnus
htlb.casalemedia.com/
25 B
375 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=193651&v=7.2&r=%7B%22id%22%3A%22372eb1b7ea13b66%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22380f5b7a1b169de%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193651%22%2C%22sid%22%3A%22728x90%22%7D%2C%22banner%22%3A%7B%22w%22%3A728%2C%22h%22%3A90%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22391474266b3df6d%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193651%22%2C%22sid%22%3A%22900x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A900%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%224010a118171c93e%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193651%22%2C%22sid%22%3A%22970x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A970%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2241928b692cbcaa7%22%2C%22ext%22%3A%7B%22siteID%22%3A%22503169%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2242336483629d66d%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193657%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%224342b461c6b7b6e%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193661%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2244d318e94590663%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193661%22%2C%22sid%22%3A%22300x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2245307a2d43adda4%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193665%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2246987280f6206a9%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193667%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2247a69d941d2adb1%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193673%22%2C%22sid%22%3A%22300x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%224863670cbb100e1%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193673%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22491e3da1b78eb7e%22%2C%22ext%22%3A%7B%22siteID%22%3A%22217825%22%2C%22sid%22%3A%22160x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A160%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2250031a52fc8182b%22%2C%22ext%22%3A%7B%22siteID%22%3A%22217825%22%2C%22sid%22%3A%22120x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A120%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22518f795b24bd4df%22%2C%22ext%22%3A%7B%22siteID%22%3A%22217826%22%2C%22sid%22%3A%22160x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A160%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2252408c7199de7ca%22%2C%22ext%22%3A%7B%22siteID%22%3A%22217826%22%2C%22sid%22%3A%22120x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A120%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2253d6c38e326d86c%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22970x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A970%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%225489a5563fd5c5%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22900x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A900%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%225596561b9261d81%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22728x90%22%7D%2C%22banner%22%3A%7B%22w%22%3A728%2C%22h%22%3A90%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2256ea6293eb23a33%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193670%22%2C%22sid%22%3A%22160x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A160%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%2257944c0fd0f1731%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193670%22%2C%22sid%22%3A%22120x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A120%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22583c0a888448571%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193671%22%2C%22sid%22%3A%22160x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A160%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%225984784e587d3a4%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193671%22%2C%22sid%22%3A%22120x600%22%7D%2C%22banner%22%3A%7B%22w%22%3A120%2C%22h%22%3A600%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
4686fa0fb41663a5058fb8e605a6166439c31718414139264da50aa4c4a7e172

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
45
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:48:44 GMT
auction
tlx.3lift.com/header/
19 B
395 B
XHR
General
Full URL
https://tlx.3lift.com/header/auction?lib=prebid&v=4.13.0-mol-1&referrer=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&tmax=3000
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.159.48.82 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
0535c3bb3a17e4ac0fb7d29214d2181275662129dc2bdd2a89c35934e9fc5ba5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
x-auction-status
12, 12, 12, 12, 12, 12, 12, 12
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
19
x-xss-protection
0
expires
Thu, 15 Oct 1992 20:10:00 GMT
arj
mailonline-uk-d.openx.net/w/1.0/
172 B
560 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=5034be96-9cd0-4f46-bc79-e2a3b99bb7cc%2C217829b7-7363-4dd1-9187-cb554960ca64%2C7a55ebfc-9198-4faf-b7ac-d4e932ef3943%2Cece18280-e62b-494d-abe6-e715b432e055%2Caa744f8d-8959-4181-92e5-3ccadbd3ead5%2Cf8057b1b-2096-4812-9ee5-6d3a508a23f5%2Ca7156595-8ca8-4a8b-b936-00e5cf66c834%2Caef08801-79fe-4527-88d9-56d8257f6807%2Cc8c01bea-9f8b-431a-892d-bebe58c963df%2C9a22ca1e-011c-4be2-9ce7-4d3204313cff%2C53fa6a71-c912-40f3-b5b2-7574219e4c3b&nocache=1608036524384&pubcid=3093687966&aus=728x90%7C300x250%7C300x250%7C300x250%7C300x250%7C160x600%2C120x600%7C160x600%2C120x600%7C160x600%2C120x600%7C160x600%2C120x600%7C300x250%7C300x250&divIds=leader_wide%2Cmpu_left%2Cmpu_middle%2Cmpu_puff_20%2Cmpu_puff_45%2Csky_left_bottom%2Csky_right_bottom%2Csky_left_top%2Csky_right_top%2Cmpu_mobile_top%2Cmpu_top&auid=540437664%2C537316799%2C538767661%2C538767664%2C538767666%2C539384356%2C539384357%2C538767667%2C538767668%2C538767673%2C539384359
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
504df7a2ac43055903e0309fe116f6cdfcc90c027b7dad958ef9e7d0f72e82f0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
162
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
xhr
pre.ads.justpremium.com/v/2.0/t/
43 B
254 B
XHR
General
Full URL
https://pre.ads.justpremium.com/v/2.0/t/xhr?i=1608036524385
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.106.210 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
d34e8a1a381b203e3d1f7c6ed4f077038e91782ea254c7a7e4785462147a385a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:48:44 GMT
cache-control
public, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-encoding
gzip
content-type
application/json
prebid
ib.adnxs.com/ut/v3/
19 B
715 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.179:80
AN-X-Request-Uuid
f4afd8ae-2b45-40ec-955b-7bd461696616
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
715 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.141:80
AN-X-Request-Uuid
ae3e7523-fae2-4019-878d-abfefd4304c7
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bid-request
a.teads.tv/hb/
16 B
301 B
XHR
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 15 Dec 2020 12:48:44 GMT
v2
mfad.inskinad.com/api/
93 B
746 B
XHR
General
Full URL
https://mfad.inskinad.com/api/v2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.225.161.250 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-225-161-250.compute-1.amazonaws.com
Software
nginx/1.16.1 / adzerk bifrost/
Resource Hash
31881f50504a0fc0930fe463a932f264e1df2ff1951de8887e40dfc8359aef58

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:45 GMT
ETag
W/"5d-VOI/j+d/E/e3JbXy/B0HlYaJH3g"
Server
nginx/1.16.1
x-powered-by
adzerk bifrost/
Access-Control-Allow-Methods
GET, PUT, POST, DELETE, OPTIONS
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Expires
0
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
Accept, Origin, Content-Type, Content-Length, X-Adzerk-Explain, X-Adzerk-Sdk-Version
Content-Length
93
x-served-by
engine-production-i-040df25403896831a
fastlane.json
fastlane.rubiconproject.com/a/api/
1 KB
11 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=587732%3B587734%3B1102954%3B1694086%3B587746%3B587754%3B587764%3B587782%3B724806%3B587784&size_id=2%3B2%3B2%3B15%3B15%3B15%3B15%3B15%3B15%3B9&alt_size_ids=57%3B57%3B%3B%3B%3B10%3B%3B%3B10%3B8%2C10&p_pos=atf%3B%3B%3B%3B%3Batf%3B%3B%3Batf%3Batf&eid_pubcid.org=3093687966%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=1abe9a9b-1e11-40a0-99cb-675629d97ee1%3B466ebeae-aec2-46a8-ba43-28909c3ac710%3B5034be96-9cd0-4f46-bc79-e2a3b99bb7cc%3B217829b7-7363-4dd1-9187-cb554960ca64%3B7a55ebfc-9198-4faf-b7ac-d4e932ef3943%3Bfb3e4033-739d-445b-bc90-3acc7f18cb86%3Bece18280-e62b-494d-abe6-e715b432e055%3Baa744f8d-8959-4181-92e5-3ccadbd3ead5%3Bc5450962-ddd4-4b8a-a547-136e188e5ca3%3B5f9fe984-51d7-4a49-a7ce-53ccaf6382f1&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=10&rand=0.37353477933646584
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
69.173.144.143 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
77ecd1d86a08f187322ac6d5940211ae3cfbb11e7666d900712866e78d1bb38c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Content-Encoding
gzip
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
433
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
486 B
4 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=724800%3B587786%3B724804&size_id=9&alt_size_ids=8%2C10&p_pos=%3Batf%3B&eid_pubcid.org=3093687966%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=2d1dde68-e60f-42f2-9935-4de1d6d567d1%3B0f263823-f476-4030-81d8-141b118fbb09%3B261a2d5a-2f2b-4be8-93ff-8b1a3875f6c6&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=3&rand=0.9347382792310002
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
69.173.144.143 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
9e3c5a7e89b10c142f4a24273e15cca5f45c91ceec6e486e34aca28bd6701f6d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
486
Expires
Wed, 17 Sep 1975 21:32:10 GMT
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_billboard&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
60718f69e04d763072acdce69934949e2995bb7949adaa0e56f40d1da5848a42

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_left&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
33b99e05b0155f92358829dcde9f2457fb89ea4d0fe957742d8c189648e73c7e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_puff_20&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
e283c9043b358968da275894059e609c1a063609b71c911acc8f92e5844b6163

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_puff_45&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
f9998dea483cc85a934c8bc3dac9c6a275fecf7d34da18ce0d86571f614373e7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_top&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
bdba6fd4e822361c837b0e32b8a6cea8256e4ab628a945d5281407ac3de60196

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_leader_very_bottom&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
41edba2193d524b6844f7c35e8082b4711b57d47b231cba68b7fdb66e8100d0f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_sky_left_bottom&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
c769bf0b2c3b27b1689751e0adcae8a554de8c8c208f2bddd77a58e1d5bdbdfb

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_sky_left_top&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
5f43fabee3b3ced09fcb154a1b786a88b7f6df252b0ade784fcabb4969b6d77b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_sky_right_bottom&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
360612813b672272be808381af2775a7d70bbe96ca7d7da875c8764246b93433

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
390 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_sky_right_top&cmd=bid&secure=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
8fa66cbe146582ab25611e0d72c646fcd59283f984574341a9899595b7fbc9be

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
ATS/7.1.2.128
Age
0
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD
s.go-mpulse.net/boomerang/
205 KB
49 KB
Script
General
Full URL
https://s.go-mpulse.net/boomerang/RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:6c00:287::11a6 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
09ebd7f407439990aac227e70da23e1a819e8e30282928e324370805f480bec4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
br
last-modified
Tue, 10 Nov 2020 10:33:41 GMT
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
cache-control
max-age=604800
timing-allow-origin
*
content-length
50393
ga.js
google-analytics.com/
45 KB
17 KB
Script
General
Full URL
https://google-analytics.com/ga.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
1259ea99bd76596239bfd3102c679eb0a5052578dc526b0452f4d42f8bcdd45f
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 23 Oct 2020 03:00:57 GMT
server
Golfe2
age
5757
date
Tue, 15 Dec 2020 11:12:47 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
17168
expires
Tue, 15 Dec 2020 13:12:47 GMT
fbds.js
connect.facebook.net/en_US/
4 KB
3 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbds.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
3436badfb4cde4f9fcfdebc1ddd208c49eaffb8834f46b89e991af6f4cac5cb8
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
content-md5
8AVZSXRDJVl6Y9J0CMHUuQ==
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
2117
etag
"8079f56753a4a94e54779cd208225068"
x-fb-debug
gCwor6dyxPKKpey1hVhmO77mLJkEa/a8mOFVdfvZPiJRLFoHSnTHNppZlIsDS6h7eZqK80YYFleMndMcyE/vRw==
x-fb-trip-id
436667874
x-fb-content-md5
1d6dcb0e254400f371a32548b5007cf9
x-frame-options
DENY
date
Tue, 15 Dec 2020 12:48:44 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
*
access-control-expose-headers
X-FB-Content-MD5
cache-control
public,max-age=1200,stale-while-revalidate=3600
timing-allow-origin
*
expires
Tue, 15 Dec 2020 12:58:32 GMT
truncated
/
37 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/gif
sci_tech_masthead.gif
i.dailymail.co.uk/i/pix/channelheaders/
22 KB
22 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/channelheaders/sci_tech_masthead.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
a526255a9e1cbe99e7ac0f5822f568fc4ce2b8cc7b8e23273266f54c8669d4c0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Mon, 15 Dec 2008 11:14:15 GMT
server
Apache
etag
"f45db57af9925ea9dac596bf296b1e8f:1229339655"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
22399
expires
Thu, 14 Jan 2021 12:48:44 GMT
navigation_bottom.gif
www.dailymail.co.uk/i/furniture/structure/
154 B
510 B
Image
General
Full URL
https://www.dailymail.co.uk/i/furniture/structure/navigation_bottom.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
4eaa63fe224cad73f3348b716855de0ace8a3169abfc0d7b2845d083172f53dd

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Fri, 25 Sep 2020 10:44:28 GMT
etag
W/"154-1601030668000"
x-rs-time
Mon, 05 Oct 2020 08-02-58 GMT
vary
User-Agent
content-type
image/gif
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
x-mol-georesp
de
content-length
154
x-rs-ops
molfejava-a2-fe.hsk.mol.dmgt.net:8081
spt_weather_nav.png
i.dailymail.co.uk/i/furniture/weather/
2 KB
2 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/weather/spt_weather_nav.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
0bf60782546bae441a6ce4783c2169777d728af37759e9805acbdaa48122cf36

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Wed, 23 Dec 2009 12:07:55 GMT
server
Apache
etag
"2a0a9e4a75bf8d1c816c273119256500:1261570075"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
2301
expires
Thu, 14 Jan 2021 12:48:44 GMT
pubads_impl_2020120801.js
securepubads.g.doubleclick.net/gpt/
274 KB
97 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
sffe /
Resource Hash
5f02981bfcab6807a15ddfea1babc7cee05cd0f1f59abe712928de44fb6c1f0d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 08 Dec 2020 09:42:29 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, immutable, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
98829
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:45 GMT
truncated
/
42 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/gif
twitter_icon_tiny.png
i.dailymail.co.uk/i/furniture/icons/
1 KB
1 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/icons/twitter_icon_tiny.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
38f28716c48a39ee9a7bbaad9879c2330e1a394bbba98e83425920410342ac14

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Mon, 12 Jan 2015 12:09:29 GMT
server
Apache
etag
"238ff7fea119e41aea5f80988ff8c4c8:1421064569"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
1247
expires
Thu, 14 Jan 2021 12:48:44 GMT
spt_socialicons_40x40eachbttn9.png
i.dailymail.co.uk/i/furniture/articles/
26 KB
26 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/articles/spt_socialicons_40x40eachbttn9.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
3381376497b5b338f301a29f4b399d81331e55a568f02df5db466149e5826f13

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Thu, 17 May 2018 13:20:45 GMT
server
Apache
etag
"bab988d64a75ef93640c8ed16e05987b:1526563245"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
26818
expires
Thu, 14 Jan 2021 12:48:44 GMT
truncated
/
233 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b707cea228ebd1afe82a1840449e8c14d79bb62ec828d1ca7c3b6832a6905133

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
663 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
deb959c047f364b4d81eb0b735fd60c7172cb808ddad43546948d90a38ad362e

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
44 KB
44 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b0a9ac514283709cb85750e1a15f4ed549be7d0caa7711a70a3249d15538ac44

Request headers

Origin
https://www.dailymail.co.uk
Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
font/woff
truncated
/
41 KB
41 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
0b7e7d1bedae2fca5895468c68d7a3f06c5fa573a19fbdc1ea4da51441d59458

Request headers

Origin
https://www.dailymail.co.uk
Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
font/woff
graphik-medium.woff2
i.dailymail.co.uk/i/fonts/graphik-official/
33 KB
34 KB
Font
General
Full URL
https://i.dailymail.co.uk/i/fonts/graphik-official/graphik-medium.woff2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:289::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
a889d45fd306329c8c05ecfdd48f114b5ad8fb64a766c103b88cbe19a5c4b6bc

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Tue, 29 Nov 2016 11:56:15 GMT
server
Apache
etag
"199e5924b9ba81084b56514905d2215d:1480420575"
access-control-max-age
0
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/x-font-woff
access-control-allow-origin
*
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Content-Type
content-length
34109
expires
Thu, 14 Jan 2021 12:48:44 GMT
34725488-8869893-image-a-42_1603399659388.jpg
i.dailymail.co.uk/1s/2020/10/22/21/
31 KB
31 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/10/22/21/34725488-8869893-image-a-42_1603399659388.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f136f4b3a437e9f7fdbfe4f638e92b53e5c6ee4ecd48238f7e0e78a46b12bc88

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
UFnQBbUN.nd2h3iuoG_fO.78zbf2VYpG
last-modified
Thu, 22 Oct 2020 20:47:41 GMT
server
AmazonS3
x-amz-request-id
FK2Q1H9Y3P3N9W7M
etag
"cfd94bf2b3d471ff5275ba1fa3e3ec9c"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:44 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
31605
x-amz-id-2
E0v1LRYSgFe1CusRROtrlfZjjdL+jsWhiFdXd30jUbjzAQtDnhHNaPVawR+j5h0qCRtvT5PDFUo=
expires
Thu, 14 Jan 2021 12:48:44 GMT
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
30b84e578afd3be87e53111b4e261b4e3ac3a7601f4905f18e56eaea100cd6b6

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=501785&v=7.2&r=%7B%22id%22%3A%22140d3841e7883731%22%2C%22imp%22%3A%5B%7B%22id%22%3A%2214140e5f845e7ecb%22%2C%22ext%22%3A%7B%22siteID%22%3A%22501785%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
adc17314e6438d403c53f6de9bee9b057772d8e762a2909c0fdae2d0f0fb6245

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:48:44 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
715 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.141:80
AN-X-Request-Uuid
2efd330a-6eb1-4faf-b21a-90e8de5bf245
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
2 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=1635080&size_id=15&eid_pubcid.org=3093687966%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=d34947ac-7565-4244-94d7-d00bee672d4a&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.6662621608317778
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
69.173.144.143 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
c781728677b2afe38f107ef22dc56640b3316b52929b380e8d5749f92dd76d11

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
arj
mailonline-uk-d.openx.net/w/1.0/
172 B
359 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=d34947ac-7565-4244-94d7-d00bee672d4a&nocache=1608036524606&pubcid=3093687966&aus=300x250&divIds=mpu_factbox_1&auid=541058631
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
3119e2ba6fb979b70b752ec2f7ab0dbe2b3f19963d8de7e94b48e47857df078f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
163
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
bid-request
a.teads.tv/hb/
16 B
301 B
XHR
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 15 Dec 2020 12:48:44 GMT
cdb
bidder.criteo.com/
0
149 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=32&wv=4.13.0-mol-1&cb=79477949694
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:48:44 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
truncated
/
715 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
truncated
/
381 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
63271dcce1a2518271ecc2b0bdcc5afc9c5f0968a8635e0f97a4c9747309eb82

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
setuid
ib.adnxs.com/prebid/
Redirect Chain
  • https://x.bidswitch.net/check_uuid/https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dgrid%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24%7BBSW_UUID%7D?gdpr=0&gdpr_consent=&us_privacy=
  • https://x.bidswitch.net/ul_cb/check_uuid/https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dgrid%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24%7BBSW_UUID%7D?gdpr=0&gdpr_consent=&us_privacy=
  • https://ib.adnxs.com/prebid/setuid?bidder=grid&gdpr=0&gdpr_consent=&uid=f644313d-5c9b-496a-98b0-21d748a69350
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/prebid/setuid?bidder=grid&gdpr=0&gdpr_consent=&uid=f644313d-5c9b-496a-98b0-21d748a69350
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:45 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.81:80
AN-X-Request-Uuid
d2ed241f-3b93-4cb3-9d81-09adbc0d30e9
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

location
https://ib.adnxs.com/prebid/setuid?bidder=grid&gdpr=0&gdpr_consent=&uid=f644313d-5c9b-496a-98b0-21d748a69350
date
Tue, 15 Dec 2020 12:48:45 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
b7540164ddf9122d3b79747c54e91c9b569102cb916503053d313c25669fe445

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
bid-request
a.teads.tv/hb/
16 B
251 B
XHR
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 15 Dec 2020 12:48:44 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
714 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.51:80
AN-X-Request-Uuid
ef1acd1a-3613-4859-88d8-dd74a1e21d9e
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/
0
149 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=32&wv=4.13.0-mol-1&cb=32174779111
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:48:44 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
arj
mailonline-uk-d.openx.net/w/1.0/
172 B
361 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=84684051-4548-490e-b200-f24970b490e6&nocache=1608036524783&pubcid=3093687966&aus=300x250&divIds=mpu_factbox_2&auid=541058631
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
e11794eed6b6674a8f50cc0f6c6924a0d5f8ffb0e45573c3fd550934f22af1ea

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
165
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=1635080&size_id=15&eid_pubcid.org=3093687966%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=84684051-4548-490e-b200-f24970b490e6&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.47363656853775593
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
69.173.144.143 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
c303d4d2401f88e2bbef18b24d6b2be09ccd458747cf63a93f133d9cfa62f28a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:44 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Keep-Alive
timeout=5
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=501785&v=7.2&r=%7B%22id%22%3A%22165e374d047cf34a%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22166a919c57212914%22%2C%22ext%22%3A%7B%22siteID%22%3A%22501785%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
e4e068f97c2d66c64d8aad7664a0e13bd17c55f995b21a9d78b8f5a02740b000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:48:44 GMT
truncated
/
547 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
eb14baeac955bb11e33cd7fd3fd2f698cf20db1b450325f45ea843b6cdc82366

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
552 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
62f3f809487194fcc55a3ebd88811a604ae496027bb425d4ebd15d9ae1921945

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
178 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
3ee0806e69f2ae70a2267a58ac5fc5d52b5aa7aca6f3c0c08adad605fd8fbc16

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
352 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5f3592a8b8037ea064764a2815799612063c6722d314d1d66d3a9391c3c16d66

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
243 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9d2d8043c302d3a9da9277374a53e2285c471d5dc8397885b4931b82771d5cae

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
loader.js
cdn.taboola.com/libtrc/dailymail-row/
253 KB
33 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/dailymail-row/loader.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
00e885d1932c734d6dca1b0ff4b175fb1729c4173dde2bf0321b49058b4216f4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
cNo9WZ36Mx.68LJAL2pG7w7TW8P_p_1c
content-encoding
gzip
etag
"dc806877dc6b156c4201a91e6ff7756d"
age
71
x-cache
HIT
content-length
33891
x-amz-id-2
fe9LgsIA+YycFdqLFMbz1XwX5WPZS8M9f2cDlQ/hgXTswDnpTh7E6O3JXQN4FBATwUtu5bDunpA=
x-served-by
cache-fra19151-FRA
last-modified
Mon, 14 Dec 2020 12:06:40 GMT
server
AmazonS3
x-timer
S1608036525.890900,VS0,VE0
date
Tue, 15 Dec 2020 12:48:44 GMT
vary
Accept-Encoding
x-amz-request-id
74C49AAD9CD52C5F
via
1.1 varnish
cache-control
private,max-age=14401
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
94
x-cache-hits
3
button_bg.gif
i.dailymail.co.uk/i/furniture/articles/
450 B
662 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/articles/button_bg.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
6b0a9a3f89a5a9633f8b55cefc8e8c937e742f77e16a7f517e245bdec940913d

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Sun, 28 Sep 2008 03:10:39 GMT
server
AkamaiNetStorage
etag
"660ebcf51de684aabd5640c5400a2a17:1222571440"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
450
expires
Thu, 14 Jan 2021 12:48:44 GMT
spt_previewlinks_5.gif
i.dailymail.co.uk/i/furniture/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/spt_previewlinks_5.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
23f72af4e882a0195f05a66774f002805a01ee4c3812d480e51aeeefbae092b3

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Tue, 28 Feb 2017 12:31:27 GMT
server
Apache
etag
"6dc31044422de3f1f57a962c4036655e:1488285087"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
2587
expires
Thu, 14 Jan 2021 12:48:44 GMT
comment_ticker.png
i.dailymail.co.uk/i/furniture/comments/articles/
85 B
290 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/comments/articles/comment_ticker.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
541c63ae81fe7799a19523dc8f2500646043eaa70d36985c3f2fc86264e4e71e

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/rc-main--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Tue, 28 Feb 2017 12:52:42 GMT
server
Apache
etag
"18d36c5e83cfde23a9f5103f33f6ad32:1488286362"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
85
expires
Thu, 14 Jan 2021 12:48:44 GMT
spt_socialicons_40x40eachbttn8.png
i.dailymail.co.uk/i/furniture/articles/
9 KB
9 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/articles/spt_socialicons_40x40eachbttn8.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
1d188cadb253c70a5a87ebdcea65f7407044606b5c4cf2ca9891970161aa9232

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Mon, 06 Nov 2017 11:53:19 GMT
server
Apache
etag
"d5fb4ae159a29d51d27aaf551c71298a:1509969199"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
8735
expires
Thu, 14 Jan 2021 12:48:44 GMT
json
trc.taboola.com/1125455/trc/3/
813 B
770 B
Script
General
Full URL
https://trc.taboola.com/1125455/trc/3/json?tim=1608036524902&data=%7B%22id%22%3A989%2C%22ii%22%3A%22%2Fsciencetech%2Farticle-9050821%2Fremdesivir-beneficial-patients-doctors-reveal.html%22%2C%22it%22%3A%22text%22%2C%22sd%22%3Anull%2C%22ui%22%3Anull%2C%22vi%22%3A1608036524897%2C%22cv%22%3A%2220201123-29-RELEASE%22%2C%22uiv%22%3A%22default%22%2C%22u%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%22%2C%22e%22%3Anull%2C%22cb%22%3A%22TFASC.trkCallback%22%2C%22qs%22%3A%22%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%2C%22r%22%3A%5B%7B%22li%22%3A%22rbox-tracking%22%2C%22s%22%3A0%2C%22uim%22%3A%22rbox-tracking%3Apub%3Dmailonline-sc%3Aabp%3D0%22%2C%22uip%22%3A%22rbox-tracking%22%2C%22orig_uip%22%3A%22rbox-tracking%22%7D%5D%2C%22mpv%22%3Atrue%2C%22supv%22%3Atrue%2C%22mpvd%22%3A%7B%22en%22%3A%22page_view%22%2C%22tim%22%3A1608036524901%2C%22ref%22%3Anull%2C%22item-url%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%2C%22supv%22%3Atrue%7D%7D&pubit=i
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
34302d04fc6f863324b151d1f1cd3f86afeae8e8e77b9b66601fc5efc916a2e0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
20
date
Tue, 15 Dec 2020 12:48:44 GMT
content-encoding
gzip
server
nginx
x-timer
S1608036525.935925,VS0,VE20
x-served-by
cache-fra19151-FRA
vary
Accept-Encoding
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
*
access-control-allow-credentials
true
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
via
1.1 varnish
x-cache-hits
0
collect
stats.g.doubleclick.net/r/
Redirect Chain
  • https://ssl.google-analytics.com/r/__utm.gif?utmwv=5.7.2&utms=1&utmn=265532343&utmhn=www.dailymail.co.uk&utmcs=UTF-8&utmsr=1600x1200&utmvp=1600x1200&utmsc=24-bit&utmul=en-us&utmje=0&utmfl=-&utmdt=R...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-3639451-1&cid=1453141251.1608036525&jid=919056266&_v=5.7.2&z=265532343
35 B
113 B
Image
General
Full URL
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-3639451-1&cid=1453141251.1608036525&jid=919056266&_v=5.7.2&z=265532343
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c0c::9c Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Tue, 15 Dec 2020 12:48:44 GMT
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
35
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
location
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-3639451-1&cid=1453141251.1608036525&jid=919056266&_v=5.7.2&z=265532343
content-type
text/html; charset=UTF-8
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
368
expires
Fri, 01 Jan 1990 00:00:00 GMT
hit.gif
uk-script.dotmetrics.net/
43 B
1 KB
Image
General
Full URL
https://uk-script.dotmetrics.net/hit.gif?id=4626&url=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&dom=www.dailymail.co.uk&r=1608036524930&pvs=1&pvid=kipzffk2cii2qts2uda&c=true
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.68.93 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Kestrel /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
dotmetrics-hit-status
01 OK
server
Kestrel
x-amz-cf-pop
FRA56-C1
x-cache
Miss from cloudfront
p3p
policyref="https://uk-script.dotmetrics.net/w3c/p3p.xml", CP="NOI DSP LAW CURa ADMa DEVa PSAa HISa OUR IND STA"
via
1.1 106758604a7f1ae0fa6678cd3d828d62.cloudfront.net (CloudFront)
cache-control
no-cache
content-type
image/gif
x-amz-cf-id
Ozf3g-AxVkqH5xZvwLiiuJWIt-ESCUtTrCIw43kbPbOFene0UceYNQ==
aps_csm.js
c.amazon-adsystem.com/bao-csm/aps-comm/
6 KB
3 KB
XHR
General
Full URL
https://c.amazon-adsystem.com/bao-csm/aps-comm/aps_csm.js
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
06b99248a163333e36980a6cfb756f1a7de60fa49517162b87b1a44d5d48f844

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
null
content-encoding
gzip
etag
"a4d296427fc806b21335359e398c025c"
age
78394
x-cache
Hit from cloudfront
access-control-max-age
3000
access-control-allow-origin
*
last-modified
Sat, 05 Dec 2020 02:12:39 GMT
server
AmazonS3
date
Mon, 14 Dec 2020 15:02:12 GMT
vary
Origin
access-control-allow-methods
GET
content-type
application/javascript
via
1.1 a19127e21dc5a939819061334abff380.cloudfront.net (CloudFront)
cache-control
public, max-age=86400
x-amz-cf-pop
MUC50-C1
x-amz-cf-id
k5Rmxod1MI5EJ1FG5jUwJMD6H6vHbrtNIGHdozOKeabCbzJVr8jRNg==
truncated
/
1 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5887b03f44a197fcdc5400caec10de1c69f29619c1fdc868d4d461130e0f9efc

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
spt_rndcorner_4.png
i.dailymail.co.uk/i/furniture/corners/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/corners/spt_rndcorner_4.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
be6aaae29a207bdea28a1e545c6f5652abcd30845290ec990892805c895d78f6

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Mon, 06 Nov 2017 11:54:17 GMT
server
Apache
etag
"8709d0e0c6ea65aa87db0884a31b5355:1509969257"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
2998
expires
Thu, 14 Jan 2021 12:48:44 GMT
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=0&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22billBoard%22%2C%22s%22%3A%5B%222000x1200%22%2C%22970x250%22%2C%22900x250%22%2C%22728x90%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
745a085b52b8371ec6705413fca70a28c6d8bff0db480e6b124bd08c54e95ef8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
ImshRJMOPWDCxagcHS1M0yOP6gAyfOzAD2MZGdMi-lK245Zl4zdYDg==
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=1&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_factbox_1%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
89b4aa9e9bf8516c2ab7b5134f65d47b02071637259a14c9f60dccc207e05ce4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
MqyzOhHQv0gtrbGyj--GgyVf8aB-ixZyqLydX95tsjtNnU-dWRPnmQ==
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=2&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22inread_player_top%22%2C%22s%22%3A%5B%22480x270%22%2C%22636x1%22%2C%22480x1%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
5d7c7d25a0da74c0dd466120c3c09bd94cb982fc66ebc4a78675339f37323bf5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
t8A4qS6M7aJxX4BPnVCsIskkFldB8ASuREyfkAGFNZC2jc3rrioEwQ==
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=3&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_factbox_2%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
1c4777fe3a673a05492e27d08032cc91c23ac5389897c9235b09b8b0f5a74db3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
5LzHVQTxTQIEWViff_F3tbQt7-lb4Qos8Sp6ajKDs_xXQqoTwYVy9w==
bid
c.amazon-adsystem.com/e/dtb/
23 B
375 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=4&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_top%22%2C%22s%22%3A%5B%22300x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
6139dddd3b6b6b847bccd476918dc8fb4f4f5a10908e5707c704f155e0918e84

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
EddU8jnmBhZZtPCqkHYpp3KrglgPHSIICKDnXA2ndyaGmMvMZMTz_w==
/
www.facebook.com/tr/
44 B
376 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1401367413466420&ev=PixelInitialized&dl=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&rl=&if=false&ts=1608036524965
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:44 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-29=":443"; ma=3600,h3-27=":443"; ma=3600
content-length
44
expires
Tue, 15 Dec 2020 12:48:44 GMT
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=5&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22half_mpu_top%22%2C%22s%22%3A%5B%22300x150%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
111041158b9290ae7cc0c6da69d7c4f5600e8a73b4c7399d675df7f15ba7b063

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
855h68TpqQQ5gXAmi42wZXkBgXzVyinSLsBsaW_LbA38fvhCS-Xuvg==
truncated
/
504 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7a745591034534431b4e5e32815599cef3101631f9e6a9052a687d96dac1a3ea

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
62675c01ca7a9e7af102c699f55fa970eee7f0106984839722e018e733744c03

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
996 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f650676047609c72f3c893b13a7148916bb0a9a5ff1f6ca9c531d07038ba31ae

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
868 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
4717410c1ef684a572d4662c8bc6860a753e6ea7e9640d699c4f2a0e4d08c9e2

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b27cc2654c00d737f49cb68b74ba7893c151612b1ad52543f4691f67db0cdf97

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
390 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
285e1fb1c37c145d2372d6c64bb188b4cc6e82855b1c4d4d6bfcbcdb6f4543fa

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
impl.20201214-6-RELEASE.js
cdn.taboola.com/libtrc/
450 KB
104 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/dailymail-row/loader.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
3d46904b944d38dac0fe78cc6c3aad567ac826a9079ce9522147ef1c7feb158b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
2sVTA33cfaRgn0Prw5U.XCwVzohq6ybg
content-encoding
br
etag
"10bdb5807bdff4c42c4587c2d03bb5d3"
age
4611
x-cache
HIT
content-length
106007
x-amz-id-2
27Bxf87SsWW7Z9R2qIVMcSYoU0fVZAPqLVzYq0lJPpRmTgRaLODbtW20Sr2c9AfJpfGjJ+b9K5M=
x-served-by
cache-fra19151-FRA
last-modified
Mon, 14 Dec 2020 11:30:09 GMT
server
AmazonS3-br
x-timer
S1608036525.038519,VS0,VE0
date
Tue, 15 Dec 2020 12:48:45 GMT
vary
Accept-Encoding
x-amz-request-id
51DADEDDBF5F4FEB
via
1.1 varnish
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
application/javascript
abp
33
x-cache-hits
25988
bid
c.amazon-adsystem.com/e/dtb/
23 B
372 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=6&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_puff_20%22%2C%22s%22%3A%5B%22300x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
0cff03129f16a73a8ff89d06578b0b1a1127bddb582fd05f0ab62f8ccc6b62f7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
2HPXSA_SgH_IWaXctU_upVAxL3uBWQK7QAja0F9_1-2cbswAMzJgeg==
bid
c.amazon-adsystem.com/e/dtb/
23 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=7&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_puff_45%22%2C%22s%22%3A%5B%22300x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
8ec3cdfcdc79223ee04ed060812314854cb3b3d9d1914390c755934366fc3693

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
E1c6EOmkNPtyYThtKKzVQZ0sAyuSDnIGPaO4beJSHIPk9tDRTWFFgQ==
2
www.dailymail.co.uk/abe/a9/price/
4 B
705 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
2
www.dailymail.co.uk/abe/a9/price/
4 B
703 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
2
www.dailymail.co.uk/abe/a9/price/
4 B
704 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
2
www.dailymail.co.uk/abe/a9/price/
4 B
702 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
2
www.dailymail.co.uk/abe/a9/price/
4 B
703 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
2
www.dailymail.co.uk/abe/a9/price/
4 B
702 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
json
trc.taboola.com/dailymail-row/trc/3/
42 KB
14 KB
XHR
General
Full URL
https://trc.taboola.com/dailymail-row/trc/3/json?tim=13%3A48%3A45.248&lti=deflated&data=%7B%22id%22%3A994%2C%22ii%22%3A%22%2Fsciencetech%2Farticle-9050821%2Fremdesivir-beneficial-patients-doctors-reveal.html%22%2C%22it%22%3A%22text%22%2C%22sd%22%3Anull%2C%22ui%22%3A%225d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c%22%2C%22uifp%22%3Anull%2C%22lbt%22%3A1607947590030%2C%22vi%22%3A1608036524897%2C%22cv%22%3A%2220201214-6-RELEASE%22%2C%22uiv%22%3A%22default%22%2C%22u%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%22%2C%22bv%22%3A%220%22%2C%22ul%22%3A%5B%22en-US%22%5D%2C%22btv%22%3A%220%22%2C%22cos%22%3A%224g%22%2C%22bad%22%3A-1%2C%22sw%22%3A1600%2C%22sh%22%3A1200%2C%22bw%22%3A1600%2C%22sde%22%3A%221.000%22%2C%22bh%22%3A1200%2C%22dw%22%3A1600%2C%22dh%22%3A18889%2C%22qs%22%3A%22%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%2C%22r%22%3A%5B%7B%22li%22%3A%22rbox-t2v%22%2C%22s%22%3A15%2C%22uim%22%3A%22autosized-generated-text-under-1r-row%3Aabp%3D0%22%2C%22uip%22%3A%22desktop-Desktop-Wide%22%2C%22orig_uip%22%3A%22Desktop-Wide%22%2C%22cd%22%3A5810.75%2C%22mw%22%3A632%7D%2C%7B%22li%22%3A%22rbox-t2m%22%2C%22s%22%3A3%2C%22uim%22%3A%22thumbnails-b%3Aabp%3D0%22%2C%22uip%22%3A%22Below%20Article%20Thumbnails%202nd%22%2C%22orig_uip%22%3A%22Below%20Article%20Thumbnails%202nd%22%2C%22cd%22%3A5838.75%2C%22mw%22%3A636%7D%5D%2C%22cacheKey%22%3A%22text%3D%2Fsciencetech%2Farticle-9050821%2Fremdesivir-beneficial-patients-doctors-reveal.html%2CBelow%20Article%20Thumbnails%202nd%3Dthumbnails-b%3Aabp%3D0%2C%2Cdesktop-Desktop-Wide%3Dautosized-generated-text-under-1r-row%3Aabp%3D0%22%2C%22cb%22%3A%22TRC.callbacks.recommendations_1%22%2C%22lt%22%3A%22deflated%22%7D
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
3819bcc9b00e9d61f3326b53d8baf399dba62bef153bebd18706ab30395de5c5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

x-vcl-time-ms
704
date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
gzip
server
nginx
x-timer
S1608036525.276340,VS0,VE704
x-served-by
cache-fra19151-FRA
vary
Accept-Encoding
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
via
1.1 varnish
x-cache-hits
0
2
www.dailymail.co.uk/abe/a9/price/
4 B
704 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
2
www.dailymail.co.uk/abe/a9/price/
4 B
703 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
bid
c.amazon-adsystem.com/e/dtb/
23 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=8&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_middle%22%2C%22s%22%3A%5B%22300x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
c905a799c91593b68a840f7aae0bd411b7f0d2d475c8f5f5a780d54018fb61b8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
_YUkEBY9b9e-svmsTKnpVgUQisJ3o3nH3NPF0EvRT66I2blEy5H8RQ==
5714758-0-image-a-6_1541433836539.jpg
i.dailymail.co.uk/1s/2018/11/05/16/
6 KB
7 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/11/05/16/5714758-0-image-a-6_1541433836539.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
ae3e170e857bed9e494a304a2eecf39a59568cdff6d2bf09c3cee6890e0bcacd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
8udGaw_.zf9v4BX7M8p2K6tfHwqSkMnb
last-modified
Mon, 05 Nov 2018 16:03:57 GMT
server
AmazonS3
x-amz-request-id
E7A0692A85D80106
etag
"ace7b561b8f0eb5f29cd074a93e1ee06"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
6366
x-amz-id-2
G2eCKACtmNsPMKzCKDzdBzGqRM+YrKPWZpCC2laNFFcXh3oB4xPpdxkYEdd3/bpnCYlD8ZSi3IA=
expires
Thu, 14 Jan 2021 12:48:45 GMT
spt_previewlinks_11.png
i.dailymail.co.uk/i/furniture/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/spt_previewlinks_11.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
2de827c9500598749eea66b8b160381c4d3f879c83b9566ddefff4f4835709ef

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Mon, 31 Mar 2014 16:12:17 GMT
server
AkamaiNetStorage
etag
"9397e448905fdab93b871a5fb55e462f:1396282337"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
4126
expires
Thu, 14 Jan 2021 12:48:45 GMT
5412846-0-image-a-8_1540488021535.jpg
i.dailymail.co.uk/1s/2018/10/25/18/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/10/25/18/5412846-0-image-a-8_1540488021535.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
362d6daba2e9b6130e3fe509a9f735607e5966e8aaf6138ac6b95e14c67eb07d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
VWsy3jgni4v9i6MG0ucvSZkA0iese3vX
last-modified
Thu, 25 Oct 2018 17:20:23 GMT
server
AmazonS3
x-amz-request-id
3D7BAA4960483DA8
etag
"f18ad24d9e3dd72b45c31f6503f72cd1"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3041
x-amz-id-2
ZDIU7AMgY6GtSK/+aop6Z55v7CGcoUPEv+2SZHzUcFLkoitCXgk4AvBy7RH5D52+Qtz8d97r9W0=
expires
Thu, 14 Jan 2021 12:48:45 GMT
5331710-0-image-m-8_1540317153365.jpg
i.dailymail.co.uk/1s/2018/10/23/18/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/10/23/18/5331710-0-image-m-8_1540317153365.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
262eabf7f738e525ef65ad6ba22f1595014f904547f4ee8a4e40e51cbf7f951b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
lCiHpzJhyh7dfbvC3ZUYFIY.jEGfeLbl
last-modified
Tue, 23 Oct 2018 17:52:39 GMT
server
AmazonS3
x-amz-request-id
B25B72521DAF46FE
etag
"d88d0d9e743da6df855ba49b3616006a"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
3147
x-amz-id-2
uKqsxHcuL+SdWEXAk+UoSmFd+0pZ1rOvAxO65pitt/Pcc+A1AccZms7aqomI1UphF5vhZf6xCIU=
expires
Thu, 14 Jan 2021 12:48:45 GMT
5215280-0-image-m-52_1539982417591.jpg
i.dailymail.co.uk/1s/2018/10/19/21/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/10/19/21/5215280-0-image-m-52_1539982417591.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
d86145e800b2edf1e5eb56d69b8d4b032e3fe80d188b214b2d96a1f2bf4b4489

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wvBKzifmNudP.Ud9eG49QPa2Njfq7qCY
last-modified
Fri, 19 Oct 2018 20:53:50 GMT
server
AmazonS3
x-amz-request-id
744361A841DB8ECA
etag
"cad5372398912247eec9726be5c76b02"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
4013
x-amz-id-2
fO1bNdsbqd9r0PagUHZ6Ui5DN9oOP7VzisMWyqLH+EsVXzO/nHRG0miyu6KQrxyI0PgCBXqGSR8=
expires
Thu, 14 Jan 2021 12:48:45 GMT
50187CA400000578-0-image-m-6_1537221081247.jpg
i.dailymail.co.uk/i/newpix/2018/09/17/22/
9 KB
9 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/newpix/2018/09/17/22/50187CA400000578-0-image-m-6_1537221081247.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
7715a959ab7727da10cf349d186ac930deee63caa1da57b6a06f593169120463

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
69XQkAdVBDtAZqQwrQNlsWb9zFfn0i8C
content-type
image/jpeg
x-amz-request-id
BA63AE5D99967E3F
x-amz-meta-mode
33188
x-amz-replication-status
COMPLETED
content-length
9027
x-amz-id-2
HlYBC06mNW5p6g2x1UDB9gpwGfQ+L2E4OM1vtmw9+BLK74qjEQxqVKGKNrkTzB3rlAZXvan4SWM=
last-modified
Mon, 17 Sep 2018 21:51:50 GMT
server
AmazonS3
etag
"66be7a043c74435e66d39c6e56d5b080"
x-amz-meta-uid
1001
x-amz-meta-gid
1001
expires
Thu, 14 Jan 2021 12:48:45 GMT
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-meta-mtime
1537221109
5103536-0-image-a-19_1539725071750.jpg
i.dailymail.co.uk/1s/2018/10/16/22/
2 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2018/10/16/22/5103536-0-image-a-19_1539725071750.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
0beaf04aa3ffe6710f5c82bcabc2abe511e502e0a6efb67d3c0f6f0a16e1ecaf

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
THriLqeUHwahvD58RwbYcp4aNG2c1ppO
last-modified
Tue, 16 Oct 2018 21:24:33 GMT
server
AmazonS3
x-amz-request-id
55C607FE5E420A8D
etag
"d07a1976ac9cc106db68ffdc9b413903"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
2457
x-amz-id-2
CpvSA1FMvjJ2LWtOS9k71tdARmmCEWPKfrph246dtxx73wpVOkAfLi0/2VmYA6XN+ndc5TB5bsI=
expires
Thu, 14 Jan 2021 12:48:45 GMT
5018D69B00000578-0-image-m-25_1537206890240.jpg
i.dailymail.co.uk/i/newpix/2018/09/17/18/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/newpix/2018/09/17/18/5018D69B00000578-0-image-m-25_1537206890240.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
762b7e0a62a387d1c30959378b78a1d3ba353af55627d535008eed4d40cb2304

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
TgpbUsNqviYpWo4sBOS3jj.EbD1xHQqV
content-type
image/jpeg
x-amz-request-id
AB45D2C875F31C61
x-amz-meta-mode
33188
x-amz-replication-status
COMPLETED
content-length
3670
x-amz-id-2
g/1X7iIUAVCnVdNTSYphsRiHimeMd8BfA+u/CgCISnZMY460LXScRtDFlhqdsVIkwPdqGUrujXA=
last-modified
Mon, 17 Sep 2018 17:55:01 GMT
server
AmazonS3
etag
"01fdc609cc6cf31cbefa585ed3f7e0c6"
x-amz-meta-uid
1001
x-amz-meta-gid
1006
expires
Thu, 14 Jan 2021 12:48:45 GMT
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-meta-mtime
1537206900
47A0BC8600000578-0-image-m-9_1514842576590.jpg
i.dailymail.co.uk/i/pix/2018/01/01/21/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2018/01/01/21/47A0BC8600000578-0-image-m-9_1514842576590.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
f9379aa18d07b23638150a9dd541fc3b1b067b630deeeb82acce091bb0c804bc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Mon, 01 Jan 2018 21:36:33 GMT
server
Apache
etag
"8ffaaa4e9a4498b9a4cc2fc0138126e9:1514842593"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3351
expires
Thu, 14 Jan 2021 12:48:45 GMT
30E0B9C900000578-0-image-m-23_1454693647723.jpg
i.dailymail.co.uk/i/pix/2016/02/05/17/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2016/02/05/17/30E0B9C900000578-0-image-m-23_1454693647723.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
e9de05ef39f54d3d1e517f917de4391be1ce2082481b776d224e1d0109ea082e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Fri, 05 Feb 2016 17:34:16 GMT
server
AkamaiNetStorage
etag
"3cb57b1741b4544e2644221548784472:1454693656"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
2912
expires
Thu, 14 Jan 2021 12:48:45 GMT
3158355B00000578-0-image-m-5_1455807123483.jpg
i.dailymail.co.uk/i/pix/2016/02/18/14/
4 KB
4 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2016/02/18/14/3158355B00000578-0-image-m-5_1455807123483.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
c80e4716674a9b307269ad181a8985f1b97cdfd4065e7384dfcadbbd5e657520

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Thu, 18 Feb 2016 14:52:13 GMT
server
Apache
etag
"b49c58d2f5207cf6b67c42a54240c5d5:1455807133"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3705
expires
Thu, 14 Jan 2021 12:48:45 GMT
294F489500000578-0-image-m-22_1433292308497.jpg
i.dailymail.co.uk/i/pix/2015/06/03/01/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2015/06/03/01/294F489500000578-0-image-m-22_1433292308497.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
db1bdd24b8e6603a6c27576228d57eb0db7518a781a33a614ff63a28b005f841

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Wed, 03 Jun 2015 00:45:32 GMT
server
AkamaiNetStorage
etag
"b81aaa0b69e4389fea9c60a44d84695a:1433292332"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3061
expires
Thu, 14 Jan 2021 12:48:45 GMT
/
crta.dailymail.co.uk/
8 B
451 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:45 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:48:45 GMT
spt_previewlinks_12.png
i.dailymail.co.uk/i/furniture/
777 B
983 B
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/spt_previewlinks_12.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
570e1f285b390e0f3d884194a0ff4dfa733fec75c306f437b7a6b8e30ba31034

Request headers

Referer
https://www.dailymail.co.uk/static/gunther/17.14.0/all--.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Mon, 06 Nov 2017 11:51:20 GMT
server
Apache
etag
"89d33ecb32c726c50934f04d4af5876b:1509969080"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
777
expires
Thu, 14 Jan 2021 12:48:45 GMT
2
www.dailymail.co.uk/abe/a9/price/
4 B
704 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
bid
c.amazon-adsystem.com/e/dtb/
23 B
372 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=9&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22sky-left%22%2C%22s%22%3A%5B%22300x600%22%2C%22160x600%22%2C%22120x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
4b8f230af668f20a7b50021f1edb1fac1c96cab1aa576933a2064e5d7807179b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
23
x-amz-cf-id
5r6faet6RuIO2EguKYKeh-fSYtG2BNLXjXy-Gh8c1RxvB9t56xiuSA==
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=10&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22sky-right%22%2C%22s%22%3A%5B%22300x600%22%2C%22160x600%22%2C%22120x600%22%2C%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
b84677c9d507861ede2db86349957b3fff926d3857fb11595ab96d8866314798

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
otNEA41TldDvUtiGfCX38etnjnAzzRFTSoI8TV9f6kLRX51RQECarg==
bid
c.amazon-adsystem.com/e/dtb/
24 B
375 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=11&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22sky_left_bottom%22%2C%22s%22%3A%5B%22300x600%22%2C%22160x600%22%2C%22120x600%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
843ca27aa5a55f23f36493f7a6c93bd16bae165e07e4be441ea45723b586eae2

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
ahKMANxnOW7givyDH4KbFRmOuC6hnScjVAmiYKqAQsHiYfYnEvEqWQ==
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=12&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22sky_right_bottom%22%2C%22s%22%3A%5B%22300x600%22%2C%22160x600%22%2C%22120x600%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
63c3f35eed8f9fae951373f4f0642d09521b1b86c8d3a6d679047bc5440790fb

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
gISIA_RVxuo92OCXKyZ_-bQMuAK8-YL4leeA_CsdVq_whvgy74Oytg==
preload-inline.gif
i.dailymail.co.uk/i/furniture/fff/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/fff/preload-inline.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
aebc793d0064383ee6b1625bf3bb32532ec30a5c12bf9117066107d412119123

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Tue, 02 Jul 2013 10:22:29 GMT
server
Apache
etag
"a51c5608d01acf32df728f299767f82b:1372760549"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3208
expires
Thu, 14 Jan 2021 12:48:45 GMT
icon_camera_90x68.png
i.dailymail.co.uk/i/furniture/mobile/
876 B
1 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/mobile/icon_camera_90x68.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
be5c85bf40c3790d8bb01cbf334c014a920ad644d8ea3b61a3b8ed755b73a114

Request headers

Referer
https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-async-bundle/6.18.1/articleDefer.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Tue, 28 Feb 2017 12:53:16 GMT
server
Apache
etag
"8d29fb626b73132ae1d4b6540c126c58:1488286396"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
876
expires
Thu, 14 Jan 2021 12:48:45 GMT
currencyExchangeRate
fff.dailymail.co.uk/
19 B
166 B
XHR
General
Full URL
https://fff.dailymail.co.uk/currencyExchangeRate
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/fff.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:289::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
f4be37ae6f3da730d311ea6ff931acc51d1ae189ec3c2d28869cb00e536605cd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

access-control-allow-origin
*
x-rs-ops
fff2-fe:8180
date
Tue, 15 Dec 2020 12:48:45 GMT
cache-control
max-age=48182
content-length
19
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
1.0.1
fff.dailymail.co.uk/templates/
9 KB
2 KB
XHR
General
Full URL
https://fff.dailymail.co.uk/templates/1.0.1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/fff.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:289::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
6b8474a0f9c6b3c69e02409f7eeb8faa908b8b18e64fdf7cc88a9129585fc7c3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=511867
content-length
1941
x-rs-ops
fff1-fe:8180
55199X1584066.skimlinks.js
s.skimresources.com/js/
58 KB
22 KB
Script
General
Full URL
https://s.skimresources.com/js/55199X1584066.skimlinks.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.139.128.11 Dallas, United States, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
d15d47ae173596cea02055037e0583eee0b1c9fce6179a4fbcb5faf296fea2f2

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
gzip
last-modified
Mon, 30 Nov 2020 17:56:03 GMT
server
AmazonS3
x-amz-request-id
5W4HASEZCJ6K3GAM
etag
"7f46ae8cd859199c8b62c24129e50c89"
x-hw
1608036525.cds006.lo4.hn,1608036525.cds062.lo4.c
content-type
application/octet-stream
cache-control
max-age=3600
accept-ranges
bytes
content-length
21929
x-amz-id-2
N/TA2eZj3rlSeAwKiT7xHsFpOs3Qk6xPwvuKwoHSQQBGob9UhrW51cDpzhhHQ51Mom7zrH+XTLQ=
truncated
/
174 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
52efd6959ae8fb441d9b7bce3624bcbda0b601316751028b16b31484124019c5

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
685 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
fce704a574001e626087c28db6ba29c8c6bce20f156a7fc3a321b505326be3b5

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
35301122-0-image-a-72_1604597135950.jpg
i.dailymail.co.uk/1s/2020/11/05/17/
39 KB
39 KB
Image
General
Full URL
https://i.dailymail.co.uk/1s/2020/11/05/17/35301122-0-image-a-72_1604597135950.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
97cdff8479a3f6226825bdfce4a1b3321e9ed6a8dbd421ce7fe0938fceff6b36

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
yp7jOty6Pityry1xyBlnwow665j9.BNt
last-modified
Thu, 05 Nov 2020 17:25:37 GMT
server
AmazonS3
x-amz-request-id
F11CC7ECC78A2F15
etag
"567f119af5c2cf8c56a640be41f0d247"
content-type
image/jpeg
cache-control
max-age=2592000
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
accept-ranges
bytes
timing-allow-origin
*
content-length
39446
x-amz-id-2
SittGBFE+HRht6X/BaHNWvcxyuDU2gT1ffxTK5Y9b8c8FK/3Ehwv2l4gUuaudyMUInxx0DDCo4M=
expires
Thu, 14 Jan 2021 12:48:45 GMT
mol-video.woff
www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/font/
3 KB
4 KB
Font
General
Full URL
https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/font/mol-video.woff
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/styles/mol-fe-videoplayer.min.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
4e89866ffba8b06a31d366ea9f6f5331f87fe29877bfce5381b78a46ddb7fd19

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/styles/mol-fe-videoplayer.min.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Sun, 13 Dec 2020 22:55:47 GMT
server
AkamaiNetStorage
etag
"485a02e860743f3a21195c18ca687a40:1607900147.982203"
vary
User-Agent
content-type
font/woff
access-control-allow-origin
*
cache-control
max-age=2514527
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
content-length
3376
expires
Wed, 13 Jan 2021 15:17:32 GMT
bridge3.431.1_en.html
imasdk.googleapis.com/js/core/ Frame 8B9B
0
0
Document
General
Full URL
https://imasdk.googleapis.com/js/core/bridge3.431.1_en.html
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/ima3.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
imasdk.googleapis.com
:scheme
https
:path
/js/core/bridge3.431.1_en.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
192077
date
Tue, 15 Dec 2020 11:15:04 GMT
expires
Wed, 15 Dec 2021 11:15:04 GMT
last-modified
Mon, 14 Dec 2020 09:10:26 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
5621
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
client.js
s0.2mdn.net/instream/video/
26 KB
11 KB
Script
General
Full URL
https://s0.2mdn.net/instream/video/client.js
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/ima3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
62f2eeec7851ae0d5e322062cf40092478236d4a4fc5a2cfd87b257739104147
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10523
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:45 GMT
video-sources.json
www.dailymail.co.uk/api/player/8132733030895302559/
1 KB
1002 B
Fetch
General
Full URL
https://www.dailymail.co.uk/api/player/8132733030895302559/video-sources.json?geo=DE
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/mol-fe-videoplayer.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
12e37e027ca2c71961fa9bb81688795414a682fea3f110e747b075763742be6c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
gzip
vary
Accept-Encoding, User-Agent
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
server-timing
cdn-cache; desc=HIT, edge; dur=1
content-length
329
x-rs-ops
varnish-web-a1-fe.hsk.mol.dmgt.net:6081
x-graced
false
x-rs-time
Tue, 15 Dec 2020 12-45-02 GMT
restarts
0
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
*
x-rs-ben
cljfe-b1:8181
accept-ranges
bytes
x-mol-georesp
de
access-control-allow-headers
*
x-storage
api
chromeless_closer.png
i.dailymail.co.uk/video/
372 B
584 B
Image
General
Full URL
https://i.dailymail.co.uk/video/chromeless_closer.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
9dff2251abbde2c57b87b8e340e8cc695637fa72f8ff311c61c37b97ec5810c1

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Mon, 01 Jul 2019 16:55:07 GMT
server
AkamaiNetStorage
etag
"8de2a98adb80767b95658b4b19f1342c:1562000107"
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
372
expires
Thu, 14 Jan 2021 12:48:45 GMT
bid
c.amazon-adsystem.com/e/dtb/
24 B
375 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=13&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22id%22%3A%22ctp_video_desktop%22%2C%22mt%22%3A%22v%22%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
af058bc0a949d80a2234f297e983e6fb3438a7f360daf4cdecd3d717ce047ea7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
oiFd6XPNELCkal7fQHONF7C8zOEIaajS0qw2C1w-Ttb8mQGGq_MqZg==
partner
sync.search.spotxchange.com/
Redirect Chain
  • https://sync.search.spotxchange.com/partner?source=dados
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=de90a433-3ed3-11eb-a754-15ce3e534d06
0
589 B
Image
General
Full URL
https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=de90a433-3ed3-11eb-a754-15ce3e534d06
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.94.180.125 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-spotx-halt-type
Audience Dsp sync Priority Sync endpoint Source ID is not on enabled source whitelist
Date
Tue, 15 Dec 2020 12:48:45 GMT
Server
nginx
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
110
Connection
keep-alive
Content-Length
0

Redirect headers

Date
Tue, 15 Dec 2020 12:48:45 GMT
Server
nginx
Location
/partner?source=dados&__user_check__=1&sync_id=de90a433-3ed3-11eb-a754-15ce3e534d06
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
18
Connection
keep-alive
Content-Length
0
bid
c.amazon-adsystem.com/e/dtb/
24 B
375 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=14&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22id%22%3A%22jw_video_desktop%22%2C%22mt%22%3A%22v%22%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
36a74661dfb652c289dd3bdccf3c31dc9ba453a328a4318aa72a34f1454f0842

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
1rug0vjYNqTog5gjMnwELqTQgMzQeEMOQOQq50y5AZ8COzVtWSjGxg==
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
22fb714ec02d2ed7b2736d523d3772b16a3dd5bd06fc913a1246f290331b7cc3

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:45 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
avjp
mailonline-uk-d.openx.net/v/1.0/
92 B
285 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=64304301-e8d0-4bf7-b2ea-bd30afa19976&nocache=1608036525625&pubcid=3093687966&auid=540675380&vwd=636&vht=358
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=293355&v=8.1&r=%7B%22id%22%3A%22172584eba712c682%22%2C%22imp%22%3A%5B%7B%22id%22%3A%221739988978b08de%22%2C%22ext%22%3A%7B%22siteID%22%3A%22293355%22%2C%22sid%22%3A%22636x358%22%7D%2C%22video%22%3A%7B%22startdelay%22%3A0%2C%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A0%2C%22maxduration%22%3A30%2C%22protocols%22%3A%5B1%2C2%2C3%2C4%2C5%2C6%5D%2C%22api%22%3A%5B1%2C2%5D%2C%22w%22%3A636%2C%22h%22%3A358%2C%22placement%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1&nf=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
380b10712a3db293925cfec37beb79818160553ed95dc74514135f451ec9f83a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:48:45 GMT
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=MailOnline
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.189.33 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
568e670c088836f8e6add3fd1114c1be8502af6fa3946d922b4767c03f1fd353

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:45 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=MailOnline
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.189.33 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=293354&v=8.1&r=%7B%22id%22%3A%221815d422fb44e513%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22182395deb37f3d8b%22%2C%22ext%22%3A%7B%22siteID%22%3A%22293354%22%2C%22sid%22%3A%22401x225%22%7D%2C%22video%22%3A%7B%22startdelay%22%3A0%2C%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A0%2C%22maxduration%22%3A30%2C%22protocols%22%3A%5B1%2C2%2C3%2C4%2C5%2C6%5D%2C%22api%22%3A%5B1%2C2%5D%2C%22w%22%3A401%2C%22h%22%3A225%2C%22placement%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1&nf=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
9fdb306e0309493f400228dd477acaa4a6a6ed05528069a6982d3a522471c4bc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:48:45 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
715 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:45 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.139:80
AN-X-Request-Uuid
4b117aaf-850f-477e-9b0b-6b3a758b5f20
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
avjp
mailonline-uk-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=21581dd9-e76e-487b-8574-b6df6fa7c2d8&nocache=1608036525633&pubcid=3093687966&auid=540675388&vwd=401&vht=225
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
Cookie set usermatch
ssum-sec.casalemedia.com/ Frame 1DF2
Redirect Chain
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
0
0
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
ssum-sec.casalemedia.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
CMID=X9iws47XVyph4E9x3bGiYgAA; CMPS=1155
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache
Content-Type
text/html
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Vary
Is-Traffic-Usersync
Content-Length
1581
Expires
Tue, 15 Dec 2020 12:48:51 GMT
Cache-Control
max-age=0, no-cache, no-store
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:51 GMT
Connection
keep-alive
Set-Cookie
CMID=X9iws47XVyph4E9x3bGiYgAA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:48:51 GMT CMPS=1155;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:48:51 GMT CMPRO=1211;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:48:51 GMT CMST=X9iws1-YsLMA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 16 Dec 2020 12:48:51 GMT CMRUM3=e65fd8b0b327600&085fd8b0b305a00&f15fd8b0b305a00&825fd8b0b3a8c0&275fd8b0b30b40&9c5fd8b0b305a00&335fd8b0b305a0&2d5fd8b0b305a0;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:48:51 GMT

Redirect headers

Server
Apache
Content-Length
338
Content-Type
text/html; charset=iso-8859-1
Location
https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Expires
Tue, 15 Dec 2020 12:48:51 GMT
Cache-Control
max-age=0, no-cache, no-store
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:51 GMT
Connection
keep-alive
Set-Cookie
CMID=X9iws47XVyph4E9x3bGiYgAA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:48:51 GMT CMPS=1155;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:48:51 GMT
6.gif
id5-sync.com/c/167/146/4/
Redirect Chain
  • https://id5-sync.com/i/167/9.gif?gdpr=&gdpr_consent=
  • https://id5-sync.com/c/167/0/9/1.gif?gdpr=1&gdpr_consent=
  • https://ice.360yield.com/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMO6tA3QNYViPdwxqXlM7pRwmnB91HmAtL0p2oNRg&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F167%2F124%2F8%2F2.gif%3Fpuid%3D...
  • https://ice.360yield.com/ul_cb/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMO6tA3QNYViPdwxqXlM7pRwmnB91HmAtL0p2oNRg&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F167%2F124%2F8%2F2.gif%3Fp...
  • https://id5-sync.com/cq/167/124/8/2.gif?puid=1d8dd5a5-48ae-4ede-8ff4-0b58c8740c50&gdpr=1&gdpr_consent=&gdpr=1&gdpr_consent=
  • https://sync.crwdcntrl.net/map/c=13953/tp=IDFI/gdpr=1/gdpr_consent=?https://id5-sync.com/c/167/19/7/3.gif?puid=${profile_id}&gdpr=1&gdpr_consent=
  • https://id5-sync.com/c/167/19/7/3.gif?puid=b8757e1265bd76128ab1634229ce863a&gdpr=1&gdpr_consent=
  • https://ads.creative-serving.com/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F101%2F6%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/167/101/6/4.gif?puid=c09025a4-3ce0-4ccf-aa9e-425c20b4837e&gdpr=1&gdpr_consent=
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F108%2F5%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_con...
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F108%2F5%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gd...
  • https://id5-sync.com/c/167/108/5/5.gif?puid=dfe301f4-3ed3-11eb-a599-e2dd7f45358e&gdpr=1&gdpr_consent=
  • https://ads.avocet.io/getuid?url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F4%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://ads.avct.cloud/getuid?r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F4%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://ads.avct.cloud/getuid?bounce=true&r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F167%2F146%2F4%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/167/146/4/6.gif?puid=acaaa0c8-2a7a-4890-bbea-931320f979cb&gdpr=1&gdpr_consent=
43 B
1 KB
Image
General
Full URL
https://id5-sync.com/c/167/146/4/6.gif?puid=acaaa0c8-2a7a-4890-bbea-931320f979cb&gdpr=1&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
51.89.20.87 , Germany, ASN16276 (OVH, FR),
Reverse DNS
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:51 GMT
Transfer-Encoding
chunked
Content-Type
image/gif;charset=UTF-8
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
P3P
CP="CAO PSA OUR"

Redirect headers

location
https://id5-sync.com/c/167/146/4/6.gif?puid=acaaa0c8-2a7a-4890-bbea-931320f979cb&gdpr=1&gdpr_consent=
date
Tue, 15 Dec 2020 12:48:51 GMT
p3p
policyref="http://cdn.avocet.io/w3c/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-length
132
content-type
text/html; charset=utf-8
top-videos.jpg
creative.dailymail.co.uk/videos/
111 KB
111 KB
Image
General
Full URL
https://creative.dailymail.co.uk/videos/top-videos.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:eb:3a5::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
6924aeec6e6de01dfd439327c170d8adc2f9dd8415e9903e3b24f2c3b6506389

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:45 GMT
Last-Modified
Wed, 01 May 2019 13:28:47 GMT
Server
AkamaiNetStorage
ETag
"41c301b2aac4a100430b42c8cf52583e:1556717327"
Content-Type
image/jpeg
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
113532
black-preload.gif
i.dailymail.co.uk/i/furniture/fff/hub/
3 KB
3 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/furniture/fff/hub/black-preload.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
babed8ddf22ed2e66590a4f75773661304242a4f4167d52e165652fee492933e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
last-modified
Tue, 19 Nov 2013 14:19:15 GMT
server
Apache
etag
"37e24e0370847870c1c43ea9ce19b1f4:1384870755"
content-type
image/gif
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
3208
expires
Thu, 14 Jan 2021 12:48:45 GMT
script.js
uk-script.dotmetrics.net/Scripts/
76 KB
34 KB
Script
General
Full URL
https://uk-script.dotmetrics.net/Scripts/script.js?v=175
Requested by
Host: uk-script.dotmetrics.net
URL: https://uk-script.dotmetrics.net/door.js?d=www.dailymail.co.uk&t=sciencetech
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.68.93 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Kestrel /
Resource Hash
baefc8e2d17efa61e19c14031bc6e61cd89718a052276151bd4c7fdfac723598

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
content-encoding
br
last-modified
Mon, 30 Nov 2020 14:50:31 GMT
server
Kestrel
x-amz-cf-pop
FRA56-C1
etag
"1d6c728265824d3"
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
application/javascript
via
1.1 106758604a7f1ae0fa6678cd3d828d62.cloudfront.net (CloudFront)
accept-ranges
bytes
x-amz-cf-id
nG_y9NbCs7Xw75sK-n_LOlcTkc8DsQ_88u_iovlk-Ujfb9MOXV3XKQ==
2
www.dailymail.co.uk/abe/a9/price/
4 B
703 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
products
fff.dailymail.co.uk/
2 B
135 B
XHR
General
Full URL
https://fff.dailymail.co.uk/products?articleId=9050821&geo=gb
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-fff/1.3.16/scripts/fff.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:289::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

access-control-allow-origin
*
x-rs-ops
fff1-fe:8180
date
Tue, 15 Dec 2020 12:48:45 GMT
content-length
2
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
2
www.dailymail.co.uk/abe/a9/price/
4 B
701 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
2
www.dailymail.co.uk/abe/a9/price/
4 B
701 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
2
www.dailymail.co.uk/abe/a9/price/
4 B
703 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094419
date
Tue, 15 Dec 2020 12:48:45 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
setuid
ib.adnxs.com/prebid/
Redirect Chain
  • https://pr-bh.ybp.yahoo.com/sync/appnexusprebidserver/?gdpr=0&euconsent=&us_privacy=&url=https%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Dbrightroll%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24UID
  • https://ib.adnxs.com/prebid/setuid?bidder=brightroll&gdpr=0&gdpr_consent=&uid=y-wPf9RO51lxbqnPJgiGb0zMM0bDiELEJLhaAaxcungM9JDgUuJ0BB_.0-
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/prebid/setuid?bidder=brightroll&gdpr=0&gdpr_consent=&uid=y-wPf9RO51lxbqnPJgiGb0zMM0bDiELEJLhaAaxcungM9JDgUuJ0BB_.0-
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:45 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.41:80
AN-X-Request-Uuid
a83b2a45-c1e6-4642-9c0d-c8473df0e997
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:48:45 GMT
referrer-policy
strict-origin-when-cross-origin
server
ATS
age
0
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
strict-transport-security
max-age=31536000
location
https://ib.adnxs.com/prebid/setuid?bidder=brightroll&gdpr=0&gdpr_consent=&uid=y-wPf9RO51lxbqnPJgiGb0zMM0bDiELEJLhaAaxcungM9JDgUuJ0BB_.0-
x-xss-protection
1; mode=block
content-length
0
x-content-type-options
nosniff
expires
Thu, 01 Jan 1970 00:00:00 GMT
robots.txt
t.skimresources.com/api/v2/ Frame F267
0
61 B
Image
General
Full URL
https://t.skimresources.com/api/v2/robots.txt?__skimjs_preflight__please_ignore__=true&rnd=0.4568768790418434
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.67.47 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Python/3.7 aiohttp/3.5.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
via
1.1 google
server
Python/3.7 aiohttp/3.5.4
alt-svc
clear
content-length
0
content-type
text/plain charset=UTF-8
px.gif
p.skimresources.com/
43 B
102 B
Image
General
Full URL
https://p.skimresources.com/px.gif?ch=1&rn=2.444491532192282
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.91.160 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Skimlinks Pixel 1.0 /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 google
server
Skimlinks Pixel 1.0
p3p
policyref="http://skimlinks.com/w3c/p3p.xml", CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
alt-svc
clear
content-length
43
content-type
image/gif
px.gif
p.skimresources.com/
43 B
244 B
Image
General
Full URL
https://p.skimresources.com/px.gif?ch=2&rn=2.444491532192282
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.91.160 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Skimlinks Pixel 1.0 /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:45 GMT
via
1.1 google
server
Skimlinks Pixel 1.0
p3p
policyref="http://skimlinks.com/w3c/p3p.xml", CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
alt-svc
clear
content-length
43
content-type
image/gif
/
r.skimresources.com/api/
Redirect Chain
  • https://r.skimresources.com/api/
  • https://r.skimresources.com/api/?xguid=01ESK74ATS6N9SWYC3BV06G4AP&persistence=1&checksum=e4f9793094f15d319101de2a54d6ee9ced3dc890dc276ab94659cec811174d68
208 B
512 B
XHR
General
Full URL
https://r.skimresources.com/api/?xguid=01ESK74ATS6N9SWYC3BV06G4AP&persistence=1&checksum=e4f9793094f15d319101de2a54d6ee9ced3dc890dc276ab94659cec811174d68
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.190.59.101 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
openresty/1.11.2.5 /
Resource Hash
8412cf903dcfdf06b90f6f10bf1a8cf3a36ea84980ca67cd72a44831a650785b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
openresty/1.11.2.5
strict-transport-security
max-age=31536000
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
https://www.dailymail.co.uk
vary
Accept-Encoding
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
via
1.1 google

Redirect headers

date
Tue, 15 Dec 2020 12:48:46 GMT
via
1.1 google
server
openresty/1.11.2.5
access-control-allow-origin
https://www.dailymail.co.uk
strict-transport-security
max-age=31536000
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
location
https://r.skimresources.com/api/?xguid=01ESK74ATS6N9SWYC3BV06G4AP&persistence=1&checksum=e4f9793094f15d319101de2a54d6ee9ced3dc890dc276ab94659cec811174d68
access-control-allow-credentials
true
content-type
text/html
alt-svc
clear
content-length
193
userreport.js
cdn.userreport.com/
241 KB
72 KB
Script
General
Full URL
https://cdn.userreport.com/userreport.js
Requested by
Host: sak.userreport.com
URL: https://sak.userreport.com/mol/launcher.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:9c00:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5a678a064b3f5f09f5013253c5cdf3f5df2d891c91ff4c1a967b6a0a7d342e24

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
mdUZv96Md1dlaUizZhqdBDLDgPlccOik
content-encoding
gzip
last-modified
Mon, 16 Nov 2020 11:36:20 GMT
server
AmazonS3
age
2291
etag
"4d30966c7f3304e37c730f73ba404918"
x-cache
Hit from cloudfront
content-type
application/x-javascript
via
1.1 241b025da3883bdb653910a6da97c0a8.cloudfront.net (CloudFront)
cache-control
max-age=3600
date
Tue, 15 Dec 2020 12:10:35 GMT
x-amz-cf-pop
AMS1-C1
accept-ranges
bytes
content-length
73144
x-amz-cf-id
Ka6hWToR7pyl0cRXRJno0j_s7CoQDUJwgeKdl20rnsvxoamCvOetuw==
hit
visitanalytics.userreport.com/
43 B
678 B
Image
General
Full URL
https://visitanalytics.userreport.com/hit?t=MOLm-YY4kURA16Uq4pnEr5N0VXg&rnd=17rq7yx3nm&dsu=1.b673c08b2400cd69.cbc7ef7e-726c-41d3-337f-bfa6a44b801a.1.714.f5c3d815d3687b09&med=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.91 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Mon, 14 Dec 2020 18:13:36 GMT
Via
1.1 3108b3c3c306768051fa0658c0445308.cloudfront.net (CloudFront)
Age
66910
x-amz-meta-cb-modifiedtime
Tue, 14 Apr 2015 11:43:27 GMT
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
43
Last-Modified
Thu, 04 Jun 2020 12:03:06 GMT
Server
AmazonS3
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3"
x-amz-version-id
vrBc0EhGKa8dl_tujGhI9Fe7xKDJ.7QF
Cache-Control
no-cache, no-store, must-revalidate
X-Amz-Cf-Pop
AMS1-C1
Accept-Ranges
bytes
Content-Type
image/gif
X-Amz-Cf-Id
0EqCWXg9lGRRqFMjf9WcDhCgyrv_RTHl0JV7UUWQiWHS5F46mJKPxA==
Expires
0
whoami
tag.userreport.com/
77 B
423 B
XHR
General
Full URL
https://tag.userreport.com/whoami
Requested by
Host: sak.userreport.com
URL: https://sak.userreport.com/mol/launcher.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:6200:11:af01:b40:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash
2b39727a2eac335fd8cbcf27595b217bb681b19fee3a8f49458229bc4ff6d102

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:29:59 GMT
via
1.1 3108b3c3c306768051fa0658c0445308.cloudfront.net (CloudFront)
server
nginx/1.12.2
age
1126
x-cache
Hit from cloudfront
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
access-control-allow-origin
*
cache-control
max-age=3600
x-amz-cf-pop
AMS1-C1
content-type
application/json
content-length
77
x-amz-cf-id
_76gt3g0HaC7P-6Z8WCSsTi-if1Dm1S1x7Op51HyPTiRbHiEV6eD2w==
config.json
c.go-mpulse.net/api/
5 KB
2 KB
XHR
General
Full URL
https://c.go-mpulse.net/api/config.json?key=RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD&d=www.dailymail.co.uk&t=5360122&v=1.720.0&sl=0&si=b685ccee-05e3-47c7-907a-aa13a6da2211-qldsx7&plugins=AK,ConfigOverride,Continuity,PageParams,IFrameDelay,AutoXHR,SPA,History,Angular,Backbone,Ember,RT,CrossDomain,BW,PaintTiming,NavigationTiming,ResourceTiming,Memory,CACHE_RELOAD,Errors,TPAnalytics,UserTiming,Akamai,Early,EventTiming,LOGN&acao=&ak.ai=145913
Requested by
Host: s.go-mpulse.net
URL: https://s.go-mpulse.net/boomerang/RQAJ2-Q4TGF-HEKJL-TAEAK-5V3VD
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2a02:26f0:6c00:19a::11a6 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
9b5207b583bd87f146970cb92de2f0807fe4a668cd1958fb9ff52ca36092839d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:45 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
private, max-age=300, stale-while-revalidate=60, stale-if-error=120
Connection
keep-alive
Timing-Allow-Origin
*
Content-Length
1339
json
relay.userreport.com/f/pageview/
14 B
149 B
XHR
General
Full URL
https://relay.userreport.com/f/pageview/json
Requested by
Host: sak.userreport.com
URL: https://sak.userreport.com/mol/launcher.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.33.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
4300d4e45e836ccd4946ff5e566c14ed0f3cfe8be4c1f43966ff4ae0ae3bf9bb

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:48:47 GMT
access-control-allow-credentials
true
content-type
application/json
json
relay.userreport.com/f/pageview/ Frame
0
0
Other
General
Full URL
https://relay.userreport.com/f/pageview/json
Protocol
H2
Server
52.1.33.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-requested-with
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
access-control-allow-credentials
true
access-control-allow-headers
content-type,x-requested-with
access-control-allow-methods
POST
access-control-allow-origin
https://www.dailymail.co.uk
settings.js
cdn.userreport.com/w_51248e61-3510-4ae9-b8a6-712be4dd155e/
5 KB
2 KB
Script
General
Full URL
https://cdn.userreport.com/w_51248e61-3510-4ae9-b8a6-712be4dd155e/settings.js
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:9c00:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
eae5fa416343a7c9494925c49cc48570b457c562a25a388a9fbfa39e405d57d8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
oKKUtr9VrqsV2HkWDM2dVmdvbyg0.yq4
content-encoding
gzip
last-modified
Thu, 14 May 2020 09:32:50 GMT
server
AmazonS3
x-amz-cf-pop
AMS1-C1
etag
"4eb5cc0a9ea3469c133043e9f20606fe"
x-cache
RefreshHit from cloudfront
content-type
text/javascript
via
1.1 241b025da3883bdb653910a6da97c0a8.cloudfront.net (CloudFront)
cache-control
max-age=0
date
Tue, 15 Dec 2020 12:48:46 GMT
accept-ranges
bytes
content-length
1737
x-amz-cf-id
gkU0USMeRzHGTLd0Z1ia_NSrRsbJCm6lgKZ4DJgsKJYZiWyz5Kc7Jw==
SiteEvent.dotmetrics
uk-script.dotmetrics.net/
316 B
1 KB
Script
General
Full URL
https://uk-script.dotmetrics.net/SiteEvent.dotmetrics?v=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%3D%3D&r=1608036525981
Requested by
Host: uk-script.dotmetrics.net
URL: https://uk-script.dotmetrics.net/Scripts/script.js?v=175
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.68.93 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Kestrel /
Resource Hash
2c2ab294436ecc82c873320a8e996c4d4785dc02c58364de96338d97ecc41d5d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
content-encoding
br
server
Kestrel
x-amz-cf-pop
FRA56-C1
vary
Accept-Encoding
x-cache
Miss from cloudfront
p3p
policyref="https://uk-script.dotmetrics.net/w3c/p3p.xml", CP="NOI DSP LAW CURa ADMa DEVa PSAa HISa OUR IND STA"
via
1.1 106758604a7f1ae0fa6678cd3d828d62.cloudfront.net (CloudFront)
cache-control
no-cache
content-type
application/javascript
x-amz-cf-id
N5Uf_9pYrBSQqdiQjOLnLc_JtE77Z12kB7rlb3xc89lf093bVrOt0Q==
5f42864d-a421-4f37-9478-00266f871d68-models.bin
cdn.permutive.com/models/
20 KB
21 KB
XHR
General
Full URL
https://cdn.permutive.com/models/5f42864d-a421-4f37-9478-00266f871d68-models.bin
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.19.149.54 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4c45cd70d2ed7d0949de5f5d8f7570e1d5a3e8ac60f5e83421f79ff32b71f14e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
cf-cache-status
HIT
age
77
x-guploader-uploadid
ABg5-UxILulDle9pme_8tLTb0jc8L_VzfsK3EZXEhbH21gy9pBM7G_twpraYqCNxYwL6JRFJkSWh7GFFXkp8yn16Rw
x-goog-storage-class
REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
gzip
content-type
application/x-binary
cf-request-id
07080b413e0000c775e7a30000000001
last-modified
Tue, 15 Dec 2020 05:25:37 GMT
server
cloudflare
etag
W/"ac8f35721a5b6a1246ee9c95067ddb4d"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
x-goog-hash
crc32c=1H0qnA==, md5=rI81chpbahJG7pyVBn3bTQ==
x-goog-generation
1608009937921506
access-control-allow-origin
*
access-control-expose-headers
Content-Length, Date, Server, Transfer-Encoding, X-GUploader-UploadID, X-Google-Trace
cache-control
public, max-age=300
x-goog-stored-content-length
20390
cf-ray
602047e1fae7c775-AMS
expires
Tue, 15 Dec 2020 12:53:46 GMT
getuidj
ib.adnxs.com/
11 B
706 B
XHR
General
Full URL
https://ib.adnxs.com/getuidj
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
31b45c462302ac175bfa43f9e5591491db780ca094f6ecdd2907f25ad578448d
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:46 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.45:80
AN-X-Request-Uuid
053b53f8-8a2c-45b7-ba59-2e9528bb3284
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
11
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
integrator.js
adservice.google.de/adsid/
109 B
803 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.dailymail.co.uk
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:46 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
247 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.dailymail.co.uk
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:46 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
43 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cbillboard&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=2000x1200%7C970x250%7C900x250%7C728x90&prev_scp=pos%3Dbillboard%26amznbid%3D2%26amznp%3D2%26adx_channel%3D4%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526095&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=315&adys=-278&adks=1878184308&ucis=1&ifi=1&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x250&msz=967x250&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=967&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
781e14d3ae7021cc09eb940521244adcda81ac0c4b65a6c4da71c2120547f545
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10769
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com/safeframe/1-0-37/html/
0
0
Other
General
Full URL
https://45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

ads
securepubads.g.doubleclick.net/gampad/
484 B
292 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cbillboard&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=1x1&ists=1&prev_scp=pos%3Dbillboard%26adx_channel%3D4%26nobids%3Dfalse%26refreshCount%3D0%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526105&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=-12245933&adys=-12245933&adks=2298815886&ucis=2&ifi=2&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x250&msz=1x1&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=132&ohw=1600&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
b8da54857d2023384b05a65a0888d203d75c824ae55b0d848dd885cc309f0979
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
257
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
43 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_factbox_1&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x250&prev_scp=pos%3Dmpu_factbox%26puff_offset%3D1%26adx_channel%3D10%26nobids%3Dtrue%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526111&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=650&adys=3409&adks=406235259&ucis=3&ifi=3&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=276x250&msz=300x250&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=1&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e1574d9ec03337aa1f78e4b71e2d82037f62926ed6de0b4ea85e8f51b59c3649
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10926
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
6 KB
3 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cinread_player_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=480x270%7C636x1%7C480x1&prev_scp=pos%3Dinread_player_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D2%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526114&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=396&adys=1173&adks=26236092&ucis=4&ifi=4&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=636x5210&msz=636x270&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
11b730d6f188acfbd336c15beff495053267f7f72acbc23e954a07459d18cb77
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2993
x-xss-protection
0
google-lineitem-id
5343416350
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138308123804
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
6 KB
3 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_factbox_2&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x250&prev_scp=pos%3Dmpu_factbox%26puff_offset%3D2%26adx_channel%3D15%26nobids%3Dtrue%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526116&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=650&adys=5776&adks=3738025968&ucis=5&ifi=5&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=276x250&msz=300x250&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=2&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
bf031051938b923d821baafd4dfa089328d85bec88847e8978c8d409aba7715b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
3161
x-xss-protection
0
google-lineitem-id
5378736227
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138312189788
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
43 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&prev_scp=pos%3Dmpu_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D9%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526119&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=978&adys=553&adks=1173142669&ucis=6&ifi=6&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x627&msz=308x627&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
ef034ad33558eb6d9706bc39a4427e135e15844a11053b6efe675dcc895aeb1f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10788
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
490 B
307 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Chalf_mpu_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x150&prev_scp=pos%3Dhalf_mpu_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D5%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526123&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=974&adys=1309&adks=3278541271&ucis=7&ifi=7&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x36962&msz=308x150&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=3&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
24ba79277b0588f3bb9365a7677d12275f0a11b65e145d158b8cb44f75261d31
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
264
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
43 KB
13 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_puff_20&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&prev_scp=pos%3Dmpu_puff_20%26amznbid%3D2%26amznp%3D2%26adx_channel%3D7%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526126&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=978&adys=5068&adks=34998414&ucis=8&ifi=8&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x627&msz=308x627&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=4&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
16e596eb0d2e7840093bc8f3e5d1d819a030cc2993d014fb153b016ab4dfe450
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13017
x-xss-protection
0
google-lineitem-id
5550703650
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138332606087
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
40 KB
12 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_puff_45&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&prev_scp=pos%3Dmpu_puff_45%26amznbid%3D2%26amznp%3D2%26adx_channel%3D11%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526130&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=978&adys=8845&adks=3500948802&ucis=9&ifi=9&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x627&msz=308x627&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=5&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e6a12968699cb4602dc0ca899aa2dab4dcdbfa228f2ee0b2e46510926d7cc6a9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
12186
x-xss-protection
0
google-lineitem-id
5550703650
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138332653878
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
65 KB
15 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_middle&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C300x250&prev_scp=pos%3Dmpu_middle%26amznbid%3D2%26amznp%3D2%26adx_channel%3D20%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526134&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=978&adys=33930&adks=3722470808&ucis=a&ifi=10&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=308x627&msz=308x627&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=6&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
42746ae5692b8df142c4d85ad3c8d10a36c727ac3edc5716323971318621b2fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15682
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
42 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Csky_left_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C160x600%7C120x600%7C300x250&prev_scp=pos%3Dsky_left_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D16%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526137&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=3&adys=20&adks=1681991210&ucis=b&ifi=11&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x620&msz=300x600&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
f8faa1810684fd9c26a13355bd9ed29f21429638a1380fe5675a99eedd6ea760
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10629
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
43 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Csky_right_top&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C160x600%7C120x600%7C300x250&prev_scp=pos%3Dsky_right_top%26amznbid%3D2%26amznp%3D2%26adx_channel%3D3%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526140&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=1297&adys=20&adks=3607738367&ucis=c&ifi=12&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x620&msz=300x600&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
35aed979a422b2e0359b9d6a4d6df39b98482e1f4096cfef2f9fbb2ae93255a3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10764
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
6 KB
3 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Csky_left_bottom&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C160x600%7C120x600&prev_scp=pos%3Dsky_left_bottom%26amznbid%3D2%26amznp%3D2%26adx_channel%3D14%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526142&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=3&adys=37021&adks=1756589617&ucis=d&ifi=13&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x37621&msz=300x600&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=7&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
6748cefbe7d5f18af8b772f90b98da8610a6a7b532222fa96df6644bce813372
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
3419
x-xss-protection
0
google-lineitem-id
5436450396
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138318400913
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
40 KB
12 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Csky_right_bottom&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x600%7C160x600%7C120x600&prev_scp=pos%3Dsky_right_bottom%26amznbid%3D2%26amznp%3D2%26adx_channel%3D8%26nobids%3Dfalse%26refreshCount%3D0%26amznsz%3D0x0&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036526145&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=1297&adys=37021&adks=118847816&ucis=e&ifi=14&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x37621&msz=300x600&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&ga_fc=true&fws=4&ohw=1600&btvi=8&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
2b4842f37e2832acc1184ccd6c484e097ce190d5239ba068a30dfbedb6424f47
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
12047
x-xss-protection
0
google-lineitem-id
4444921622
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138236649600
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
cta-branding.js
cdn.taboola.com/demand-formats/cta-branding/
8 KB
3 KB
Script
General
Full URL
https://cdn.taboola.com/demand-formats/cta-branding/cta-branding.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
0c56a21524db6a9ae3e1969698a146013f95b2fab9ac4ed167048d7e5d3c0830

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
zMWJo1PVj_h5BEu57MrR0ouiGawOeH2Y
content-encoding
gzip
etag
"2f4d244e58c3b6e32e449819d4fe0da1"
age
10027
x-cache
HIT
x-amz-replication-status
PENDING
content-length
2983
x-amz-id-2
UrqGF85PdXRhKnUzExvGW2WYb6SeGntEowKtDacaaZ9nc/UoQj+MisXht2ltBkCE5LBTYqqc2BY=
x-served-by
cache-fra19151-FRA
last-modified
Sun, 13 Dec 2020 10:01:26 GMT
server
AmazonS3
x-timer
S1608036526.216611,VS0,VE0
date
Tue, 15 Dec 2020 12:48:46 GMT
vary
Accept-Encoding
x-amz-request-id
3EE68CC59824B1CF
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
application/javascript
abp
23
x-cache-hits
93468
cta-branding.css
cdn.taboola.com/demand-formats/cta-branding/
3 KB
1 KB
Stylesheet
General
Full URL
https://cdn.taboola.com/demand-formats/cta-branding/cta-branding.css
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
b2cb57515497d75f4345929ae896c87c21f27d609aed94fb83f857e5b96f9835

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
tcahAQL7SM5vHmChLog9xryayd2KNhUu
content-encoding
gzip
etag
"9e155136143a96e23a99757df9aa3cc8"
age
12463
x-cache
HIT
x-amz-replication-status
PENDING
content-length
728
x-amz-id-2
f65xj6iuxogMKrz0V0PcFaMwZec2VDREXRA0jdjbf3aLNlkxtn2vhTmCXQ21535SK5HpYLHFJGI=
x-served-by
cache-fra19151-FRA
last-modified
Sun, 15 Nov 2020 09:20:35 GMT
server
AmazonS3
x-timer
S1608036526.216865,VS0,VE0
date
Tue, 15 Dec 2020 12:48:46 GMT
vary
Accept-Encoding
x-amz-request-id
414C1B5C7AA1A893
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
text/css
abp
23
x-cache-hits
112399
tb
15.taboola.com/
29 KB
9 KB
Script
General
Full URL
https://15.taboola.com/tb?oid=15&pubnm=dailymail-row&unitType=226&tbloc=&pageType=text&pstn=Below%20Article%20Thumbnails%202nd&uuip=&cisrf=&cirf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&encoded=1&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&variant=-100|421&callback=TRC.videoTagCallbacks.videoCallback1&cb=1608036526217&tagid=&cntry=PL&platform=1&sesid=e6302e1f13019910a997e6806c02579f&itemid=/sciencetech/article-9050821/remdesivir-beneficial-patients-doctors-reveal.html&viewid=1608036524897&geolat=&geoing=&deviceifa=&appid=&sd=v2_e6302e1f13019910a997e6806c02579f_5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c_1608036525_1608036525_CNawjgYQ-4w9GOHGyLPmLiABKAQwrgE47qgMQO3xK0jp2dgDUP___________wFYAGAAaOKmqpGyrZficA&ri=451d2ef0671c6dff1adb57d73f60686e&appname=&cdb=&gdprApplies=true&rid=&sii=3375619910924715558&oee=true&tpubid=1001083&uis=4&fagg=1&ccpaDns=false&ccpaPrivacy=&region=12&hasGDPRConsent=true&tcfVersion=&cmpStatus=&tnetid=1001079
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
5426560b522d3a4fdee512a7848240eed9856cdf884eb158faa0231b196d5561

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
content-encoding
gzip
machineid
1417
x-cache
MISS
x-cache-hits
0
x-served-by
cache-fra19151-FRA
pragma
no-cache
server
nginx
x-timer
S1608036526.245510,VS0,VE229
vary
Accept-Encoding
content-type
text/html;charset=ISO-8859-1
via
1.1 varnish
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
accept-ranges
bytes
link
<https://am-wf.taboola.com>; rel=preconnect
expires
Sat, 26 Jul 1997 05:00:00 GMT
userx.20201214-6-RELEASE.es6.js
cdn.taboola.com/libtrc/
23 KB
8 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/userx.20201214-6-RELEASE.es6.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/dailymail-row/loader.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
727885a70a1364d1fb91147b801bdc8f7dede4774fd1c9ae833850ed71fc29ce

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
Y0ss_Jafd96z_HkO2cF.Em0G3eY1Is9S
content-encoding
gzip
etag
"cfd0cc9c6be211947cf31df27de14f76"
age
16203
x-cache
HIT
x-amz-replication-status
PENDING
content-length
7879
x-amz-id-2
XLrx3K8fe/oa6Kfi/rG4gcK23ZBpn2W29w3g+mGMz+j61ELj8e81BP4fZw913s0CuASzBtUTGIo=
x-served-by
cache-fra19151-FRA
last-modified
Tue, 15 Dec 2020 08:18:39 GMT
server
AmazonS3
x-timer
S1608036526.244564,VS0,VE0
date
Tue, 15 Dec 2020 12:48:46 GMT
vary
Accept-Encoding
x-amz-request-id
2ABC199CCE0964B5
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
23
x-cache-hits
44850
tb
15.taboola.com/
33 KB
10 KB
Script
General
Full URL
https://15.taboola.com/tb?oid=15&pubnm=dailymail-row&unitType=244&tbloc=&pageType=text&pstn=Desktop-Wide&uuip=Feed%20-%20desktop-Desktop-Wide&cisrf=&cirf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&encoded=1&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&variant=-100|421&callback=TRC.videoTagCallbacks.videoCallback2&cb=1608036526220&tagid=&cntry=PL&platform=1&sesid=e6302e1f13019910a997e6806c02579f&itemid=/sciencetech/article-9050821/remdesivir-beneficial-patients-doctors-reveal.html&viewid=1608036524897&geolat=&geoing=&deviceifa=&appid=&sd=v2_e6302e1f13019910a997e6806c02579f_5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c_1608036525_1608036525_CNawjgYQ-4w9GOHGyLPmLiABKAQwrgE47qgMQO3xK0jp2dgDUP___________wFYAGAAaOKmqpGyrZficA&ri=05c06d6dd6c2ecf3c8bab6a8bbdd8065&appname=&cdb=&gdprApplies=true&rid=&sii=3375619910924715558&oee=true&tpubid=1001083&uis=4&fagg=1&ccpaDns=false&ccpaPrivacy=&region=12&hasGDPRConsent=true&tcfVersion=&cmpStatus=&tnetid=1001079
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
1771664cbe30da0446e2e061457a1a152996c5a4de31504b2c4bc9e5f1ffa42c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
content-encoding
gzip
machineid
1429
x-cache
MISS
x-cache-hits
0
x-served-by
cache-fra19151-FRA
pragma
no-cache
server
nginx
x-timer
S1608036526.246138,VS0,VE19
vary
Accept-Encoding
content-type
text/html;charset=ISO-8859-1
via
1.1 varnish
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
accept-ranges
bytes
link
<https://am-wf.taboola.com>; rel=preconnect
expires
Sat, 26 Jul 1997 05:00:00 GMT
feed-card-placeholder.20201214-6-RELEASE.es6.js
cdn.taboola.com/libtrc/
5 KB
2 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/feed-card-placeholder.20201214-6-RELEASE.es6.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/dailymail-row/loader.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
0db846dc61339c357dd05512f87a0c17edff73892a40cfdc9cc99e9a6a87c2de

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
1N_QgF8B43Ufhx3IGB4dyPFi6gyUlKhG
content-encoding
gzip
etag
"46667327073dd22e72d64173fcceee57"
age
16168
x-cache
HIT
x-amz-replication-status
PENDING
content-length
1269
x-amz-id-2
iDORd5mP3ruvGTFfTBUVv9TqGW+N8KDLWpS1YSX8aK0QXBSWT8MZSgzysEPqGnmkenwTsTAsMBQ=
x-served-by
cache-fra19151-FRA
last-modified
Tue, 15 Dec 2020 08:19:15 GMT
server
AmazonS3
x-timer
S1608036526.250431,VS0,VE0
date
Tue, 15 Dec 2020 12:48:46 GMT
vary
Accept-Encoding
x-amz-request-id
0AE60F5492B9C1F0
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
23
x-cache-hits
78516
f89e1763-220d-4e09-ba69-9e040548fb7a.svg
cdn.taboola.com/static/f8/
4 KB
2 KB
Image
General
Full URL
https://cdn.taboola.com/static/f8/f89e1763-220d-4e09-ba69-9e040548fb7a.svg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
39b076e4bb4fab9b8a142499cf6155f8c128464974691a04de7e764f71b72618

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
cMrDKn.emLmm9kiiOOF64ulDT4DRy6LK
content-encoding
gzip
etag
"b8b410e4b18d45aa2f3d9bc09cd335fb"
age
100
via
1.1 varnish
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
1758
x-amz-id-2
GFFBZiYr8EfRQVO22BVguu3tcQoWriDU4+e/Shm9C5asLqbab74JOY1R9fsMhrMMqRCBiYUSNQQ=
x-served-by
cache-fra19151-FRA
last-modified
Wed, 07 Feb 2018 11:15:52 GMT
server
AmazonS3
x-timer
S1608036526.253477,VS0,VE0
date
Tue, 15 Dec 2020 12:48:46 GMT
vary
Accept-Encoding
access-control-allow-methods
GET
x-amz-request-id
7V6J8M4G7K4P5VER
access-control-allow-origin
*
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/svg+xml
access-control-allow-headers
*
abp
23
x-cache-hits
257
c5ef96bc-30ab-456a-b3d5-a84f367c6a46.svg
cdn.taboola.com/static/c5/
3 KB
2 KB
Image
General
Full URL
https://cdn.taboola.com/static/c5/c5ef96bc-30ab-456a-b3d5-a84f367c6a46.svg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
1d89405054b0eccfd66baa763bf4781b8dff83824636284b79800ecdc25579f1

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
3GoWmPpnzFDs5CP3.ebHbCmhALWQMuvH
content-encoding
gzip
etag
"11d8569a7da0739259e3ac0b0d666e94"
age
105
via
1.1 varnish
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
1502
x-amz-id-2
LwAbM/TqYBcy8MmWt42d3nIT8MVIJbcor/NMIveZB5jhLN35dP/PtcEOLo4NPissi5fqZFiAxoA=
x-served-by
cache-fra19151-FRA
last-modified
Sun, 10 Jun 2018 13:23:55 GMT
server
AmazonS3
x-timer
S1608036526.261852,VS0,VE0
date
Tue, 15 Dec 2020 12:48:46 GMT
vary
Accept-Encoding
access-control-allow-methods
GET
x-amz-request-id
B4390413E103EA3C
access-control-allow-origin
*
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/svg+xml
access-control-allow-headers
*
abp
23
x-cache-hits
146
tpid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/ Frame 49FE
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=10924/tp=OOLA/tpid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
  • https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
49 B
710 B
Image
General
Full URL
https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.245.253.34 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-245-253-34.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
2f561b02a49376e3679acd5975e3790abdff09ecbadfa1e1858c7ba26e3ffcef

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:46 GMT
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
access-control-allow-origin
*
cache-control
no-cache
x-server
10.45.17.237
content-type
image/gif
content-length
49
expires
0

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:46 GMT
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
location
https://sync.crwdcntrl.net/map/ct=y/c=10924/tp=OOLA/tpid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
cache-control
no-cache
x-server
10.45.19.0
content-length
0
expires
0
rtb-h
match.taboola.com/sg/mediaforcebidder-network/1/ Frame 49FE
Redirect Chain
  • https://rtb.mfadsrvr.com/sync?ssp=taboola
  • https://rtb.mfadsrvr.com/ul_cb/sync?ssp=taboola
  • https://sync.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=dfac0f09-7b02-45bd-9865-aa7db649c705
  • https://match.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=dfac0f09-7b02-45bd-9865-aa7db649c705&tbid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&query=taboola_hm%3Ddfac0f09-7b02-...
0
147 B
Image
General
Full URL
https://match.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=dfac0f09-7b02-45bd-9865-aa7db649c705&tbid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&query=taboola_hm%3Ddfac0f09-7b02-45bd-9865-aa7db649c705&isDirect=0
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036527.400430,VS0,VE9
x-cache
MISS
x-cache-hits
0
accept-ranges
bytes
content-length
0
x-served-by
cache-hhn4026-HHN

Redirect headers

location
https://match.taboola.com/sg/mediaforcebidder-network/1/rtb-h?taboola_hm=dfac0f09-7b02-45bd-9865-aa7db649c705&tbid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&query=taboola_hm%3Ddfac0f09-7b02-45bd-9865-aa7db649c705&isDirect=0
tbl-x-upstream
10.41.24.10:10213
date
Tue, 15 Dec 2020 12:48:46 GMT
server
nginx
x-fastly-to-nlb-rtt
22484
sync.php
pixel.rubiconproject.com/exchange/ Frame 49FE
0
0

/
sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/ Frame 49FE
Redirect Chain
  • https://bh.contextweb.com/bh/rtset?pid=562107&ev=1&rurl=https%3A%2F%2Fsync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=%%VGUID%%&orig=trc
  • https://sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=NF7WK0yOs2i7&ev=1&orig=trc&pid=562107
0
217 B
Image
General
Full URL
https://sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=NF7WK0yOs2i7&ev=1&orig=trc&pid=562107
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.40.20.11:10213
date
Tue, 15 Dec 2020 12:48:51 GMT
server
nginx
x-fastly-to-nlb-rtt
25635

Redirect headers

strict-transport-security
max-age=15768000
server
Jetty(9.4.14.v20181114)
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
content-language
en-US
location
https://sync.taboola.com/sg/pulsepointrtb-network/1/rtb-h/?taboola_hm=NF7WK0yOs2i7&ev=1&orig=trc&pid=562107
cache-control
private, max-age=0, no-cache, no-store
cw-server
bh-deployment-stage-0
expires
-1
35702
tags.bluekai.com/site/ Frame 49FE
62 B
329 B
Image
General
Full URL
https://tags.bluekai.com/site/35702?id=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.246.202 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-246-202.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
0af3aae90b7de9fdceee2ab421378ea2f54c74be81ef43fc6c1790a032755d80

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:47 GMT
X-N
S
Connection
keep-alive
P3P
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
Content-Length
62
BK-Server
ba43
Content-Type
image/gif
mw
mwzeom.zeotap.com/ Frame 49FE
95 B
572 B
Image
General
Full URL
https://mwzeom.zeotap.com/mw?zpartnerid=1367&env=mWeb&cid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&gdpr=$0&gdpr_consent=$
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:1857 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
via
1.1 google
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
content-type
image/png
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
602047e1be560625-FRA
access-control-allow-headers
*
content-length
95
cf-request-id
07080b410f0000062504202000000001
sync
odr.mookie1.com/t/v2/ Frame 49FE
43 B
324 B
Image
General
Full URL
https://odr.mookie1.com/t/v2/sync?tagid=V2_866925&src.visitorId=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.67.61 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Apache /
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:46 GMT
via
1.1 google
server
Apache
p3p
CP="NON DSP COR NID CURa PSAa PSDa OUR STP UNI COM NAV STA LOC OTC",policyref="/w3c/p3p.xml"
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif;charset=UTF-8
alt-svc
clear
content-length
43
x-application-context
application
expires
Thu, 01 Jan 1970 00:00:00 GMT
cm
trc.taboola.com/sg/neustar/1/ Frame 49FE
Redirect Chain
  • https://aa.agkn.com/adscores/g.pixel?sid=9212237748&puid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
  • https://trc.taboola.com/sg/neustar/1/cm?taboola_hm=164970703636000653469
0
256 B
Image
General
Full URL
https://trc.taboola.com/sg/neustar/1/cm?taboola_hm=164970703636000653469
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
9
pragma
no-cache
date
Tue, 15 Dec 2020 12:48:46 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036527.937031,VS0,VE9
x-served-by
cache-fra19151-FRA
x-cache
MISS
cache-control
no-cache, no-store
accept-ranges
bytes
content-length
0
x-cache-hits
0

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:46 GMT
server
AAWebServer
p3p
policyref="https://www.agkn.com/p3p/p3p.xml",CP="NOI NID"
location
https://trc.taboola.com/sg/neustar/1/cm?taboola_hm=164970703636000653469
cache-control
no-cache, no-store, must-revalidate
content-length
0
expires
0
32441
i6.liadm.com/s/ Frame 49FE
Redirect Chain
  • https://i.liadm.com/s/32441?bidder_id=88068&bidder_uuid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
  • https://i.liadm.com/s/32441?bidder_id=88068&bidder_uuid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_li_chk=true&previous_uuid=7d9ade16903e4d9f9839cf862cb8c597
  • https://i6.liadm.com/s/32441?bidder_id=88068&bidder_uuid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
43 B
419 B
Image
General
Full URL
https://i6.liadm.com/s/32441?bidder_id=88068&bidder_uuid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:444a:4602:fff0:3de7:a67e:fe5f Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
caa849b179befa2645a8e2c474d2e82a76777a3305315ece911013e8ee9a916c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:50 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Strict-Transport-Security
max-age=31536000; includeSubDomains
Content-Type
image/gif

Redirect headers

Location
https://i6.liadm.com/s/32441?bidder_id=88068&bidder_uuid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Date
Tue, 15 Dec 2020 12:48:50 GMT
Connection
keep-alive
Content-Length
0
Strict-Transport-Security
max-age=31536000; includeSubDomains
/
pixel.onaudience.com/ Frame 49FE
Redirect Chain
  • https://pixel.onaudience.com/?partner=137085097&mapped=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=xksw9la&ttd_tpi=1
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=xksw9la&ttd_tpi=1
  • https://pixel.onaudience.com/?partner=147&mapped=756bd07b-da9f-4519-81af-bb93a5ce71b6&icm
  • https://sync.crwdcntrl.net/map/c=8587/tp=CLOD?https%3A%2F%2Fpixel.onaudience.com%2F%3Fpartner%3D104%26icm%26mapped%3D%24%7Bprofile_id%7D
  • https://pixel.onaudience.com/?partner=104&icm&mapped=b8757e1265bd76128ab1634229ce863a
35 B
248 B
Image
General
Full URL
https://pixel.onaudience.com/?partner=104&icm&mapped=b8757e1265bd76128ab1634229ce863a
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
51.210.112.66 , France, ASN16276 (OVH, FR),
Reverse DNS
ns3174888.ip-51-210-112.eu
Software
/
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-length
35
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
location
https://pixel.onaudience.com/?partner=104&icm&mapped=b8757e1265bd76128ab1634229ce863a
cache-control
no-cache
x-server
10.45.3.58
content-length
0
expires
0
getuidnb
ib.adnxs.com/ Frame 49FE
43 B
690 B
Image
General
Full URL
https://ib.adnxs.com/getuidnb?https://sync.taboola.com/sg/appnexus-network/1/rtb-h/?taboola_hm=$UID&orig=trc
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:46 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.55:80
AN-X-Request-Uuid
4a64192f-0c0c-4a4f-a740-b479819d9946
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
/
trc.taboola.com/sg/google-network/1/rtb-h/ Frame 49FE
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_cm&google_sc
  • https://trc.taboola.com/sg/google-network/1/rtb-h/?taboola_hm=CAESEKbcyJrl95BxMcRtbC_wd94&google_cver=1
0
200 B
Image
General
Full URL
https://trc.taboola.com/sg/google-network/1/rtb-h/?taboola_hm=CAESEKbcyJrl95BxMcRtbC_wd94&google_cver=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
9
date
Tue, 15 Dec 2020 12:48:47 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036527.222158,VS0,VE9
x-cache
MISS
x-cache-hits
0
accept-ranges
bytes
content-length
0
x-served-by
cache-fra19151-FRA

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://trc.taboola.com/sg/google-network/1/rtb-h/?taboola_hm=CAESEKbcyJrl95BxMcRtbC_wd94&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
304
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
Pug
simage2.pubmatic.com/AdServer/ Frame 49FE
42 B
1009 B
Image
General
Full URL
https://simage2.pubmatic.com/AdServer/Pug?vcode=bz0yJnR5cGU9MSZjb2RlPTM0MjcmdGw9MTI5NjAw&piggybackCookie=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c:$UID
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.190.80 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
Apache/2.2.24 (Unix) mod_ssl/2.2.24 OpenSSL/1.0.0-fips mod_fastcgi/2.4.6 /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

X-Cnection
close
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:46 GMT
X-lat
Pug23033:0:242
Server
Apache/2.2.24 (Unix) mod_ssl/2.2.24 OpenSSL/1.0.0-fips mod_fastcgi/2.4.6
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Cache-Control
no-store, no-cache, private
Content-Type
image/gif; charset=utf-8
Content-Length
42
csync.ashx
ml314.com/ Frame 49FE
Redirect Chain
  • https://ml314.com/utsync.ashx?eid=50077&et=0&fp=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&return=https%3a%2f%2fidsync.rlcdn.com%2f395886.gif%3fpartner_uid%3d%5bPersonID%5d
  • https://idsync.rlcdn.com/395886.gif?partner_uid=3615253859167895625
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTMzYxNTI1Mzg1OTE2Nzg5NTYyNRAAGg0IsOHi_gUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=22a6ad8e161b85079896f268e0670ce6647ddb1005e9c0165d3f112159e41947f4cb09cee1a4f8eb&person_id=3615253859167895625&eid=50082
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=22a6ad8e161b85079896f268e0670ce6647ddb1005e9c0165d3f112159e41947f4cb09cee1a4f8eb&person_id=3615253859167895625&eid=50082
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.18.215.87 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-18-215-87.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:48 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Wed, 16 Dec 2020 07:48:49 GMT

Redirect headers

date
Tue, 15 Dec 2020 12:48:49 GMT
via
1.1 google
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=22a6ad8e161b85079896f268e0670ce6647ddb1005e9c0165d3f112159e41947f4cb09cee1a4f8eb&person_id=3615253859167895625&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
pixel
cm.g.doubleclick.net/ Frame 49FE
Redirect Chain
  • https://sync.taboola.com/sg/google-network/1/rtb?redir=https%3A%2F%2Fcm.g.doubleclick.net%2Fpixel%3Fgoogle_nid%3Dtaboola_dbm%26google_sc%26gdpr%3D0%26gdpr_consent%3D&orig=trc
  • https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_sc&gdpr=0&gdpr_consent=&google_hm=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
170 B
306 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_sc&gdpr=0&gdpr_consent=&google_hm=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=taboola_dbm&google_sc&gdpr=0&gdpr_consent=&google_hm=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
tbl-x-upstream
10.41.24.10:10213
date
Tue, 15 Dec 2020 12:48:47 GMT
server
nginx
x-fastly-to-nlb-rtt
27810
/
trc.taboola.com/sg/thetradedesk-network/1/rtb-h/ Frame 49FE
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=054f32o&ttd_tpi=1
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=054f32o&ttd_tpi=1
  • https://trc.taboola.com/sg/thetradedesk-network/1/rtb-h/?taboola_hm=756bd07b-da9f-4519-81af-bb93a5ce71b6
0
60 B
Image
General
Full URL
https://trc.taboola.com/sg/thetradedesk-network/1/rtb-h/?taboola_hm=756bd07b-da9f-4519-81af-bb93a5ce71b6
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
10
date
Tue, 15 Dec 2020 12:48:47 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036528.823461,VS0,VE10
x-cache
MISS
x-cache-hits
0
accept-ranges
bytes
content-length
0
x-served-by
cache-fra19151-FRA

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://trc.taboola.com/sg/thetradedesk-network/1/rtb-h/?taboola_hm=756bd07b-da9f-4519-81af-bb93a5ce71b6
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
239
merge
ce.lijit.com/ Frame 49FE
Redirect Chain
  • https://ce.lijit.com/merge?pid=42&3pid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&us_privacy=&gdpr=0&gdpr_consent=
  • https://ce.lijit.com/merge?pid=42&3pid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&us_privacy=&gdpr=0&gdpr_consent=&dnr=1
0
433 B
Image
General
Full URL
https://ce.lijit.com/merge?pid=42&3pid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&us_privacy=&gdpr=0&gdpr_consent=&dnr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
72.251.249.9 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET, US),
Reverse DNS
Software
nginx / raptor
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:49 GMT
Server
nginx
X-Powered-By
raptor
P3P
CP="CUR ADM OUR NOR STA NID"
Cache-Control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
X-Sovrn-Pod
ad_ap3ams1
Expires
Fri, 20 Mar 2009 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:49 GMT
Server
nginx
X-Powered-By
raptor
P3P
CP="CUR ADM OUR NOR STA NID"
Location
https://ce.lijit.com/merge?pid=42&3pid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&us_privacy=&gdpr=0&gdpr_consent=&dnr=1
Cache-Control
private, no-cache, no-store, must-revalidate, proxy-revalidate, max-age=0, s-maxage=0
X-Sovrn-Pod
ad_ap3ams1
Content-Length
0
Expires
Fri, 20 Mar 2009 00:00:00 GMT
rtset
bh.contextweb.com/bh/ Frame 49FE
49 B
406 B
Image
General
Full URL
https://bh.contextweb.com/bh/rtset?do=add&pid=553204&ev=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.139 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
Jetty(9.4.14.v20181114) /
Resource Hash
d0409a1b73dab4e29dc40f92fb431fa9133baa23b4a1ffae4897f39068110e32
Security Headers
Name Value
Strict-Transport-Security max-age=15768000

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=15768000
server
Jetty(9.4.14.v20181114)
content-language
en-US
p3p
policyref="/bh/w3c/p3p.xml", CP="NOI DSP COR NID CURa DEVa PSAa OUR BUS COM NAV INT"
cache-control
private, max-age=0, no-cache, no-store
content-type
image/gif;charset=iso-8859-1
cw-server
bh-deployment-659d447f4f-wrmf8
expires
-1
rtb-h
sync.taboola.com/sg/storygize-network/1/ Frame 49FE
Redirect Chain
  • https://www.storygize.net/ccm/4b560cdd-91f9-422b-adb7-e9dff26bc3ad?u=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
  • https://sync.taboola.com/sg/storygize-network/1/rtb-h?taboola_hm=37cf273d-6031-4a9e-b4c2-17b86d952301
0
227 B
Image
General
Full URL
https://sync.taboola.com/sg/storygize-network/1/rtb-h?taboola_hm=37cf273d-6031-4a9e-b4c2-17b86d952301
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.40.20.14:10213
date
Tue, 15 Dec 2020 12:48:49 GMT
server
nginx
x-fastly-to-nlb-rtt
27146

Redirect headers

Location
https://sync.taboola.com/sg/storygize-network/1/rtb-h?taboola_hm=37cf273d-6031-4a9e-b4c2-17b86d952301
Pragma
no-cache
cache-control
no-cache, no-store, must-revalidate
Connection
keep-alive
P3P
CP ALL ADM DEV PSAi COM OUR OTRo STP IND ONL
Content-Length
0
expires
0
/
rtb-csync.smartadserver.com/redir/ Frame 49FE
43 B
697 B
Image
General
Full URL
https://rtb-csync.smartadserver.com/redir/?partnerid=107&partneruserid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
185.86.139.115 , France, ASN201081 (SMARTADSERVER, FR),
Reverse DNS
Software
/
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
cache-control
no-cache,no-store
content-type
image/gif
transfer-encoding
chunked
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
sync
dsp.adkernel.com/ Frame 49FE
42 B
233 B
Image
General
Full URL
https://dsp.adkernel.com/sync?exchange=281&r=%2F%2Fsync.taboola.com%2Fsg%2Fadkernelrtb-network%2F1%2Frtb-h%3Ftaboola_hm%3D%7BUID%7D
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
174.137.133.49 Garden City, United States, ASN27257 (WEBAIR-INTERNET, US),
Reverse DNS
Software
nginx /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:49 GMT
Server
nginx
Age
0
Content-Type
image/gif
Cache-Control
no-store
Connection
keep-alive
Content-Length
42
put
e1.emxdgt.com/ Frame 49FE
43 B
124 B
Image
General
Full URL
https://e1.emxdgt.com/put?d=d41&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.195.155.181 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:50 GMT
content-length
43
x-nosync
emp
content-type
image/gif
pixel.gif
sync.1dmp.io/ Frame 49FE
Redirect Chain
  • https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
  • https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&cs=1
35 B
376 B
Image
General
Full URL
https://sync.1dmp.io/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&cs=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
88.99.214.77 Ludwigshafen am Rhein, Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
static.88-99-214-77.clients.your-server.de
Software
nginx /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:56 GMT
cache-control
private, no-cache, no-store, no-cache=Set-Cookie, proxy-revalidate
server
nginx
content-type
image/gif
content-length
35
expires
0

Redirect headers

location
/pixel.gif?cid=bbd655c2-4912-4064-9036-7e0aec8fb8f2&brid=1ad3958e-57cd-4f58-80a2-9c478e047fdd&pid=w&uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&cs=1
date
Tue, 15 Dec 2020 12:48:56 GMT
cache-control
private, no-cache, no-store, no-cache=Set-Cookie, proxy-revalidate
server
nginx
content-length
0
expires
0
/
loadm.exelator.com/load/ Frame 49FE
Redirect Chain
  • https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c
  • https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&xl8blockcheck=1
0
2 KB
Image
General
Full URL
https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&xl8blockcheck=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.102.200 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS
Software
nginx / Undertow/1
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:52 GMT
cache-control
no-cache
access-control-allow-credentials
true
server
nginx
x-powered-by
Undertow/1
p3p
policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA, policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA

Redirect headers

date
Tue, 15 Dec 2020 12:48:52 GMT
server
nginx
x-powered-by
Undertow/1
p3p
policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA, policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA
location
https://loadm.exelator.com/load/?p=204&g=1270&j=0&BUID=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&xl8blockcheck=1
cache-control
no-cache
access-control-allow-credentials
true
content-type
image/gif
content-length
0
/
sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/ Frame 49FE
Redirect Chain
  • https://dis.criteo.com/dis/usersync.aspx?r=29&p=282&cp=taboolaortb&cu=1&url=https%3A%2F%2Fsync-t1.taboola.com%2Fsg%2Fcriteortb-network%2F1%2Frtb-h%2F%3Ftaboola_hm%3D%40%40CRITEO_USERID%40%40
  • https://sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/?taboola_hm=93d2da82-af3b-4ee8-9308-b0f68c7b854c
0
227 B
Image
General
Full URL
https://sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/?taboola_hm=93d2da82-af3b-4ee8-9308-b0f68c7b854c
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.41.34.222:10213
date
Tue, 15 Dec 2020 12:48:50 GMT
server
nginx
x-fastly-to-nlb-rtt
26075

Redirect headers

pragma
no-cache
x-errorlevel
0
server
Microsoft-IIS/10.0
x-powered-by
ASP.NET
p3p
CP="NON DSP COR CURa PSA PSD OUR BUS NAV STA"
location
https://sync-t1.taboola.com/sg/criteortb-network/1/rtb-h/?taboola_hm=93d2da82-af3b-4ee8-9308-b0f68c7b854c
cache-control
no-cache
date
Tue, 15 Dec 2020 12:48:50 GMT
server-processing-duration-in-ticks
3484
content-type
text/html; charset=utf-8
content-length
222
expires
Tue, 15 Dec 2020 00:00:00 GMT
mw
mwzeom.zeotap.com/ Frame 49FE
95 B
386 B
Image
General
Full URL
https://mwzeom.zeotap.com/mw?zpartnerid=1412&env=mWeb&cid=d92bd314127fac2cd12b3155a94a3b1bdb08a82c0239a551c698d9469c591b6e&gdpr=$0&gdpr_consent=$
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:1857 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:50 GMT
via
1.1 google
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
content-type
image/png
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
602047fae9ce0625-FRA
access-control-allow-headers
*
content-length
95
cf-request-id
07080b50d600000625379ee000000001
6.gif
id5-sync.com/c/464/146/2/ Frame 49FE
Redirect Chain
  • https://id5-sync.com/s/464/9.gif?puid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&gdpr=0&gdpr_consent=&callback=https%3A%2F%2Fsync.taboola.com%2Fsg%2Fid5-network%2F1%2Frtb-h%2F%3Ftaboola_hm%3D...
  • https://id5-sync.com/c/464/464/7/1.gif?puid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&gdpr=1&gdpr_consent=
  • https://ice.360yield.com/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMO5fexWetOj-d8VxjB-SIDrzkh2U9KCoF8riX9QQ&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F464%2F124%2F6%2F2.gif%3Fpuid%3D...
  • https://ice.360yield.com/ul_cb/match?publisher_dsp_id=79&dsp_callback=1&external_user_id=ID5-ZHMO5fexWetOj-d8VxjB-SIDrzkh2U9KCoF8riX9QQ&r=https%3A%2F%2Fid5-sync.com%2Fcq%2F464%2F124%2F6%2F2.gif%3Fp...
  • https://id5-sync.com/cq/464/124/6/2.gif?puid=32e0a8e4-4532-4c65-a0f9-911fc13b4927&gdpr=1&gdpr_consent=&gdpr=1&gdpr_consent=
  • https://sync.crwdcntrl.net/map/c=13953/tp=IDFI/gdpr=1/gdpr_consent=?https://id5-sync.com/c/464/19/5/3.gif?puid=${profile_id}&gdpr=1&gdpr_consent=
  • https://sync.crwdcntrl.net/map/ct=y/c=13953/tp=IDFI/gdpr=1/gdpr_consent=?https://id5-sync.com/c/464/19/5/3.gif?puid=${profile_id}&gdpr=1&gdpr_consent=
  • https://id5-sync.com/c/464/19/5/3.gif?puid=b8757e1265bd76128ab1634229ce863a&gdpr=1&gdpr_consent=
  • https://ads.creative-serving.com/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F101%2F4%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D
  • https://ads.creative-serving.com/ul_cb/id5_cm?callback=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F101%2F4%2F4.gif%3Fpuid%3D%5BUID%5D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/464/101/4/4.gif?puid=1ffe5f45-8d53-444d-987d-373a6dc53240&gdpr=1&gdpr_consent=
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F108%2F3%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gdpr_con...
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2922&partner_url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F108%2F3%2F5.gif%3Fpuid%3D%24%7BTA_DEVICE_ID%7D%26gdpr%3D1%26gdpr_consent%3D&gdpr=1&gd...
  • https://id5-sync.com/c/464/108/3/5.gif?puid=e1b37c33-3ed3-11eb-984f-2ace66be1f57&gdpr=1&gdpr_consent=
  • https://ads.avocet.io/getuid?url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F2%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://ads.avct.cloud/getuid?r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F2%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://ads.avct.cloud/getuid?bounce=true&r=1&url=https%3A%2F%2Fid5-sync.com%2Fc%2F464%2F146%2F2%2F6.gif%3Fpuid%3D%7B%7BUUID%7D%7D%26gdpr%3D1%26gdpr_consent%3D
  • https://id5-sync.com/c/464/146/2/6.gif?puid=acaaa0c8-2a7a-4890-bbea-931320f979cb&gdpr=1&gdpr_consent=
43 B
1 KB
Image
General
Full URL
https://id5-sync.com/c/464/146/2/6.gif?puid=acaaa0c8-2a7a-4890-bbea-931320f979cb&gdpr=1&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
51.89.20.87 , Germany, ASN16276 (OVH, FR),
Reverse DNS
Software
/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:51 GMT
Transfer-Encoding
chunked
Content-Type
image/gif;charset=UTF-8
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
P3P
CP="CAO PSA OUR"

Redirect headers

location
https://id5-sync.com/c/464/146/2/6.gif?puid=acaaa0c8-2a7a-4890-bbea-931320f979cb&gdpr=1&gdpr_consent=
date
Tue, 15 Dec 2020 12:48:51 GMT
p3p
policyref="http://cdn.avocet.io/w3c/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
content-length
132
content-type
text/html; charset=utf-8
rtb-h
sync.taboola.com/sg/appierrtb-network/1/ Frame 49FE
Redirect Chain
  • https://s.c.appier.net/taboola
  • https://sync.taboola.com/sg/appierrtb-network/1/rtb-h?taboola_hm=w0qjRnFhA4iB9jjds7DYXw
0
218 B
Image
General
Full URL
https://sync.taboola.com/sg/appierrtb-network/1/rtb-h?taboola_hm=w0qjRnFhA4iB9jjds7DYXw
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.41.24.10:10213
date
Tue, 15 Dec 2020 12:48:51 GMT
server
nginx
x-fastly-to-nlb-rtt
24630

Redirect headers

location
https://sync.taboola.com/sg/appierrtb-network/1/rtb-h?taboola_hm=w0qjRnFhA4iB9jjds7DYXw
date
Tue, 15 Dec 2020 12:48:51 GMT
cache-control
no-store
server
nginx
content-type
text/html; charset=utf-8
content-length
110
p3p
CP="CUR ADM DEV TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
sync
ups.analytics.yahoo.com/ups/55973/ Frame 49FE
Redirect Chain
  • https://pixel.advertising.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1
  • https://pixel.advertising.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1&verify=true
  • https://ups.analytics.yahoo.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1&apid=UPe17b2eaa-3ed3-11eb-a111-065bccc7e89e
  • https://ups.analytics.yahoo.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1&apid=UPe17b2eaa-3ed3-11eb-a111-065bccc7e89e&verify=true
0
964 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1&apid=UPe17b2eaa-3ed3-11eb-a111-065bccc7e89e&verify=true
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:50 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

Date
Tue, 15 Dec 2020 12:48:50 GMT
Server
ATS/7.1.2.128
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
Location
https://ups.analytics.yahoo.com/ups/55973/sync?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_origin=1&apid=UPe17b2eaa-3ed3-11eb-a111-065bccc7e89e&verify=true
Connection
keep-alive
Content-Length
0
cookiesync
bttrack.com/pixel/ Frame 49FE
35 B
380 B
Image
General
Full URL
https://bttrack.com/pixel/cookiesync?source=14b8c562-d12b-418b-b680-ad517d5839ec
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
192.132.33.46 , United States, ASN18568 (BIDTELLECT, US),
Reverse DNS
46.bidtellect.com
Software
Microsoft-IIS/8.5 /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

X-ServerName
Track004-dc3
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:49 GMT
X-AspNetMvc-Version
5.2
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
P3P
CP="CAO DSP COR ADMo DEVo PSAo PSDo HISo IVAo IVDo OUR IND OTC"
Cache-Control
private,no-cache
Content-Type
image/gif
Content-Length
35
Expires
-1
/
cds.taboola.com/ Frame 49FE
0
155 B
Image
General
Full URL
https://cds.taboola.com/?uid=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&_r=2210625
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.224.32 , United States, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Date
Tue, 15 Dec 2020 12:48:52 GMT
Cache-Control
no-store
Server
nginx
Connection
close
rtb-h
sync-t1.taboola.com/sg/bidswitch-network/1/ Frame 49FE
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=taboola&gdpr=0&gdpr_consent=
  • https://cm.smadex.com/sync?sm_did=bds&bds_ssp_id=taboola&bds_param=f644313d-5c9b-496a-98b0-21d748a69350
  • https://x.bidswitch.net/sync?dsp_id=340&user_id=e0d5220c-1391-4c16-872e-57b645103fee&expires=10&ssp=taboola&bsw_param=f644313d-5c9b-496a-98b0-21d748a69350
  • https://sync-t1.taboola.com/sg/bidswitch-network/1/rtb-h?taboola_hm=f644313d-5c9b-496a-98b0-21d748a69350
0
226 B
Image
General
Full URL
https://sync-t1.taboola.com/sg/bidswitch-network/1/rtb-h?taboola_hm=f644313d-5c9b-496a-98b0-21d748a69350
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

tbl-x-upstream
10.41.24.10:10213
date
Tue, 15 Dec 2020 12:48:47 GMT
server
nginx
x-fastly-to-nlb-rtt
22483

Redirect headers

location
//sync-t1.taboola.com/sg/bidswitch-network/1/rtb-h?taboola_hm=f644313d-5c9b-496a-98b0-21d748a69350
date
Tue, 15 Dec 2020 12:48:46 GMT
cache-control
no-cache, no-store, must-revalidate
content-length
0
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
abtests
trc.taboola.com/dailymail-row/log/3/
0
394 B
Image
General
Full URL
https://trc.taboola.com/dailymail-row/log/3/abtests?route=AM:AM:V&lti=deflated&ri=451d2ef0671c6dff1adb57d73f60686e&sd=v2_e6302e1f13019910a997e6806c02579f_5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c_1608036525_1608036525_CNawjgYQ-4w9GOHGyLPmLiABKAQwrgE47qgMQO3xK0jp2dgDUP___________wFYAGAAaOKmqpGyrZficA&ui=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&pi=/sciencetech/article-9050821/remdesivir-beneficial-patients-doctors-reveal.html&wi=3375619910924715558&pt=text&vi=1608036524897&d=%7B%22abTestsEventType%22%3A%22simple%22%2C%22name%22%3A%22DEDUP_DEBUG%22%2C%22type%22%3A%22true%22%2C%22eventTime%22%3A1608036526225%7D&tim=13%3A48%3A46.225&id=1448&llvl=1&cv=20201214-6-RELEASE&
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
10
pragma
no-cache
date
Tue, 15 Dec 2020 12:48:51 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036531.399443,VS0,VE10
x-served-by
cache-fra19151-FRA
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-credentials
true
accept-ranges
bytes
content-type
image/gif
x-cache-hits
0
debug
trc-events.taboola.com/dailymail-row/log/2/
0
276 B
Image
General
Full URL
https://trc-events.taboola.com/dailymail-row/log/2/debug?tim=13%3A48%3A46.226&type=warn&msg=Duplicated%20items%20monitoring%20enabled&id=1831&cv=20201214-6-RELEASE&lt=deflated&pcs=%5Bdata-feed-main-container-id%3D%22taboola-below-article-thumbnails%22%5D&vi=1608036524897
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:51 GMT
server
nginx
x-fastly-to-nlb-rtt
25240
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.24.10:10213
24015022-35ce-4454-8c00-dfee1989ffa1.png
cdn.taboola.com/static/24/
2 KB
2 KB
Image
General
Full URL
https://cdn.taboola.com/static/24/24015022-35ce-4454-8c00-dfee1989ffa1.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
53eeac6afb74c6a3b1aca65c7ec44883268d44023b4565eccdd8ee5a68db4e63

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
UbzmkdKVxR2hexvCtEoBTeEkUjPghW4t
via
1.1 varnish
etag
"ebe314a8ee4abde6826bbe25039672bb"
age
7437
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
1644
x-amz-id-2
nli5miVdAU6/Vl/efztVyviOjBTkFyTokNBiHIbc2pn+UJkcc+SDt2wi8hG+goplrv20hLxC7MY=
x-served-by
cache-fra19151-FRA
last-modified
Sun, 18 Mar 2018 11:55:49 GMT
server
AmazonS3
x-timer
S1608036526.355284,VS0,VE0
date
Tue, 15 Dec 2020 12:48:46 GMT
x-amz-request-id
5879D2F0DF068D76
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/png
abp
23
x-cache-hits
83
debug
trc-events.taboola.com/dailymail-row/log/2/
0
277 B
Image
General
Full URL
https://trc-events.taboola.com/dailymail-row/log/2/debug?tim=13%3A48%3A46.276&type=info&msg=Load%20publisher%20card%3A%20most%20watched%20videos%20on%20Card%3A%209%20with%20the%20anchor%20element%20selector%3A%20%23most-watched-videos-lazy-container%20succeed&id=4753&cv=20201214-6-RELEASE&lt=deflated&idx=pc&pc=most%20watched%20videos&st=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:51 GMT
server
nginx
x-fastly-to-nlb-rtt
25240
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
*
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.34.222:10213
e0235994-ac35-437b-a427-a2da79110614
https://www.dailymail.co.uk/
473 KB
0
Other
General
Full URL
blob:https://www.dailymail.co.uk/e0235994-ac35-437b-a427-a2da79110614
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
6eca6b453d53f500b779a87493d7079d7119d8715f999c1f5fb6aeee18b7cbb9

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Length
484070
Content-Type
application/javascript
graphql
api.permutive.com/
684 B
693 B
XHR
General
Full URL
https://api.permutive.com/graphql?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
9ec38f67a5b9902e3fd600379a6cd7633669716622a35dce040d8099687535f4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
433
via
1.1 google
225114
search.spotxchange.com/openrtb/2.3/dados/
0
988 B
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Requested by
Host: js.spotx.tv
URL: https://js.spotx.tv/directsdk/v1/234272.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
x-openrtb-version
2.3
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 15 Dec 2020 12:48:54 GMT
X-SpotX-Timing-Transform
0.000371
X-SpotX-Timing-SpotMarket
0.010925
X-SpotX-Timing-Page-Mux
0.001361
X-SpotX-Timing-Page-Require
0.000396
X-fe
088
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000005
X-SpotX-Timing-Page
0.014862
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000326
Last-Modified
Tue, 15 Dec 2020 12:48:54 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.010925
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.001463
X-SpotX-Timing-Page-Exception
0.000000
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000015
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
225114
search.spotxchange.com/openrtb/2.3/dados/ Frame
0
0
Other
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Protocol
HTTP/1.1
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-openrtb-version
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Server
nginx
Date
Tue, 15 Dec 2020 12:48:53 GMT
Content-Type
text/plain;charset=UTF-8
Content-Length
0
Connection
keep-alive
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Tue, 15 Dec 2020 12:48:53 GMT
Cache-Control
no-cache, must-revalidate post-check=0, pre-check=0
Pragma
no-cache
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Access-Control-Allow-Headers
content-type,x-openrtb-version
Access-Control-Allow-Credentials
true
Access-Control-Max-Age
2592000
1211115025__bvahx2CN.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/SKP/
11 KB
11 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/SKP/1211115025__bvahx2CN.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
3149ce1ab2cdf5b0a4107659afbb09ddc58ac4111afb64879fbe567539790f6c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2184902
edge-cache-tag
495871871037269826393563905755201106416,534554604223319601008643105194670925976,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Sun, 06 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/SKP/1211115025__bvahx2CN.jpg
content-length
10759
x-served-by
cache-dca17775-DCA, cache-dca17735-DCA, cache-lon4226-LON
last-modified
Thu, 05 Nov 2020 06:18:15 GMT
server
cloudinary
x-timer
S1608036533.034729,VS0,VE1
etag
"06a86604491ef9a14eaffe883529b5c6"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
handscheiding_1000x600_879bf556b5a17320dc0277983391d29a.png
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//console.brax-cdn.com/creatives/099cab32-1f9c-46de-9f8d-52272754f9c5/
17 KB
17 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//console.brax-cdn.com/creatives/099cab32-1f9c-46de-9f8d-52272754f9c5/handscheiding_1000x600_879bf556b5a17320dc0277983391d29a.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
126c9984859f2b6e23c35ee06e35465170ee6d922705f6886b25c13e3e347e5b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1042919
edge-cache-tag
624014457060149946618617367421010122824,534554604223319601008643105194670925976,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Thu, 31 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//console.brax-cdn.com/creatives/099cab32-1f9c-46de-9f8d-52272754f9c5/handscheiding_1000x600_879bf556b5a17320dc0277983391d29a.png
content-length
17060
x-served-by
cache-dca17736-DCA, cache-dca17758-DCA, cache-lon4226-LON
last-modified
Mon, 30 Nov 2020 16:52:16 GMT
server
cloudinary
x-timer
S1608036533.034985,VS0,VE0
etag
"5aac2a96bc13a4a8f4689ebe20213772"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 2
700c23403a8860bcc7bbadd54b613e24.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
15 KB
15 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/700c23403a8860bcc7bbadd54b613e24.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
2999c0fa0407826744625bcfcc67242d4b5765409c6ac5b3a61a3d56f4925966

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
589848
edge-cache-tag
520953156222275311582199418110952501386,534554604223319601008643105194670925976,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Fri, 18 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_217%2Cw_260%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/700c23403a8860bcc7bbadd54b613e24.jpg
content-length
15208
x-served-by
cache-dca17743-DCA, cache-dca17744-DCA, cache-lon4226-LON
last-modified
Tue, 17 Nov 2020 13:53:16 GMT
server
cloudinary
x-timer
S1608036533.034868,VS0,VE1
etag
"788904d6806b560d9b8507f0be4405cf"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
tbp
15.taboola.com/
7 KB
3 KB
Script
General
Full URL
https://15.taboola.com/tbp?oid=15&pubid=166277&tagid=948107&pstn=[pstn]&cb=[cb]&callback=TRC.pVideoCallbacks.videoCallback1
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
96374ed4371afe422f2c79f3a6e0a0a2b3f255e4d96b22e392b78fde7be59c9a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:52 GMT
content-encoding
gzip
server
nginx
x-timer
S1608036532.071700,VS0,VE29
machineid
1418
vary
Accept-Encoding
x-cache
MISS
content-type
text/html;charset=ISO-8859-1
via
1.1 varnish
expires
Sat, 26 Jul 1997 05:00:00 GMT
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
x-cache-hits
0
accept-ranges
bytes
x-served-by
cache-fra19151-FRA
6b68fbc8ae3631ec48f097384495ad59.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
64 KB
65 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/6b68fbc8ae3631ec48f097384495ad59.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
f2de579375a03b06357be7d5b1d80a41010e84e6f38f7922b32dacb3a22edcc8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
4974134
edge-cache-tag
327488782157785223649913794111829872760,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Thu, 12 Nov 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/6b68fbc8ae3631ec48f097384495ad59.jpg
content-length
65800
x-served-by
cache-dca17724-DCA, cache-dca17724-DCA, cache-lon4226-LON
last-modified
Mon, 12 Oct 2020 23:48:14 GMT
server
cloudinary
x-timer
S1608036533.034712,VS0,VE0
etag
"a9380099bebb90a302552bc1aac9ba13"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 4, 225
36864288-0-image-a-32_1608031011154.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/
53 KB
54 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36864288-0-image-a-32_1608031011154.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
0ddcfc6ca0e5344b21b089b56eb02d9fe140360fad23a5005ec94c57cbd4930a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
3928
edge-cache-tag
498406811844573353818915344189419530848,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36864288-0-image-a-32_1608031011154.jpg
content-length
54716
x-request-id
25193682c2c56fa23827f0fc010dc290
x-served-by
cache-dca17779-DCA, cache-dca17773-DCA, cache-lon4226-LON
last-modified
Tue, 15 Dec 2020 11:37:14 GMT
server
cloudinary
x-timer
S1608036533.034973,VS0,VE0
etag
"e9836a653e29f6eade4ad883571f1c23"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 2, 20
1211115025__bvahx2CN.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/SKP/
38 KB
39 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/SKP/1211115025__bvahx2CN.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
ae91777082abe862dc3ff94db963f657a56192016ab72829df400ef979887452

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1034228
edge-cache-tag
495871871037269826393563905755201106416,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Tue, 22 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/SKP/1211115025__bvahx2CN.jpg
content-length
39030
x-served-by
cache-dca17783-DCA, cache-dca17778-DCA, cache-lon4226-LON
last-modified
Sat, 21 Nov 2020 14:08:23 GMT
server
cloudinary
x-timer
S1608036533.034851,VS0,VE0
etag
"8f491cedf8f8fd835e04f6a5227bfa38"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 2
72f60fdcf5f4099ad33d77a5b15e9812.png
images.taboola.com/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_540,y_540/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
102 KB
102 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_540,y_540/http%3A//cdn.taboola.com/libtrc/static/thumbnails/72f60fdcf5f4099ad33d77a5b15e9812.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
a26050f19141c4fcc92703fafc3a717be85946bc637eaaca29b8b3fa0d7675b5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2430775
edge-cache-tag
448216317224176864378261551820031483503,381923969784057603022005834186027398459,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_540,y_540/http%3A//cdn.taboola.com/libtrc/static/thumbnails/72f60fdcf5f4099ad33d77a5b15e9812.png
content-length
104055
x-request-id
84b7159e0ac5280735e990bf7b5b4294
x-served-by
cache-dca17759-DCA, cache-dca17773-DCA, cache-lon4226-LON
last-modified
Wed, 11 Nov 2020 09:29:51 GMT
server
cloudinary
x-timer
S1608036533.065736,VS0,VE1
etag
"f649f4a674bbc91980c870bac36370e4"
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
27cd61fac4d1a1b7fcfaabe3674df8b6.jpeg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
28 KB
28 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/27cd61fac4d1a1b7fcfaabe3674df8b6.jpeg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
11e44cd98e3a5e7a8e00263dcb78c9ace52f65db7dd5592160c84bb9a8720a70

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2484572
edge-cache-tag
398970825508036587155477090882462687373,309727233042263395173288000816347086757,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Thu, 19 Nov 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
HIT, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/27cd61fac4d1a1b7fcfaabe3674df8b6.jpeg
content-length
28450
x-served-by
cache-dca17754-DCA, cache-dca17732-DCA, cache-lon4226-LON
last-modified
Mon, 19 Oct 2020 14:45:15 GMT
server
cloudinary
x-timer
S1608036533.065791,VS0,VE0
etag
"34fb3bc931e9b5fed9c8bd804ac38dc7"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
1, 1, 4
700c23403a8860bcc7bbadd54b613e24.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
73 KB
74 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/700c23403a8860bcc7bbadd54b613e24.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
33dfbdca1fd1bb1930babf0a0e9a674e51ea1b58e63e146748a2bd8290bd9a3a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
588103
edge-cache-tag
520953156222275311582199418110952501386,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Fri, 18 Dec 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/700c23403a8860bcc7bbadd54b613e24.jpg
content-length
74896
x-served-by
cache-dca17735-DCA, cache-dca17755-DCA, cache-lon4226-LON
last-modified
Tue, 17 Nov 2020 14:09:54 GMT
server
cloudinary
x-timer
S1608036533.066110,VS0,VE0
etag
"e660487c44b3d74cd13b853a434f7028"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 2
36864398-0-image-a-9_1608031034675.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/
126 KB
127 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36864398-0-image-a-9_1608031034675.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
0334183c58bf858d0fdc9afdf827160f5e823f0cfa684dd043340c1bddce81f0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
3920
edge-cache-tag
542001804757772578068281699394848725510,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/11/36864398-0-image-a-9_1608031034675.jpg
content-length
129213
x-request-id
0dbc514c97df0f7b5395ec2001487d3c
x-served-by
cache-dca17774-DCA, cache-dca17731-DCA, cache-lon4226-LON
last-modified
Tue, 15 Dec 2020 11:37:08 GMT
server
cloudinary
x-timer
S1608036533.066084,VS0,VE0
etag
"dde52c9afe71c71d04be150518b0e103"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 11
1197866211__9IWfucmO.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/DV/
40 KB
40 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/DV/1197866211__9IWfucmO.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
b08ecbb053f7f80c39bd65d86afa6cfd440da84c889b6856c1f58ec837474776

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
2190843
edge-cache-tag
617407679821223008185201174978288978763,575325974753229111106645491868203992126,29ecf9b93bbf306179626feeda1fab70
expiration
expiry-date="Fri, 20 Nov 2020 00:00:00 GMT", rule-id="delete fetch for taboola after 30 days"
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_380%2Cw_760%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/GETTY_IMAGES/DV/1197866211__9IWfucmO.jpg
content-length
40653
x-served-by
cache-dca17765-DCA, cache-dca17739-DCA, cache-lon4226-LON
last-modified
Tue, 20 Oct 2020 09:32:33 GMT
server
cloudinary
x-timer
S1608036533.066071,VS0,VE1
etag
"32d5879aad8d9bb1d29af277ad49ddd5"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
36828664-0-image-a-2_1607961316348.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/14/15/
55 KB
55 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/14/15/36828664-0-image-a-2_1607961316348.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
34ae88c87a1e06c66b949bf5c0a837a5ae992511ef0da02a37b8c67e4a2104a8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
3926
edge-cache-tag
386006052944374092763941514549466808094,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/14/15/36828664-0-image-a-2_1607961316348.jpg
content-length
56018
x-request-id
9cec93934a7a4fbc2a134fac6e44f7ab
x-served-by
cache-dca17738-DCA, cache-dca17732-DCA, cache-lon4226-LON
last-modified
Tue, 15 Dec 2020 11:37:59 GMT
server
cloudinary
x-timer
S1608036533.066048,VS0,VE0
etag
"aca7fefdaa2bf682350a2153fc35cbd8"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 7
truncated
/
120 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
902899b8dd3a6b30f6bc1be0f39f48ce72d0c41357d8bf521cd86f58bb633b7e

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
bridge3.431.1_en.html
imasdk.googleapis.com/js/core/ Frame 7AA9
0
0
Document
General
Full URL
https://imasdk.googleapis.com/js/core/bridge3.431.1_en.html
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/ima3.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
imasdk.googleapis.com
:scheme
https
:path
/js/core/bridge3.431.1_en.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
192077
date
Tue, 15 Dec 2020 11:15:04 GMT
expires
Wed, 15 Dec 2021 11:15:04 GMT
last-modified
Mon, 14 Dec 2020 09:10:26 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
5622
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
de745c71001f4f88974be1120587ceb3.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
105 KB
106 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/de745c71001f4f88974be1120587ceb3.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
7ba5432412dbbee155d74aaa7828571a6b462301da23d41ab115614030917035

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
476016
edge-cache-tag
568388379171008990904922312270953673460,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/de745c71001f4f88974be1120587ceb3.jpg
content-length
107938
x-request-id
5a8f1253363e0a8ba960d02bc4d9163b
x-served-by
cache-dca17736-DCA, cache-dca17779-DCA, cache-lon4226-LON
last-modified
Tue, 08 Dec 2020 10:53:48 GMT
server
cloudinary
x-timer
S1608036533.066402,VS0,VE1
etag
"aa79334c67937a13b13f91926e23b384"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
36860176-0-image-a-8_1608023224587.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/09/
98 KB
98 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/09/36860176-0-image-a-8_1608023224587.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
04d9380c3e345e7c14d977684cc8ff98fc42378d864059e3275b4d6500ccb662

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
7166
edge-cache-tag
552788768624551994179887240537823959374,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/09/36860176-0-image-a-8_1608023224587.jpg
content-length
99859
x-request-id
f28aed51db893c62eda2b8576c801d80
x-served-by
cache-dca17739-DCA, cache-dca17749-DCA, cache-lon4226-LON
last-modified
Tue, 15 Dec 2020 10:47:17 GMT
server
cloudinary
x-timer
S1608036533.066386,VS0,VE1
etag
"5f303bcf1d6933fd019979cd253d6f9f"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
36863210-0-image-a-4_1608028754431.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/10/
39 KB
40 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/10/36863210-0-image-a-4_1608028754431.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
20414171181adf8daf34ae56d534ab7b92b72f29078707ec2293124f4251947f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
7167
edge-cache-tag
518171499635724812058070267829861616699,586447576921672440320975332630694222884,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/10/36863210-0-image-a-4_1608028754431.jpg
content-length
40023
x-request-id
6128307821a3bf96ae690725b2b4dd33
x-served-by
cache-dca17769-DCA, cache-dca17735-DCA, cache-lon4226-LON
last-modified
Tue, 15 Dec 2020 10:47:17 GMT
server
cloudinary
x-timer
S1608036533.066371,VS0,VE0
etag
"cf346b32c581bc817b825102fd92805c"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 9
36758314-0-image-a-70_1607782958811.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/12/14/
13 KB
13 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/12/14/36758314-0-image-a-70_1607782958811.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
85dc4e795c87ebf54a6cdde2eba0fb6c40650fbeacd09449f9433c48bf5d7d40

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
7127
edge-cache-tag
595608459744218311490255434674267014600,586447576921672440320975332630694222884,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_190%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/12/14/36758314-0-image-a-70_1607782958811.jpg
content-length
13158
x-request-id
dd2eda5f7df567e4f6f0175b1f8dbb7d
x-served-by
cache-dca17742-DCA, cache-dca17759-DCA, cache-lon4226-LON
last-modified
Tue, 15 Dec 2020 10:48:27 GMT
server
cloudinary
x-timer
S1608036533.066345,VS0,VE1
etag
"3c89806ff8556d6c5ede54b7986fe559"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
b233ce8524cad98bf344d71759653e7f.png
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
50 KB
51 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/b233ce8524cad98bf344d71759653e7f.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
2edccccd61b8e78c3897a5fd222f87227e738553c54634a42ef4ecdb81e54ad6

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
4747037
edge-cache-tag
383119871205474938496842034232857444474,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
HIT, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/b233ce8524cad98bf344d71759653e7f.png
content-length
51267
x-request-id
2e4a60da69cb988c221925424dda7da2
x-served-by
cache-dca17740-DCA, cache-dca17771-DCA, cache-lon4226-LON
last-modified
Wed, 21 Oct 2020 11:23:52 GMT
server
cloudinary
x-timer
S1608036533.090827,VS0,VE1
etag
"4d64f3c798b96ebedd6342d871f51e76"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
1, 1, 1
36863204-0-image-a-38_1608028749299.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/10/
87 KB
88 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/10/36863204-0-image-a-38_1608028749299.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
2b0637590c01f9ffbfb0a3541d4fea22b7f68238e82a693d3205467e2131a1b7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
4422
edge-cache-tag
601585176809917240659585045771317744349,356737923103245843458775926512817796149,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_390%2Cw_780%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//i.dailymail.co.uk/1s/2020/12/15/10/36863204-0-image-a-38_1608028749299.jpg
content-length
89346
x-request-id
0c673fbed962191849ec751d61320046
x-served-by
cache-dca17736-DCA, cache-dca17756-DCA, cache-lon4226-LON
last-modified
Tue, 15 Dec 2020 10:54:04 GMT
server
cloudinary
x-timer
S1608036533.090798,VS0,VE1
etag
"6ecf3146ec9b0fc3cd12cd803589c99d"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 2, 1
7c614f0956f5b9a9acd7d0c7c8762779.png
images.taboola.com/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_484,y_393/http%3A//cdn.taboola.com/libtrc/static/thumbnails/
97 KB
97 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_484,y_393/http%3A//cdn.taboola.com/libtrc/static/thumbnails/7c614f0956f5b9a9acd7d0c7c8762779.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
06a8bac74bdf0b053ccb25702b1a25f8969e916080ded2c6715e69304aeb974c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
92250
edge-cache-tag
540290039503598090121303650011129028940,544636287639714264771167706208469123544,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/h_212,w_380,c_fill,g_xy_center,x_484,y_393/http%3A//cdn.taboola.com/libtrc/static/thumbnails/7c614f0956f5b9a9acd7d0c7c8762779.png
content-length
99326
x-request-id
046a5f31ace0928d5e29e5f03d8130dd
x-served-by
cache-dca17737-DCA, cache-dca17755-DCA, cache-lon4226-LON
last-modified
Mon, 16 Nov 2020 12:15:19 GMT
server
cloudinary
x-timer
S1608036533.090784,VS0,VE1
etag
"8b6e5ab340dbe23e0b3d9e864f0e31f2"
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
handscheiding_1000x600_879bf556b5a17320dc0277983391d29a.png
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//console.brax-cdn.com/creatives/099cab32-1f9c-46de-9f8d-52272754f9c5/
25 KB
25 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//console.brax-cdn.com/creatives/099cab32-1f9c-46de-9f8d-52272754f9c5/handscheiding_1000x600_879bf556b5a17320dc0277983391d29a.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
44a33d9f81e2ee85626c3f48c17f694bf8154ae65a703513e3df41649ea12640

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
1
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
950265
edge-cache-tag
624014457060149946618617367421010122824,309727233042263395173288000816347086757,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_212%2Cw_380%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/https%3A//console.brax-cdn.com/creatives/099cab32-1f9c-46de-9f8d-52272754f9c5/handscheiding_1000x600_879bf556b5a17320dc0277983391d29a.png
content-length
25503
x-request-id
61a85177cb5d5e721f4fc12c82459e7f
x-served-by
cache-dca17746-DCA, cache-dca17728-DCA, cache-lon4226-LON
last-modified
Mon, 30 Nov 2020 14:50:31 GMT
server
cloudinary
x-timer
S1608036533.090768,VS0,VE1
etag
"16ebc87d5cc29cbc80b91ef057706ac6"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
unip
trc-events.taboola.com/1125455/log/3/
0
296 B
XHR
General
Full URL
https://trc-events.taboola.com/1125455/log/3/unip?en=pre_d_eng_tb&tos=1534&scd=18&ssd=1&est=1608036524900&ver=27&isls=true&src=i&invt=1500&tim=1608036526435&vi=1608036524897&ri=33989576fd58a84e73b3f9a0b11cec49&sd=v2_bf71d5d1fc71f64880fa94a010aa143c_5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c_1608036524_1608036524_CNawjgYQz9hEGOHGyLPmLiABKAEwrgE47qgMQO3xK0jp2dgDUP___________wFYAWAAaOKmqpGyrZficA&ui=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&ref=null&cv=20201123-29-RELEASE
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:46 GMT
server
nginx
x-fastly-to-nlb-rtt
22491
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.40.0.117:10213
f539211219b796ffbb49949997c764f0.png
cdn.taboola.com/libtrc/static/thumbnails/
254 B
597 B
Image
General
Full URL
https://cdn.taboola.com/libtrc/static/thumbnails/f539211219b796ffbb49949997c764f0.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f68019eb4b4e5933301d4ee75969e0cb94ed8333bf514630fa749eb9c3e483c9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
hL.cyLD7Q4TL5ceY.7JQwF9m5IYI8mkC
via
1.1 varnish
etag
"dfa7b52c86e56bd67fa4002f6ed19854"
age
3115
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
254
x-amz-id-2
Vjnfq2okxpLEG/cBVxSfv3DOOCGN7KTpixt29L7DwUhoZL6eRlgDSODZqhfatrYL58q01gaLKf4=
x-served-by
cache-fra19151-FRA
last-modified
Wed, 24 Jun 2015 07:14:11 GMT
server
AmazonS3
x-amz-meta-s3cmd-attrs
uid:0/gname:root/uname:root/gid:0/mode:33188/mtime:1377415166/atime:1435052450/md5:dfa7b52c86e56bd67fa4002f6ed19854/ctime:1422381567
x-timer
S1608036526.484245,VS0,VE0
date
Tue, 15 Dec 2020 12:48:46 GMT
x-amz-request-id
F6D91014AAA6CDC4
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/png
abp
23
x-cache-hits
5283
UnitFeedManagerDesktop.min.js
vidstat.taboola.com/lite-unit/2.4.6/
89 KB
26 KB
Script
General
Full URL
https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
48857dcfba3940d2477a3402b30975809d401a6ec2f10ba3fc93b3dee833151b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:52 GMT
via
1.1 5ab5e654a3dc7079aad7ac64ec697d82.cloudfront.net (CloudFront), 1.1 varnish
age
615004
x-cache
Hit from cloudfront, HIT
content-encoding
gzip
content-length
26200
x-served-by
cache-hhn4026-HHN
last-modified
Mon, 07 Dec 2020 16:23:05 GMT
server
AmazonS3
x-timer
S1608036533.742233,VS0,VE0
etag
"079a63ee7debd7b5ba6f8cae9d86fb21"
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA56-C1
accept-ranges
bytes
access-control-allow-headers
*
x-amz-cf-id
03-ygKaEkfuiBSGS56tvaod3wjham-OSMd6qwTmMfARvaiyoHkUQcA==
x-cache-hits
136371
SystemSettings.js
cdn.userreport.com/
894 B
840 B
Script
General
Full URL
https://cdn.userreport.com/SystemSettings.js
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:9c00:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
9464552e64337889ef3a9dc120396d91f87b2015ad60a8bc0b61d846839f28af

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
6kJ.oVpG3emizYDtxaJznkN1t118DNMr
content-encoding
gzip
last-modified
Thu, 26 Nov 2020 08:23:54 GMT
server
AmazonS3
x-amz-cf-pop
AMS1-C1
etag
"fbcd727c30fa10bc139aca4aec81f8e3"
x-cache
RefreshHit from cloudfront
content-type
text/javascript
via
1.1 241b025da3883bdb653910a6da97c0a8.cloudfront.net (CloudFront)
cache-control
max-age=0
date
Tue, 15 Dec 2020 12:48:47 GMT
accept-ranges
bytes
content-length
442
x-amz-cf-id
CNuJbtid0h1uAdYV10Nb6g9a4eV2Jz7JJiypoAZRipemFrnIzVbmnA==
video_info
context.iris.tv/
100 B
443 B
XHR
General
Full URL
https://context.iris.tv/video_info?access_token=1d9f05c8b00daddfbffcf5afa8a0691bf6370c0cd9dfc8bc6fb38e13c4474dab&global=GlobalIrisPlayer&client_token=W491AUI45FTTFWD&platform_id=1225476966369939162
Requested by
Host: ovp.iris.tv
URL: https://ovp.iris.tv/libs/context/iris-context.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.91 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Zer01ne /
Resource Hash
626ac4ac15ab3d8edcd2f1d3541747d8ad2433d7761b17010dfb2d86e6fe74cf

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:17:02 GMT
via
1.1 bf5caee39117de5337c47c748b716e80.cloudfront.net (CloudFront)
server
Zer01ne
age
1907
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, stale-while-revalidate=600, stale-if-error=600
x-amz-cf-pop
AMS1-C1
x-robots-tag
noindex, follow
x-amz-cf-id
1q8mt1ow8Cg8wHJpW1XumOTFKPnnMkXiiCPmAMvpMWzQECxORkG05w==
video_info
context.iris.tv/
100 B
434 B
XHR
General
Full URL
https://context.iris.tv/video_info?access_token=1d9f05c8b00daddfbffcf5afa8a0691bf6370c0cd9dfc8bc6fb38e13c4474dab&global=GlobalIrisPlayer&client_token=W491AUI45FTTFWD&platform_id=1225476966369939162
Requested by
Host: ovp.iris.tv
URL: https://ovp.iris.tv/libs/context/iris-context.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.91 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Zer01ne /
Resource Hash
626ac4ac15ab3d8edcd2f1d3541747d8ad2433d7761b17010dfb2d86e6fe74cf

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:17:02 GMT
via
1.1 bf5caee39117de5337c47c748b716e80.cloudfront.net (CloudFront)
server
Zer01ne
age
1907
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, stale-while-revalidate=600, stale-if-error=600
x-amz-cf-pop
AMS1-C1
x-robots-tag
noindex, follow
x-amz-cf-id
Xp-PELi78GrNMyU_ySoyPFSrKzgP-TQpD97oo_NyyjjbSqisFx16nQ==
partner
sync.search.spotxchange.com/
Redirect Chain
  • https://sync.search.spotxchange.com/partner?source=dados
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=e2c02f16-3ed3-11eb-a489-1f6fc1874306
0
589 B
Image
General
Full URL
https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=e2c02f16-3ed3-11eb-a489-1f6fc1874306
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.94.180.125 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-spotx-halt-type
Audience Dsp sync Priority Sync endpoint Source ID is not on enabled source whitelist
Date
Tue, 15 Dec 2020 12:48:52 GMT
Server
nginx
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
104
Connection
keep-alive
Content-Length
0

Redirect headers

Date
Tue, 15 Dec 2020 12:48:52 GMT
Server
nginx
Location
/partner?source=dados&__user_check__=1&sync_id=e2c02f16-3ed3-11eb-a489-1f6fc1874306
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
10
Connection
keep-alive
Content-Length
0
bid
c.amazon-adsystem.com/e/dtb/
24 B
375 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=15&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22id%22%3A%22jw_video_desktop%22%2C%22mt%22%3A%22v%22%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
08ec332c446e727696ff53c4c9ee2f3f5f605ce5672021e9691f89bd12c02f43

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:46 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
PIj7FB_CRWrvJBwL86nIy4R35hnNDs3ahHkX9opYnV-QOj8Dsh82Gw==
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
a9ed102047ce2c1a035777c0fa300f5a4df5a1d23900ec479a2336378727ad68

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:46 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=MailOnline
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.189.33 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=293354&v=8.1&r=%7B%22id%22%3A%22192d2fad4ae1b016%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22193b2da95816aacd%22%2C%22ext%22%3A%7B%22siteID%22%3A%22293354%22%2C%22sid%22%3A%22401x225%22%7D%2C%22video%22%3A%7B%22startdelay%22%3A0%2C%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A0%2C%22maxduration%22%3A30%2C%22protocols%22%3A%5B1%2C2%2C3%2C4%2C5%2C6%5D%2C%22api%22%3A%5B1%2C2%5D%2C%22w%22%3A401%2C%22h%22%3A225%2C%22placement%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1&nf=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
bf64a12c4c612c8d664686ae9ef91af25df639f38ebbd410bd1a85d7148d0071

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:46 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:48:46 GMT
avjp
mailonline-uk-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=ad516116-d91d-4c3a-8256-5b66f3f61f3d&nocache=1608036526527&pubcid=3093687966&auid=540675388&vwd=401&vht=225
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:46 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
714 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:46 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.49:80
AN-X-Request-Uuid
645df72e-8460-4654-a6b8-d75958dae14b
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
server.html
tag.userreport.com/ Frame 57BF
0
0
Document
General
Full URL
https://tag.userreport.com/server.html
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:6200:11:af01:b40:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.12.2 /
Resource Hash

Request headers

:method
GET
:authority
tag.userreport.com
:scheme
https
:path
/server.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

content-type
text/html
server
nginx/1.12.2
last-modified
Mon, 26 Oct 2020 12:54:03 GMT
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-encoding
gzip
date
Tue, 15 Dec 2020 12:09:52 GMT
etag
"5f96c6eb-9d35"
cache-control
max-age=3600
vary
Accept-Encoding
x-cache
Hit from cloudfront
via
1.1 0186e9c41d0aebb13c1398b95b7f4757.cloudfront.net (CloudFront)
x-amz-cf-pop
AMS1-C1
x-amz-cf-id
0VUJkZVFdfSEMPM32NhQZSDp6aCZ4uJBtjWxfvzhcTywi4VKsVbZXA==
age
2334
UnitWidgetItemDesktop.min.js
vidstat.taboola.com/lite-unit/2.4.6/
89 KB
26 KB
Script
General
Full URL
https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
1326ea711c56158154751b7c597f07f1dd4ab7ce180aa5f39693d83b2a5662fd

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:52 GMT
via
1.1 29d33c5cd70a6501fde7bc2dba557906.cloudfront.net (CloudFront), 1.1 varnish
age
615004
x-cache
Hit from cloudfront, HIT
content-encoding
gzip
content-length
25989
x-served-by
cache-hhn4026-HHN
last-modified
Mon, 07 Dec 2020 16:23:05 GMT
server
AmazonS3
x-timer
S1608036533.930609,VS0,VE0
etag
"365143735d44746a7fb7a87ce519c4ed"
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA56-C1
accept-ranges
bytes
access-control-allow-headers
*
x-amz-cf-id
JLvT98NSk_SF4l1AtUfSbMByRgA7ez_6sSyUnugeZaVOVEWcur_n3w==
x-cache-hits
88071
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 1CE4
180 KB
51 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
398143
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 1CE4
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285660
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 1CE4
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475830
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 1CE4
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355752
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 1CE4
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353864
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
truncated
/ Frame 1CE4
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
db1a21df5ae20edda44725e6a0c331582ffaa7468fe1d7aa4593be9f7fa2eb68

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
4426494739309785151
tpc.googlesyndication.com/simgad/ Frame 1CE4
112 KB
112 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/4426494739309785151?sqp=4sqPyQQrQikqJwhfEAEdAAC0QiABKAEwCTgDQPCTCUgAUAFYAWBfcAJ4AcUBLbKdPg&rs=AOga4qkyY8rZXMr3dB8Wb0MLugE_otD86g
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
814efb4f7cf8df16a49777f600412259293d00f2a9a747d82211496c54bd781c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 11 Dec 2020 09:29:50 GMT
x-content-type-options
nosniff
last-modified
Tue, 28 Aug 2018 05:00:08 GMT
server
sffe
age
357536
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
114876
x-xss-protection
0
expires
Sat, 11 Dec 2021 09:29:50 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 1CE4
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47659
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 1CE4
295 B
748 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53725
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
l
www.google.com/ads/measurement/ Frame 1CE4
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRz1a2Y3CgDI4cUdhtooDk475uh6ClhE0cWDjQreoAMPbqwr1RAgjHBehuZBc1YbyIdDB-R
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

adview
securepubads.g.doubleclick.net/pagead/ Frame 1CE4
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CGTrbrrDYX-_5ENKlx_AP1rO80Azyud2xYIKauK_3C9vZHhABIKzZuCJg6eTJhdgaoAGI_7L6AsgBAqkCUw-c4tq9aD7gAgCoAwHIAwiqBL8CT9DmNK6BN62WEA811Afi9LOKGuxctPSjFA8bErlAqnjJJgurnZaAzmyb_JQ5YUORs8EQ1PsNxc26dyM8whfLRAPdyzKXGVnB7lj6l813vfUCBbFtRopkXS8AuCAhnblB45Mw31N_ncgEu9Izaac2gCV7px6z7_PSXtgrWeKvfT0dxZRz9w--g2moc9OnEG_8Ya5GUGP3QHIGimD1YRt6tAa3APR3T_oYgCkfeXBD4R0cY6BzXeOkEGrSnOPqUl3UE-ZpC_IokKSQM5oD0PCJFZm1rwYK2q-h0gz56TzkDTe8oag4wQfMHSQGcwl9FFVcrg8RYu_1D8vj3aIHd-4w7jX_KiaYBLbSpBvSt1oU-JdHf2p1rfo8rgxHPGHEmM2VTmQ8MxVYNcByU-r5Qba3LcSqp8pFbjfRdPfQ6pJoPcAE58iDwakD4AQBkgUECAQYAZIFBAgFGASgBgKAB-CAzYUBqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQjq0R0ggJCIDhgFAQARgdgAoDyAsB2BMNshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=0_LlE4X9NvA&tpd=AGWhJmvfT5yMVeHNlnzKHZpVzuS461mA4Rqpc4CqKPRUc1AsWg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

si
googleads.g.doubleclick.net/pagead/drt/ Frame 1CE4
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:48:52 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
analytics-tags.js
cdn.userreport.com/
265 B
650 B
Script
General
Full URL
https://cdn.userreport.com/analytics-tags.js
Requested by
Host: cdn.userreport.com
URL: https://cdn.userreport.com/userreport.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:2104:9c00:19:d208:7940:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
7d8c62049816b4a834204bb3a79b014f88a6c6dc916e7ab26abf0d40c2e69ed4

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
BQ4neG9T5yHFyGCIm7yA158D1GNg0I81
via
1.1 241b025da3883bdb653910a6da97c0a8.cloudfront.net (CloudFront)
last-modified
Fri, 03 Aug 2018 07:14:09 GMT
server
AmazonS3
age
2292
etag
"b9c284ba1fea2a6f6c2de5d0d9904ee9"
x-cache
Hit from cloudfront
content-type
application/javascript
cache-control
max-age=3600
date
Tue, 15 Dec 2020 12:10:35 GMT
x-amz-cf-pop
AMS1-C1
accept-ranges
bytes
content-length
265
x-amz-cf-id
Hcx2odCLME1wBJ4SBkiHqi-lqrypzhjuUZfRu_IhwntYOF3sDt7fSA==
pixel.gif
cdw-dcl.userreport.com/gs/init/
43 B
441 B
Image
General
Full URL
https://cdw-dcl.userreport.com/gs/init/pixel.gif
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.31 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:45:05 GMT
Via
1.1 cca9137c259ad738f790039a45561cef.cloudfront.net (CloudFront)
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
nginx/1.16.1
Age
228
X-Cache
Hit from cloudfront
Content-Type
image/gif
Connection
keep-alive
X-Amz-Cf-Pop
AMS1-C1
Content-Length
43
X-Amz-Cf-Id
l3WBkuoBTBy4yVsueAm3G2utv9ZYciTVfFO_b4rQjNgNuMsoB165hQ==
adform
audex.userreport.com/sync/put/
Redirect Chain
  • https://dmp.adform.net/serving/cookie/match/?party=1001&cid=612561e1-b6af-4af8-9302-cfd9ad491e75
  • https://dmp.adform.net/serving/cookie/match/?CC=1&party=1001&cid=612561e1-b6af-4af8-9302-cfd9ad491e75
  • https://audex.userreport.com/sync/put/adform?adfusr=2560869188276099566
43 B
432 B
Image
General
Full URL
https://audex.userreport.com/sync/put/adform?adfusr=2560869188276099566
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.118 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.16.1 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:53 GMT
Via
1.1 fb8f21b90b0483bdc64e7c79b3e007e0.cloudfront.net (CloudFront)
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
nginx/1.16.1
X-Amz-Cf-Pop
AMS1-C1
X-Cache
Miss from cloudfront
Content-Type
image/gif
Connection
keep-alive
Content-Length
43
X-Amz-Cf-Id
F-0A2d6SbNqRveSbOQfQyfbbxfcPWIy0DbMc1aut07PFoNzNiBQbaA==

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:53 GMT
server
nginx
location
https://audex.userreport.com/sync/put/adform?adfusr=2560869188276099566
strict-transport-security
max-age=31536000; includeSubDomains
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate, no-transform
content-length
0
expires
-1
/
crta.dailymail.co.uk/
8 B
574 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:53 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:48:53 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 19E7
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstCVRFTGDauQdHqrCWQbKtpGOrOEbmCcM6DFf6_udvYlzfJPewn0DiLTS-dFhMXfuJeVV21avqojKHU595--2mgCdJJhu73xXQQK9N4lrSIOq02PYIBehYIZYF5KuD8iNU1UKc3Iwkz1iw7EfK1dc7ACN8om4U_5d8LCiMGUMkyrt_Z4Dr4cm2-nJzrR9gBkKTvEgXhZwH2ewV8xi28q8wGhtVOdsJElg6rCYm65i93EgHxbthbaZfvloHLYAlE6xr_zaNCfPpV7Mb1SXJkLXRYYG4e5wfPifAH9PZMO5AOVys_BCUfKrbheHYNr_-QU5TbAyrF&sai=AMfl-YT_GgTE73f22JEuwZ-GFjbv0gODaDI8JMbaxeV2v8qm5MVDHZCdXCbJnCQKn4Ui3Li4KpQhLNHhhb6waG9hhnaJ6HcyD_O0JG1l1DibtlSJ5B_wwOqtuQkw1_JIWP4j&sig=Cg0ArKJSzO8H0wXtLuNVEAE&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:47 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/ Frame 19E7
18 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
631c6a3617e2f5860eaa62155f5200b6ca156c00438445f9862089ef785e4542
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 15:46:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
75755
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7483
x-xss-protection
0
server
cafe
etag
7789600959769866771
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 28 Dec 2020 15:46:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/ Frame 19E7
3 KB
2 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:27:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33660
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Dec 2020 03:27:47 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 19E7
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
07a3eb8be1687dc1ee377d85bffd51891d0fd539258b63ab4031b012bd77f5fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29432
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
l
www.google.com/ads/measurement/ Frame 19E7
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaT6qjs4cs3ZcV5x6CBRIlMBlahMQmEMPvGh0qDKRuJRuab-MtwJ3_h-npE1wjH4zCSacMGP
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

11821856140203563031
tpc.googlesyndication.com/simgad/ Frame 19E7
62 KB
62 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/11821856140203563031
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6b8c8ec959d13923fd3cdeac5539407f5e1d5eb7b3aee26fb0928ab7c2c3a921
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 10 Dec 2020 18:23:25 GMT
x-content-type-options
nosniff
age
411922
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
63373
x-xss-protection
0
last-modified
Tue, 01 Dec 2020 18:13:35 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 18:23:25 GMT
DOUBLE-MPU-1.jpg
i.dailymail.co.uk/i/pix/2016/03/23/
12 KB
12 KB
Image
General
Full URL
https://i.dailymail.co.uk/i/pix/2016/03/23/DOUBLE-MPU-1.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.desktop.css
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
Apache /
Resource Hash
981793c8e58a9ebc2fa825db3f2e1de282a682d2158238d497cca1af74844116

Request headers

Referer
https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.desktop.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
last-modified
Tue, 24 Apr 2018 08:44:48 GMT
server
Apache
etag
"80b954e5f874a18861095c8c9da27bb0:1524559488"
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
content-length
12558
expires
Thu, 14 Jan 2021 12:48:47 GMT
osd.js
www.googletagservices.com/activeview/js/current/
74 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c1c9310eb6a56101c2133db372cfbe9cefb5ff6b90a02ded916984c975b813b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28334
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
225114
search.spotxchange.com/openrtb/2.3/dados/
0
988 B
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Requested by
Host: js.spotx.tv
URL: https://js.spotx.tv/directsdk/v1/234272.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
x-openrtb-version
2.3
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 15 Dec 2020 12:48:54 GMT
X-SpotX-Timing-Transform
0.000385
X-SpotX-Timing-SpotMarket
0.022121
X-SpotX-Timing-Page-Mux
0.001936
X-SpotX-Timing-Page-Require
0.000576
X-fe
073
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000006
X-SpotX-Timing-Page
0.050144
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000458
Last-Modified
Tue, 15 Dec 2020 12:48:54 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.022121
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.024645
X-SpotX-Timing-Page-Exception
0.000001
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000016
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
225114
search.spotxchange.com/openrtb/2.3/dados/ Frame
0
0
Other
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Protocol
HTTP/1.1
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-openrtb-version
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Server
nginx
Date
Tue, 15 Dec 2020 12:48:53 GMT
Content-Type
text/plain;charset=UTF-8
Content-Length
0
Connection
keep-alive
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Tue, 15 Dec 2020 12:48:53 GMT
Cache-Control
no-cache, must-revalidate post-check=0, pre-check=0
Pragma
no-cache
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Access-Control-Allow-Headers
content-type,x-openrtb-version
Access-Control-Allow-Credentials
true
Access-Control-Max-Age
2592000
iab
api.skimlinks.mgr.consensu.org/
0
0

link
t.skimresources.com/api/v2/
22 B
88 B
XHR
General
Full URL
https://t.skimresources.com/api/v2/link
Requested by
Host: s.skimresources.com
URL: https://s.skimresources.com/js/55199X1584066.skimlinks.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.67.47 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Python/3.7 aiohttp/3.5.4 /
Resource Hash
fcc83a5b6aef86420c1ad553167106df96bd0ff4192ffe52b1647599948edbcf
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
via
1.1 google
x-content-type-options
nosniff
server
Python/3.7 aiohttp/3.5.4
access-control-allow-headers
Origin, Accept, Content-Type, X-Requested-With, X-CSRF-Token
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/plain; charset=utf-8, application/javascript
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-store, no-cache, must-revalidate
access-control-allow-credentials
true
alt-svc
clear
content-length
22
225114
search.spotxchange.com/openrtb/2.3/dados/
0
988 B
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Requested by
Host: js.spotx.tv
URL: https://js.spotx.tv/directsdk/v1/234272.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
x-openrtb-version
2.3
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 15 Dec 2020 12:48:54 GMT
X-SpotX-Timing-Transform
0.000684
X-SpotX-Timing-SpotMarket
0.008404
X-SpotX-Timing-Page-Mux
0.000941
X-SpotX-Timing-Page-Require
0.000366
X-fe
106
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000003
X-SpotX-Timing-Page
0.012028
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000415
Last-Modified
Tue, 15 Dec 2020 12:48:54 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.008404
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.001202
X-SpotX-Timing-Page-Exception
0.000001
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000012
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
225114
search.spotxchange.com/openrtb/2.3/dados/ Frame
0
0
Other
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Protocol
HTTP/1.1
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-openrtb-version
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Server
nginx
Date
Tue, 15 Dec 2020 12:48:54 GMT
Content-Type
text/plain;charset=UTF-8
Content-Length
0
Connection
keep-alive
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Tue, 15 Dec 2020 12:48:54 GMT
Cache-Control
no-cache, must-revalidate post-check=0, pre-check=0
Pragma
no-cache
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Access-Control-Allow-Headers
content-type,x-openrtb-version
Access-Control-Allow-Credentials
true
Access-Control-Max-Age
2592000
view
securepubads.g.doubleclick.net/pcs/ Frame 19E7
0
22 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvVqIHwHjv5aniHCJQGDtfER24KiySz-TGZf8TbkW22UdZvBZEL9UNi-yMn_TLZbxWYBj_UFwxlHPiEy3h0WlOsqxX-H119EOhkODRUNrDul87eHenuTBHOUXryPwLwiERvPDTvb803sYXo3yMe9-msJK5w--ot87G1mlV66EmiXvsdWY7zde0YXz8Bg6si7q9-kwy8SjtB5pGFEXUVDFKaD8DDfdD3yhddjhVYA3jPJNGovfYR-JrI2e9_-ZezvPoCo09Jrx-EzNY03Z6JdSrN8pgIG48nIs7-SwuDKqDbIBrvL3Y_WGC3ALbN-prkKESgLpR4D4Y&sai=AMfl-YRF2_5w9FOGHRH1mStNj4GGT_Gf_BQ7q2Ga-AmiNSBxT3APLTN-CrKfiaR5Q5Og0M3DNnqHpd-7IbbHBWKHyct01riG7s5rImrGpqiwDhse5W2hWMKijqLB3xEGNTRd&sig=Cg0ArKJSzE_-D66L7hFLEAE&adurl=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:47 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
truncated
/ Frame 19E7
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
fdec62b119e5c725ba485821a8cf31b63137c21ec35caa2212d63a73bd961217

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
page
t.skimresources.com/api/v2/
22 B
384 B
XHR
General
Full URL
https://t.skimresources.com/api/v2/page
Requested by
Host: s.skimresources.com
URL: https://s.skimresources.com/js/55199X1584066.skimlinks.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.201.67.47 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Python/3.7 aiohttp/3.5.4 /
Resource Hash
fcc83a5b6aef86420c1ad553167106df96bd0ff4192ffe52b1647599948edbcf
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
via
1.1 google
x-content-type-options
nosniff
server
Python/3.7 aiohttp/3.5.4
access-control-allow-headers
Origin, Accept, Content-Type, X-Requested-With, X-CSRF-Token
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/plain; charset=utf-8, application/javascript
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-store, no-cache, must-revalidate
access-control-allow-credentials
true
alt-svc
clear
content-length
22
view
securepubads.g.doubleclick.net/pcs/ Frame 80B4
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstolr8H42Ka-9i_jvkbQIigHL_feb0LCM41TJaDHRHmnAciWdCCsWRV9d22smgr01lFT84OZ6oVlwtL1mMsIOJ52YS3UnvZc0Z9T5xlubTxGnM4uBiyMKhoB6Fo3iaFBv9Uta99dWUcR4Wb9gMmvXSThI3BTK5PPER3FEZ9QGwmfxH4VuN_n9wNKPrYUudY-hpgj3RKT-WtQZSeznWw8c90AM2Nero7vIQH4hGk5Ht8UXi4adMFnm4FB2GkrT6Ata6QnW2IuX1sS9EZlRiLmdlbA2iBAmvVK3Al-LlA8_KEtdbtZa3Z4I-ahCeFK0OoRClr2D25tZs&sai=AMfl-YTuh16fbMMKe4eSrwXJHaQVdFuVvaYVjOPwiC4XPucGvC1vsc3B_i9WBFeOW7YImjABgjcZOGdM7abuOTu31Yt1A_f8SsGLHFUPHMUgL_dBWQ5z0PP8JjZNG0TGomHJ&sig=Cg0ArKJSzPY4oc-5O6ALEAE&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:47 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/ Frame 80B4
18 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
631c6a3617e2f5860eaa62155f5200b6ca156c00438445f9862089ef785e4542
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 15:46:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
75755
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7483
x-xss-protection
0
server
cafe
etag
7789600959769866771
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 28 Dec 2020 15:46:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/ Frame 80B4
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:27:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33660
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Dec 2020 03:27:47 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 80B4
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
07a3eb8be1687dc1ee377d85bffd51891d0fd539258b63ab4031b012bd77f5fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29432
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
2372239932193196690
tpc.googlesyndication.com/simgad/ Frame 80B4
80 KB
80 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/2372239932193196690
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6edd38aac0568ccb6d5e16653372139450baf060813e25aefae4103bd6320898
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 12 Dec 2020 05:27:53 GMT
x-content-type-options
nosniff
age
285654
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
82242
x-xss-protection
0
last-modified
Wed, 20 Jun 2018 11:14:02 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:53 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 80B4
0
24 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvvXbFhKSqGgfETp2zsiDFVQmhOTG5feSSM1DMLlk-4xTcCru9ppfIT4fnN4BX9hTUF_71bYBhmRuG_FYg4HxHor1iK0ReqRyETUDz81KC7kgJw5c3KPwlLphWnqiHfX0dXEW_i3EizPQMxulkTsPb4sZKhpXdtJTWnRRR76233nk5Rxs0eZE4EtJIi3PYDr-_gOFdu7wLAqYIzu-eFrjNZli4s9cmFCl73auv6Lxe7WGDgOf7MFIly59ErQSRSOwo5AfGmnR_v9HLtl1CV4-v7vxR4rVFRkpsNCx_Gp2K7YuN85gi4lM-Hq_LIVX7Hi8DONP-yD5PZBQ&sai=AMfl-YQtodhRIGg6_94UM-cQBImxHpd5dBn-V_LOrvAsThfWOPCQZiJCn7KHWOWefjGREU1lTCZqZu7Q3k5JUCc7np2ueUzYu_uz135OB8SCE38vlRpredWNYQmrMSQF91e6&sig=Cg0ArKJSzHuBU1MDdhWnEAE&adurl=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:47 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
truncated
/ Frame 80B4
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8a87b25301c567c27bed04f162b3ade727c57213de7240d30034a7a136e17ff4

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
bulk
trc.taboola.com/dailymail-row/log/3/
0
269 B
XHR
General
Full URL
https://trc.taboola.com/dailymail-row/log/3/bulk?route=AM%3AAM%3AV&lti=deflated&bulkSize=15
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

x-vcl-time-ms
70
pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036527.401720,VS0,VE70
x-served-by
cache-fra19151-FRA
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
accept-ranges
bytes
content-type
image/gif
x-cache-hits
0
publishertag.prebid.js
static.criteo.net/js/ld/
77 KB
25 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
6d8ffd84868d7c4232e88167eb1adc0a83d4c1f5efb41d78eb1a03127dcdb625

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
last-modified
Tue, 17 Nov 2020 07:57:58 GMT
server
nginx
etag
W/"5fb38286-13244"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
timing-allow-origin
*
expires
Wed, 16 Dec 2020 12:48:53 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 507C
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssIJrIZLo7ii-rCKBzWrXCVYeYtMZBAVFg1_RUKWrL0ymIHDfdJVSY0ey-v-iNrdyojS45W0QdKaM_gKiPkqgekXYIDItyyiFgF4Oapu9_rAGDqbQ2GwrEJ4YdTZ68Sxfp4TKhvq68zBm_7VrCMnKgcYdM9P7RqlM6RvbiU7FcwyX7ubEQsA8YbfEKKDGg2ArQRXDfnhLf8ohyYSJc3BKzfFGAHQzR_xhqp1UEx2dUh7sXhaud6LcS0cnXDctLi85dM0pX5ZEoYNmUkKPefCOyU7tAXay97JdKv7izzbPiN6cdw4XWN5aqt6SGjS67wOBdrX_-p2Pit64tX&sai=AMfl-YR8BF-L1Old-uLWihMgRujvwp_HSMfcoY_NxBakrPBwuagIE00p8SYHdxrwrLDrvK5j3yhSZrvveqHuw2wSRn47_lxNDtmz8675dwRQkKuqP5wfhdeAk85JhBS7XEI&sig=Cg0ArKJSzCgzclF5vGImEAE&urlfix=1&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:47 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
dailymail.co.uk_mix.js
play.selectmedia.asia/58fcbed1073ef420086c9d08/5e84b6a4f3500a68ee259b56/ Frame 507C
11 KB
5 KB
Script
General
Full URL
https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5e84b6a4f3500a68ee259b56/dailymail.co.uk_mix.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:bb28 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
0e6f013f6485ea79d57880c3ef0b5279c8883af65ec13705d2ef91b882053d48

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:53 GMT
Content-Encoding
gzip
X-GUploader-UploadID
ABg5-Uzd29CyY9OXcobUmxpUIp7S1eEQOiVllR5wNOsFx-Vlpb0h4IA1k5kTfg-g9OR3Xtd-_k6DcOjD4UNGd7XDShk
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
Connection
keep-alive
Content-Length
4075
Last-Modified
Mon, 19 Oct 2020 10:29:47 GMT
Server
UploadServer
ETag
"cb8a878188fb8134ee6a133228b58381"
Vary
Accept-Encoding
x-goog-hash
crc32c=knlHQA==
x-goog-generation
1603103387919090
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Content-Type
Cache-Control
public, max-age=1800
x-goog-stored-content-length
10861
Accept-Ranges
bytes
Content-Type
text/javascript
Expires
Tue, 15 Dec 2020 13:18:53 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 507C
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
07a3eb8be1687dc1ee377d85bffd51891d0fd539258b63ab4031b012bd77f5fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29432
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame DBCC
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvwM-2qXEz67vG1vKHi2oTDHS_AqNmdcVt-eKclTpPtc2mdaRJ4JqY4r1BKsMJPW7zLLsO5hNaviNQQXb0UfiAYLtCRf5m18II4kn5So3FFXUxcCLpl6LaL5AOyHVo4AOTU48-VyNCu9tAiIXBh3xHsgsXNBqQzXxMXaqvjYrfzo58BcxJ-Ln5UehnTxu7f-KE_BSfSi8qhpPd0YoYXZg7AvwcdWAHVDXSP6B3mQP7X8US1qTb5WiXQlGAnPuL84uXz69t_m-p_NwD8aHMDPZejD9bVkg0W_Ka99OkMbco3lrBqq38tyk3c9WiNN9JjtuHeqW8P&sai=AMfl-YQ04QpMesqhvehAPHpzDgXOUnuqL79jJTr9RBlUevo3pHcs8RqVA0tyyLpiFtQY-iafoZVx-L9gn1QSFfrE_VllS-PcyPS5om83UNgVACXwjIsTMng-e6GjMzHLbH8&sig=Cg0ArKJSzDfAIQgD0qNfEAE&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:47 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
11821856140203563031
tpc.googlesyndication.com/simgad/ Frame DBCC
62 KB
62 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/11821856140203563031
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6b8c8ec959d13923fd3cdeac5539407f5e1d5eb7b3aee26fb0928ab7c2c3a921
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 10 Dec 2020 18:23:25 GMT
x-content-type-options
nosniff
age
411922
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
63373
x-xss-protection
0
last-modified
Tue, 01 Dec 2020 18:13:35 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 18:23:25 GMT
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/ Frame DBCC
18 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
631c6a3617e2f5860eaa62155f5200b6ca156c00438445f9862089ef785e4542
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 15:46:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
75755
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7483
x-xss-protection
0
server
cafe
etag
7789600959769866771
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 28 Dec 2020 15:46:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/ Frame DBCC
3 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:27:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33660
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Dec 2020 03:27:47 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame DBCC
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
07a3eb8be1687dc1ee377d85bffd51891d0fd539258b63ab4031b012bd77f5fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29432
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:47 GMT
l
www.google.com/ads/measurement/ Frame DBCC
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaS1z8sOPkGeysYtdLoOAqpg8N2QWVXej7ykZ9-ch1ybAXQarEcqht3r7OtOR1pIc6oqLtzT
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

truncated
/ Frame 507C
207 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
304c2aaa82df30e55357a5d9b8ca191bd9757299c047a388e68562d518c60320

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame DBCC
0
22 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstCPKV81TlVBFWZRIFsAMol5NNgkfVr9mCSWz5QqLtYOEE7JSCRAML3Na2xzXTIp9EX1yeJq2KNEf9vs7mcMU0yibE4E4xmaPxlL4OHLFXeIf2ZG7Vq4hUDyYTQPj-la89gsd2bwmESh_FzCB2c1-eVrJYUeicWe-rWPLTE263VLAMVzfmNk9gppbw7h5HlF6pTG8Ih4VK6QYsV1aP_9BTNwm6qs_xe_GWyDXoYxHKF755OAaEcCgH3Xj1Dmpme4ty9BzRowX0hcQ4uKSQS9wvN1GzfvxTxMsbMoS9zGLbZbGOIs0GqLedSsu-rKi3BfbQa9jBck0s&sai=AMfl-YQrr8uDbdvw2VrXswKwVTokmoYyni3hbQS259bGaU3RDK7ykD5GuFHPW0feRGn68IlfuzmO41a5rm3snqN3wJqESdUn094pY46WGTdU3paxeeWpX4CybNkWUn9-JP0&sig=Cg0ArKJSzGA2n5PyXjb7EAE&adurl=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:47 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
truncated
/ Frame DBCC
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
2fcc4494d84ffce6e36b173651d55f78753936d8ed7a395cb5b24e00ae06ddfc

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
sync
googlesync.permutive.com/v2.0/px/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=permutive_dmp&google_cm&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=8ae168bc-50cf-4fd5-aa08-6b927e71518c
  • https://googlesync.permutive.com/v2.0/px/sync?alias=CAESELhJCqdGkLSnc1gDOhVCFVs&error=&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=8ae168bc-50cf-4fd5-aa08-6b927e71518c&google_cver=1
35 B
107 B
Image
General
Full URL
https://googlesync.permutive.com/v2.0/px/sync?alias=CAESELhJCqdGkLSnc1gDOhVCFVs&error=&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=8ae168bc-50cf-4fd5-aa08-6b927e71518c&google_cver=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
via
1.1 google
server
Permutive
alt-svc
clear
content-length
35
content-type
image/gif

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:47 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://googlesync.permutive.com/v2.0/px/sync?alias=CAESELhJCqdGkLSnc1gDOhVCFVs&error=&type=ddp&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e&u=8ae168bc-50cf-4fd5-aa08-6b927e71518c&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
404
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
Artemis
aud.pubmatic.com/AdServer/
Redirect Chain
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Faud.pubmatic.com%2FAdServer%2FArtemis%3Fdpid%3D267%26segid%3D10277
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Faud.pubmatic.com%2FAdServer%2FArtemis%3Fdpid%3D267%26segid%3D10277
  • https://aud.pubmatic.com/AdServer/Artemis?dpid=267&segid=10277
7 B
147 B
Image
General
Full URL
https://aud.pubmatic.com/AdServer/Artemis?dpid=267&segid=10277
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.64.189.249 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:54 GMT
Connection
keep-alive
Content-Length
7
Content-Type
text/plain; charset=utf-8

Redirect headers

Location
https://aud.pubmatic.com/AdServer/Artemis?dpid=267&segid=10277
Date
Tue, 15 Dec 2020 12:48:51 GMT
X-Cnection
close
Server
Apache/2.2.24 (Unix) mod_ssl/2.2.24 OpenSSL/1.0.0-fips mod_fastcgi/2.4.6
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
385
Content-Type
text/html; charset=iso-8859-1
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 6619
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
398144
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 6619
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285655
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 6619
90 KB
28 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475825
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 6619
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355747
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 6619
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353859
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 6619
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47660
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 6619
295 B
325 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53726
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 6619
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
03dff319cad7455db15934f26551651296f2452d4ccd5befe6f442d0a0ac949a

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
8379803558052769245
tpc.googlesyndication.com/simgad/ Frame 6619
68 KB
68 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/8379803558052769245?sqp=4sqPyQQ7QjkqNxABHQAAtEIgASgBMAk4A0DwkwlYAWBfcAKAAQGIAQGdAQAAgD-oAQGwAYCt4gS4AV_FAS2ynT4&rs=AOga4qlpkamXECN-v-LyMPRPwG2YB4E3bA
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
436902546a292b78b027a970716dab597f2c407092e97563cb3ee8812e7efc63
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 23:05:46 GMT
x-content-type-options
nosniff
last-modified
Fri, 20 Nov 2020 09:48:19 GMT
server
sffe
age
49381
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
69700
x-xss-protection
0
expires
Tue, 14 Dec 2021 23:05:46 GMT
l
www.google.com/ads/measurement/ Frame 6619
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQ454qJXrsUlM1clKKwtLyV7hsSGRBKsV9pJziqnyq-cjytaLncvweSVFikrCR2OCMFcK-g
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

adview
securepubads.g.doubleclick.net/pagead/ Frame 6619
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CMG5gr7DYX_KuJM3ugAfGoovoB-7nmIZg6erey_wMvuOaigQQASCs2bgiYOnkyYXYGqABtK365gLIAQKpAlOXI8kiY5I-4AIAqAMByAMIqgTAAk_Qul3WhMYN8jOAC6ePvaa13x5tVkUJJymQl57-jnaUHHI8BMe2PYF60kiy145kSNttQ_9-PjxZukjkrPuz6D22BS4uQgrsuJtAL_l68GvS9OyJ1Ms3jUCszHBCkBxkqv8m2sosV7SgI7zN3kbI1eQ3f_l4YSNHaNusIu3zXwqkIi0Ey_xELt-yDB7KVW6se4H1GWhPX340sTyrd9Fnt-3FP4ZRxUovszfJVncIiA_nvCV64TRAd44oJIJ-CV_kuRAxi8KlImAWLz1jP9mkkO1_1KtwqxbPCOWx3CERb2ejbRudR8jd7Wd8yh75Chrre4ztLJhZyPfSvYY_ekyR39brJ9bQXQ2Z8B4jrKyd5gJVs-QugfuTzaLz89lpcNKMnfEgAPre-63BDKaByelhpLglFepp5vUSX6ZYZrKgUcXrwATv18GRnQPgBAGgBgKAB7yX-cMBqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQhJwH0ggJCIDhgFAQARgdgAoDyAsB2BMDmBYBshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=x31SJpFmAPM&tpd=AGWhJmsmYfIBnCRbryj3xQniFz2ZEdWEnvgWUIQ1eS6ibLob5A
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

167.json
id5-sync.com/g/v2/
346 B
895 B
XHR
General
Full URL
https://id5-sync.com/g/v2/167.json?gdpr_consent=&gdpr=0
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
51.89.20.87 , Germany, ASN16276 (OVH, FR),
Reverse DNS
Software
/
Resource Hash
1dd26706ab8973221caf05d095ca7062aba5a7288199e189a06d78cf197178f7
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:47 GMT
Vary
Origin
P3P
CP="CAO PSA OUR"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
Content-Type
application/json;charset=UTF-8
Transfer-Encoding
chunked
rid
match.adsrvr.org/track/
108 B
654 B
XHR
General
Full URL
https://match.adsrvr.org/track/rid?ttd_pid=a8r0pns&fmt=json
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.50.156.162 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
7c47f3b578dcd62294c1051f5ce31b9b16942f186941cb77ca6e25dac6017669

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:47 GMT
x-aspnet-version
4.0.30319
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Content-Length, Content-Encoding, Vary, Cache-Control, Accept
content-length
108
expires
Thu, 14 Jan 2021 12:48:47 GMT
pd
u.openx.net/w/1.0/ Frame 98DB
0
0
Document
General
Full URL
https://u.openx.net/w/1.0/pd
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
u.openx.net
:scheme
https
:path
/w/1.0/pd
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; Version=1; Expires=Wed, 15-Dec-2021 12:48:47 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036527|gekin0vNiygu; Version=1; Expires=Wed, 30-Dec-2020 12:48:47 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:48:47 GMT
content-type
text/html
content-length
420
content-encoding
gzip
via
1.1 google
alt-svc
clear
async_usersync.html
acdn.adnxs.com/dmp/ Frame FAA9
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.13.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
anj=dTM7k!M4/AfQBY/ghqdmU(7TTXvi.N#[2R$J=#_59bw%SYq_]f<y+3+Q9[ftQUY`!E[o6UZ03SvZ.%Tz^-!1QaZ[gPVEM3kNabzuS<hGZ3M4ud*cV_pAbSfU$KgO/v6w?g@%[7D#fLpZalNDuvB+!XaVe?Na=ixb/[`<U/f`^nvha@ZYpg:c++x]vqTau)=MfQQCyf#`!!*D'3QvkQ; uids=eyJ0ZW1wVUlEcyI6eyJncmlkIjp7InVpZCI6ImY2NDQzMTNkLTVjOWItNDk2YS05OGIwLTIxZDc0OGE2OTM1MCIsImV4cGlyZXMiOiIyMDIxLTAzLTE1VDEyOjQ4OjQ1WiJ9LCJicmlnaHRyb2xsIjp7InVpZCI6Inktd1BmOVJPNTFseGJxblBKZ2lHYjB6TU0wYkRpRUxFSkxoYUFheGN1bmdNOUpEZ1V1SjBCQl8uMC0iLCJleHBpcmVzIjoiMjAyMS0wMy0xNVQxMjo0ODo0NVoifX0sImJpcnRoZGF5IjoiMjAyMC0xMi0xNVQxMjo0ODo0NVoifQ==
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:48:49 GMT
Age
56330
X-Served-By
cache-lga21927-LGA, cache-fra19131-FRA
X-Cache
HIT, HIT
X-Cache-Hits
1, 290747
X-Timer
S1608036529.067322,VS0,VE0
Vary
Accept-Encoding
async_usersync.html
acdn.adnxs.com/dmp/ Frame 0507
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.13.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
anj=dTM7k!M4/AfQBY/ghqdmU(7TTXvi.N#[2R$J=#_59bw%SYq_]f<y+3+Q9[ftQUY`!E[o6UZ03SvZ.%Tz^-!1QaZ[gPVEM3kNabzuS<hGZ3M4ud*cV_pAbSfU$KgO/v6w?g@%[7D#fLpZalNDuvB+!XaVe?Na=ixb/[`<U/f`^nvha@ZYpg:c++x]vqTau)=MfQQCyf#`!!*D'3QvkQ; uids=eyJ0ZW1wVUlEcyI6eyJncmlkIjp7InVpZCI6ImY2NDQzMTNkLTVjOWItNDk2YS05OGIwLTIxZDc0OGE2OTM1MCIsImV4cGlyZXMiOiIyMDIxLTAzLTE1VDEyOjQ4OjQ1WiJ9LCJicmlnaHRyb2xsIjp7InVpZCI6Inktd1BmOVJPNTFseGJxblBKZ2lHYjB6TU0wYkRpRUxFSkxoYUFheGN1bmdNOUpEZ1V1SjBCQl8uMC0iLCJleHBpcmVzIjoiMjAyMS0wMy0xNVQxMjo0ODo0NVoifX0sImJpcnRoZGF5IjoiMjAyMC0xMi0xNVQxMjo0ODo0NVoifQ==
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:48:49 GMT
Age
56330
X-Served-By
cache-lga21927-LGA, cache-fra19131-FRA
X-Cache
HIT, HIT
X-Cache-Hits
1, 290751
X-Timer
S1608036529.143266,VS0,VE0
Vary
Accept-Encoding
ixmatch.html
js-sec.indexww.com/um/ Frame 74C1
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
js-sec.indexww.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache
Last-Modified
Tue, 06 Oct 2020 14:04:48 GMT
ETag
"e20015-8f4-5b10114f2003a"
Accept-Ranges
bytes
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
text/html; charset=UTF-8
Vary
Accept-Encoding
Content-Encoding
gzip
Content-Length
1136
Date
Tue, 15 Dec 2020 12:48:55 GMT
Connection
keep-alive
ixmatch.html
js-sec.indexww.com/um/ Frame CC16
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
js-sec.indexww.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache
Last-Modified
Tue, 06 Oct 2020 14:04:48 GMT
ETag
"e20015-8f4-5b10114f2003a"
Accept-Ranges
bytes
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
text/html; charset=UTF-8
Vary
Accept-Encoding
Content-Encoding
gzip
Content-Length
1136
Date
Tue, 15 Dec 2020 12:48:55 GMT
Connection
keep-alive
async_usersync.html
acdn.adnxs.com/dmp/ Frame 07E5
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.13.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
anj=dTM7k!M4/AfQBY/ghqdmU(7TTXvi.N#[2R$J=#_59bw%SYq_]f<y+3+Q9[ftQUY`!E[o6UZ03SvZ.%Tz^-!1QaZ[gPVEM3kNabzuS<hGZ3M4ud*cV_pAbSfU$KgO/v6w?g@%[7D#fLpZalNDuvB+!XaVe?Na=ixb/[`<U/f`^nvha@ZYpg:c++x]vqTau)=MfQQCyf#`!!*D'3QvkQ; uids=eyJ0ZW1wVUlEcyI6eyJncmlkIjp7InVpZCI6ImY2NDQzMTNkLTVjOWItNDk2YS05OGIwLTIxZDc0OGE2OTM1MCIsImV4cGlyZXMiOiIyMDIxLTAzLTE1VDEyOjQ4OjQ1WiJ9LCJicmlnaHRyb2xsIjp7InVpZCI6Inktd1BmOVJPNTFseGJxblBKZ2lHYjB6TU0wYkRpRUxFSkxoYUFheGN1bmdNOUpEZ1V1SjBCQl8uMC0iLCJleHBpcmVzIjoiMjAyMS0wMy0xNVQxMjo0ODo0NVoifX0sImJpcnRoZGF5IjoiMjAyMC0xMi0xNVQxMjo0ODo0NVoifQ==
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:48:49 GMT
Age
56330
X-Served-By
cache-lga21927-LGA, cache-fra19131-FRA
X-Cache
HIT, HIT
X-Cache-Hits
1, 290752
X-Timer
S1608036529.198335,VS0,VE0
Vary
Accept-Encoding
ixmatch.html
js-sec.indexww.com/um/ Frame A63D
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
js-sec.indexww.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache
Last-Modified
Tue, 06 Oct 2020 14:04:48 GMT
ETag
"e20015-8f4-5b10114f2003a"
Accept-Ranges
bytes
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
text/html; charset=UTF-8
Vary
Accept-Encoding
Content-Encoding
gzip
Content-Length
1136
Date
Tue, 15 Dec 2020 12:48:55 GMT
Connection
keep-alive
sync
pre.ads.justpremium.com/v/1.0/t/ Frame 7A20
0
0
Document
General
Full URL
https://pre.ads.justpremium.com/v/1.0/t/sync?_c=aqsy8qr1608036524841
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.106.210 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash

Request headers

:method
GET
:authority
pre.ads.justpremium.com
:scheme
https
:path
/v/1.0/t/sync?_c=aqsy8qr1608036524841
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-type
text/html; charset=utf-8
cache-control
public, no-cache, no-store, must-revalidate
sync
eb2.3lift.com/ Frame 6CF6
Redirect Chain
  • https://eb2.3lift.com/sync?
  • https://eb2.3lift.com/sync?&ld=1
0
0
Document
General
Full URL
https://eb2.3lift.com/sync?&ld=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.29.22.19 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash

Request headers

:method
GET
:authority
eb2.3lift.com
:scheme
https
:path
/sync?&ld=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
tluid=5810176028621894902
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

date
Tue, 15 Dec 2020 12:48:51 GMT
content-type
text/html; charset=utf-8
content-length
536
set-cookie
sync=CgoIgQIQt_jIs-YuCgoI4gEQt_jIs-YuCgoI5gEQt_jIs-YuCgoIhwIQt_jIs-YuCgkIORC3-Miz5i4KCQg6ELf4yLPmLgoJCAsQt_jIs-YuCgoIjAIQt_jIs-YuCgkIXxC3-Miz5i4KCQgfELf4yLPmLg==; Max-Age=7776000; Expires=Mon, 15 Mar 2021 12:48:51 GMT; Path=/sync; Domain=.3lift.com; SameSite=None; Secure tluid=5810176028621894902; Max-Age=7776000; Expires=Mon, 15 Mar 2021 12:48:51 GMT; Path=/; Domain=.3lift.com; SameSite=None; Secure
content-encoding
gzip
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
cache-control
no-cache, no-store, must-revalidate

Redirect headers

date
Tue, 15 Dec 2020 12:48:51 GMT
content-length
0
set-cookie
tluid=5810176028621894902; Max-Age=7776000; Expires=Mon, 15 Mar 2021 12:48:51 GMT; Path=/; Domain=.3lift.com; SameSite=None; Secure
location
/sync?&ld=1
cache-control
no-cache, no-store, must-revalidate
p3p
policyref="http://cdn.3lift.com/w3c/p3p.xml", CP="NON DSP COR NID OUR DEL SAM OTR UNR COM NAV INT DEM CNT STA PRE LOC OTC"
usync.html
eus.rubiconproject.com/ Frame 7197
0
0
Document
General
Full URL
https://eus.rubiconproject.com/usync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.108.50.124 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-108-50-124.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
eus.rubiconproject.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
rsid=1|AIfsdBUH+v3fWCPuzNowDE/csJlhOqmt03ZRUZWfOgZ1rOqUPHfhRs3ya9WQiOHKKRWt2j6qYTD2eRvLWSDhFgX3ng06hUEE9RUpasHbexkkvGugYKBWI6L/JKS3dwHNbrrxlA==; ses9=; vis9=124374^1; ses15=; vis15=124374^1; khaos=KIPZFFB4-1L-B5F2; ses2=; vis2=124374^1; audit=1|hLZGFuTafB3N05zAsPSwgJqpp78UDnSwo/35WNfb8oX41MesxV8qc7Vfrxdy/JuMJj+nfjXWofEikLZnp+mTxkS+nStejD8b3OlDu/ORdD8=
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache/2.2.15 (CentOS)
Last-Modified
Mon, 28 Sep 2020 17:02:39 GMT
ETag
"4000c-123-5b062a240e9c0"
Accept-Ranges
bytes
Content-Encoding
gzip
Content-Length
238
Content-Type
text/html; charset=UTF-8
Date
Tue, 15 Dec 2020 12:48:49 GMT
Connection
keep-alive
Vary
Accept-Encoding
async_usersync.html
acdn.adnxs.com/dmp/ Frame 0B3B
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.13.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
anj=dTM7k!M4/AfQBY/ghqdmU(7TTXvi.N#[2R$J=#_59bw%SYq_]f<y+3+Q9[ftQUY`!E[o6UZ03SvZ.%Tz^-!1QaZ[gPVEM3kNabzuS<hGZ3M4ud*cV_pAbSfU$KgO/v6w?g@%[7D#fLpZalNDuvB+!XaVe?Na=ixb/[`<U/f`^nvha@ZYpg:c++x]vqTau)=MfQQCyf#`!!*D'3QvkQ; uids=eyJ0ZW1wVUlEcyI6eyJncmlkIjp7InVpZCI6ImY2NDQzMTNkLTVjOWItNDk2YS05OGIwLTIxZDc0OGE2OTM1MCIsImV4cGlyZXMiOiIyMDIxLTAzLTE1VDEyOjQ4OjQ1WiJ9LCJicmlnaHRyb2xsIjp7InVpZCI6Inktd1BmOVJPNTFseGJxblBKZ2lHYjB6TU0wYkRpRUxFSkxoYUFheGN1bmdNOUpEZ1V1SjBCQl8uMC0iLCJleHBpcmVzIjoiMjAyMS0wMy0xNVQxMjo0ODo0NVoifX0sImJpcnRoZGF5IjoiMjAyMC0xMi0xNVQxMjo0ODo0NVoifQ==
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:48:49 GMT
Age
56330
X-Served-By
cache-lga21927-LGA, cache-fra19131-FRA
X-Cache
HIT, HIT
X-Cache-Hits
1, 290754
X-Timer
S1608036529.252200,VS0,VE0
Vary
Accept-Encoding
Cookie set usermatch
ssum-sec.casalemedia.com/ Frame F9DD
Redirect Chain
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D
  • https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
0
0
Document
General
Full URL
https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
ssum-sec.casalemedia.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
CMPS=1155; CMID=X9iws7niHq6YTPQ3bBMqvgAA
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache
Content-Type
text/html
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Vary
Is-Traffic-Usersync
Content-Length
1764
Expires
Tue, 15 Dec 2020 12:48:51 GMT
Cache-Control
max-age=0, no-cache, no-store
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:51 GMT
Connection
keep-alive
Set-Cookie
CMID=X9iws7niHq6YTPQ3bBMqvgAA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:48:51 GMT CMPS=1155;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:48:51 GMT CMPRO=1162;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:48:51 GMT CMST=X9iws1-YsLMA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 16 Dec 2020 12:48:51 GMT CMRUM3=2d5fd8b0b305a0&be5fd8b0b305a0&055fd8b0b305a0&f15fd8b0b305a00&275fd8b0b30b40&c45fd8b0b305a0&585fd8b0b305a0&e65fd8b0b327600;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:48:51 GMT

Redirect headers

Server
Apache
Content-Length
338
Content-Type
text/html; charset=iso-8859-1
Location
https://ssum-sec.casalemedia.com/usermatch?s=184665&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D&C=1
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Expires
Tue, 15 Dec 2020 12:48:51 GMT
Cache-Control
max-age=0, no-cache, no-store
Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:51 GMT
Connection
keep-alive
Set-Cookie
CMID=X9iws7niHq6YTPQ3bBMqvgAA;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Wed, 15 Dec 2021 12:48:51 GMT CMPS=1155;domain=casalemedia.com;path=/;sameSite=None;Secure;expires=Mon, 15 Mar 2021 12:48:51 GMT
pd
u.openx.net/w/1.0/ Frame 0C4C
0
0
Document
General
Full URL
https://u.openx.net/w/1.0/pd
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
u.openx.net
:scheme
https
:path
/w/1.0/pd
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; pd=v2|1608036527|gekin0vNiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; Version=1; Expires=Wed, 15-Dec-2021 12:48:48 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036527.1|kiiygevNgun0.mWgqsLommOns; Version=1; Expires=Wed, 30-Dec-2020 12:48:48 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:48:48 GMT
content-type
text/html
content-length
317
content-encoding
gzip
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame CB02
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; pd=v2|1608036527|gekin0vNiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; Version=1; Expires=Wed, 15-Dec-2021 12:48:48 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036527.1|kiiygevNgun0.mWgqsLommOns; Version=1; Expires=Wed, 30-Dec-2020 12:48:48 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:48:48 GMT
content-type
text/html
content-length
317
content-encoding
gzip
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame 47B7
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; pd=v2|1608036527|gekin0vNiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; Version=1; Expires=Wed, 15-Dec-2021 12:48:48 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036527.1|kiiygevNgun0.mWgqsLommOns; Version=1; Expires=Wed, 30-Dec-2020 12:48:48 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:48:48 GMT
content-type
text/html
content-length
317
content-encoding
gzip
via
1.1 google
alt-svc
clear
async_usersync.html
acdn.adnxs.com/dmp/ Frame D22F
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.13.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Cookie
anj=dTM7k!M4/AfQBY/ghqdmU(7TTXvi.N#[2R$J=#_59bw%SYq_]f<y+3+Q9[ftQUY`!E[o6UZ03SvZ.%Tz^-!1QaZ[gPVEM3kNabzuS<hGZ3M4ud*cV_pAbSfU$KgO/v6w?g@%[7D#fLpZalNDuvB+!XaVe?Na=ixb/[`<U/f`^nvha@ZYpg:c++x]vqTau)=MfQQCyf#`!!*D'3QvkQ; uids=eyJ0ZW1wVUlEcyI6eyJncmlkIjp7InVpZCI6ImY2NDQzMTNkLTVjOWItNDk2YS05OGIwLTIxZDc0OGE2OTM1MCIsImV4cGlyZXMiOiIyMDIxLTAzLTE1VDEyOjQ4OjQ1WiJ9LCJicmlnaHRyb2xsIjp7InVpZCI6Inktd1BmOVJPNTFseGJxblBKZ2lHYjB6TU0wYkRpRUxFSkxoYUFheGN1bmdNOUpEZ1V1SjBCQl8uMC0iLCJleHBpcmVzIjoiMjAyMS0wMy0xNVQxMjo0ODo0NVoifX0sImJpcnRoZGF5IjoiMjAyMC0xMi0xNVQxMjo0ODo0NVoifQ==
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:48:49 GMT
Age
56330
X-Served-By
cache-lga21927-LGA, cache-fra19131-FRA
X-Cache
HIT, HIT
X-Cache-Hits
1, 290755
X-Timer
S1608036529.305276,VS0,VE0
Vary
Accept-Encoding
ixmatch.html
js-sec.indexww.com/um/ Frame 8E9F
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
js-sec.indexww.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache
Last-Modified
Tue, 06 Oct 2020 14:04:48 GMT
ETag
"e20015-8f4-5b10114f2003a"
Accept-Ranges
bytes
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
text/html; charset=UTF-8
Vary
Accept-Encoding
Content-Encoding
gzip
Content-Length
1136
Date
Tue, 15 Dec 2020 12:48:55 GMT
Connection
keep-alive
pd
eu-u.openx.net/w/1.0/ Frame 6267
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=6&ph=36664cef-3484-4aa7-9d01-fa4f6f6b2d4e&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; pd=v2|1608036527|gekin0vNiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=24596e50-ba71-0d9d-1bc9-868f4d787c1e|1608036524; Version=1; Expires=Wed, 15-Dec-2021 12:48:48 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036527.1|kiiygevNgun0.mWgqsLommOns; Version=1; Expires=Wed, 30-Dec-2020 12:48:48 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:48:48 GMT
content-type
text/html
content-length
317
content-encoding
gzip
via
1.1 google
alt-svc
clear
ixmatch.html
js-sec.indexww.com/um/ Frame FEC9
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
js-sec.indexww.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache
Last-Modified
Tue, 06 Oct 2020 14:04:48 GMT
ETag
"e20015-8f4-5b10114f2003a"
Accept-Ranges
bytes
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
text/html; charset=UTF-8
Vary
Accept-Encoding
Content-Encoding
gzip
Content-Length
1136
Date
Tue, 15 Dec 2020 12:48:55 GMT
Connection
keep-alive
sync
ups.analytics.yahoo.com/ups/55986/
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=
  • https://sync-tm.everesttech.net/ct/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=&_...
  • https://pixel.advertising.com/ups/55986/sync?uid=X9iwtQAAALpUgSzr&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwtQAAALpUgSzr&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwtQAAALpUgSzr&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86&verify=true
0
964 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwtQAAALpUgSzr&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86&verify=true
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:53 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

Date
Tue, 15 Dec 2020 12:48:53 GMT
Server
ATS/7.1.2.128
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
Location
https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwtQAAALpUgSzr&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwtQAAALpUgSzr&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86&verify=true
Connection
keep-alive
Content-Length
0
sync
pixel.advertising.com/ups/55953/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adaptv&ttd_tpi=1
  • https://pixel.advertising.com/ups/55953/sync?uid=756bd07b-da9f-4519-81af-bb93a5ce71b6&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=756bd07b-da9f-4519-81af-bb93a5ce71b6
0
125 B
Image
General
Full URL
https://pixel.advertising.com/ups/55953/sync?uid=756bd07b-da9f-4519-81af-bb93a5ce71b6&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=756bd07b-da9f-4519-81af-bb93a5ce71b6
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.124.119.192 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:48 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://pixel.advertising.com/ups/55953/sync?uid=756bd07b-da9f-4519-81af-bb93a5ce71b6&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=756bd07b-da9f-4519-81af-bb93a5ce71b6
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
369
i.gif
mfad.inskinad.com/udb/9874/sync/
Redirect Chain
  • https://ssum.casalemedia.com/usermatchredir?s=185638&cb=https%3A%2F%2Fmfad.inskinad.com%2Fudb%2F9874%2Fsync%2Fi.gif%3FpartnerId%3D1%26userId%3D
  • https://mfad.inskinad.com/udb/9874/sync/i.gif?partnerId=1&userId=X9iws7niHq6YTPQ3bBMqvgAA%261162
43 B
780 B
Image
General
Full URL
https://mfad.inskinad.com/udb/9874/sync/i.gif?partnerId=1&userId=X9iws7niHq6YTPQ3bBMqvgAA%261162
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.225.161.250 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-225-161-250.compute-1.amazonaws.com
Software
nginx/1.16.1 / adzerk bifrost/
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:54 GMT
ETag
W/"2b-6KwiS6nul+h2cO1vOi8BKLevn+Q"
Server
nginx/1.16.1
x-powered-by
adzerk bifrost/
Access-Control-Allow-Methods
GET, PUT, POST, DELETE, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
undefined
Expires
0
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Access-Control-Allow-Headers
Accept, Origin, Content-Type, Content-Length, X-Adzerk-Explain, X-Adzerk-Sdk-Version
Content-Length
43
x-served-by
engine-production-i-0dfb6fcc03ed232ba

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:54 GMT
Server
Apache
P3p
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Location
https://mfad.inskinad.com/udb/9874/sync/i.gif?partnerId=1&userId=X9iws7niHq6YTPQ3bBMqvgAA%261162
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Content-Type
text/html; charset=iso-8859-1
Content-Length
284
Expires
Tue, 15 Dec 2020 12:48:54 GMT
sync
ups.analytics.yahoo.com/ups/57304/
Redirect Chain
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&verify=true
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86&verify=true
  • https://cm.g.doubleclick.net/pixel?google_nid=adaptv_dbm&google_cm&google_hm=VVBlMmY3NmVhYi0zZWQzLTExZWItYTYxMS0wNjljZmQxYjZlODY%3D
  • https://pixel.advertising.com/ups/57304/sync?uid=CAESEHtsl8YElh_NAhXjwjiB5TQ&google_cver=1
  • https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEHtsl8YElh_NAhXjwjiB5TQ&google_cver=1&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86
0
976 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEHtsl8YElh_NAhXjwjiB5TQ&google_cver=1&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:53 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEHtsl8YElh_NAhXjwjiB5TQ&google_cver=1&apid=UPe2f76eab-3ed3-11eb-a611-069cfd1b6e86
date
Tue, 15 Dec 2020 12:48:53 GMT
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
sync
x.bidswitch.net/
Redirect Chain
  • https://x.bidswitch.net/sync?ssp=themediagrid
  • https://pixel.quantserve.com/pixel/p-zLwwakwy-hZw3.gif?idmatch=0&ssp=themediagrid&gdpr=&gdpr_consent=
  • https://x.bidswitch.net/sync?dsp_id=76&user_group=2&ssp=themediagrid&gdpr=1&user_id=EhOoYEVFrmgKR65pEUDhOkMRqm4KR6g5H0bz4jdY
43 B
212 B
Image
General
Full URL
https://x.bidswitch.net/sync?dsp_id=76&user_group=2&ssp=themediagrid&gdpr=1&user_id=EhOoYEVFrmgKR65pEUDhOkMRqm4KR6g5H0bz4jdY
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.93.211.166 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
548f2d6f4d0d820c6c5ffbeffcbd7f0e73193e2932eefe542accc84762deec87

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
content-length
43
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:48 GMT
strict-transport-security
max-age=86400
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAo PSDo OUR SAMa IND COM NAV"
location
https://x.bidswitch.net/sync?dsp_id=76&user_group=2&ssp=themediagrid&gdpr=1&user_id=EhOoYEVFrmgKR65pEUDhOkMRqm4KR6g5H0bz4jdY
cache-control
private, no-cache, no-store, proxy-revalidate
content-length
0
expires
Fri, 04 Aug 1978 12:00:00 GMT
si
googleads.g.doubleclick.net/pagead/drt/ Frame 6619
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:48:53 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 2D4A
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
398145
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 2D4A
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285656
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 2D4A
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475826
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 2D4A
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355748
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 2D4A
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353860
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 2D4A
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47661
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 2D4A
295 B
325 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53727
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 2D4A
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
91232e9a92b830342d77f22502996b2120ef27fb519cb3b8a9daf6f5c1864587

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
6947752918169721918
tpc.googlesyndication.com/simgad/ Frame 2D4A
72 KB
72 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/6947752918169721918?sqp=4sqPyQQrQikqJwhfEAEdAAC0QiABKAEwCTgDQPCTCUgAUAFYAWBfcAJ4AcUBLbKdPg&rs=AOga4qmDVjfLXfezj-HQE-RRAQcA4Eutnw
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a7f31c35beb8975f7ca791bd909b602ee4d25fe0f973fbe8bd30258151f9800b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:53:36 GMT
x-content-type-options
nosniff
last-modified
Tue, 28 Aug 2018 05:00:07 GMT
server
sffe
age
32112
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
73837
x-xss-protection
0
expires
Wed, 15 Dec 2021 03:53:36 GMT
l
www.google.com/ads/measurement/ Frame 2D4A
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRIhL5OppWl4TAt9q-4UajLKqUOk3vd9TwYFSz9ItDAbBTdNcjTdpHNiwIbw3ZUh89nJjxd
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

adview
securepubads.g.doubleclick.net/pagead/ Frame 2D4A
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CbSP1r7DYX5SRMNaG-gaM64zYCfK53bFgkpi4r_cL2tkeEAEgrNm4ImDp5MmF2BqgAYj_svoCyAECqQKY1A5BZcBoPuACAKgDAcgDCKoEzQJP0I7QbwXAYpDoeuZHN6irkhNB6NIk3ksqnwxQYlXthh3M9cMgBpgNS-f57ZuE--V2mUUujGGuA9H0MwdPX8il_rCTBzVKXfDtcEzEXEYLpuG7V9jnvJ7h9GhSnDQhl3VgY1mRrd9eQ51ZB-dQhWUz2Gcv1WCGjrVR3d48xNru7wuF6z3737z4mzr3_4r94AWZWQaquWwDFQlau4KoEphZrtJNXBsa3LGu4RAlsuafpZ8qs4TF4Egfa79BMNF6p60bO1YXID129--FzeK8HiLssJjHs9N2XUXXFo805F98D8zTmb5t7ozeez05XBjDrnjUXYjkBq4DBP0rCLRYzERQ5Wv8BGmI5oQ36NVxxRAsan0sdS3OZZmhgOYXx0-QH8qau-dYGd2D1HjTfnqb2OKumuB6nGA-FSYL70GsV-lxPv6Entw44leO3eWNNu_ABOfIg8GpA-AEAZIFBAgEGAGSBQQIBRgEoAYCgAfggM2FAagH1ckbqAfw2RuoB_LZG6gHlJixAqgHpd8bqAeOzhuoB5PYG6gHugaoB-6WsQKoB6a-G6gH7NUb2AcB8gcEEL3iBtIICQiA4YBQEAEYHYAKA8gLAdgTDbIXGgoYCAESFHB1Yi00MTgwODM1Njk0MTY2MjU1&sigh=2KJAh3CpcsM&tpd=AGWhJmv7fspdvPa-Xg7YOLNjkZuLcG2JBtSf9J3S9lyiveJGPQ
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

view
securepubads.g.doubleclick.net/pcs/ Frame D53F
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss7jbowWmnGemZR_x3VRSUwwwKahINab3XnmHU0uYEmy-9cOGGx1xFLgyB0f-jo0sOOloTrv1zqzP0AJoWmAD_furwo8sghxjWSlI0ZRSAGqZy9wMXZ7Hr212vBfMMaNyFbZY5h3V32KDzr_t_7hg9UJR49ZRbDQAFidJtkGWRyMDkCKRNYiojqcin2i0_QvtTPcbxlhIVQna1ruTS_dkOIAAYAThV4HDFSxC9F2H95UEJiw44D99pLCHB4-pPWVlbX2hZsmmDiijm1f5-x3KY7pv4N-dlAdtjTtxCNxVTeD9l3AvwW_NQN_MZG0r7ahJnXeItzYcMXS2pNfbZ7DMpZzgXIk7H7sp4fExN33jLYYeE&sai=AMfl-YQwGUmKf2e8bxjAQuE4VNoQrvoLINu0mK5pevWwj2qOdKunM0xQIpbcQxBkWa7apOYacbx3tTZRWHu1CgGe8Ub9uvKz1FLvQv9Q36Imt4vZcJ7Qz5P6V07l6H8bykvJ&sig=Cg0ArKJSzE6cibwlZ8PUEAE&urlfix=1&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:48 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:48 GMT
loader.js
cdn.taboola.com/libtrc/dailymail-dfpads/ Frame D53F
82 KB
20 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/dailymail-dfpads/loader.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
6448c9200c9ac61898e97b41588a07b891216e86b4ae680c091366055298c92c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
JYAetQPEnD7nRUAGhkYNQbN5ao9StNvV
content-encoding
gzip
etag
"d070ba9e059aaa082cf5c9209b13f549"
age
56
x-cache
HIT
content-length
20228
x-amz-id-2
vtUZbtDOJXFbmIiUdk4P6nEyz1uvYoOj6SDFgITKlM3cmrXmdeXWqLOmu+CowW/N6UDMhkkSnLA=
x-served-by
cache-fra19151-FRA
last-modified
Mon, 14 Dec 2020 11:48:44 GMT
server
AmazonS3
x-timer
S1608036528.377649,VS0,VE1
date
Tue, 15 Dec 2020 12:48:48 GMT
vary
Accept-Encoding
x-amz-request-id
1F6535C396884E71
via
1.1 varnish
cache-control
private,max-age=14401
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
58
x-cache-hits
1
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame D53F
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
07a3eb8be1687dc1ee377d85bffd51891d0fd539258b63ab4031b012bd77f5fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29432
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:48 GMT
events
api.permutive.com/v2.0/batch/
701 B
516 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
a8eda4e7e13a3d0c27373385300ace98985eef87ba26f87bcb5051f93a10873b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
256
via
1.1 google
si
googleads.g.doubleclick.net/pagead/drt/ Frame 2D4A
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:48:53 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
impl.20201214-6-RELEASE.js
cdn.taboola.com/libtrc/ Frame D53F
450 KB
104 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/dailymail-dfpads/loader.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
3d46904b944d38dac0fe78cc6c3aad567ac826a9079ce9522147ef1c7feb158b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
2sVTA33cfaRgn0Prw5U.XCwVzohq6ybg
content-encoding
br
etag
"10bdb5807bdff4c42c4587c2d03bb5d3"
age
4614
x-cache
HIT
content-length
106007
x-amz-id-2
27Bxf87SsWW7Z9R2qIVMcSYoU0fVZAPqLVzYq0lJPpRmTgRaLODbtW20Sr2c9AfJpfGjJ+b9K5M=
x-served-by
cache-fra19151-FRA
last-modified
Mon, 14 Dec 2020 11:30:09 GMT
server
AmazonS3-br
x-timer
S1608036528.460468,VS0,VE0
date
Tue, 15 Dec 2020 12:48:48 GMT
vary
Accept-Encoding
x-amz-request-id
51DADEDDBF5F4FEB
via
1.1 varnish
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
application/javascript
abp
23
x-cache-hits
26012
truncated
/ Frame D53F
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
a3ea392462123eee478df050a67bb54e1cbfb146d3f2e590bac44f92776536fe

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
480x270_MP4_1225476966369939162.mp4
video.dailymail.co.uk/video/mol/2020/10/09/1225476966369939162/
64 KB
0
Media
General
Full URL
https://video.dailymail.co.uk/video/mol/2020/10/09/1225476966369939162/480x270_MP4_1225476966369939162.mp4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
last-modified
Fri, 09 Oct 2020 09:54:05 GMT
server
AkamaiNetStorage
etag
"ca85077d6ba1579f077d6d790b182b5c:1602237245.871325"
content-type
video/mp4
Content-Range
bytes 0-1997031/1997032
accept-ranges
bytes
Content-Length
1997032
view
securepubads.g.doubleclick.net/pcs/ Frame D53F
0
22 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsssLmNqpkrj7NWAGMGH7yf0Q2lYIPhc6KeEgTcOI1jF-vt3ED70oMaidFbGHATbpRQcitTOXpM-FaWK_fmI0-az0uJWOxsZnCk8iRN1M2CjnhBCH51A3HTXey5hBF5sEAoGZjXxMyyyVktinIg_tZkwrRzmP7J_SN4gzUe3IUMvLJb4xMd3eAW-EV4O4akCyxRpxHTTTZqZXvZx0lrpain4Pbn9Ph4aZOZE6NV0xaqvXsUpHWjlv9O1W2ecopwYNiKobGnR99yGC2pgHIR4N6DV5yLGPhdQL1cJnSvzXyN56nKmwCOqylhmO3fygK78jyjPUPSP-Xbg&sai=AMfl-YST8jtapRyPO-3bJG6QVx0k18WshIXROriiTUqwCB-7Aa8glEry8SA9GGlrwdxY0YC7TQ6CDWiQOv8TwbYIcCDqK61Gk3M5TrYNubtvtFVloNFQAU1oP3SBB5aQ9Gyd&sig=Cg0ArKJSzMAPbcWxmPvLEAE&urlfix=1&adurl=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:48 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
container.html
45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame D31C
0
0
Document
General
Full URL
https://45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Tue, 15 Dec 2020 12:48:46 GMT
expires
Wed, 15 Dec 2021 12:48:46 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
2
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
sa
ted.dailymail.co.uk/s/
65 B
610 B
XHR
General
Full URL
https://ted.dailymail.co.uk/s/sa
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/rta2/v-0.56.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
8ca400ee51713a464ee8323318972afd159a0552615bb028da1a947796aa4d49

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 12:48:48 GMT
cache-control
private, no-cache, proxy-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, documentReferer
content-length
65
x-rs-ops
rta2-rufus-a1-fe.hsk.mol.dmgt.net:8180
sa
t.dailymail.co.uk/s/
65 B
612 B
XHR
General
Full URL
https://t.dailymail.co.uk/s/sa
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/rta2/v-0.56.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
fbeddb80122a5256df6bb32c1301d794be106c1a28ea49abd325b6bad253dc70

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 15 Dec 2020 12:48:48 GMT
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 12:48:48 GMT
cache-control
private, no-cache, proxy-revalidate
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, documentReferer
content-length
65
x-rs-ops
rta2-rufus-c3-fe.rdg.mol.dmgt.net:8180
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 6F27
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
398145
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 6F27
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285656
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 6F27
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475826
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 6F27
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355748
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 6F27
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353860
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 6F27
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47661
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 6F27
295 B
384 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53727
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 6F27
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
cca4ba3f2531e7adff922f52863b0b44f55ccd9e2c5c6e51b939ece1e2dc13c6

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
4496573240285201189
tpc.googlesyndication.com/simgad/ Frame 6F27
40 KB
40 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/4496573240285201189?sqp=4sqPyQQ7QjkqNxABHQAAtEIgASgBMAk4A0DwkwlYAWBfcAKAAQGIAQGdAQAAgD-oAQGwAYCt4gS4AV_FAS2ynT4&rs=AOga4qn8BqpBhV7g2hwwS0lN5zSkqSkm2Q
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
3664d176a1f56678f369047eaf416d6638356a75652b4600d7659919d33ca930
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 23:37:16 GMT
x-content-type-options
nosniff
last-modified
Tue, 20 Oct 2020 08:20:16 GMT
server
sffe
age
47492
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
41217
x-xss-protection
0
expires
Tue, 14 Dec 2021 23:37:16 GMT
l
www.google.com/ads/measurement/ Frame 6F27
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaT_gpxSxIjsLmoWwt3-prRQJ_-XplR-Hx92cclpYTKJHaq93D7RTZQD3E2h2vaCeHu0Zxvh
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

adview
securepubads.g.doubleclick.net/pagead/ Frame 6F27
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=Caw09sLDYX7vkItbB-gak2ZDICuvVnMVgjOOcyq8MyKfdr_obEAEgrNm4ImDp5MmF2BqgAYeDv_cDyAEC4AIAqAMByAMIqgS9Ak_QCxWks-zP5PjtUEsvYIkKOuAGIgkIK4sD4h6LRES7ID4_qXdYlTDOEOhFpq4Oy1v_7G0LuG9mlHzdeSchTle7vHo5axKvhzwMdlHlTllLPqt8Dp9gloM_W6bmaSx-z870wouwWrmRhF0WAG-1_yvDMYOWvpT8-FukBPDc1XmXnFi8C9cLrYwpx5df4I1YiAXODecDTS95Lds0XD3ojMpvGqOGPT8RTIXMGOvICc-UM2oL-aWQ6GWcsqXpCp6ky-saqCiG9OLo0ZNsn88Ib0ZBsr8ETotdYXaEUSuvaebBR_Jvb_XwJMZkETnZYiQ32Lrf2diPh_hDxe64UX72Iy-IqaUibMpvY5hxnHWT_Zyky44GqqqIc9cadaH4EtK6rzZ2jHYtI4zOsz6hK2wX1T_ANii3F1-wBVCoyDZ5wASOxZXajQPgBAGSBQQIBBgBkgUECAUYBJIFBAgFGBiSBQUIBRioAaAGAoAH5PSXiQGoB9XJG6gH8NkbqAfy2RuoB5SYsQKoB6XfG6gHjs4bqAeT2BuoB7oGqAfulrECqAemvhuoB-zVG9gHAfIHBBDV_wTSCAkIgOGAUBABGB2ACgPICwHYEwyyFxoKGAgBEhRwdWItNDE4MDgzNTY5NDE2NjI1NQ&sigh=lxdQNVCkVfg&tpd=AGWhJmsWDIgBPbPJmvoJ39XQvFj_svCEHZ7_4EDRsE4mXA7E2w
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

si
googleads.g.doubleclick.net/pagead/drt/ Frame 6F27
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:48:53 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
json
trc.taboola.com/dailymail-dfpads/trc/3/ Frame D53F
3 KB
2 KB
XHR
General
Full URL
https://trc.taboola.com/dailymail-dfpads/trc/3/json?tim=13%3A48%3A49.026&lti=deflated&data=%7B%22id%22%3A902%2C%22ii%22%3A%22%2Fsciencetech%2Farticle-9050821%2Fremdesivir-beneficial-patients-doctors-reveal.html%22%2C%22it%22%3A%22other%22%2C%22sd%22%3Anull%2C%22ui%22%3A%225d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c%22%2C%22uifp%22%3Anull%2C%22lbt%22%3A1607946522421%2C%22vi%22%3A1608036524897%2C%22cv%22%3A%2220201214-6-RELEASE%22%2C%22uiv%22%3A%22default%22%2C%22u%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%2C%22bv%22%3A%220%22%2C%22ul%22%3A%5B%22en-US%22%5D%2C%22btv%22%3A%220%22%2C%22lspb%22%3A%22CwsIQRDAv18MCwhCEMC_XwwLCIkBEMC_XwwLCJEBEMC_XwwLCBwQwL9fDAsInAEQwL9fDAsInQEQwL9fDAsIHRDAv18MCwgfEMC_XwwLCJ8BEMC_XwwLCCAQwL9fDAsIoQEQwL9fDAsIogEQwL9fDAsIIxCgjmAMCwgkEMC_XwwLCCcQwL9fDAsIqwEQwL9fDAsIrQEQwL9fDAsILRDAv18MCwiuARDAv18MCwivARDAv18MCwiwARDAv18MCwixARDAv18MCwgxEMC_XwwLCLIBEMC_XwwLCLQBEMC_XwwLCLUBEMC_XwwLCLYBEMC_XwwLCLcBEMC_XwwLCDsQwL9fDAsIPRDh8F4MCwg_EMC_XwwMExQ%22%2C%22cos%22%3A%224g%22%2C%22plf%22%3A%7B%22ack_exm%22%3Atrue%7D%2C%22e%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%2C%22bad%22%3A-1%2C%22sw%22%3A1600%2C%22sh%22%3A1200%2C%22bw%22%3A300%2C%22sde%22%3A%221.000%22%2C%22bh%22%3A250%2C%22dw%22%3A300%2C%22dh%22%3A250%2C%22qs%22%3A%22%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%2C%22r%22%3A%5B%7B%22li%22%3A%22rbox-o2m%22%2C%22s%22%3A1%2C%22uim%22%3A%22thumbnasils-b-300x250%3Aabp%3D0%22%2C%22uip%22%3A%22300x250%22%2C%22orig_uip%22%3A%22300x250%22%2C%22cd%22%3A0%2C%22mw%22%3A300%7D%5D%2C%22cacheKey%22%3A%22other%3D%2Fsciencetech%2Farticle-9050821%2Fremdesivir-beneficial-patients-doctors-reveal.html%2C300x250%3Dthumbnasils-b-300x250%3Aabp%3D0%22%2C%22cb%22%3A%22TRC.callbacks.recommendations_1%22%2C%22lt%22%3A%22deflated%22%7D
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
2bced8d6ef6c5f7a6744d80550f61ece58bab921b1e965784ad6b06e848c1b45

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

x-vcl-time-ms
217
date
Tue, 15 Dec 2020 12:48:49 GMT
content-encoding
gzip
server
nginx
x-timer
S1608036529.055732,VS0,VE217
x-served-by
cache-fra19151-FRA
vary
Accept-Encoding
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
via
1.1 varnish
x-cache-hits
0
view
securepubads.g.doubleclick.net/pcs/ Frame 37E4
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssyvsSJ3OINZ3ZriS2SJkM5J9NFvBeAY1LFo2GKEo9GzEpeKb9FbKrQaCwipNS6AkXYuPAReFwrm-hWjJ82UrG1-1qQquq_-A1cWNf_swA_-I0bezvLFw9wOY0EMmvrRlGxCqu7dXzIbDAA8Rl4n2JzhBBCK5lNW8x1YYVkUFOIKedcV8oX8hKxJqetKwgXPyAT2oMckYD8qXnIXi8EkQ5TKRZefTjt5OD6a94H828jd_eTDwaZS1W3BFuXApRtXHa_O3qrMmX8_Or_IdHAIrgMiN6pIeQp3lNWlrSLh3kPKDtOdzZ5XfeIZM5OcE9ZuilOCeJuww&sai=AMfl-YRBRRRUsLGE-qj7eWPh5NNGid0k5uAw7O87FEO5X8lXlS9ntiq6m2l8vcBhV1QjmfO4Esv4M0Sd6s6wWIiInewMP2KYg1yeJ4FC1jDJuG_capVlwUhfOGuXnpNziWNM&sig=Cg0ArKJSzGatvCiFk8FxEAE&urlfix=1&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:49 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:49 GMT
mpuCarousel.html
scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/ Frame 1FE6
542 B
821 B
Document
General
Full URL
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
b353ebc19cae4d93c9934616502d097e8f26cfa656801c539ac637363b1e69fd

Request headers

:method
GET
:authority
scripts.dailymail.co.uk
:scheme
https
:path
/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
same-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
__gads=ID=ea1f7182e06d9078-22ba14f364b900d1:T=1608036526:S=ALNI_MZDGnuW9dhJESk3Gb1Trc7NfbbG-g
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

accept-ranges
bytes
content-type
text/html
etag
"cee3a33fb1d66f0cb0187823e34f8735:1596014725.011076"
last-modified
Wed, 29 Jul 2020 09:25:24 GMT
server
AkamaiNetStorage
content-length
542
cache-control
max-age=2592000
expires
Thu, 14 Jan 2021 12:48:49 GMT
date
Tue, 15 Dec 2020 12:48:49 GMT
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
access-control-allow-origin
*
timing-allow-origin
*
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 37E4
104 KB
32 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
641620cb44b22d924bd94996adebcd8cf56e65629af1ba9d98a7371d07be127d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690634902976"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
32509
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:49 GMT
truncated
/ Frame 37E4
209 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
eced1bb7d0acd8d2b6c5035cc29bb2772e7a98d1b70aafacb2605cdadda262c2

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
cta-branding.js
cdn.taboola.com/demand-formats/cta-branding/ Frame D53F
8 KB
3 KB
Script
General
Full URL
https://cdn.taboola.com/demand-formats/cta-branding/cta-branding.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
0c56a21524db6a9ae3e1969698a146013f95b2fab9ac4ed167048d7e5d3c0830

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
zMWJo1PVj_h5BEu57MrR0ouiGawOeH2Y
content-encoding
gzip
etag
"2f4d244e58c3b6e32e449819d4fe0da1"
age
10034
x-cache
HIT
x-amz-replication-status
PENDING
content-length
2983
x-amz-id-2
UrqGF85PdXRhKnUzExvGW2WYb6SeGntEowKtDacaaZ9nc/UoQj+MisXht2ltBkCE5LBTYqqc2BY=
x-served-by
cache-fra19151-FRA
last-modified
Sun, 13 Dec 2020 10:01:26 GMT
server
AmazonS3
x-timer
S1608036533.192054,VS0,VE0
date
Tue, 15 Dec 2020 12:48:53 GMT
vary
Accept-Encoding
x-amz-request-id
3EE68CC59824B1CF
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
application/javascript
abp
25
x-cache-hits
93542
cta-branding.css
cdn.taboola.com/demand-formats/cta-branding/ Frame D53F
3 KB
1 KB
Stylesheet
General
Full URL
https://cdn.taboola.com/demand-formats/cta-branding/cta-branding.css
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
b2cb57515497d75f4345929ae896c87c21f27d609aed94fb83f857e5b96f9835

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
tcahAQL7SM5vHmChLog9xryayd2KNhUu
content-encoding
gzip
etag
"9e155136143a96e23a99757df9aa3cc8"
age
12466
x-cache
HIT
x-amz-replication-status
PENDING
content-length
728
x-amz-id-2
f65xj6iuxogMKrz0V0PcFaMwZec2VDREXRA0jdjbf3aLNlkxtn2vhTmCXQ21535SK5HpYLHFJGI=
x-served-by
cache-fra19151-FRA
last-modified
Sun, 15 Nov 2020 09:20:35 GMT
server
AmazonS3
x-timer
S1608036529.336380,VS0,VE0
date
Tue, 15 Dec 2020 12:48:49 GMT
vary
Accept-Encoding
x-amz-request-id
414C1B5C7AA1A893
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
text/css
abp
23
x-cache-hits
112432
userx.20201214-6-RELEASE.es6.js
cdn.taboola.com/libtrc/ Frame D53F
23 KB
8 KB
Script
General
Full URL
https://cdn.taboola.com/libtrc/userx.20201214-6-RELEASE.es6.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/dailymail-dfpads/loader.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
727885a70a1364d1fb91147b801bdc8f7dede4774fd1c9ae833850ed71fc29ce

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
Y0ss_Jafd96z_HkO2cF.Em0G3eY1Is9S
content-encoding
gzip
etag
"cfd0cc9c6be211947cf31df27de14f76"
age
16210
x-cache
HIT
x-amz-replication-status
PENDING
content-length
7879
x-amz-id-2
XLrx3K8fe/oa6Kfi/rG4gcK23ZBpn2W29w3g+mGMz+j61ELj8e81BP4fZw913s0CuASzBtUTGIo=
x-served-by
cache-fra19151-FRA
last-modified
Tue, 15 Dec 2020 08:18:39 GMT
server
AmazonS3
x-timer
S1608036533.223113,VS0,VE0
date
Tue, 15 Dec 2020 12:48:53 GMT
vary
Accept-Encoding
x-amz-request-id
2ABC199CCE0964B5
via
1.1 varnish
cache-control
private,max-age=14400
accept-ranges
bytes
content-type
application/javascript; charset=utf-8
abp
25
x-cache-hits
44953
view
securepubads.g.doubleclick.net/pcs/ Frame 37E4
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssIpzmhNVtrG24-TANvZLYhV2BCQiohxA3GY_q2edg0GX0a5sj8XucZEmymasd6tjEWO1XmhMyPrAYCLjbm2_jayD8CJbHbCTNyvP9_UBWITBvrhBVm1wzl2iWvLEgkUqJB_rpx9icnKA-EHIZEqjqSCe5E6BNjHHzOyfuRbtymuDaERi279DyaYxlhsjOsfVihbRbyNfcNwvFtn8q2V-O7WnX8_x5URVIkajY4lv1l5TT4jLMt0AwEJpcBRATWvhWG7Yq_f0behT3RfTiXaWM3csvNKHK0fgM6Si32K-qzHmRhGBUCsRt5w0Dqq3w-IaMmBNmyhhtw&sai=AMfl-YSXVHsYwUUi2APKTEzo1bmT-QwxsMcnXeYOiLvf7yKWFBx98tVQhbWEYt7xIcX3EIgmTNnMhnt3aR0Nok8vuLGc3JCPfl4L_BnKdeQg55HmTKuWlsNSFxIbF8m0lANw&sig=Cg0ArKJSzFgeKasDtzy5EAE&urlfix=1&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:49 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:49 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame 6619
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=C9Q5cr7DYX_KuJM3ugAfGoovoB-7nmIZg6erey_wMvuOaigQQASCs2bgiYOnkyYXYGqABtK365gLIAQKpAlOXI8kiY5I-4AIAqAMBqgTAAk_Qul3WhMYN8jOAC6ePvaa13x5tVkUJJymQl57-jnaUHHI8BMe2PYF60kiy145kSNttQ_9-PjxZukjkrPuz6D22BS4uQgrsuJtAL_l68GvS9OyJ1Ms3jUCszHBCkBxkqv8m2sosV7SgI7zN3kbI1eQ3f_l4YSNHaNusIu3zXwqkIi0Ey_xELt-yDB7KVW6se4H1GWhPX340sTyrd9Fnt-3FP4ZRxUovszfJVncIiA_nvCV64TRAd44oJIJ-CV_kuRAxi8KlImAWLz1jP9mkkO1_1KtwqxbPCOWx3CERb2ejbRudR8jd7Wd8yh75Chrre4ztLJhZyPfSvYY_ekyR39brJ9bQXQ2Z8B4jrKyd5gJVs-QugfuTzaLz89lpcNKMnfEgAPre-63BDKaByelhpLglFepp5vUSX6ZYZrKgUcXrwATv18GRnQPgBAGgBgKAB7yX-cMBqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQhJwH0ggJCIDhgFAQARgdgAoDyAsB2BMDmBYBshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=JuHeBWIiVLQ&vt=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

activeview
pagead2.googlesyndication.com/pcs/ Frame 6619
42 B
108 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsv90lOSqg6f5yYrNFPsPxIKaSsr3ZE-w-BFDiNZ-kmqo7D8_-weYNiEE6SoBGSGw4pvz1UzMBGaFi7UM_fOQ1JHgP6xNmPY8S6RtsXI8KvaPdyJNavmomvu3x97RzUW-52VmBIAI50tXoayBKjYwaPB&sai=AMfl-YRLHBpS7E6YJfEfE4qiBxikSN_5O0MjJh6k6ruDXqUXnzyMkrENYcyxO_XfTYW9Aw9dnUiR0ou2b4V9ULkxK2ic8Jcyy4t5MIAyOP-bRGl7owIGo6fMjm8qJSJCBmbf&sig=Cg0ArKJSzK1PpCmNncVGEAE&cid=CAASPeRoJoPuSNVu-KoEG5V7Vx-Vv3Yvsctjxc36XnCdIAdXe8V5zdYQjf6noF4Vni9KiBm81BlQ8PXiBovO9zc&id=ampim&o=1297,20&d=300,600&ss=1600,1200&bs=1600,1200&mcvt=1022&mtos=0,0,1022,1022,1022&tos=0,0,1022,0,0&tfs=208&tls=1230&g=100&h=100&tt=1230&r=v&avms=ampa&adk=3607738367
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:53 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ee500aae51ffba23e63b960314802ac8.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_180%2Cw_360%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/ Frame D53F
8 KB
9 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_180%2Cw_360%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/ee500aae51ffba23e63b960314802ac8.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
09e660034589d9f35a32ebc5dad839f4bbbd2095f07e6f35cdaf758613447bde

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1199575
edge-cache-tag
602296728692249640601002917896816616473,341818766630488423269086991181948173068,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_180%2Cw_360%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/ee500aae51ffba23e63b960314802ac8.jpg
content-length
8623
x-request-id
52984376eebb57ce34616561cd855b7e
x-served-by
cache-dca17723-DCA, cache-dca17729-DCA, cache-lon4226-LON
last-modified
Sat, 21 Nov 2020 07:44:50 GMT
server
cloudinary
x-timer
S1608036533.245621,VS0,VE0
etag
"dda644926a7b972ff142fbb299345b0d"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 1
mpuCarousel.css
scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/ Frame 1FE6
4 KB
2 KB
Stylesheet
General
Full URL
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.css
Requested by
Host: scripts.dailymail.co.uk
URL: https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
b37883b41725849d3cd6e7b879429ea23b3c85a94c112bd63caf09e940bd6a63

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
content-encoding
gzip
last-modified
Wed, 29 Jul 2020 09:25:15 GMT
server
AkamaiNetStorage
etag
"6acfba106a2f54c780d6c3128c5d9580:1596014715.525657"
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
content-length
1242
expires
Thu, 14 Jan 2021 12:48:49 GMT
mpuCarousel.js
scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/ Frame 1FE6
199 KB
70 KB
Script
General
Full URL
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.js
Requested by
Host: scripts.dailymail.co.uk
URL: https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
2c35effc381ffc291c8cc250560cd944c3c5c9dad3fd146fe0f9d3a19b7bdd00

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
content-encoding
gzip
last-modified
Wed, 29 Jul 2020 09:25:24 GMT
server
AkamaiNetStorage
etag
"aa75c84f39b95cda17db90488a08186d:1596014724.432392"
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
*
cache-control
max-age=2592000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept
expires
Thu, 14 Jan 2021 12:48:49 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 2D4A
42 B
317 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsux80dAMPfoPbCw31zHSBSHdtt2cWTnsfNWCortjvCdZasxB64iKxX4Q5UfUalDFy5MuY4V-zCZw2n_iqgdegQVarLsHEF1AKhUH_skFnYEFBXLxwsdfs2i2yxL7A&sai=AMfl-YRmN_H4OvzDJHDiyZM2H3fGqCAXnxt4dQrQixv-tdrNfNu_HrwC0MCKighx0a2msyQiE6XB_7oMoqP1p6GBPjV8Wbeq8zb33hLVXSZC4VdtNbHOs3PdlQOXqeheFMfX&sig=Cg0ArKJSzAWVM2MqL6tMEAE&cid=CAASPeRozwxhusv_YEpgZmgddMQWvy-yc7LnDx_zypGWAT5WznIof6H5RS8mQ7XQeQPvz3GQ_RwXRys_v67kGfY&id=ampim&o=978,529&d=300,600&ss=1600,1200&bs=1600,1200&mcvt=1014&mtos=0,0,1014,1014,1014&tos=0,0,1014,0,0&tfs=105&tls=1119&g=100&h=100&tt=1119&r=v&avms=ampa&adk=1173142669
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:53 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 4A35
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
398146
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 4A35
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285661
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 4A35
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475831
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 4A35
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355753
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 4A35
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353865
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 4A35
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47662
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 4A35
295 B
399 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53728
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 4A35
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
aa26255323957b91fb2b3171adf04412d837d3dce01bb97792697ff97dd6acdc

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
2412915266699584311
tpc.googlesyndication.com/simgad/ Frame 4A35
45 KB
45 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/2412915266699584311?sqp=4sqPyQQ7QjkqNxABHQAAtEIgASgBMAk4A0DwkwlYAWBfcAKAAQGIAQGdAQAAgD-oAQGwAYCt4gS4AV_FAS2ynT4&rs=AOga4qnCZS050zLezae_B9V9ET-x2BH-7A
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f81696fa42436fd0fac962aff24a93165aeecbc2c3e8c50cc1fc8ef9ec371fbb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 10 Dec 2020 11:17:38 GMT
x-content-type-options
nosniff
last-modified
Thu, 03 Dec 2020 10:16:57 GMT
server
sffe
age
437471
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
46150
x-xss-protection
0
expires
Fri, 10 Dec 2021 11:17:38 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame 4A35
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=C1aSWsbDYX5v8C8P5-ga1x7-AC7mTtrpg2KKn4NUMwYTA_PoBEAEgrNm4ImDp5MmF2BqgAYXQq7gDyAECqQJTlyPJImOSPuACAKgDAcgDCKoEuAJP0IAMhd_E_3I6vhMgInyUpdmVve2bwXbUl1_LyJGb8pPJ0Rws7UJydZfAlbZfPK5UTgNqCIqpP5Ha7cjw1VoGKGgR-LAlIH_B94acZklFIC8tJlzPBUljDQVqG5DEZM2mvD_y3ihXo5A-BRINpA6Kosa9y3jY1xHxgQiaV7Q8uEHl87YrNFYSFJ5dlMRBxqbtU1Idg4k31Z7SOpNAnJ-7iNm-PmNBlr0tAFZPGasylOWYONwCisP6H1ZcbZB1VEor1iQUQZTPCXUv1ALvkjaC5bBkDaVhUO2POJOlQnlMYTyeT4pyujYUdd6uW_E-2c-c0qVnr9tdjIxgmGc61Hf3qiyB28bSfJiRa_m3rmXTRg26rF-JsAQgOop0yeaqDUpWi_g3Vtq2VsxGqFYW3lP3LzVxFaIo9RXABK3U9p2eA-AEAZIFBAgEGAGSBQQIBRgEoAYCgAfjr9RHqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQ_c4G0ggJCIDhgFAQARgdgAoDyAsB2BMNmBYBshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=_wP84TgRIt4&tpd=AGWhJmuot6R-1bui_Ov9o9TrHzCLQhk02Bv7wilqNxCQXypNTg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

unip
trc-events.taboola.com/1125455/log/3/
0
295 B
XHR
General
Full URL
https://trc-events.taboola.com/1125455/log/3/unip?en=pre_d_eng_tb&tos=4565&scd=18&ssd=1&est=1608036524900&ver=27&isls=true&src=i&invt=3000&tim=1608036529465&vi=1608036524897&ri=33989576fd58a84e73b3f9a0b11cec49&sd=v2_bf71d5d1fc71f64880fa94a010aa143c_5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c_1608036524_1608036524_CNawjgYQz9hEGOHGyLPmLiABKAEwrgE47qgMQO3xK0jp2dgDUP___________wFYAWAAaOKmqpGyrZficA&ui=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&ref=null&cv=20201123-29-RELEASE
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:49 GMT
server
nginx
x-fastly-to-nlb-rtt
26580
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.40.20.11:10213
setABframe.html
www.newzit.com/ Frame F1DF
0
0
Document
General
Full URL
https://www.newzit.com/setABframe.html
Requested by
Host: scripts.dailymail.co.uk
URL: https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:11::b856:679b , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash

Request headers

:method
GET
:authority
www.newzit.com
:scheme
https
:path
/setABframe.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D

Response headers

accept-ranges
bytes
content-type
text/html
etag
"fb18a4470d51b82cec9df8136d7cfb55:1607507043.8888"
last-modified
Wed, 09 Dec 2020 09:44:03 GMT
server
AkamaiNetStorage
content-encoding
gzip
content-length
171
cache-control
max-age=1324
expires
Tue, 15 Dec 2020 13:10:53 GMT
date
Tue, 15 Dec 2020 12:48:49 GMT
vary
Accept-Encoding
set-cookie
X-GEO=DE; path=/; secure AKA_A2=A; expires=Tue, 15-Dec-2020 13:48:49 GMT; path=/; domain=newzit.com; secure; HttpOnly
bid
c.amazon-adsystem.com/e/dtb/
24 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=16&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_left%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
134f4a39b11972e436ad81464caa48cf07310f1d14e4397a763c4b30782ea3bf

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
wlNhxijeNxDIdoPl2aCQrNTnl4eM10wFY5brnohAmmX8iWYh56F5TA==
locationjson.html
www.dailymail.co.uk/geo/ Frame 1FE6
57 B
685 B
XHR
General
Full URL
https://www.dailymail.co.uk/geo/locationjson.html
Requested by
Host: scripts.dailymail.co.uk
URL: https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
70ea2a28b9bf9b61fc5c8fc83e8a8af92c8ad70dc21e6636613bc74c71d72c9c

Request headers

Accept
application/json, text/plain, */*
Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:49 GMT
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
vary
User-Agent
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3118
server-timing
edge; dur=65, cdn-cache; desc=HIT
access-control-allow-headers
content-length
57
si
googleads.g.doubleclick.net/pagead/drt/ Frame 4A35
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:48:53 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
2
www.dailymail.co.uk/abe/a9/price/
4 B
825 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094415
date
Tue, 15 Dec 2020 12:48:49 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
ads
securepubads.g.doubleclick.net/gampad/
40 KB
12 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=1437416706367317&output=ldjh&impl=fif&adsid=NT&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_left&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x250&prev_scp=pos%3Dmpu_left%26adx_channel%3D6%26nobids%3Dfalse%26refreshCount%3D0%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D10277%252C31736%252Crts%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie=ID%3Ded5d4084ff16d8bf-2255d62b66b900f1%3AT%3D1608036526%3AS%3DALNI_MYEa75ffHmuyAlBVac6bXlQb4HZ8w&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036529729&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=3&adys=670&adks=565397896&ucis=f&ifi=15&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x620&msz=300x-1&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H_S_JiAPTCyLnMXW-8Gme6kBHd_2URHTKn6UxAt4OXnVhd4HbWzUCtAHwDLVusbgx2bo6bmjazmc9v6aTx04RKP4lYsb2jmbZQu4kgEE9dO%2CAGkb-H_u2rhcq2eyu3egZcbj8dURn95XJjputWUBai9BFigYSdmhIaqyJAhwg6KNQ9pjRGHQZDqe-xk_QRiBRTfz2bi5nh_As6oweLXIPw%2CAGkb-H-uMrLNKXTs-hRPWBx2zwC_USTq2e7VmLk2hFofoUPxHZEgFeF3mZVo2D5qrFqi2f8q-oFtFA8TEpBmo41dL2gSnVGVCFOAz1RVUQ%2CAGkb-H8DivnnHBMmqJ7nFxiA5jiKyWlvBrKy0iQsA5wcQNMjDdGfO-4RdmMdCNYJw-G_QED8f7AMXvQJJIC64Uggcg%2CAGkb-H_RL5E7JsgzlS14x5s12oFLmAw98o5FTCGiFhaw1FIvL7B1FinjVPaSh2583MFAOfVbrtOPvLtjiGH8FAFwwg%2CAGkb-H_ikEHuq1ahXuqVuAtyt7YIj8sjRajCRvidSdAEDDYgt-t5i-BGKnW8D_umOayQeNVMVFHRrGJpYS7z4osNeMBWFjX6JBU&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&fws=516&ohw=1600&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
84194d58037f7784746bb17b684bb9ccf2632f014fc066c9da7fed78ca553c10
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:50 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11820
x-xss-protection
0
google-lineitem-id
5368555632
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138315019146
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame 1FE6
8 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
6a4055df87fb1d7107976b40c27409f42d0e58278bd88e24e49109f09a8de14d

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
events
api.permutive.com/v2.0/batch/
401 B
256 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
fc219b2a130f32cbe0ad5d272753fe8cc7bad49b0df6ccee07910fe587960181

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:50 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
187
via
1.1 google
view
securepubads.g.doubleclick.net/pcs/ Frame 861F
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssxYG8aFou-EVCY1QktXzCww_QFLSSL_rFBKDfn9AhvmPzznDVc3pDQi6WE0Bxz-Fn6eI8frMRWhax_4rPzDH3KubLgD843T4r_epP2f7-f-5a_fe2eeRCHG7u8iA7BRixA_F6n4SnMQ09Jp1UEmERrEMhzKHplkZUToo1wRHk3dDbuUN9H7-sR34pQHVUD9XfOOz_r2eUz9z6ucO7x0PGy6091d9nCpFu2VNeDgjlhHp6t1FHoZtX7lTma5YBUg4v31kE5X2nFGjVwZyI8F_cgQEnBrvncvoMh2M3vgmkuZvTXDWKSfsbM1hMeSQp4CB0&sig=Cg0ArKJSzCNOM_wDsa5gEAE&adurl=
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:50 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
abg_lite_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/ Frame 861F
18 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/abg_lite_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
631c6a3617e2f5860eaa62155f5200b6ca156c00438445f9862089ef785e4542
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 15:46:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
75758
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
7483
x-xss-protection
0
server
cafe
etag
7789600959769866771
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Mon, 28 Dec 2020 15:46:12 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/ Frame 861F
3 KB
2 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20201203/r20110914/client/window_focus_fy2019.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
f8f96b0cc81405b2a95c412dbf43aebae111f11e98ad743b8fff74b2d5c793a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 03:27:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33663
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1494
x-xss-protection
0
server
cafe
etag
5335486849732140232
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 29 Dec 2020 03:27:47 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 861F
76 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
07a3eb8be1687dc1ee377d85bffd51891d0fd539258b63ab4031b012bd77f5fc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1607690616793149"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
29432
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:50 GMT
l
www.google.com/ads/measurement/ Frame 861F
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaR752jYhUH0Xu-vC3S9nS1d_helZGqjUjh-kCREN4a_Ld5wWAfoZziojqGi6BrYrBEjv9Zc17HnyVZMfwBIOWivz2HwaQ
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

694953248294808830
tpc.googlesyndication.com/simgad/ Frame 861F
74 KB
75 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/694953248294808830
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
6c3498c31122e7f232a3e624d3ba0ee9cbef547fb5b8629e5e280fef84caff2d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Sat, 12 Dec 2020 05:38:25 GMT
x-content-type-options
nosniff
age
285025
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
76246
x-xss-protection
0
last-modified
Tue, 12 May 2020 13:03:22 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:38:25 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 861F
0
22 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstUeW9RdDsYV8EfZFNM2H-EhoeXxoXhxAbvToKO9hxJuX-Ub8VZuOLPmenhHTMqzuSPNfAk-2bRdVEVT2XduY0HeRKIR9t2ITH_dQHFTDIeqVSQbqsvNUWyiiNkFQBAuMVTuQXrj6muuLqUx2iH6mxfDoEJvohdlS0nPTvCL_vPqcBbe3dSXn1hHS2dnwHkfB1KSSLCr_X_CQmDnCGqLCg-QdAtlfdBMIHK_ciZdtKVvkTh9SUOpGNxPGLVWE3UPHuZripU_UoHybiW30feOWOVdG6n9dP56c_SnBLCJMQjXkvDwoFDYymGIruFp4x0HQutJg&sig=Cg0ArKJSzJwaJg7Cbk8mEAE&adurl=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:50 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
truncated
/ Frame 861F
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
982f38d29a5cffd337f745ca4e00ae9a831d0df33888d0228e3e3420a71ccd8f

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
moatvideo.js
z.moatads.com/mailonlinejsvideo243552997523/
303 KB
102 KB
Script
General
Full URL
https://z.moatads.com/mailonlinejsvideo243552997523/moatvideo.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/mol-fe-videoplayer.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.21.38.40 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-38-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
98e5fa7e584ae32cf8038a77daffe47225b714a939bd685d36fb79993e0035c1

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
last-modified
Mon, 14 Dec 2020 16:26:20 GMT
server
AmazonS3
x-amz-request-id
3627978F81121321
etag
"5f18b9b8575ad8a6beca99c6ae94ec3e"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=27657
accept-ranges
bytes
content-length
104201
x-amz-id-2
Z5o5LvcDwfZT1DGIDFKElLMQyg8aiTOMY0iGNvY3AP9HCEaa/Ol9BAlJn4v56OgamIKHs/WAIDc=
loader.js
imasdk.googleapis.com/js/sdkloader/ Frame 709A
52 KB
19 KB
Script
General
Full URL
https://imasdk.googleapis.com/js/sdkloader/loader.js
Requested by
Host: imasdk.googleapis.com
URL: https://imasdk.googleapis.com/js/sdkloader/ima3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a54bce3233c930b9799a20a1b806eee59f74c318c0361da6755b27d84e67778e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:37:53 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Dec 2020 09:15:17 GMT
server
sffe
age
657
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=900
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18835
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:52:53 GMT
vpaid-adapter.min.js
cdn.stickyadstv.com/mustang/ Frame 709A
0
0

bulk
trc.taboola.com/dailymail-dfpads/log/3/ Frame D53F
0
233 B
XHR
General
Full URL
https://trc.taboola.com/dailymail-dfpads/log/3/bulk?route=AM%3AAM%3AV&lti=deflated&bulkSize=1
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

x-vcl-time-ms
9
pragma
no-cache
date
Tue, 15 Dec 2020 12:48:50 GMT
via
1.1 varnish
server
nginx
x-timer
S1608036530.361172,VS0,VE9
x-served-by
cache-fra19151-FRA
x-cache
MISS
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
accept-ranges
bytes
content-type
image/gif
x-cache-hits
0
/
crta.dailymail.co.uk/
8 B
452 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:53 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:48:53 GMT
topArticlesXP
www.newzit.com/api/59/ Frame 1FE6
6 KB
2 KB
XHR
General
Full URL
https://www.newzit.com/api/59/topArticlesXP?{%22key%22:%22entertainmentGB%22}
Requested by
Host: scripts.dailymail.co.uk
URL: https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:11::b856:679b , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
/
Resource Hash
e3551d304e0ca14bd9baf0d9ec5d464b661c9f6cb10a5f36b2386c4e0bfc3615

Request headers

Accept
application/json, text/plain, */*
Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-rs-ops
varnish-news-search-c2-fe:6081
date
Tue, 15 Dec 2020 12:48:50 GMT
content-encoding
gzip
x-cache-origin
["MSn0oxoHUNc1l8%2FOr9qPuohLXZGP0dgTS87xbfv2gSc%3D","local(news-search-api-c4.rdg.mol.dmgt.net%3A8489)","sync"]
vary
Accept-Encoding
content-type
application/json; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=12
server-timing
cdn-cache; desc=HIT, edge; dur=9
accept-ranges
bytes
x-rs-ben
news-search-api-c4.rdg.mol.dmgt.net:4444
content-length
2119
expires
Tue, 15 Dec 2020 12:49:02 GMT
/
crta.dailymail.co.uk/ Frame 1FE6
8 B
571 B
XHR
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: scripts.dailymail.co.uk
URL: https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Accept
application/json, text/plain, */*
Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:50 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:48:50 GMT
vqhvJ%252FUNIPc4DrBJXfSIhsdpcz6LljF%252FuDdwNUB5mWE%253D-resultThumbUrl.jpg
i.newzit.com/i/newzit/ Frame 1FE6
12 KB
12 KB
Image
General
Full URL
https://i.newzit.com/i/newzit/vqhvJ%252FUNIPc4DrBJXfSIhsdpcz6LljF%252FuDdwNUB5mWE%253D-resultThumbUrl.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:b::b856:675f , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
7557c9500e35025431301230ded4a933dcab414944a68eefd2a5e9a930770a99

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:50 GMT
Last-Modified
Tue, 15 Dec 2020 11:24:45 GMT
Server
AmazonS3
x-amz-request-id
87D4A68FDED0846E
ETag
"16448f7fce9cde9d8f73198c5fb4818b"
Content-Type
image/jpeg
Cache-Control
max-age=1556
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
11954
x-amz-id-2
lw6PUPXHwq2cDVfNIMC2v3EjtVEmac2bhOgg9Wm5CnK3WVC5imHpddRfIOQ3cQFPW12N2C/rQcQ=
Expires
Tue, 15 Dec 2020 13:14:46 GMT
hellomagazine.com.png
i.newzit.com/favicons/ Frame 1FE6
2 KB
3 KB
Image
General
Full URL
https://i.newzit.com/favicons/hellomagazine.com.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:b::b856:675f , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
b6d71cf9953177f0b6738105b74818f746d012106251ef568cbdd1c3ee29e4cc

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:50 GMT
Last-Modified
Mon, 01 Jun 2020 14:52:31 GMT
Server
AkamaiNetStorage
ETag
"c0b28cadadd24280bbdbb7f83a7207fd:1591023151.50783"
Content-Type
image/png
Cache-Control
max-age=1626
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
2309
Expires
Tue, 15 Dec 2020 13:15:56 GMT
/
crta.dailymail.co.uk/
8 B
451 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:51 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:48:51 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 861F
42 B
613 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssKIxVmYChSvIHXc98c9gd7sK8neNQR__66y131QNKbYeqKE06FFfLtkcr0iY4dqNPRVjpoBw96DHXHoazr8x3Km--FngSyZJWIAfJ7rrg&sig=Cg0ArKJSzF1xb6ifHu82EAE&adk=565397896&tt=-1&bs=1600%2C1200&mtos=1016,1016,1016,1016,1016&tos=1016,0,0,0,0&p=670,3,920,303&mcvt=1016&rs=0&ht=0&tfs=104&tls=1120&mc=1&lte=-1&bas=0&bac=0&met=mue&avms=nio&niot_obs=3&niot_cbk=15&md=2&btr=0&cpmav=0&lm=2&rst=1608036530072&dlt&rpt=31&isd=0&msd=0&xdi=0&ps=1600%2C37018&scs=1600%2C1200&pt=-1&bin=4&deb=1-0-0-12-3-11-11-0-0-0&tvt=1119&is=300%2C250&iframe_loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&r=v&id=osdim&vs=4&uc=12&upc=1&tgt=DIV&cl=1&cec=1&wf=0&cac=1&cd=300x250&itpl=3&v=20201211
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:53 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
events
api.permutive.com/v2.0/batch/
101 B
179 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
1341719e382237ec2da46f461e85cc883069c4f2f3d604059855effbbad5ffca

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:51 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
111
via
1.1 google
creative_js.js
vidstat.taboola.com/vpaid/units/27_2_17/creatives/
4 KB
2 KB
Script
General
Full URL
https://vidstat.taboola.com/vpaid/units/27_2_17/creatives/creative_js.js
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/impl.20201214-6-RELEASE.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
6258018e9f890f2383a09a2be6df7792affd977d856e7247ace8341f5b5487f0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 0e75d8f2d484ce463fc04f5c422aa179.cloudfront.net (CloudFront), 1.1 varnish
age
1061980
x-amz-meta-mtime
1580720676
x-cache
RefreshHit from cloudfront, HIT
x-amz-meta-ctime
1580720957
x-amz-meta-mode
33188
content-encoding
gzip
content-length
1904
x-served-by
cache-hhn4026-HHN
last-modified
Mon, 03 Feb 2020 09:09:18 GMT
server
AmazonS3
x-timer
S1608036533.292612,VS0,VE0
etag
"d80eacb3ed43f93a2da80d76e65d19a8"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-meta-gid
0
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-type
application/javascript
access-control-allow-headers
*
x-amz-cf-id
wmzh0cDjDIUcI3Wel4tio7NVrqgrg1rCz2Rz1knjAiGHpx_HwKnRPQ==
x-cache-hits
171334
metrics
api.permutive.com/v2.0/internal/
2 B
108 B
XHR
General
Full URL
https://api.permutive.com/v2.0/internal/metrics?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
2689367b205c16ce32ed4200942b8b8b1e262dfc70d9bc9fbc77c49699a4f1df

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:52 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
22
via
1.1 google
rum.js
securepubads.g.doubleclick.net/pagead/js/ Frame 19E7
53 KB
21 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/pagead/js/rum.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
1ab93462fa03e6a552a857fe7005098fe133645b3d88f82feaa91a31c7a9d9a5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:50 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
3
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20879
x-xss-protection
0
server
cafe
etag
11997025105020960252
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Tue, 15 Dec 2020 13:48:50 GMT
st
imprammp.taboola.com/ Frame 0867
0
0
Document
General
Full URL
https://imprammp.taboola.com/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4901665&dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&cmcv=&pix=undefined&cb=1608036533064&uv=2853&tms=1608036533064&abt=expn_vJ!heavyc_vA!lapams_vA!rev_vG!spa2_vB!t45!ufm_vE&ft=0&su=6&unm=FEED_MANAGER&aure=false&agl=1&cirid=68B45114834771126741973585882&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
imprammp.taboola.com
:scheme
https
:path
/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4901665&dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&cmcv=&pix=undefined&cb=1608036533064&uv=2853&tms=1608036533064&abt=expn_vJ!heavyc_vA!lapams_vA!rev_vG!spa2_vB!t45!ufm_vE&ft=0&su=6&unm=FEED_MANAGER&aure=false&agl=1&cirid=68B45114834771126741973585882&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=fb8f5127-6a72-41d5-805a-6af819fd0cae-tuct6d23633
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

server
nginx
content-type
text/html;charset=ISO-8859-1
content-encoding
gzip
accept-ranges
bytes
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish
x-served-by
cache-hhn4026-HHN
x-cache
MISS
x-cache-hits
0
x-timer
S1608036533.093368,VS0,VE10
vary
Accept-Encoding
sync
am-match.taboola.com/ Frame E3DD
0
0
Document
General
Full URL
https://am-match.taboola.com/sync?dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&excid=22&docw=0&cijs=1&nlb=true
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
am-match.taboola.com
:scheme
https
:path
/sync?dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&excid=22&docw=0&cijs=1&nlb=true
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=fb8f5127-6a72-41d5-805a-6af819fd0cae-tuct6d23633
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

server
nginx
date
Tue, 15 Dec 2020 12:48:53 GMT
content-type
text/html;charset=ISO-8859-1
machineid
3405
st
am-vid-events.taboola.com/
0
43 B
Image
General
Full URL
https://am-vid-events.taboola.com/st?cijs=convusmp&ttype=45&cisd=convusmp&cipid=8060095&crid=4901665&dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&cmcv=&pix=31589837&cb=1608036533064&uv=2853&tms=1608036533064&abt=expn_vJ!heavyc_vA!lapams_vA!rev_vG!spa2_vB!t45!ufm_vE&ft=0&su=6&unm=FEED_MANAGER&debug=pn:!sqg:!torgn:1608036523451.727!ts:1608036533064&mntl=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-length
0
server
nginx
player.js
player.aniview.com/script/6.1/
24 KB
9 KB
Script
General
Full URL
https://player.aniview.com/script/6.1/player.js
Requested by
Host: play.selectmedia.asia
URL: https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5e84b6a4f3500a68ee259b56/dailymail.co.uk_mix.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:10c:48b::2c79 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
e48b41194e160d21995423b168df29c00140d84105e6907bba5d4522150e3213

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
x-guploader-uploadid
ABg5-UzBu-vRrdVAbR9K-CGSbHVSshqTSn3SwaUerAcRu1YD1lAtcBwliYp4dywzGUvbwWTObHXJILRPw2jZI-J2h9v1DAvB1w
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
gzip
content-length
8944
last-modified
Wed, 18 Nov 2020 12:57:23 GMT
server
UploadServer
etag
"e3bddd782aa5424c55e550284384b173"
vary
Accept-Encoding
x-goog-hash
crc32c=IW+Krg==, md5=473deCqlQkxV5VAoQ4Sxcw==
content-language
en
access-control-allow-origin
*
x-goog-generation
1605704243561772
access-control-expose-headers
Content-Type
cache-control
public, max-age=300
x-goog-stored-content-length
8944
accept-ranges
bytes
content-type
application/javascript
expires
Tue, 15 Dec 2020 12:53:53 GMT
track
track1.aniview.com/ Frame 507C
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?pid=5e3a966128a06134f417790e&cid=5e3a987528a0611c3444f80c&e=playerLoaded&cb=1608036533170
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.81.198.99 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
publishertag.prebid.js
static.criteo.net/js/ld/
77 KB
25 KB
XHR
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
6d8ffd84868d7c4232e88167eb1adc0a83d4c1f5efb41d78eb1a03127dcdb625

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
last-modified
Tue, 17 Nov 2020 07:57:58 GMT
server
nginx
etag
W/"5fb38286-13244"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
timing-allow-origin
*
expires
Wed, 16 Dec 2020 12:48:53 GMT
st
imprammp.taboola.com/ Frame 3F36
0
0
Document
General
Full URL
https://imprammp.taboola.com/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7BqQCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBuIHGzhYLVYTxmw2W-02i81uNZpsBsvlcjNaDoEDB6vFasKYzWar3Wax2a02i91kMlttFrPlFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ABQ5TBYy8Pr9_0DAOChAAQAYECBBGBA7agEQEIh8QQAAAAAAAAAgOX___8_BkCP_1cG4EKuvwfgwQfggaggsYgRAAAAgPBY2tjRpE6oLKoAAAjSrQCuAAAC7MzkUq7CAAAABsYW6GHx-80Ou8bvdhkAAAAAAAAAgNn_2T-aEFIUe1qQZ_2w2i8gAMDaLyAAAJu6AQC8CcAFHUErBoPVDdBkMTsAAACAu____389kLJtBpOVY-bYDBbL5WKwcC53K9twMNsYJqvdcuY9XVgzz3WrDrw-DmGZ_b6DgnJ6eswug6joelvsDqfZc5DMTfabsMVoNZlslsPZcjEZDEfD0Wh_ArgZ4AQNh4PFbrDYLRbDyWIyGiwHCxSIwQQnZDjaTFaj3Wo3WQ4no9FsM9kgRatWs9FmMFzNJrPdbjUcDJejEVK0ZjGbTBaz0XK3GSwno8FwMhwiTI1cG4vNMXMrNjbXWjSY2dbKwWDk1i1GLs9kYTMsFp616PUx3UaWzWyy8aJgQNleBBfpRORwmp1vh9Pslvx9F7FEc7JIJ7LLvmXbDCYrx8yxGSyWy8Vg4VzuVrbhYLYxTFa75czfGrk2Fptj5lZsbK61aDCzrZWDwcitW4xcnsnCZlgsPGvR62O6jSyb2WTjb8wGw8Fmtpqs9o3ZYDjYzFaT1b5DZ_iuPmejLdo9d3wij3kmtM1MB4XLYPQuPxdpt_i5GX3O8EuYGi4jn4lV6Pf7_X6_3-_3-70bs8FjMBh-Lttx-DEv15rT46CIJYLTRToRvYyni1gieVqkE9FqMbKsbIbZbrGxjWw2x8Jkce1Gvs3MNpgNZyuLWKI0XaQTvebjdNk9LtPLY_QrLKenx-xyKwerwXCy2EtebpPL87Q9LW-Jy-6yOT1Oh9kteJieLrvp8xb5Paa_5fOWvGwvh9kuNL3NFvUfG2I5miuXc8VgNVcuVwkAAAAAAAAAYAlz5k0AAAAATgOZbIaL1XIBHoz2dH8c7cjUQEePdl2wOdkuz4xMihs_biCH0-x8O5xmt-TvuzLAg9Ed82bPBLFWq2UNAABAgA0AABDArZu3QExGDg!&cmcv=&pix=undefined&cb=1608036533249&uv=2853&tms=1608036533249&abt=expn_vJ!heavyc_vA!rev_vG!spa2_vB!t45!ufm_vA&ft=0&su=0&unm=WIDGET_ITEM&aure=false&cirid=80515B166657313754230999349&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
imprammp.taboola.com
:scheme
https
:path
/st?cijs=convusmp&ttype=0&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7BqQCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBuIHGzhYLVYTxmw2W-02i81uNZpsBsvlcjNaDoEDB6vFasKYzWar3Wax2a02i91kMlttFrPlFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ABQ5TBYy8Pr9_0DAOChAAQAYECBBGBA7agEQEIh8QQAAAAAAAAAgOX___8_BkCP_1cG4EKuvwfgwQfggaggsYgRAAAAgPBY2tjRpE6oLKoAAAjSrQCuAAAC7MzkUq7CAAAABsYW6GHx-80Ou8bvdhkAAAAAAAAAgNn_2T-aEFIUe1qQZ_2w2i8gAMDaLyAAAJu6AQC8CcAFHUErBoPVDdBkMTsAAACAu____389kLJtBpOVY-bYDBbL5WKwcC53K9twMNsYJqvdcuY9XVgzz3WrDrw-DmGZ_b6DgnJ6eswug6joelvsDqfZc5DMTfabsMVoNZlslsPZcjEZDEfD0Wh_ArgZ4AQNh4PFbrDYLRbDyWIyGiwHCxSIwQQnZDjaTFaj3Wo3WQ4no9FsM9kgRatWs9FmMFzNJrPdbjUcDJejEVK0ZjGbTBaz0XK3GSwno8FwMhwiTI1cG4vNMXMrNjbXWjSY2dbKwWDk1i1GLs9kYTMsFp616PUx3UaWzWyy8aJgQNleBBfpRORwmp1vh9Pslvx9F7FEc7JIJ7LLvmXbDCYrx8yxGSyWy8Vg4VzuVrbhYLYxTFa75czfGrk2Fptj5lZsbK61aDCzrZWDwcitW4xcnsnCZlgsPGvR62O6jSyb2WTjb8wGw8Fmtpqs9o3ZYDjYzFaT1b5DZ_iuPmejLdo9d3wij3kmtM1MB4XLYPQuPxdpt_i5GX3O8EuYGi4jn4lV6Pf7_X6_3-_3-70bs8FjMBh-Lttx-DEv15rT46CIJYLTRToRvYyni1gieVqkE9FqMbKsbIbZbrGxjWw2x8Jkce1Gvs3MNpgNZyuLWKI0XaQTvebjdNk9LtPLY_QrLKenx-xyKwerwXCy2EtebpPL87Q9LW-Jy-6yOT1Oh9kteJieLrvp8xb5Paa_5fOWvGwvh9kuNL3NFvUfG2I5miuXc8VgNVcuVwkAAAAAAAAAYAlz5k0AAAAATgOZbIaL1XIBHoz2dH8c7cjUQEePdl2wOdkuz4xMihs_biCH0-x8O5xmt-TvuzLAg9Ed82bPBLFWq2UNAABAgA0AABDArZu3QExGDg!&cmcv=&pix=undefined&cb=1608036533249&uv=2853&tms=1608036533249&abt=expn_vJ!heavyc_vA!rev_vG!spa2_vB!t45!ufm_vA&ft=0&su=0&unm=WIDGET_ITEM&aure=false&cirid=80515B166657313754230999349&excid=e22lLINE_ITEM_ID_WILL_BE_HERE_ON_SERVINGc&tst=1&docw=0&cs=true&cias=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=fb8f5127-6a72-41d5-805a-6af819fd0cae-tuct6d23633
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

server
nginx
content-type
text/html;charset=ISO-8859-1
content-encoding
gzip
accept-ranges
bytes
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish
x-served-by
cache-hhn4026-HHN
x-cache
MISS
x-cache-hits
0
x-timer
S1608036533.292567,VS0,VE10
vary
Accept-Encoding
sync
am-match.taboola.com/ Frame 97C4
0
0
Document
General
Full URL
https://am-match.taboola.com/sync?dast=V7BqQCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBuIHGzhYLVYTxmw2W-02i81uNZpsBsvlcjNaDoEDB6vFasKYzWar3Wax2a02i91kMlttFrPlFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ABQ5TBYy8Pr9_0DAOChAAQAYECBBGBA7agEQEIh8QQAAAAAAAAAgOX___8_BkCP_1cG4EKuvwfgwQfggaggsYgRAAAAgPBY2tjRpE6oLKoAAAjSrQCuAAAC7MzkUq7CAAAABsYW6GHx-80Ou8bvdhkAAAAAAAAAgNn_2T-aEFIUe1qQZ_2w2i8gAMDaLyAAAJu6AQC8CcAFHUErBoPVDdBkMTsAAACAu____389kLJtBpOVY-bYDBbL5WKwcC53K9twMNsYJqvdcuY9XVgzz3WrDrw-DmGZ_b6DgnJ6eswug6joelvsDqfZc5DMTfabsMVoNZlslsPZcjEZDEfD0Wh_ArgZ4AQNh4PFbrDYLRbDyWIyGiwHCxSIwQQnZDjaTFaj3Wo3WQ4no9FsM9kgRatWs9FmMFzNJrPdbjUcDJejEVK0ZjGbTBaz0XK3GSwno8FwMhwiTI1cG4vNMXMrNjbXWjSY2dbKwWDk1i1GLs9kYTMsFp616PUx3UaWzWyy8aJgQNleBBfpRORwmp1vh9Pslvx9F7FEc7JIJ7LLvmXbDCYrx8yxGSyWy8Vg4VzuVrbhYLYxTFa75czfGrk2Fptj5lZsbK61aDCzrZWDwcitW4xcnsnCZlgsPGvR62O6jSyb2WTjb8wGw8Fmtpqs9o3ZYDjYzFaT1b5DZ_iuPmejLdo9d3wij3kmtM1MB4XLYPQuPxdpt_i5GX3O8EuYGi4jn4lV6Pf7_X6_3-_3-70bs8FjMBh-Lttx-DEv15rT46CIJYLTRToRvYyni1gieVqkE9FqMbKsbIbZbrGxjWw2x8Jkce1Gvs3MNpgNZyuLWKI0XaQTvebjdNk9LtPLY_QrLKenx-xyKwerwXCy2EtebpPL87Q9LW-Jy-6yOT1Oh9kteJieLrvp8xb5Paa_5fOWvGwvh9kuNL3NFvUfG2I5miuXc8VgNVcuVwkAAAAAAAAAYAlz5k0AAAAATgOZbIaL1XIBHoz2dH8c7cjUQEePdl2wOdkuz4xMihs_biCH0-x8O5xmt-TvuzLAg9Ed82bPBLFWq2UNAABAgA0AABDArZu3QExGDg!&excid=22&docw=0&cijs=1&nlb=true
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
am-match.taboola.com
:scheme
https
:path
/sync?dast=V7BqQCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBuIHGzhYLVYTxmw2W-02i81uNZpsBsvlcjNaDoEDB6vFasKYzWar3Wax2a02i91kMlttFrPlFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ABQ5TBYy8Pr9_0DAOChAAQAYECBBGBA7agEQEIh8QQAAAAAAAAAgOX___8_BkCP_1cG4EKuvwfgwQfggaggsYgRAAAAgPBY2tjRpE6oLKoAAAjSrQCuAAAC7MzkUq7CAAAABsYW6GHx-80Ou8bvdhkAAAAAAAAAgNn_2T-aEFIUe1qQZ_2w2i8gAMDaLyAAAJu6AQC8CcAFHUErBoPVDdBkMTsAAACAu____389kLJtBpOVY-bYDBbL5WKwcC53K9twMNsYJqvdcuY9XVgzz3WrDrw-DmGZ_b6DgnJ6eswug6joelvsDqfZc5DMTfabsMVoNZlslsPZcjEZDEfD0Wh_ArgZ4AQNh4PFbrDYLRbDyWIyGiwHCxSIwQQnZDjaTFaj3Wo3WQ4no9FsM9kgRatWs9FmMFzNJrPdbjUcDJejEVK0ZjGbTBaz0XK3GSwno8FwMhwiTI1cG4vNMXMrNjbXWjSY2dbKwWDk1i1GLs9kYTMsFp616PUx3UaWzWyy8aJgQNleBBfpRORwmp1vh9Pslvx9F7FEc7JIJ7LLvmXbDCYrx8yxGSyWy8Vg4VzuVrbhYLYxTFa75czfGrk2Fptj5lZsbK61aDCzrZWDwcitW4xcnsnCZlgsPGvR62O6jSyb2WTjb8wGw8Fmtpqs9o3ZYDjYzFaT1b5DZ_iuPmejLdo9d3wij3kmtM1MB4XLYPQuPxdpt_i5GX3O8EuYGi4jn4lV6Pf7_X6_3-_3-70bs8FjMBh-Lttx-DEv15rT46CIJYLTRToRvYyni1gieVqkE9FqMbKsbIbZbrGxjWw2x8Jkce1Gvs3MNpgNZyuLWKI0XaQTvebjdNk9LtPLY_QrLKenx-xyKwerwXCy2EtebpPL87Q9LW-Jy-6yOT1Oh9kteJieLrvp8xb5Paa_5fOWvGwvh9kuNL3NFvUfG2I5miuXc8VgNVcuVwkAAAAAAAAAYAlz5k0AAAAATgOZbIaL1XIBHoz2dH8c7cjUQEePdl2wOdkuz4xMihs_biCH0-x8O5xmt-TvuzLAg9Ed82bPBLFWq2UNAABAgA0AABDArZu3QExGDg!&excid=22&docw=0&cijs=1&nlb=true
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=fb8f5127-6a72-41d5-805a-6af819fd0cae-tuct6d23633
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

server
nginx
date
Tue, 15 Dec 2020 12:48:53 GMT
content-type
text/html;charset=ISO-8859-1
machineid
3403
VideoBidRequestHandlerServlet
wf.taboola.com/
4 KB
3 KB
XHR
General
Full URL
https://wf.taboola.com/VideoBidRequestHandlerServlet?oid=15&width=420&height=236&pubid=169497&tagid=953497&crid=4706985&noaop=3&sortOrderType=0&cb=1608036533264&mimes=5,10,11,12&isvideo=0&plmd=2&mindur=1&maxdur=210&minbr=1&maxbr=10000&st=0&seq=1&pv=1170&pt=-977125416&tz=60&viewable=true&ddast=V7BqQCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBuIHGzhYLVYTxmw2W-02i81uNZpsBsvlcjNaDoEDB6vFasKYzWar3Wax2a02i91kMlttFrPlFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ABQ5TBYy8Pr9_0DAOChAAQAYECBBGBA7agEQEIh8QQAAAAAAAAAgOX___8_BkCP_1cG4EKuvwfgwQfggaggsYgRAAAAgPBY2tjRpE6oLKoAAAjSrQCuAAAC7MzkUq7CAAAABsYW6GHx-80Ou8bvdhkAAAAAAAAAgNn_2T-aEFIUe1qQZ_2w2i8gAMDaLyAAAJu6AQC8CcAFHUErBoPVDdBkMTsAAACAu____389kLJtBpOVY-bYDBbL5WKwcC53K9twMNsYJqvdcuY9XVgzz3WrDrw-DmGZ_b6DgnJ6eswug6joelvsDqfZc5DMTfabsMVoNZlslsPZcjEZDEfD0Wh_ArgZ4AQNh4PFbrDYLRbDyWIyGiwHCxSIwQQnZDjaTFaj3Wo3WQ4no9FsM9kgRatWs9FmMFzNJrPdbjUcDJejEVK0ZjGbTBaz0XK3GSwno8FwMhwiTI1cG4vNMXMrNjbXWjSY2dbKwWDk1i1GLs9kYTMsFp616PUx3UaWzWyy8aJgQNleBBfpRORwmp1vh9Pslvx9F7FEc7JIJ7LLvmXbDCYrx8yxGSyWy8Vg4VzuVrbhYLYxTFa75czfGrk2Fptj5lZsbK61aDCzrZWDwcitW4xcnsnCZlgsPGvR62O6jSyb2WTjb8wGw8Fmtpqs9o3ZYDjYzFaT1b5DZ_iuPmejLdo9d3wij3kmtM1MB4XLYPQuPxdpt_i5GX3O8EuYGi4jn4lV6Pf7_X6_3-_3-70bs8FjMBh-Lttx-DEv15rT46CIJYLTRToRvYyni1gieVqkE9FqMbKsbIbZbrGxjWw2x8Jkce1Gvs3MNpgNZyuLWKI0XaQTvebjdNk9LtPLY_QrLKenx-xyKwerwXCy2EtebpPL87Q9LW-Jy-6yOT1Oh9kteJieLrvp8xb5Paa_5fOWvGwvh9kuNL3NFvUfG2I5miuXc8VgNVcuVwkAAAAAAAAAYAlz5k0AAAAATgOZbIaL1XIBHoz2dH8c7cjUQEePdl2wOdkuz4xMihs_biCH0-x8O5xmt-TvuzLAg9Ed82bPBLFWq2UNAABAgA0AABDArZu3QExGDg!&proto=2,3,5,6&encoded=1&pstn=vforce2&callback=&wfv=1&amp=0&qsz=6&ft=0&pb=0&pagg=1&dtagid=1182345&dpubid=223815&abtst=expn_vJ!heavyc_vA!rev_vG!spa2_vB!t45!ufm_vA&mPre=0.033&cirf=https%3A%2F%2Fwww.dailymail.co.uk&en=1&subu=0&cdb=&gdprApplies=false
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
336f7f49d1fb25deb5c6b89bc91be7ab4815ead0d3f0eb2ece0a992465b9e22b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
access-control-allow-origin
https://www.dailymail.co.uk
machineid
1438
x-cache
MISS
x-cache-hits
0
x-served-by
cache-lon4226-LON
pragma
no-cache
server
nginx
x-timer
S1608036533.299709,VS0,VE42
vary
Accept-Encoding
content-type
application/json;charset=utf-8
via
1.1 varnish
cache-control
no-cache,must-revalidate,no-store,max-age=0,s-maxage=0
access-control-allow-credentials
true
accept-ranges
bytes
link
<https://video-ads.rubiconproject.com>; rel=preconnect
expires
Sat, 26 Jul 1997 05:00:00 GMT
st
am-vid-events.taboola.com/
0
43 B
Image
General
Full URL
https://am-vid-events.taboola.com/st?cijs=convusmp&ttype=45&cisd=convusmp&cipid=8060095&crid=4706985&dast=V7BqQCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBuIHGzhYLVYTxmw2W-02i81uNZpsBsvlcjNaDoEDB6vFasKYzWar3Wax2a02i91kMlttFrPlFDiEZfb7DgrK6ekxuwyiouttsTucZs9BMje5QQ1Np8Pnutfrfr-7yOE0O98Op9mu8dtVX7_m43TZPS7Ty2P0Kyynp8fscisHq8FwsthLWm6Ty_O0PS1vicvusjk9TofZLXiYni676fMW-T2mv-XzlrxsL4fZLjS9zXYAAAAAeAA4kk6F-AEEAIgAAAAAkAAAAACgCKj4txC4AAAAAMAAKBC90ABQ5TBYy8Pr9_0DAOChAAQAYECBBGBA7agEQEIh8QQAAAAAAAAAgOX___8_BkCP_1cG4EKuvwfgwQfggaggsYgRAAAAgPBY2tjRpE6oLKoAAAjSrQCuAAAC7MzkUq7CAAAABsYW6GHx-80Ou8bvdhkAAAAAAAAAgNn_2T-aEFIUe1qQZ_2w2i8gAMDaLyAAAJu6AQC8CcAFHUErBoPVDdBkMTsAAACAu____389kLJtBpOVY-bYDBbL5WKwcC53K9twMNsYJqvdcuY9XVgzz3WrDrw-DmGZ_b6DgnJ6eswug6joelvsDqfZc5DMTfabsMVoNZlslsPZcjEZDEfD0Wh_ArgZ4AQNh4PFbrDYLRbDyWIyGiwHCxSIwQQnZDjaTFaj3Wo3WQ4no9FsM9kgRatWs9FmMFzNJrPdbjUcDJejEVK0ZjGbTBaz0XK3GSwno8FwMhwiTI1cG4vNMXMrNjbXWjSY2dbKwWDk1i1GLs9kYTMsFp616PUx3UaWzWyy8aJgQNleBBfpRORwmp1vh9Pslvx9F7FEc7JIJ7LLvmXbDCYrx8yxGSyWy8Vg4VzuVrbhYLYxTFa75czfGrk2Fptj5lZsbK61aDCzrZWDwcitW4xcnsnCZlgsPGvR62O6jSyb2WTjb8wGw8Fmtpqs9o3ZYDjYzFaT1b5DZ_iuPmejLdo9d3wij3kmtM1MB4XLYPQuPxdpt_i5GX3O8EuYGi4jn4lV6Pf7_X6_3-_3-70bs8FjMBh-Lttx-DEv15rT46CIJYLTRToRvYyni1gieVqkE9FqMbKsbIbZbrGxjWw2x8Jkce1Gvs3MNpgNZyuLWKI0XaQTvebjdNk9LtPLY_QrLKenx-xyKwerwXCy2EtebpPL87Q9LW-Jy-6yOT1Oh9kteJieLrvp8xb5Paa_5fOWvGwvh9kuNL3NFvUfG2I5miuXc8VgNVcuVwkAAAAAAAAAYAlz5k0AAAAATgOZbIaL1XIBHoz2dH8c7cjUQEePdl2wOdkuz4xMihs_biCH0-x8O5xmt-TvuzLAg9Ed82bPBLFWq2UNAABAgA0AABDArZu3QExGDg!&cmcv=&pix=31589837&cb=1608036533248&uv=2853&tms=1608036533248&abt=expn_vJ!heavyc_vA!rev_vG!spa2_vB!t45!ufm_vA&ft=0&su=0&unm=WIDGET_ITEM&debug=pn:!sqg:!torgn:1608036523451.727!ts:1608036533248&mntl=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-length
0
server
nginx
ee500aae51ffba23e63b960314802ac8.jpg
images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_180%2Cw_360%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/ Frame D53F
8 KB
9 KB
Image
General
Full URL
https://images.taboola.com/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_180%2Cw_360%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/ee500aae51ffba23e63b960314802ac8.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
199.232.57.44 Windsor, United Kingdom, ASN54113 (FASTLY, US),
Reverse DNS
Software
cloudinary /
Resource Hash
09e660034589d9f35a32ebc5dad839f4bbbd2095f07e6f35cdaf758613447bde

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-vcl-time-ms
0
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish, 1.1 varnish, 1.1 varnish
age
1199575
edge-cache-tag
602296728692249640601002917896816616473,341818766630488423269086991181948173068,29ecf9b93bbf306179626feeda1fab70
status
200 OK
x-cache
MISS, HIT, HIT
x-debug
/taboola/image/fetch/f_jpg%2Cq_auto%2Ch_180%2Cw_360%2Cc_fill%2Cg_faces:auto%2Ce_sharpen/http%3A//cdn.taboola.com/libtrc/static/thumbnails/ee500aae51ffba23e63b960314802ac8.jpg
content-length
8623
x-request-id
52984376eebb57ce34616561cd855b7e
x-served-by
cache-dca17723-DCA, cache-dca17729-DCA, cache-lon4226-LON
last-modified
Sat, 21 Nov 2020 07:44:50 GMT
server
cloudinary
x-timer
S1608036533.331248,VS0,VE0
etag
"dda644926a7b972ff142fbb299345b0d"
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=7776000
accept-ranges
bytes
timing-allow-origin
*
access-control-allow-headers
X-Requested-With
x-cache-hits
0, 1, 2
f539211219b796ffbb49949997c764f0.png
cdn.taboola.com/libtrc/static/thumbnails/ Frame D53F
254 B
634 B
Image
General
Full URL
https://cdn.taboola.com/libtrc/static/thumbnails/f539211219b796ffbb49949997c764f0.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.13.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
f68019eb4b4e5933301d4ee75969e0cb94ed8333bf514630fa749eb9c3e483c9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
hL.cyLD7Q4TL5ceY.7JQwF9m5IYI8mkC
via
1.1 varnish
etag
"dfa7b52c86e56bd67fa4002f6ed19854"
age
3122
x-cache
HIT
x-amz-replication-status
COMPLETED
content-length
254
x-amz-id-2
Vjnfq2okxpLEG/cBVxSfv3DOOCGN7KTpixt29L7DwUhoZL6eRlgDSODZqhfatrYL58q01gaLKf4=
x-served-by
cache-fra19151-FRA
last-modified
Wed, 24 Jun 2015 07:14:11 GMT
server
AmazonS3
x-amz-meta-s3cmd-attrs
uid:0/gname:root/uname:root/gid:0/mode:33188/mtime:1377415166/atime:1435052450/md5:dfa7b52c86e56bd67fa4002f6ed19854/ctime:1422381567
x-timer
S1608036533.341407,VS0,VE0
date
Tue, 15 Dec 2020 12:48:53 GMT
x-amz-request-id
F6D91014AAA6CDC4
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
image/png
abp
25
x-cache-hits
5292
st
imprammp.taboola.com/ Frame FD0C
0
0
Document
General
Full URL
https://imprammp.taboola.com/st?cipid=7991117&ttype=0&cirid=F9D93BEDAA57331901705257486&cicmp=1337627&cijs=1&dast=V7PIoCFgPB1fY8sSPvsQTB1fY8sSPvsQUAAAAGBugHHMYcMTcTFonBYO02m8VyMFgsJ6vFaLObTKZgsIXP6e5uQ6A-mk6Hz3Wv1_1-d5HDaXa-HU6zXeO3q75-zcfpsntcppfH6FdYTk-P2eVWDlaD4WSxl7TcJpfnaXta3hKX3WVzepwOs1vwMD1ddtPnLfJ7TH_L5y152V4Os11oepv9-6Ln7XQPh8vdaDcazfRFz8vucQ8uCzrjdH2rJSynr2y6DedmnpPJaVUWN17bQrEeDUsL03khPod0Esuz4lc6XtKV9SXszi5rrWI3Ta9vFpvvofuZLsqO7-isjmO-18jgPVuW2XFufR1rZ7euyKK6tXzDqexamJ67m2Xm2ZjmAAAAAPAAQNQSDbHj29AeAQAAACDBM3KtQBFQ8W8hcAEAAACAAUAgFq4BoMphsJaH1-_7BwDAQwEIAMCAAgmAQGJhCYDD3eIJAADAQZ3M0zbL____fwxA3nuTDABF2saNQQ_Agw_AgxAAAMDFEDuO7Ht6eGYfUYFiESMAAAAA4bG0saNJnVBZVP3___9bAVwBAATYmcn9-GXdnBSzhgEAAAyMLdDD4vebHXaN3-2y_________3-z_zMANCGkKPa0IM_6YTWekWuFtV9AAAC2dwMAeBOAizkAOwAAAIC7_____zwAAICSPUq212o8e5T1PoMtfE53d_0mbDFaTSab5XC2XEwGw9FwNNqfAG4GOEHD4WCxGyx2i8VwspiMBsvBAgViMMEJGY42k9Vot9pNlsPJaDTbTDZI0arVbLQZDFezyWy3Ww0Hw-VohBStWcwmk8VstNxtBsvJaDCcDIcIYxbjzLWY7NayhW-yFi1GrrVwsFq4ZQubcbGcmQwbh8sten1Mt5FlM9ts9tgQy9FcuZwrBqu5crlKAAAAAAAAAABLmDJvAgAAAHAaxGw22e1W3HizZ4JYq9WyBgAAAODWjRw!&excid=22&tst=1&docw=0&cs=false
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
imprammp.taboola.com
:scheme
https
:path
/st?cipid=7991117&ttype=0&cirid=F9D93BEDAA57331901705257486&cicmp=1337627&cijs=1&dast=V7PIoCFgPB1fY8sSPvsQTB1fY8sSPvsQUAAAAGBugHHMYcMTcTFonBYO02m8VyMFgsJ6vFaLObTKZgsIXP6e5uQ6A-mk6Hz3Wv1_1-d5HDaXa-HU6zXeO3q75-zcfpsntcppfH6FdYTk-P2eVWDlaD4WSxl7TcJpfnaXta3hKX3WVzepwOs1vwMD1ddtPnLfJ7TH_L5y152V4Os11oepv9-6Ln7XQPh8vdaDcazfRFz8vucQ8uCzrjdH2rJSynr2y6DedmnpPJaVUWN17bQrEeDUsL03khPod0Esuz4lc6XtKV9SXszi5rrWI3Ta9vFpvvofuZLsqO7-isjmO-18jgPVuW2XFufR1rZ7euyKK6tXzDqexamJ67m2Xm2ZjmAAAAAPAAQNQSDbHj29AeAQAAACDBM3KtQBFQ8W8hcAEAAACAAUAgFq4BoMphsJaH1-_7BwDAQwEIAMCAAgmAQGJhCYDD3eIJAADAQZ3M0zbL____fwxA3nuTDABF2saNQQ_Agw_AgxAAAMDFEDuO7Ht6eGYfUYFiESMAAAAA4bG0saNJnVBZVP3___9bAVwBAATYmcn9-GXdnBSzhgEAAAyMLdDD4vebHXaN3-2y_________3-z_zMANCGkKPa0IM_6YTWekWuFtV9AAAC2dwMAeBOAizkAOwAAAIC7_____zwAAICSPUq212o8e5T1PoMtfE53d_0mbDFaTSab5XC2XEwGw9FwNNqfAG4GOEHD4WCxGyx2i8VwspiMBsvBAgViMMEJGY42k9Vot9pNlsPJaDTbTDZI0arVbLQZDFezyWy3Ww0Hw-VohBStWcwmk8VstNxtBsvJaDCcDIcIYxbjzLWY7NayhW-yFi1GrrVwsFq4ZQubcbGcmQwbh8sten1Mt5FlM9ts9tgQy9FcuZwrBqu5crlKAAAAAAAAAABLmDJvAgAAAHAaxGw22e1W3HizZ4JYq9WyBgAAAODWjRw!&excid=22&tst=1&docw=0&cs=false
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
t_gid=fb8f5127-6a72-41d5-805a-6af819fd0cae-tuct6d23633
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

server
nginx
accept-ranges
bytes
date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish
x-served-by
cache-hhn4026-HHN
x-cache
MISS
x-cache-hits
0
x-timer
S1608036533.394197,VS0,VE9
content-length
0
cmTagCUSTOM.js
vidstat.taboola.com/vpaid/units/28_3_10/infra/
727 KB
132 KB
Script
General
Full URL
https://vidstat.taboola.com/vpaid/units/28_3_10/infra/cmTagCUSTOM.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/27_2_17/creatives/creative_js.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
aa7c984cd510935c132345bc7d579dfcde68742f7b11b599b905310f7164718c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish
age
2335692
x-amz-meta-mtime
1605697226
x-cache
HIT
x-amz-meta-ctime
1605697428
x-amz-meta-mode
33188
content-encoding
br
content-length
135037
x-amz-id-2
KI2SF/tfls9aNzFjYIkFR6wX8qdltCVgzSHPgiE59aKQYwxCAoscOfpOMei0nTT4X8q8G4QXFq4=
x-served-by
cache-hhn4026-HHN
accept-ranges
bytes
last-modified
Wed, 18 Nov 2020 11:03:50 GMT
server
AmazonS3-br
x-timer
S1608036533.485990,VS0,VE0
etag
"37b0b0415484e88063c945bde767ba70"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-request-id
C652C7382C79DDF4
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-meta-gid
0
content-type
application/javascript
access-control-allow-headers
*
x-cache-hits
5115
cmOsUnit.css
vidstat.taboola.com/vpaid/units/28_3_10/assets/css/
44 KB
7 KB
Stylesheet
General
Full URL
https://vidstat.taboola.com/vpaid/units/28_3_10/assets/css/cmOsUnit.css
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/27_2_17/creatives/creative_js.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
4e7681cdfb27c5d0457c58c9f0fe26a68bbf6a8dc88defd3c43826adb1fe6ca8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish
age
2335692
x-amz-meta-mtime
1605697226
x-cache
HIT
x-amz-meta-ctime
1605697397
x-amz-meta-mode
33188
content-encoding
br
content-length
6493
x-amz-id-2
FxkOFmdqkrJXpfDrUHL5nkx7VCyVkczzOwoW4y3ViAzV9m6BCX+o+KGX/PTYgjQt6iQlI+PJ2fI=
x-served-by
cache-hhn4026-HHN
accept-ranges
bytes
last-modified
Wed, 18 Nov 2020 11:03:19 GMT
server
AmazonS3-br
x-timer
S1608036533.394875,VS0,VE0
etag
"083925e970a05bed26a70ecbfde9c0ca"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-request-id
A9AF261ECA31B798
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-meta-gid
0
content-type
text/css
access-control-allow-headers
*
x-cache-hits
53573
cmTagWIDGET_ITEM.js
vidstat.taboola.com/vpaid/units/28_5_3/infra/
710 KB
125 KB
Script
General
Full URL
https://vidstat.taboola.com/vpaid/units/28_5_3/infra/cmTagWIDGET_ITEM.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
2f17c77d5bc3e1da8f068bef5af2bd4fe10aebaf829cce8a8dbc9bbe562c7606

Request headers

Origin
https://www.dailymail.co.uk
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:56 GMT
via
1.1 varnish
age
752748
x-amz-meta-mtime
1607281997
x-cache
HIT
x-amz-meta-ctime
1607282123
x-amz-meta-mode
33188
content-encoding
br
content-length
127125
x-amz-id-2
OwdoB5Adxc+LbOzLHchOe3PH19UT7ueYnfPfwx/UtZpLQWcp/ltKxATOa83+iNRbXCkrEwhmT7A=
x-served-by
cache-hhn4053-HHN
accept-ranges
bytes
last-modified
Sun, 06 Dec 2020 19:15:25 GMT
server
AmazonS3-br
x-timer
S1608036537.598640,VS0,VE0
etag
"58da0f7034e94cfd958908251f759491"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-request-id
E33BCCA0E241443B
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-meta-gid
0
content-type
application/javascript
access-control-allow-headers
*
x-cache-hits
179981
cmOsUnit.css
vidstat.taboola.com/vpaid/units/28_5_3/assets/css/
44 KB
7 KB
Stylesheet
General
Full URL
https://vidstat.taboola.com/vpaid/units/28_5_3/assets/css/cmOsUnit.css
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitWidgetItemDesktop.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3-br /
Resource Hash
98922dfe09c8b58441d75ed77f262ddf02e6f9f30c4e9588239675b6a8e4dd06

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 varnish
age
752745
x-amz-meta-mtime
1607281997
x-cache
HIT
x-amz-meta-ctime
1607282075
x-amz-meta-mode
33188
content-encoding
br
content-length
6506
x-amz-id-2
4rufgq0rXhUtRNaNCJwv4s6Toq0MPltBOoFn0/ulF/foyixD9J0cwWpqIVA5sTtOGtiL0aFaA38=
x-served-by
cache-hhn4026-HHN
accept-ranges
bytes
last-modified
Sun, 06 Dec 2020 19:14:36 GMT
server
AmazonS3-br
x-timer
S1608036533.404605,VS0,VE0
etag
"b248e7634e81ba7c71725b68c25c3078"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-request-id
BE79434B9A20D28D
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-meta-gid
0
content-type
text/css
access-control-allow-headers
*
x-cache-hits
437383
csi
csi.gstatic.com/ Frame 19E7
0
54 B
Other
General
Full URL
https://csi.gstatic.com/csi?v=2&s=pagead&action=csi_pagead&dmc=8&puid=1~kipzfm3h&ctx=2&qqid=CIvmu--C0O0CFSWIOAodrnQAbA&met.4=fb.3~lb.53~ol.4nv~idt.fc~dt.-oe&met.3=197.4w~298.50~123.4v_8~118.5e~118.5f~118.6j~143.88_1~118.8b~118.92~143.b1_1~118.b2~118.bw~143.ei_1~118.ey~118.ff~143.ii_1~118.iq~118.is~143.mb_1~118.ng~118.nh~143.rl_1~118.tz~118.u0~143.uv_1~118.wb~118.wb~143.z1_1~118.zf~118.zh~143.12d_1~118.12s~118.12t~118.15b~143.15d_1~118.15f~118.184~143.187_1~118.187~118.1az~143.1b0_1~118.1b0~118.1ds~143.1dt_1~118.1du~143.1gz_1~118.1h9~118.1hi~118.1ju~143.1jv_1~118.1jw~118.1mp~143.1mr_1~118.1ms~118.1pk~143.1pl_1~118.1po~143.1sz_1~118.1t4~118.1t8~143.1yd_1~118.1ym~118.1zw~118.21b~143.21d_1~118.21f~118.240~143.246_1~118.247~118.26u~143.26z_1~118.270~118.29o~143.29s_1~118.29s~118.2cj~143.2ck_1~118.2cl~118.2fd~143.2ff_1~118.2ff~118.2i8~143.2i9_1~118.2ib~118.2l2~143.2l5_1~118.2l6~118.2ny~143.2o1_1~118.2o2_1~118.2qs~143.2qv~118.2qw~118.2tn~143.2to_1~118.2tq~118.2wi~143.2wj~118.2wj~118.2zb~143.2zd~118.2zd~118.326~143.328_1~118.329~118.352~143.354_1~118.355~118.37w~143.37x~118.37y~118.3ar~143.3at_1~118.3au~118.3dm~143.3dn~118.3dn~118.3gg~143.3gh~118.3gi~118.3jb~143.3jd_1~118.3je~118.3m6~143.3m8~118.3m8~118.3p1~143.3p2~118.3p3~118.3rv~143.3rx_1~118.3rx~118.3uq~143.3ur_1~118.3us~118.3xm~143.3xp_1~118.3xr~118.40k~143.40n_1~118.40o~118.43f~143.43h_1~118.43i~118.46b~143.46c_1~118.46d~118.496~143.497_1~118.498~118.4c1~143.4c5_1~118.4c6~118.4ex~143.4ey_1~118.4ez~118.4hs~143.4ht_1~118.4hu~118.4km~143.4kn~118.4ko~118.4nh~143.4ni~118.4nk~117.4nv~118.4nw~118.4nw~118.4nx~118.4qb~143.4qd_1~118.4qi~143.4u6_1~118.4uc~118.4ui~143.4xc_1~118.4xf~113.4xu_3~112.4xs_5~118.4xy&met.1=1.kipzfh5o~14.0~15.0~16.0~17.0~18.0~19.0~20.4nv~21.4nv~22.1e~23.1e&met.7=CCIQBBgBIAYoBjAGaAZwQnhQsAEBuAED~CBwQChgBIAcoBzAOOAhoB3ANeOY7gAG7OogBm5EBsAEBuAED~CBwQChgBIAcoBzAPOAhoCHAOeLgMgAHWC4gBshiwAQG4AQM~CCoQChgBIAcoBzA3ODA~CBsQBhgBIAcoBzCaLziTLw~CBcQBhgBIAgoCDAUOA1oCHAQeJTwA4ABje8DiAGN7wOwAQG4AQM~CCIQBhgBILcBKLcBMPIBODxotwFw8gF4FrABAbgBAw~CCgQChgBIJ0vKJ0vMNYxOLkCaIgxcLoxeL6kAYABj6MBiAHZpwOwAQG4AQM
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/js/rum.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:401a:805::2003 , Ireland, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:54 GMT
last-modified
Wed, 21 Jan 2004 19:51:30 GMT
server
Golfe2
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
AVmanager.js
player.aniview.com/script/6.1/ Frame A128
327 KB
93 KB
Script
General
Full URL
https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/player.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:10c:48b::2c79 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
9a134b68d3b5bc4c3874da78175bdaee9cfd415937780c7e0e786ac3e689c2d7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
x-guploader-uploadid
ABg5-Uzg6UK2fKz3A1ZYal2TeUnnQTILHs3YtQWRu_J5QK2UfWJq8DYI-WhmMj-Cdf7tSVBOV141tiW3B7lUjVueTw
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
gzip
content-length
94733
last-modified
Tue, 15 Dec 2020 08:43:51 GMT
server
UploadServer
etag
"49254afaf94e0199278b573fbf4b32ba"
vary
Accept-Encoding
x-goog-hash
crc32c=VYuz3g==, md5=SSVK+vlOAZkni1c/v0syug==
content-language
en
access-control-allow-origin
*
x-goog-generation
1608021831248560
access-control-expose-headers
Content-Type
cache-control
public, max-age=300
x-goog-stored-content-length
94733
accept-ranges
bytes
content-type
application/javascript
expires
Tue, 15 Dec 2020 12:53:53 GMT
track
track1.aniview.com/
0
71 B
Image
General
Full URL
https://track1.aniview.com/track?r=www.dailymail.co.uk&sn=&ic=0&tgt=0&app=&wi=480&he=270&test=&apppkg=&fv=3&proto=https&pid=5e3a966128a06134f417790e&cid=5e3a987528a0611c3444f80c&e=inventory&vi=100&cb=1608036533546
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.81.198.99 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
truncated
/
331 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
c9e42e2c7cd3ec42f6febe248c715522b2e5f6bc92b389b101fbd33a069ee7ed

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
740 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7a9054758a4808c97c188f5be469879eef19a2f7cbd9bb0e740cee3199a6c747

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
384 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8030594b4999eca38901464b09383ca988c454a4f7ab6b963be75e6c42da011d

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
782 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5028f77ac0afdac1bb66eaeeef41e77cea0f2487a66cb1df354d8680db1bb64e

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
395 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f0d7d05ef7ae154e283b8c8e462aeb6e9b5bca53225c42743e2028c34828c08a

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
449 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f86a1105ed755e9ae9b75708a5b19d5c478212605b9f8d7c98796b451de18c63

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
480 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ee9a49aae5d1fc7602361ae5c6d69fc8eb128d007b4dee67d42ce19bbf2c87e0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
truncated
/
577 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d23484cf0f36a73cc699ceffc6da8f0e9ffd6b372dcb615ec942cdc287845505

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
vidsplay_pass_pre.js
play.selectmedia.asia/58fcbed1073ef420086c9d08/5f50f97c29103948b5607078/
3 KB
2 KB
Script
General
Full URL
https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5f50f97c29103948b5607078/vidsplay_pass_pre.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:bb28 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
05739efd89e90ee51ff01da4cc9218904c15bcc4b8ebef478e45e19ceb935314

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:53 GMT
Content-Encoding
gzip
X-GUploader-UploadID
ABg5-UxAXHAdEzdBBMegTPuDa-aMXCSzb9no7c2-6HT-RIaKq19Ep_QkHPEiVHCyUFwZNG1SNnhXqqGvhQy1TsJIng
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
Connection
keep-alive
Content-Length
1083
Last-Modified
Sun, 01 Nov 2020 14:36:25 GMT
Server
UploadServer
ETag
"101bdb042b1b6998da460a905ad8fee5"
Vary
Accept-Encoding
x-goog-hash
crc32c=oiZvmA==
x-goog-generation
1604241385418739
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Content-Type
Cache-Control
public, max-age=1800
x-goog-stored-content-length
3384
Accept-Ranges
bytes
Content-Type
text/javascript
Expires
Tue, 15 Dec 2020 13:18:53 GMT
/
go1.aniview.com/api/adserver/tag/
18 KB
3 KB
XHR
General
Full URL
https://go1.aniview.com/api/adserver/tag/?AV_SECURED=1&AV_LANGUAGE=en&AV_URL=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&AV_PUBLISHERID=5e3a966128a06134f417790e&AV_CHANNELID=5e3a987528a0611c3444f80c&format=json&tgt=0&AV_SUBID=&AV_CDIM1=&AV_CDIM2=&AV_CDIM3=&AV_ABT=&pce=1&npx=1&AV_DNT=0&AV_DETDOMAIN=www.dailymail.co.uk&AV_DADPOS=3&v=6.1.1.243&avtoken=533545&AV_WIDTH=480&AV_HEIGHT=270&cb=1608036533588
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.171.145.49 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
b96df826db0dce0a0af14f1023d0e40a9aa1ea291b4e761666851a484396c889

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:58 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
expires
Thu, 03 Dec 2020 23:02:18 GMT
selectmedia-logo56x10.png
play.selectmedia.asia/58fcbed1073ef420086c9d08/5942ae55073ef42ccf4fae29/
2 KB
3 KB
Image
General
Full URL
https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5942ae55073ef42ccf4fae29/selectmedia-logo56x10.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:bb28 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
f564399443d3c5b5169fe11e1ca826d562933353f3b08c8bb235bfd0b5a44867

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:53 GMT
X-GUploader-UploadID
ABg5-UxmhblX2Ef0GrN6F5hWlyUR6ruY2-5YPN2s0I86W9SFu2jTpGmdp-ZEWtAhWzDELBj8q5tOm-8QlPSYNgN6BLA
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
Connection
keep-alive
Content-Length
2342
Last-Modified
Thu, 18 Jul 2019 10:38:43 GMT
Server
UploadServer
ETag
"213172f2d54764531a0427b6f4a1357f"
x-goog-hash
crc32c=yrppbQ==
x-goog-generation
1563446323633469
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Content-Type
Cache-Control
public, max-age=1800
x-goog-stored-content-length
2342
Accept-Ranges
bytes
Content-Type
image/png
Expires
Tue, 15 Dec 2020 13:18:53 GMT
PMS.js
vidstat.taboola.com/PMS/2.2.1/
51 KB
16 KB
Script
General
Full URL
https://vidstat.taboola.com/PMS/2.2.1/PMS.js
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/vpaid/units/28_3_10/infra/cmTagCUSTOM.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a9e402d2d19f1057cdea09b2152d8cfd35664182564595e19bb83916c1f00201

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
via
1.1 79503619d600dbc1c9e04a650d3d7f3f.cloudfront.net (CloudFront), 1.1 varnish
age
433860
x-amz-meta-mtime
1542789750
x-cache
Miss from cloudfront, HIT
x-amz-meta-mode
33188
content-encoding
gzip
content-length
15795
x-served-by
cache-hhn4026-HHN
last-modified
Wed, 21 Nov 2018 08:42:31 GMT
server
AmazonS3
x-timer
S1608036534.780010,VS0,VE0
etag
"57a7ebef371550a9ab54a2f0f82547af"
x-amz-meta-uid
0
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS, HEAD
x-amz-meta-gid
0
access-control-allow-origin
*
cache-control
public, max-age=2592000
x-amz-cf-pop
FRA54
accept-ranges
bytes
content-type
application/javascript
access-control-allow-headers
*
x-amz-cf-id
lMRV4ZYRLUDUMKGvesgs0u-Y5sc28vP_gLLzPdzi8CsYM5e0lWSbBA==
x-cache-hits
146441
view
securepubads.g.doubleclick.net/pcs/ Frame 507C
0
45 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsullscWUeCnnqvoQfJ08lyJ__SaXiujhM56Cm3qj2ZEiuFNBT6o24zxqDiDNisRnLcMv_ABLmNcr2N09h535BhGNbJrN1ZUy8M5XfH1YyqgX6LlI1LvjyQpD_OSepD39_V8PfXdXnxNlQEHdIa-YgCG7gxXjT7WcyhTDTARIXr1hnd1TNr8TBYJUMATwu6NdFDZbEaScgW1PshGBOGcn-AKjCnW2k1Q9RhP3bMVpBIi0ONEkrjsHXZBwP2ax_lsmW_FUd5hlbK6mbubOVgSq6K65MF2lUkrTfYokEpbEozTAJ5iSCir1mra3hKXQ8SK-dtyVgc47dhKmCNg-f8&sai=AMfl-YTr-0l_WnLI698aXEQ6iHF119ki3USjNEoiQzbqNN7mW8oJN2tALiI4cwlO6fVEUZgAAXP4txZ9xNPWW3XgIPW6vsKin4IuHcgOXgrPCJ79U3M2iscQOWJhrBeLb6Q&sig=Cg0ArKJSzCvNPBF1a6OdEAE&urlfix=1&adurl=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:53 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
hb_310028_7816.js
player.hb.selectmedia.asia/prebidlink/446676/ Frame DF1E
314 KB
99 KB
Script
General
Full URL
https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.1 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
838dd22220890ec10ced23466e87d604e5d45acf5f103aa15634a8d4fa0e158b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
last-modified
Tue, 15 Dec 2020 09:44:57 GMT
server
nginx
etag
W/"5fd88599-4e934"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 15 Dec 2020 13:48:53 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/ Frame DF1E
54 KB
19 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
sffe /
Resource Hash
e9cf43afad0cd90d17eb4e1dd9fbd5e8bd2cf07ace134853680e06dcc1ef5ef1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"724 / 787 of 1000 / last-modified: 1608034737"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18850
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:53 GMT
wrapper_hb_310028_7816.js
player.hb.selectmedia.asia/prebidlink/446676/ Frame DF1E
252 KB
37 KB
Script
General
Full URL
https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Requested by
Host: info.silobreaker.com
URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.1 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
25d9ab4344e5c1eb4e8def288490bfc867c3be6acbce291dbf61af3fa317fed9

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:53 GMT
content-encoding
gzip
last-modified
Tue, 15 Dec 2020 09:44:57 GMT
server
nginx
etag
W/"5fd88599-3efdf"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 15 Dec 2020 13:48:53 GMT
6983a75b-cbd3-4cb8-9de6-153b57324af5
https://www.dailymail.co.uk/
1 KB
0
Media
General
Full URL
blob:https://www.dailymail.co.uk/6983a75b-cbd3-4cb8-9de6-153b57324af5
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
60ddc774c7b5fd0c01d169321a444da403d60c0042f6bee01b0c96f6e1535fda

Request headers

Referer
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

Content-Range
bytes 0-1492/1493
Content-Length
1493
Content-Type
video/mp4
07f0b200-e1e8-42ab-b12a-69e754f728d4
https://www.dailymail.co.uk/
1 KB
0
Media
General
Full URL
blob:https://www.dailymail.co.uk/07f0b200-e1e8-42ab-b12a-69e754f728d4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
60ddc774c7b5fd0c01d169321a444da403d60c0042f6bee01b0c96f6e1535fda

Request headers

Referer
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

Content-Range
bytes 0-1492/1493
Content-Length
1493
Content-Type
video/mp4
jvgblwzncdo04h4dxahs.mp4
c3.taboola.com/libtrc/static/video/t_PERFORMANCE_VIDEO_DEFAULT/v1600355107/
249 KB
250 KB
Media
General
Full URL
https://c3.taboola.com/libtrc/static/video/t_PERFORMANCE_VIDEO_DEFAULT/v1600355107/jvgblwzncdo04h4dxahs.mp4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.113.44 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
c3c854b28f23996cbf155a883308d4604c09fb3331c5779d8659819ccfb6f40a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

x-amz-version-id
TtR9OFNZAmJQCx8tVICw1btSL7Ivls2s
via
1.1 varnish
etag
"a6734e7423d565595522c7ac23c71038"
age
17
x-cache
HIT
Content-Range
bytes 0-255119/255120
x-amz-replication-status
COMPLETED
Content-Length
255120
x-amz-id-2
WxbK6/kEnM+c2HRkHlcRUPS0zWc+xLgePjWOLyS648iA6ZDR/OPTgSyp7A3xZ2LBHQ1nr0Bsfgc=
x-served-by
cache-hhn4026-HHN
last-modified
Thu, 17 Sep 2020 15:05:16 GMT
server
AmazonS3
x-timer
S1608036534.012771,VS0,VE1
date
Tue, 15 Dec 2020 12:48:54 GMT
x-amz-request-id
A48A2533E449575E
cache-control
private,max-age=31536000
accept-ranges
bytes
content-type
video/mp4;codecs=avc1
abp
25
x-cache-hits
0
pubads_impl_2020120801.js
securepubads.g.doubleclick.net/gpt/ Frame DF1E
274 KB
97 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
sffe /
Resource Hash
5f02981bfcab6807a15ddfea1babc7cee05cd0f1f59abe712928de44fb6c1f0d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 08 Dec 2020 09:42:29 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, immutable, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
98829
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:54 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 1CE4
42 B
89 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsv3vf2NOsisCngEpZRbm66CFv4CUWxShzTmuybUAxFAJKf2YZpXeJcwzhaUae-LGPH-JhzmM6e3tdZunMbIpFYObqcHWAFswgZljWk7Tftba0KWjrObZcMuC1aklw&sai=AMfl-YSaTGL4aCOMyVwJ5AzNm_Hjsex5mXG1ztySnGsL6-ICW3RGFTADWv3BugaGMG8W5ir1is1Fm5H-il7LQf-6TmyycoxaOI7_2JJ3UGDSj6SY8QDzDP9Pnu7SACgtX_M&sig=Cg0ArKJSzNRxRFKlbzM3EAE&cid=CAASPeRoLMcsRPonF68t8OyBFmIqxb0xDDBqBre1Dz8K5b2TmNMLsmizzQeEgZRJgLzKN_smCLQpOLEHgP0hgRk&id=ampim&o=315,197&d=970,250&ss=1600,1200&bs=1600,1200&mcvt=1182&mtos=0,0,0,1182,1182&tos=0,0,0,1182,0&tfs=6415&tls=7597&g=99.69072341918945&h=99.69072341918945&tt=7597&r=v&avms=ampa&adk=1878184308
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:54 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
hb.hb.selectmedia.asia/geo/ Frame DF1E
131 B
386 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/geo/
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
b5ba3a53f9df59e6a3f5421331f14e4f1c495550d35134e8211c92d3833751cf

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:48:54 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
131
Content-Type
application/json
tracking
hb.hb.selectmedia.asia/adunit/ Frame DF1E
43 B
425 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/adunit/tracking?event=11&type=0&client_id=310028&site_id=7816&full_page_url=https%3A%2F%2Fwww.dailymail.co.uk&adid=pzfms3.0z&vpbv=0699&lifecycle_tte=722
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:48:54 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif
config.json
player.adtelligent.com/exchange_rates/305666/ Frame DF1E
26 KB
12 KB
XHR
General
Full URL
https://player.adtelligent.com/exchange_rates/305666/config.json?cb=https%3A%2F%2Fwww.dailymail.co.uk
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.1 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
07922d6ee25f39bb9548a4efad40d22ac0b0fab3e37cda0e9eb83b2430c0a916

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:54 GMT
content-encoding
gzip
last-modified
Tue, 15 Dec 2020 12:01:32 GMT
server
nginx
etag
W/"5fd8a59c-692c"
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
expires
Tue, 15 Dec 2020 13:48:54 GMT
cache-control
max-age=3600
x-proxy-cache
HIT
activeview
pagead2.googlesyndication.com/pcs/ Frame 4A35
42 B
66 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstu_gV9BgdsBnc-ZhY-aRu2deRDs38XUq5hG6SwcVZFpA2D5SdqSoPQXubpwcO4hEUlbkdrek7OnXWsviTw8qtBLxFbg3qtPgtbdd3gCvqilBLJ5CBRNfAi6wlz7Q&sai=AMfl-YRjonLuYvlaaubL5INbghoB_6WBke8zZu1_7hWR9bYUKe1eF08kgJQLFpazE4BenTbQwLYwOUsP7uAoPoHhWYXxRuuk63u5_NvYB-0L_AS-1onnBmR6r9TrbjkqPlw&sig=Cg0ArKJSzBSmiMEB7bGlEAE&cid=CAASPeRo2BnodFczsPuJC3h5wZ3K4JjoA66ZywqULcIccQzH_GySfsWKGJmd9mLvdTyXF1Xtf416xcKs9QWknQo&id=ampim&o=143,20&d=160,600&ss=1600,1200&bs=1600,1200&mcvt=1040&mtos=0,0,1040,1040,1040&tos=0,0,1040,0,0&tfs=3787&tls=4827&g=100&h=100&tt=4827&r=v&avms=ampa&adk=1681991210
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:54 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
events
api.permutive.com/v2.0/batch/
201 B
209 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
3cb1e451b5409695dff2ac56bbbb0ef9d0a77f04459bc7f69b0cc8786dc1b9d5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:54 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
141
via
1.1 google
unip
trc-events.taboola.com/1125455/log/3/
0
295 B
XHR
General
Full URL
https://trc-events.taboola.com/1125455/log/3/unip?en=pre_d_eng_tb&tos=10566&scd=18&ssd=1&est=1608036524900&ver=27&isls=true&src=i&invt=6000&tim=1608036535466&vi=1608036524897&ri=33989576fd58a84e73b3f9a0b11cec49&sd=v2_bf71d5d1fc71f64880fa94a010aa143c_5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c_1608036524_1608036524_CNawjgYQz9hEGOHGyLPmLiABKAEwrgE47qgMQO3xK0jp2dgDUP___________wFYAWAAaOKmqpGyrZficA&ui=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&ref=null&cv=20201123-29-RELEASE
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:55 GMT
server
nginx
x-fastly-to-nlb-rtt
29060
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.24.10:10213
prebid
ib.adnxs.com/ut/v3/ Frame DF1E
0
0

cygnus
htlb.casalemedia.com/ Frame DF1E
24 B
374 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=544669&v=7.2&ac=j&sd=1&r=%7B%22id%22%3A%2264925ea073da6a%22%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%2C%22ixdiag%22%3A%7B%22msd%22%3A0%2C%22msi%22%3A0%7D%7D%2C%22imp%22%3A%5B%7B%22id%22%3A%227e330b67da5d1c%22%2C%22ext%22%3A%7B%22siteID%22%3A%22544669%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A0%7D%7D%5D%7D
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
f5eb37a493731a581e1cc59070be83a43e6278deb61fd1d627e9cd6969df64de

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:55 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
44
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:48:55 GMT
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame DF1E
0
0

arj
select-d.openx.net/w/1.0/ Frame DF1E
172 B
355 B
XHR
General
Full URL
https://select-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=33d7de36-03d2-4103-8f39-9bd3aa31583c&nocache=1608036535859&aus=300x250&divIds=gpt-passback&auid=541148923
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
9a8a6f7884c6aef5a5d2b79bfb0e3a84ceab70c1a7e987671994ca20d23cff0d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:55 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
162
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/ Frame DF1E
0
0

translator
hbopenbid.pubmatic.com/ Frame DF1E
0
119 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:48:57 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
/
pub.admanmedia.com/ Frame DF1E
2 B
276 B
XHR
General
Full URL
https://pub.admanmedia.com/?c=o&m=multi
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
109.206.182.43 , Netherlands, ASN50245 (SERVEREL-AS, NL),
Reverse DNS
Software
/
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:48:56 GMT
Content-Encoding
gzip
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
22
Content-Type
application/json
csyncs
hb.hb.selectmedia.asia/ Frame DF1E
282 B
549 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/csyncs?aid1=436894
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
05b1c64aed793a93e91f226e06d8437d2c892794b6e98b06fee0f1e4deabc391

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:54 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
255
mcd
hb.hb.selectmedia.asia/ Frame DF1E
Redirect Chain
  • https://s.adtelli.com/mc?c=vmuid%3A17522445236a9257&r2=hb.hb.selectmedia.asia
  • https://hb.hb.selectmedia.asia/mcd
43 B
412 B
Image
General
Full URL
https://hb.hb.selectmedia.asia/mcd
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:48:55 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif

Redirect headers

Location
https://hb.hb.selectmedia.asia/mcd
Date
Tue, 15 Dec 2020 12:48:55 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Content-Length
0
csync
sync.ads.152media.com/ Frame DF1E
Redirect Chain
  • https://ib.adnxs.com/getuid?https%3A%2F%2Fsync.ads.152media.com%2Fcsync%3Ft%3Da%26ep%3D285868%26extuid%3D%24UID
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%253A%252F%252Fsync.ads.152media.com%252Fcsync%253Ft%253Da%2526ep%253D285868%2526extuid%253D%2524UID
  • https://sync.ads.152media.com/csync?t=a&ep=285868&extuid=1434332830242018214
86 B
532 B
Image
General
Full URL
https://sync.ads.152media.com/csync?t=a&ep=285868&extuid=1434332830242018214
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
62.149.0.72 , Ukraine, ASN15497 (COLOCALL Internet Data Center _ColoCALL_, UA),
Reverse DNS
0-72.cc86365-03-tmp.cc.colocall.com
Software
VertaMedia 1.0 /
Resource Hash
1cc9e0ac0ff231ba3fc0c9c42b40ebcc6c5a3058722ca99eeb0fed41f3efb997

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:59 GMT
Cache-Control
no-cache, no-store, must-revalidate
Server
VertaMedia 1.0
Content-Length
86
Content-Type
image/gif

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:58 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.37:80
AN-X-Request-Uuid
feeb9bff-69fa-4312-bb8b-622e53658c75
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://sync.ads.152media.com/csync?t=a&ep=285868&extuid=1434332830242018214
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
multitracking
hb.hb.selectmedia.asia/adunit/ Frame DF1E
0
210 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/adunit/multitracking
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:48:56 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
v2_310028_7816.json
player.hb.selectmedia.asia/prebidlink/2680060/ Frame DF1E
229 KB
18 KB
XHR
General
Full URL
https://player.hb.selectmedia.asia/prebidlink/2680060/v2_310028_7816.json?cb=www.dailymail.co.uk
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.1 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
d46945c2f739cd0c340a53811937643b8755d5d9d5630a342b0021feb8c60f3f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:58 GMT
content-encoding
gzip
last-modified
Tue, 15 Dec 2020 09:44:57 GMT
server
nginx
etag
W/"5fd88599-393fc"
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=3600
expires
Tue, 15 Dec 2020 13:48:58 GMT
metrics
api.permutive.com/v2.0/internal/
2 B
87 B
XHR
General
Full URL
https://api.permutive.com/v2.0/internal/metrics?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
2689367b205c16ce32ed4200942b8b8b1e262dfc70d9bc9fbc77c49699a4f1df

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:48:57 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
22
via
1.1 google
integrator.js
adservice.google.pl/adsid/ Frame DF1E
109 B
803 B
Script
General
Full URL
https://adservice.google.pl/adsid/integrator.js?domain=www.dailymail.co.uk
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:57 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ Frame DF1E
109 B
169 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.dailymail.co.uk
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:57 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/ Frame DF1E
44 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=890443373853042&correlator=2308370346763180&output=ldjh&impl=fifs&eid=21069139&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=84772874%2CVidsplay_300X250_EBDA&enc_prev_ius=%2F0%2F1&prev_iu_szs=300x250&prev_scp=excl_cat%3DPREPOST&eri=1&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&lmt=1608036537&dt=1608036537864&dlt=1608036533576&idt=820&ea=0&frm=23&biw=1600&bih=1200&isw=480&ish=270&oid=2&adxs=486&adys=1167&adks=596843069&ucis=t3va12l9mlxo&ifi=1&ifk=2380778214&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&nhd=1&url=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&top=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=480x270&msz=300x250&ga_vid=1110759869.1608036538&ga_sid=1608036538&ga_hid=445912574&fws=256&ohw=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
2c12d20cd923504dfa42a26be7502976304c6581738b7adbb82147ec5b763e1d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:58 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
11181
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
ee12f6ec35b2c173a5233b824c7d979b.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame DF1E
0
0
Other
General
Full URL
https://ee12f6ec35b2c173a5233b824c7d979b.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html?n=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ Frame DF1E
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html?n=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

AQJjxYX37bbJnFCVs5oDU%252BL0mZKFE08t%252FjFmZC4mXIs%253D-resultThumbUrl.jpg
i.newzit.com/i/newzit/ Frame 1FE6
19 KB
20 KB
Image
General
Full URL
https://i.newzit.com/i/newzit/AQJjxYX37bbJnFCVs5oDU%252BL0mZKFE08t%252FjFmZC4mXIs%253D-resultThumbUrl.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:b::b856:675f , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
6867703421f5e6007c6c830e42e87398224ccf32762897ec8594b1da92265b84

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:57 GMT
Last-Modified
Tue, 15 Dec 2020 11:49:02 GMT
Server
AmazonS3
x-amz-request-id
FFBB0E614AED0B59
ETag
"03045736dadc656d7c3e183391a40905"
Content-Type
image/jpeg
Cache-Control
max-age=3581
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
19875
x-amz-id-2
42DUIJw90thm2SnOyrXhxpSJrN2nRRwfARA3qeGHePdJFbFaNcDF8YMu6fDCSAhiCZg1ToCyFEI=
Expires
Tue, 15 Dec 2020 13:48:38 GMT
metro.co.uk.png
i.newzit.com/favicons/ Frame 1FE6
622 B
970 B
Image
General
Full URL
https://i.newzit.com/favicons/metro.co.uk.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:b::b856:675f , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
010dcc659f6a06a1ed7eb0a0dba20b032959e264d607c1c6687bddcd56f36591

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:57 GMT
Last-Modified
Tue, 02 Jun 2020 16:34:30 GMT
Server
AkamaiNetStorage
ETag
"e3d880cda4b2a59e148cf6f212954129:1591115670.391284"
Content-Type
image/png
Cache-Control
max-age=506
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
622
Expires
Tue, 15 Dec 2020 12:57:23 GMT
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 0113
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
398155
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 0113
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285666
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 0113
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475836
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 0113
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355758
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 0113
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353870
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 0113
2 KB
2 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47671
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 0113
295 B
325 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53737
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 0113
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9e2774befae1888a68485230541da3989e72e63aba03a977772a11db76c1b300

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
2018745230876869974
tpc.googlesyndication.com/simgad/ Frame 0113
19 KB
19 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/2018745230876869974?sqp=4sqPyQQrQikqJwhfEAEdAAC0QiABKAEwCTgDQPCTCUgAUAFYAWBfcAJ4AcUBLbKdPg&rs=AOga4qlDskl4J8agGmYWxA6c7aeTQyVE4Q
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
644bc6809c636598c66d064aa058ded7438730907e3fe3eccdbc840d284e6c61
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 11 Dec 2020 23:27:33 GMT
x-content-type-options
nosniff
last-modified
Mon, 07 Dec 2020 16:33:27 GMT
server
sffe
age
307285
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
19836
x-xss-protection
0
expires
Sat, 11 Dec 2021 23:27:33 GMT
l
www.google.com/ads/measurement/ Frame 0113
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaSMRAlixHtNqNAw-5lIuBNSHZEI6hy1F79WSybXzyVHXHg7mWdFZeugVn2lILmoE9STEh-L
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

adview
securepubads.g.doubleclick.net/pagead/ Frame 0113
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CUMsYubDYX-K2ON-X7_UPyKeCoAmq8aDOYM2ZiqzfDIWUoNLPCBABIKiyhXxg6eTJhdgayAECqQJTlyPJImOSPuACAKgDAcgDCKoE2wNP0H1VpanjsiBaSCO8ExK73sDs-p-SR2337pRRgAIc6DP10nCyb28OeGBNCwopKJrLodn_2byV9z2klTrd9J7ErPLSXKW4eAkMOz9y8xmDZp0f2NInGSfJWf-d8TaPRlQ-fJbGzUlA7-F-JqfM8sntS5ezxErzvPJROrBUt82W-e5oKKhDddp-x8C1iGGX6X0rNh65fWP3qG9BrfUrODpVPZMSoWaGx8Vt7xUnfLUTA3Qd-gL0lsX1Q5D4KV9EoPhL482U37rROiYVquGdruaLA2pXXQ0GRWOFEn7u8ZWukWkfdHEztbVYmRuaAOhOOWHGgkCojR9mBFeWIxEWfz1UINuT6e75-sGKMTy5ENh4pgYf4KaVQjMJnBT7Md49R8-VzQfoCVqXWehUhhpilMuXt5Dl32XBV4-nwhvDpeFGS6MRhX9CPBr_zvbxzAMrrLpylP06mfnKbQPv_nq62w0NiqDlMYRgMLbp_x8_qfMmieCgGBeMhdamWsrh03Sg0A_ASWu8MYRa5AMCpE_6iltTS0qMF0axAnSMRnObUVnqs3-Q6avzUWNBitDQLDhbE28xgngY3wSFLDqe4yMBhql22Jn9QOmIBFTZSzdW8EYS_4slbPd4nix9JV7fwATQqOX5vwPgBAGSBQQIBBgBkgUECAUYBKAGAoAHksvungKoB9XJG6gH8NkbqAfy2RuoB5SYsQKoB6XfG6gHjs4bqAeT2BuoB7oGqAfulrECqAemvhuoB-zVG9gHAfIHBBDJ5ArSCAkIgOGAUBABGB3yCBthZHgtc3Vic3luLTQzMzMwNDMyMDYxMTk1OTaACgPICwHYEwqyFxoKGAgBEhRwdWItMjkzMDgwNTEwNDQxODIwNA&sigh=aQeMNkSYHQE&tpd=AGWhJmuU7CihO4780p2g_gjpVEMeV2hjiTL0s1HR7tunb3RKKQ
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

sodar
pagead2.googlesyndication.com/getconfig/ Frame DF1E
8 KB
7 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=2020120801&st=env
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
144dbc5545f4ed5b1a3de78dfa204238d1af79e1cee65b46b4c04b05b1480756
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 15 Dec 2020 12:48:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
6448
x-xss-protection
0
7197697
ads.stickyadstv.com/vast/vpaid-adapter/
1 KB
2 KB
XHR
General
Full URL
https://ads.stickyadstv.com/vast/vpaid-adapter/7197697?_fw_gdpr=1&_fw_gdpr_consent=&schain=1.0,1!selectmedia.asia,5e3a966128a06134f417790e,1,,Mail%20Metro%20Media,mailonline.co.uk&_fw_us_privacy=1---&cbb=8036538393
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
nginx /
Resource Hash
fe5f53ff4fe4d4d8bf4b67e41428616194c64dd425acde319af6d8955907864f

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:59 GMT
Server
nginx
Content-Type
application/xml;charset=ISO-8859-1
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
1340
x-sticky-vk
1608036539558002-90
Expires
Tue, 15 Dec 2020 12:48:59 GMT
3pRrSx07Gk8Dl7mNKBWke3eC9D9nIm_aTuVZj2Zo7Wk=
ads.adaptv.advertising.com/a/h/
3 KB
2 KB
XHR
General
Full URL
https://ads.adaptv.advertising.com/a/h/3pRrSx07Gk8Dl7mNKBWke3eC9D9nIm_aTuVZj2Zo7Wk=?cb=8036538406&gdpr=1&gdpr_consent=&pet=preroll&pageUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&eov=eov&us_privacy=1---&scpid=58fcbed1073ef420086c9d08&scpid=5e3a966128a06134f417790e
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.189.33 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
adaptv/1.0 /
Resource Hash
7a113e9215c560841defb5003ce5520a50015e995f50c5b8d786f1f0e47eab49
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
strict-transport-security
max-age=31536000
content-encoding
gzip
server
adaptv/1.0
content-type
text/xml
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
1196
expires
0
avpb3.js
player.aniview.com/script/6.1/ Frame A128
241 KB
77 KB
Script
General
Full URL
https://player.aniview.com/script/6.1/avpb3.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:10c:48b::2c79 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
50c7f346e0521f5e4990a6442c179ed60970dac8eb4b6f5ae72b855fc9753a2d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:58 GMT
content-encoding
gzip
x-guploader-uploadid
ABg5-UzRygS9q8csKcK67Xz6iKZgrWYSN36ak5NNzIRtCxFXl074kNTqWMoaeG25uR1gqdxBn6_MmvajH1ItfYnD5q4
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
2
x-goog-stored-content-encoding
gzip
content-length
78002
last-modified
Tue, 15 Dec 2020 08:43:24 GMT
server
UploadServer
etag
"ba91ab7edb7b6fabf6704889aaf459a5"
vary
Accept-Encoding
x-goog-hash
crc32c=Vh6Hvw==, md5=upGrftt7b6v2cEiJqvRZpQ==
content-language
en
access-control-allow-origin
*
x-goog-generation
1608021804134933
access-control-expose-headers
Content-Type
cache-control
public, max-age=300
x-goog-stored-content-length
78002
accept-ranges
bytes
content-type
application/javascript
expires
Tue, 15 Dec 2020 12:53:58 GMT
ixmatch.html
js-sec.indexww.com/um/
0
0
Image
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

spotx-pixel.js
play.selectmedia.asia/58fcbed1073ef420086c9d08/5f1d77d19f2f1340cb280573/
417 B
417 B
Image
General
Full URL
https://play.selectmedia.asia/58fcbed1073ef420086c9d08/5f1d77d19f2f1340cb280573/spotx-pixel.js
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00::210:bb28 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
UploadServer /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:48:58 GMT
X-GUploader-UploadID
ABg5-UzLhRZTG0R-BDFh9zxp11IawfC3VkeS6yT_taWLHQ5QM_lfkuLeglNl7u8cnMi35oX4OBxnqdJRcuNEukUNVOI
x-goog-storage-class
MULTI_REGIONAL
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
Connection
keep-alive
Content-Length
417
Last-Modified
Sun, 26 Jul 2020 12:32:25 GMT
Server
UploadServer
ETag
"f70554e00ba53d6687836b60f833456e"
x-goog-hash
crc32c=bH2gjQ==
x-goog-generation
1595766745952958
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Content-Type
Cache-Control
public, max-age=1800
x-goog-stored-content-length
417
Accept-Ranges
bytes
Content-Type
text/javascript
Expires
Tue, 15 Dec 2020 13:18:58 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=11
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=MTVkYTFlYmY2NDUxZWJjOWMyN2JkZWY4MWQyYTA2ZQ==&gdpr=0&gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=MTVkYTFlYmY2NDUxZWJjOWMyN2JkZWY4MWQyYTA2ZQ==&gdpr=0&gdpr_consent=&google_tc=
170 B
224 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=MTVkYTFlYmY2NDUxZWJjOWMyN2JkZWY4MWQyYTA2ZQ==&gdpr=0&gdpr_consent=&google_tc=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:59 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:59 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=MTVkYTFlYmY2NDUxZWJjOWMyN2JkZWY4MWQyYTA2ZQ==&gdpr=0&gdpr_consent=&google_tc=
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
363
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
auto-user-sync
ads.stickyadstv.com/
43 B
597 B
Image
General
Full URL
https://ads.stickyadstv.com/auto-user-sync
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
nginx /
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:59 GMT
Server
nginx
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
x-sticky-vk
1608036539678032-90
Expires
Tue, 15 Dec 2020 12:48:59 GMT
ecm3
s.amazon-adsystem.com/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=2545
  • https://s.amazon-adsystem.com/ecm3?id=cd13812ae7acf834110947fcc38a88b&ex=freewheel.tv&gdpr=0&gdpr_consent=
43 B
344 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=cd13812ae7acf834110947fcc38a88b&ex=freewheel.tv&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.239.17.112 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:01 GMT
Server
Server
Vary
User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:59 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://s.amazon-adsystem.com/ecm3?id=cd13812ae7acf834110947fcc38a88b&ex=freewheel.tv&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036539729092-29
Expires
Tue, 15 Dec 2020 12:48:59 GMT
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=PL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=96641&t=1608036538&cip=194.99.105.99&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036538232-938474427970-020635-011-004656&imid=c8c4b999f5891c593a8ff8248e57f7b521443856872172315192&cha=0.7&cb=74377213301&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=request&cb=1608036538419&asid=5c249de6073ef47e0c19572b%2C5e43b72b28a06116af086105%2C5f058fd77374f645ec5305f4%2C5ee79c81c6d2274a5d4a428b%2C5eb677baafa269776667c5a6%2C5f46708a766d2d428339c9d3%2C5eeb836e0cb48833c651eaeb%2C5f5f7e84e602f721885bf507%2C5eb7e6462559631ad84a9a98%2C5fba6118230c015689192ce7%2C5c84e63128a06171521af324&ofpr=%2C2%2C3%2C2%2C3%2C2.4%2C3%2C2.65%2C1.25%2C3%2C&fpo=%2C%2C%2C%2C%2C%2C%2C%2C%2C%2C
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.81.198.99 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:58 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
sodar2.js
tpc.googlesyndication.com/sodar/ Frame DF1E
16 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
66bfa6dd42535b06a283b3844a0bddcfd7f1aca1368baae035a7cda89a6b97fd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:48:58 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1603823857801521"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6015
x-xss-protection
0
expires
Tue, 15 Dec 2020 12:48:58 GMT
/
crta.dailymail.co.uk/
8 B
572 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:58 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:48:58 GMT
si
googleads.g.doubleclick.net/pagead/drt/ Frame 0113
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:48:58 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
280591
search.spotxchange.com/openrtb/2.3/dados/
0
1 KB
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/280591
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 15 Dec 2020 12:48:58 GMT
X-SpotX-Timing-Transform
0.000303
X-SpotX-Timing-SpotMarket
0.012006
X-SpotX-Timing-Page-Mux
0.001566
X-SpotX-Timing-Page-Require
0.000625
X-fe
058
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000034
X-SpotX-Timing-Page
0.021412
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000588
Last-Modified
Tue, 15 Dec 2020 12:48:58 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.012006
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.006270
X-SpotX-Timing-Page-Exception
0.000001
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000019
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
138 B
833 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
289690f864bffab00c80f46903f87766bfe3a4aec6cd0ee1c34e96a42b1b1acc
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:58 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.221.8:80
AN-X-Request-Uuid
824f842b-675f-4b39-9a33-ee63c745eb8e
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
138
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
138 B
835 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
a90e43091aa5372e4fe78470a03a4a14a6e08d3a12de6153b0be596497a93183
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:48:58 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.222.240:80
AN-X-Request-Uuid
d4544ebe-b8b7-495b-a4cb-b75eaff1035a
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
138
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
avjp
select-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://select-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=22619ea2-8c04-4b73-b8fd-e4816c8b9090&nocache=1608036538608&schain=1.0%2C1!selectmedia.asia%2C5e3a966128a06134f417790e%2C1%2C%2CMail%20Metro%20Media%2Cmailonline.co.uk&openrtb=%7B%22imp%22%3A%5B%7B%22video%22%3A%7B%22mimes%22%3A%5B%22video%2Fx-ms-wmv%22%2C%22video%2Fmp4%22%2C%22application%2Fjavascript%22%5D%2C%22w%22%3A480%2C%22h%22%3A270%7D%7D%5D%2C%22w%22%3A480%2C%22v%22%3A270%7D&auid=541066210&vwd=480&vht=270&vos=101
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:58 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=SelectMedia
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.189.33 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
avjp
select-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://select-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=57e11170-2a46-486d-a881-090dcabab022&nocache=1608036538611&schain=1.0%2C1!selectmedia.asia%2C5e3a966128a06134f417790e%2C1%2C%2CMail%20Metro%20Media%2Cmailonline.co.uk&openrtb=%7B%22imp%22%3A%5B%7B%22video%22%3A%7B%22mimes%22%3A%5B%22video%2Fx-ms-wmv%22%2C%22video%2Fmp4%22%2C%22application%2Fjavascript%22%5D%2C%22w%22%3A480%2C%22h%22%3A270%7D%7D%5D%2C%22w%22%3A480%2C%22v%22%3A270%7D&auid=541066210&vwd=480&vht=270
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:58 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
auction
prebid-server.rubiconproject.com/openrtb2/
0
0

translator
hbopenbid.pubmatic.com/
0
63 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:48:58 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cygnus
htlb.casalemedia.com/
25 B
375 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=506382&v=8.1&ac=j&sd=1&nf=1&r=%7B%22id%22%3A%2217ae158de359a47%22%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%2C%22ixdiag%22%3A%7B%22msd%22%3A0%2C%22msi%22%3A0%7D%7D%2C%22source%22%3A%7B%22ext%22%3A%7B%22schain%22%3A%7B%22ver%22%3A%221.0%22%2C%22nodes%22%3A%5B%7B%22sid%22%3A%225e3a966128a06134f417790e%22%2C%22name%22%3A%22Mail%20Metro%20Media%22%2C%22hp%22%3A1%2C%22domain%22%3A%22mailonline.co.uk%22%2C%22asi%22%3A%22selectmedia.asia%22%7D%5D%2C%22complete%22%3A1%7D%7D%7D%2C%22imp%22%3A%5B%7B%22id%22%3A%2218d2f77b44798e3%22%2C%22ext%22%3A%7B%22siteID%22%3A%22506382%22%2C%22sid%22%3A%22480x270%22%7D%2C%22bidfloor%22%3A3%2C%22bidfloorcur%22%3A%22USD%22%2C%22video%22%3A%7B%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A1%2C%22maxduration%22%3A120%2C%22api%22%3A%5B2%5D%2C%22protocols%22%3A%5B2%2C3%2C5%2C6%5D%2C%22w%22%3A480%2C%22h%22%3A270%2C%22placement%22%3A1%7D%7D%5D%7D
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
1805445beb301323931d50e3df2b76f11d8ff54413342f6b51af01e8bc603358

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:58 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
45
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:48:58 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/219/ Frame 58BD
0
0
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/sodar/sodar2/219/runner.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
4867
date
Tue, 15 Dec 2020 12:20:33 GMT
expires
Wed, 15 Dec 2021 12:20:33 GMT
last-modified
Mon, 05 Oct 2020 22:33:01 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
1705
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
track
track1.aniview.com/
0
94 B
XHR
General
Full URL
https://track1.aniview.com/track?r=www.dailymail.co.uk&sn=&ic=0&tgt=0&app=&wi=480&he=270&test=&apppkg=&fv=3&proto=https
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.81.198.99 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 15 Dec 2020 12:49:04 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
2018745230876869974
tpc.googlesyndication.com/simgad/ Frame 0113
19 KB
19 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/2018745230876869974?sqp=4sqPyQQrQikqJwhfEAEdAAC0QiABKAEwCTgDQPCTCUgAUAFYAWBfcAJ4AcUBLbKdPg&rs=AOga4qlDskl4J8agGmYWxA6c7aeTQyVE4Q
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
644bc6809c636598c66d064aa058ded7438730907e3fe3eccdbc840d284e6c61
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Fri, 11 Dec 2020 23:27:33 GMT
x-content-type-options
nosniff
last-modified
Mon, 07 Dec 2020 16:33:27 GMT
server
sffe
age
307285
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
19836
x-xss-protection
0
expires
Sat, 11 Dec 2021 23:27:33 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 0113
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47671
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 0113
295 B
320 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53737
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
multitracking
hb.hb.selectmedia.asia/adunit/ Frame DF1E
0
210 B
XHR
General
Full URL
https://hb.hb.selectmedia.asia/adunit/multitracking
Requested by
Host: player.hb.selectmedia.asia
URL: https://player.hb.selectmedia.asia/prebidlink/446676/wrapper_hb_310028_7816.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.dailymail.co.uk
Date
Tue, 15 Dec 2020 12:48:58 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
gen_204
pagead2.googlesyndication.com/pagead/ Frame DF1E
0
46 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar2&v=219&t=2&li=gpt_2020120801&jk=890443373853042&bg=!_v2l_d3NAAXKjztByliMJ_Go_xM52gIAAAC1UgAAABZoAQcKALslawWW1vRlBx5JAuGPmcbdK4NU5QS93cdABnpyTyPIFOIBB3l8Y6KSvIDlYhFwrs4Hrdbm-7ewplCVDgDqBUOww04aJyLiW_PbU-IzGRbZ4K14xsaFhbSCNsR81mm0pC0M22OhrtK-o4TRRsubbkjOPtnkssxFpFSww7FnftPBfTvrpayMFcgQ7U1_tTQliWsCR4e0MotQG_A5xHbWFdmuM9zcLeGNWnYjA4Zn1fH2TSnfdYXAT85KWsLHmQHZGlgxAaPrkLl3aBc87HCX94nPvvkNovARBblgUbSOS00tO66LoAaKtuECBzP-bitLzA0BEJp9ahc57gPbWxGIMiygPD9DQPccsj6fGDUy4uIA-P5cBs5u6_ueOFfas2Gp0-vUn_bU9xlN5z2HpEo7Nmox6GAug4lDkx_e_NetMSMojp3rehgMiqrfp2gr2z0pLB50zwGCP_2gZCkSjs6huP5V23wNcJPennIut42BatRM9iY4xC7WvRMb8jr6V4vGhBDCJyZtN4fEpoWM8-kAp8R2n9gPj-i47qDnFkmCKbFqViFXwzSSgLNF1NhFizNis8i0l5Q_KOSnLt1N3NfkeJ5REWSiAb-JY_jl53Agj1QRe5iH2V6iMYPx0vl1hMK9cH4aewQyM4W_elpL4AU0gsHRfDTjBtbpYze0QVeWRz68ovWWelRS8MMxu-rqWa5mIZH2228N8OUFZ5HQEGXBl51ke_keCTv8P7ZKD2JjJy6IogrB17HNOcUsQNEYG9lhgdokNGbb5R9AJMqd4WJkhW2oGD4V7Y9slYqJx5Dgh3DlkyIGel0IvuXC1dsuKtSWHi0JXATFv2TFBm87iIX1t4fac13vnmzOtvXCXVxatsyW-JHd9m3FmUM
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:48:58 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
auction
prebid.adnxs.com/pbs/v1/openrtb2/
0
0

xhr
pre.ads.justpremium.com/v/2.0/t/
43 B
253 B
XHR
General
Full URL
https://pre.ads.justpremium.com/v/2.0/t/xhr?i=1608036541109
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.106.210 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
d34e8a1a381b203e3d1f7c6ed4f077038e91782ea254c7a7e4785462147a385a

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:49:01 GMT
cache-control
public, no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-encoding
gzip
content-type
application/json
v2
mfad.inskinad.com/api/
0
0

cdb
bidder.criteo.com/
0
0

cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=193648&v=7.2&r=%7B%22id%22%3A%22227fa84a17df64a4%22%2C%22imp%22%3A%5B%7B%22id%22%3A%222286fe8dc7956f9d%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22970x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A970%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%222294a6ddfbe03d02%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22900x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A900%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%2C%7B%22id%22%3A%22230c260bbcfcb55b%22%2C%22ext%22%3A%7B%22siteID%22%3A%22193648%22%2C%22sid%22%3A%22728x90%22%7D%2C%22banner%22%3A%7B%22w%22%3A728%2C%22h%22%3A90%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
0491b1fd2c4c7eb37afb16d514cfbc3cb2e27a428bc6c638f228f7859ff5479d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:01 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:49:01 GMT
bidRequest
c2shb.ssp.yahoo.com/
0
0

bid-request
a.teads.tv/hb/
16 B
301 B
XHR
General
Full URL
https://a.teads.tv/hb/bid-request
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
6a7b0c8bf87b2bd5ca31557f25cf2a6c80f93af72bf68a6085e9b55a87fe908c

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:01 GMT
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
42
expires
Tue, 15 Dec 2020 12:49:01 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
0
0

prebid
ib.adnxs.com/ut/v3/
0
0

bid
c.amazon-adsystem.com/e/dtb/
24 B
373 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=17&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22billBoard%22%2C%22s%22%3A%5B%222000x1200%22%2C%22970x250%22%2C%22900x250%22%2C%22728x90%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
c1059d522f4c639f77427fa309b77d7c5f02e42a44d45e2edc5113394cb51822

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:01 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
MWgmmftmw93b_fght7TNIc8jDKbSdabaskFBCjo7b9cF71j3crMk3g==
2
www.dailymail.co.uk/abe/a9/price/
4 B
826 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094403
date
Tue, 15 Dec 2020 12:49:01 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
ads
securepubads.g.doubleclick.net/gampad/
84 KB
27 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=968299714921998&output=ldjh&impl=fif&adsid=NT&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cbillboard&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=2000x1200%7C970x250%7C900x250%7C728x90&ris=17&rcs=1&prev_scp=amznbid%3D2%26amznp%3D2%26pos%3Dbillboard%26adx_channel%3D1%26nobids%3Dfalse%26refresh%3Dtrue%26refreshCount%3D1%26refreshReason%3Dsecondary%26amznsz%3D0x0&eri=5&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D10277%252C31736%252Crts%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036543127&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=315&adys=197&adks=1878184308&ucis=g&ifi=16&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=964x250&msz=967x250&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H_S_JiAPTCyLnMXW-8Gme6kBHd_2URHTKn6UxAt4OXnVhd4HbWzUCtAHwDLVusbgx2bo6bmjazmc9v6aTx04RKP4lYsb2jmbZQu4kgEE9dO%2CAGkb-H_u2rhcq2eyu3egZcbj8dURn95XJjputWUBai9BFigYSdmhIaqyJAhwg6KNQ9pjRGHQZDqe-xk_QRiBRTfz2bi5nh_As6oweLXIPw%2CAGkb-H-uMrLNKXTs-hRPWBx2zwC_USTq2e7VmLk2hFofoUPxHZEgFeF3mZVo2D5qrFqi2f8q-oFtFA8TEpBmo41dL2gSnVGVCFOAz1RVUQ%2CAGkb-H8DivnnHBMmqJ7nFxiA5jiKyWlvBrKy0iQsA5wcQNMjDdGfO-4RdmMdCNYJw-G_QED8f7AMXvQJJIC64Uggcg%2CAGkb-H_RL5E7JsgzlS14x5s12oFLmAw98o5FTCGiFhaw1FIvL7B1FinjVPaSh2583MFAOfVbrtOPvLtjiGH8FAFwwg%2CAGkb-H_ikEHuq1ahXuqVuAtyt7YIj8sjRajCRvidSdAEDDYgt-t5i-BGKnW8D_umOayQeNVMVFHRrGJpYS7z4osNeMBWFjX6JBU%2CAGkb-H-OoqSEExEm60pQM0BiNkgZJjxOKoTIRPBprqYnI2Rp2YRH8401MFCe7_rbhbEInk7QNDHdGpXY-T_c6EvYQ-N4D4xOyvQ&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&fws=4&ohw=967&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
5331223fa071fc91b77d8bf45b4e6ac720c7da58e86bc7658411994a92d8c823
Security Headers
Name Value
Content-Security-Policy child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/9861080888452222715/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/9861080888452222715/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CJvQxfeC0O0CFQo24Aodk1cB2Q&gqi=&layout=/sadbundle/%24csp%253Der3%24/9861080888452222715/index.html
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/9861080888452222715/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/9861080888452222715/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CJvQxfeC0O0CFQo24Aodk1cB2Q&gqi=&layout=/sadbundle/%24csp%253Der3%24/9861080888452222715/index.html
content-encoding
br
x-content-type-options
nosniff
google-creative-id
-1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
26492
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
date
Tue, 15 Dec 2020 12:49:03 GMT
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame C252
0
0
Document
General
Full URL
https://45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:801::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Tue, 15 Dec 2020 12:48:46 GMT
expires
Wed, 15 Dec 2021 12:48:46 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
17
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
events
bidder.criteo.com/csm/
0
149 B
Other
General
Full URL
https://bidder.criteo.com/csm/events
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:49:03 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
/
crta.dailymail.co.uk/
8 B
447 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:04 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:49:04 GMT
events
api.permutive.com/v2.0/batch/
101 B
178 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
4c3c8f942c8a0d7bbd601584cc16ca489a9da643c6fc351a2e896e6736dcf160

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:49:05 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
110
via
1.1 google
pixel.gif
static.criteo.net/images/
43 B
260 B
Image
General
Full URL
https://static.criteo.net/images/pixel.gif?ch=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:05 GMT
last-modified
Tue, 09 Dec 2008 16:52:36 GMT
server
nginx
etag
"493ea254-2b"
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=31104000, public
accept-ranges
bytes
timing-allow-origin
*
content-length
43
expires
Fri, 10 Dec 2021 12:49:05 GMT
pixel.gif
static.criteo.net/images/
43 B
260 B
Image
General
Full URL
https://static.criteo.net/images/pixel.gif?ch=2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:05 GMT
last-modified
Tue, 09 Dec 2008 16:52:36 GMT
server
nginx
etag
"493ea254-2b"
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=31104000, public
accept-ranges
bytes
timing-allow-origin
*
content-length
43
expires
Fri, 10 Dec 2021 12:49:05 GMT
auction
prebid.adnxs.com/pbs/v1/openrtb2/
156 B
505 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
6c27598537c7237629883dae138bbecbbe0072a457b30e5b1f5982fc919d7f73

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:05 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
156
Expires
0
bidRequest
c2shb.ssp.yahoo.com/
0
0

cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=503172&v=7.2&r=%7B%22id%22%3A%22244d5eb4350bcb5f%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22245c2d321cf80d73%22%2C%22ext%22%3A%7B%22siteID%22%3A%22503172%22%2C%22sid%22%3A%22300x250%22%7D%2C%22banner%22%3A%7B%22w%22%3A300%2C%22h%22%3A250%2C%22topframe%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
7d48cedae3d5a2f289d35c1f915ade5ab1c92b0013f509020afc1dcc07668a6b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:05 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:49:05 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
0
0

cdb
bidder.criteo.com/
0
149 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?ptv=100&profileId=185&av=32&wv=4.13.0-mol-1&cb=40919092831
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:49:04 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
arj
mailonline-uk-d.openx.net/w/1.0/
172 B
355 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=2a549085-f90b-40f4-be84-96469883a52b&nocache=1608036545325&id5id=ID5-ZHMO6tA3QNYViPdwxqXlM7pRwmnB91HmAtL0p2oNRg&pubcid=3093687966&ttduuid=756bd07b-da9f-4519-81af-bb93a5ce71b6&aus=300x250&divIds=mpu_player&auid=541063092
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
a91d375c9699aa2ee8855d5c12c169eb645a32f5b2028ca17ded9f70845ad09b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:05 GMT
content-encoding
gzip
server
OXGW/16.199.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
163
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
715 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:06 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.132:80
AN-X-Request-Uuid
6b0f557a-a90b-4ae3-84a4-18491924f9fb
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bid
c.amazon-adsystem.com/e/dtb/
24 B
374 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=18&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22sd%22%3A%22mpu_player%22%2C%22s%22%3A%5B%22300x250%22%5D%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
ffc733276efc796c146eccf6bc3b111f917b8e2203d25df67884786903b64c05

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:05 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
1B7Bn6l_dVKabkuXhxpnAM6Dp_O1W9qipLnPXgY9ksO9iewjh1LGJQ==
events
bidder.criteo.com/csm/
0
149 B
Other
General
Full URL
https://bidder.criteo.com/csm/events
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
date
Tue, 15 Dec 2020 12:49:04 GMT
access-control-allow-credentials
true
server
Finatra
timing-allow-origin
*
vary
Origin
2
www.dailymail.co.uk/abe/a9/price/
4 B
824 B
XHR
General
Full URL
https://www.dailymail.co.uk/abe/a9/price/2
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
561b2814d3c09e62a92442c946307918f7f63f833c84876c08bd4c406767e53b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
wDnvhJJXpo3tPt4.QtsManRqQALbFlHY
content-security-policy-report-only
block-all-mixed-content; report-uri https://mol.report-uri.io/r/default/csp/reportOnly
last-modified
Thu, 26 Jul 2018 09:55:16 GMT
server
AmazonS3
x-amz-request-id
F3B7DC261871AFAC
etag
"f7ddd489ab0a82567b241b05971cbdb3"
vary
User-Agent
content-type
text/plain
cache-control
public, max-age=1094399
date
Tue, 15 Dec 2020 12:49:05 GMT
x-amz-replication-status
COMPLETED
server-timing
cdn-cache; desc=HIT, edge; dur=1
accept-ranges
bytes
content-length
4
x-amz-id-2
yWG9gEfdLlfRIIUkBnb3BxqznyyHvNXP6lp6jKeycLsb6tJM0aZyTwjsdMJ/9E1vzr+IVcYpbIo=
vHNeqqO2EwDgECJBuu%252BUqQVOcxgwhZenhmfN5Vv7pbw%253D-resultThumbUrl.jpg
i.newzit.com/i/newzit/ Frame 1FE6
19 KB
19 KB
Image
General
Full URL
https://i.newzit.com/i/newzit/vHNeqqO2EwDgECJBuu%252BUqQVOcxgwhZenhmfN5Vv7pbw%253D-resultThumbUrl.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:b::b856:675f , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
8d41c49c447c9abe668baf72551dda022e63f622b1930915e6d0608532ae80aa

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:49:05 GMT
Last-Modified
Tue, 15 Dec 2020 12:16:26 GMT
Server
AmazonS3
x-amz-request-id
0H8VDPBZCG8T5YEW
ETag
"11b353a82dca6069550e6244fb547361"
Content-Type
image/jpeg
Cache-Control
max-age=3422
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
19056
x-amz-id-2
bW2NTWtMzK0B+3D7+vs1WNGn32M6ku2L60UcV6pfyJHOyrJLQYW7vzTOcwjzjd277QOXMO9kywU=
Expires
Tue, 15 Dec 2020 13:46:07 GMT
mirror.co.uk.png
i.newzit.com/favicons/ Frame 1FE6
3 KB
3 KB
Image
General
Full URL
https://i.newzit.com/favicons/mirror.co.uk.png
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:b::b856:675f , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
20ef39094f2cf78de1d093b5136f10da982703a0ec4568aa1778815a41c840f9

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:49:05 GMT
Last-Modified
Fri, 05 Jun 2020 17:03:55 GMT
Server
AkamaiNetStorage
ETag
"ed7b911c0d00325d73459f08ceca7b11:1591376635.513733"
Content-Type
image/png
Cache-Control
max-age=769
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
2647
Expires
Tue, 15 Dec 2020 13:01:54 GMT
/
crta.dailymail.co.uk/
8 B
451 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:06 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:49:06 GMT
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=PL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=96641&t=1608036538&cip=194.99.105.99&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036538232-938474427970-020635-011-004656&imid=c8c4b999f5891c593a8ff8248e57f7b521443856872172315192&cha=0.7&cb=74377213301&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=bid&cb=1608036546608&asid=5c84e63128a06171521af324%2C5c249de6073ef47e0c19572b&ofpr=%2C&fpo=%2C
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.81.198.99 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:06 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
vpaid-adapter.min.js
cdn.stickyadstv.com/mustang/ Frame 089D
327 KB
111 KB
Script
General
Full URL
https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2001:4de0:ac19::1:b:3b , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
/
Resource Hash
dc989373165041ad828e64f33bb534395d2ec233f5949759c911862535e77658

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:49:06 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Dec 2020 03:18:58 GMT
ETag
"1607483938"
X-HW
1608036546.dop002.fr8.t,1608036546.cds268.fr8.shn,1608036546.cds268.fr8.c
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=86400
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Accept-Ranges
bytes
Content-Length
112809
o2shim
acds.prod.vidible.tv/ Frame 3F16
15 KB
7 KB
Script
General
Full URL
https://acds.prod.vidible.tv/o2shim?companionId=&cpmPassback=&placementId=1206795&orgId=28230&injectCompanionDummy=&pauseOnClick=&d.vw=&d.app=&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vrid=2f180f54-42c7-4d69-ab74-0c70596da56b&pblob=
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.195.94.143 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
94b2beacd56a46fc59083c2418e7af25dc4c01aa350d0b63415a2d21de51a81d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:06 GMT
content-encoding
gzip
access-control-max-age
3600
access-control-allow-methods
POST, GET, HEAD, PUT, PATCH, DELETE
content-type
application/javascript
access-control-allow-origin
*
access-control-allow-headers
content-length
6837
bandwidth-test-25ko
cdn.stickyadstv.com/mustang/ Frame 089D
0
0

auto-user-sync
ads.stickyadstv.com/
43 B
601 B
Image
General
Full URL
https://ads.stickyadstv.com/auto-user-sync?gdpr=0&gdpr_consent=null
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
nginx /
Resource Hash
a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:08 GMT
Server
nginx
Content-Type
image/gif
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
x-sticky-vk
1608036548228004-151
Expires
Tue, 15 Dec 2020 12:49:08 GMT
/
ads.stickyadstv.com/additional-scripts/ Frame 089D
301 B
859 B
XHR
General
Full URL
https://ads.stickyadstv.com/additional-scripts/?zoneId=7197697&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
nginx /
Resource Hash
64a14c1566ed5e882e60ea9d6e3722949c5767823cd23dc1244503991661dc27

Request headers

Accept
application/xml, text/xml
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:08 GMT
Server
nginx
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
301
x-sticky-vk
1608036548021084-175
Expires
Tue, 15 Dec 2020 12:49:08 GMT
swfIndex.php
ads.stickyadstv.com/www/delivery/ Frame 089D
67 B
582 B
XHR
General
Full URL
https://ads.stickyadstv.com/www/delivery/swfIndex.php?zoneId=7197697&_fw_gdpr=1&cbb=8036538393&_fw_us_privacy=1---&_fw_gdpr_consent=&schain=1.0%2C1!selectmedia.asia%2C5e3a966128a06134f417790e%2C1%2C%2CMail%2BMetro%2BMedia%2Cmailonline.co.uk&vav=0e9e2b3e41ffd03a591138b976478ed7&vaviv=29d3a9b846398d1a1adc5b6897b997e7&reqType=AdsSetup&protocolVersion=2.0&mustangVersion=1.11.6.1&focus=true&percentViewable=15&componentId=vpaid-adapter&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&playerSize=480x270&supportsFlash=false&supportsJavascript=true
Requested by
Host: cdn.stickyadstv.com
URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
nginx /
Resource Hash
291437ea71e62b1c35d4ec5d3c5ad02cfa930343b41b1472fba70243089c8bbe

Request headers

Accept
application/xml, text/xml
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:08 GMT
Server
nginx
Content-Type
application/xml;charset=UTF-8
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
67
x-sticky-vk
1608036548096052-136
Expires
Tue, 15 Dec 2020 12:49:08 GMT
0.js
cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/ Frame 3F16
321 KB
104 KB
Script
General
Full URL
https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js
Requested by
Host: acds.prod.vidible.tv
URL: https://acds.prod.vidible.tv/o2shim?companionId=&cpmPassback=&placementId=1206795&orgId=28230&injectCompanionDummy=&pauseOnClick=&d.vw=&d.app=&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vrid=2f180f54-42c7-4d69-ab74-0c70596da56b&pblob=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1288:f03d:1fa::2000 , United Kingdom, ASN10310 (YAHOO-1, US),
Reverse DNS
Software
ATS /
Resource Hash
66dd5033bfecfeef06d05c3c5115bdba91710813b07c6635f91f0424223d43b4
Security Headers
Name Value
Strict-Transport-Security max-age=15552000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

ats-carp-promotion
1
date
Thu, 10 Dec 2020 16:50:10 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
417537
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-length
105542
x-amz-id-2
JK6DbToHOkJJcBvdK9U6wYGNLZ6FUDO7czFNweK/dVGehi/VGqJL5+SB0q/eQG6PBsLEmZqmF3U=
referrer-policy
no-referrer-when-downgrade
last-modified
Thu, 10 Dec 2020 16:21:44 GMT
server
ATS
etag
"d3e6dcf5eb86c562a4a5c5fa218f09fe-df"
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
strict-transport-security
max-age=15552000
access-control-allow-methods
GET
x-amz-request-id
BF7B5BFBB675E914
access-control-allow-origin
*
x-xss-protection
1; mode=block
cache-control
max-age=1209600
x-amz-version-id
null
accept-ranges
bytes
content-type
application/javascript
impression.gif
trk.vidible.tv/trk/ Frame 3F16
43 B
246 B
Image
General
Full URL
https://trk.vidible.tv/trk/impression.gif?pid=59947c0544a64b1a49e52a48&bcid=5c6c7f1c17e0e151b5b9cb66&s=true&pv=10.2.59&ifr=true&cb=0.7552821804707064&pt=o2unit&sid=d852b6e4-f455-4f04-80e0-d58f8aa289d6&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.157.226.24 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:49:07 GMT
moatapi.js
z.moatads.com/aolvidibleapi29384728347/
133 KB
44 KB
Script
General
Full URL
https://z.moatads.com/aolvidibleapi29384728347/moatapi.js
Requested by
Host: cdn-ssl.vidible.tv
URL: https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.21.38.40 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-38-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
90542f9de6cab010087ab4bcab0e3b0a2ec1e449e445434dc1bb5c852033f046

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
content-encoding
gzip
last-modified
Tue, 25 Feb 2020 18:37:38 GMT
server
AmazonS3
x-amz-request-id
323F191B2EF28804
etag
"d678022569896f7b7293494e3a69c8c7"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
max-age=27015
accept-ranges
bytes
content-length
44266
x-amz-id-2
w1vBWHvJ9SRbTv6kBUzFv3+JSN3a/Rn6XLROBEKaUemhdjhQ2HcKwcNvnRLQiZ2qBEcwDFhSxhs=
local-storage.html
cdn-ssl.vidible.tv/prod/player/ad-time/ Frame C0B1
0
0
Document
General
Full URL
https://cdn-ssl.vidible.tv/prod/player/ad-time/local-storage.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1288:f03d:1fa::2000 , United Kingdom, ASN10310 (YAHOO-1, US),
Reverse DNS
Software
ATS /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15552000
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
cdn-ssl.vidible.tv
:scheme
https
:path
/prod/player/ad-time/local-storage.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

x-amz-id-2
6VueqPfzvVrqOEE2LzriuMu3cz3f5ddPvYtnFKsPyITPrRvd9DXMHA8OBrRu1srodOEmVYOpw2E=
x-amz-request-id
6C055F680D0C8568
date
Wed, 02 Dec 2020 23:53:06 GMT
last-modified
Wed, 19 Feb 2020 12:29:18 GMT
etag
"3ba0167f9f40b17c70af8074ec7b3c55-df"
x-amz-server-side-encryption
AES256
x-amz-version-id
null
accept-ranges
bytes
content-type
text/html
server
ATS
referrer-policy
no-referrer-when-downgrade
cache-control
max-age=1209600
age
1083362
ats-carp-promotion
1
access-control-allow-methods
GET
access-control-allow-origin
*
content-encoding
gzip
vary
Accept-Encoding
content-length
557
strict-transport-security
max-age=15552000
expect-ct
max-age=31536000, report-uri="http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only"
x-xss-protection
1; mode=block
x-content-type-options
nosniff
3pRrSx07Gk8Dl7mNKBWke3eC9D9nIm_aTuVZj2Zo7Wk=
ads.adaptv.advertising.com/a/h/ Frame 3F16
249 B
549 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/a/h/3pRrSx07Gk8Dl7mNKBWke3eC9D9nIm_aTuVZj2Zo7Wk=?cb=8036538406&gdpr=1&gdpr_consent=&pet=preroll&pageUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&eov=eov&us_privacy=1---&scpid=58fcbed1073ef420086c9d08&scpid=5e3a966128a06134f417790e&a.cluster=0&a.pvt=0&a.d.pageUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&a.hasAppInfo=2&a.sdk=o2unit&a.sdkType=js&depth=0&height=270&moatViewableOpportunity=100&p.vw.active=1&p.vw.psize=2&p.vw.viewable=1&p.vw.viewableOpportunity=1&referrerUrl=&width=480
Requested by
Host: cdn-ssl.vidible.tv
URL: https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.189.33 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
adaptv/1.0 /
Resource Hash
6c138576e7381d3ab0aa7b511adc3a7cbb7fe3a3d33768bad05577f5dfc60cad
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
text/javascript, application/json, text/html, application/xml, text/xml, */*
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

pragma
no-cache
strict-transport-security
max-age=31536000
content-encoding
gzip
server
adaptv/1.0
content-type
text/xml
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
Connection
keep-alive
Content-Length
192
expires
0
display.gif
trk.vidible.tv/trk/ Frame 3F16
43 B
245 B
Image
General
Full URL
https://trk.vidible.tv/trk/display.gif?bcid=5c6c7f1c17e0e151b5b9cb66&bid=56bcd17de4b0a5976ac0da12&pid=59947c0544a64b1a49e52a48&pt=o2unit&pv=10.2.59&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&s=true&sid=d852b6e4-f455-4f04-80e0-d58f8aa289d6&vvuid=95293cf8-fd73-485a-8eb1-947b338634ea&orgId=28230&plcid=1206795&vrid=2f180f54-42c7-4d69-ab74-0c70596da56b&ab=0&dt=254&h=270&spaceid=793604934&w=480&cb=0.42704619370777763
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.157.226.24 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:49:07 GMT
ad-request.gif
trk.vidible.tv/trk/ Frame 3F16
43 B
245 B
Image
General
Full URL
https://trk.vidible.tv/trk/ad-request.gif?bcid=5c6c7f1c17e0e151b5b9cb66&bid=56bcd17de4b0a5976ac0da12&pid=59947c0544a64b1a49e52a48&pt=o2unit&pv=10.2.59&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&s=true&sid=d852b6e4-f455-4f04-80e0-d58f8aa289d6&vvuid=95293cf8-fd73-485a-8eb1-947b338634ea&orgId=28230&plcid=1206795&vrid=2f180f54-42c7-4d69-ab74-0c70596da56b&at=preroll&ps=html5-vpaid&spaceid=793604934&p.vw.active=1&p.vw.sound=0&vwa=100&vwm=-1&cb=0.9702852786303149
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.157.226.24 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:49:07 GMT
ad-engine-request.gif
trk.vidible.tv/trk/ Frame 3F16
43 B
245 B
Image
General
Full URL
https://trk.vidible.tv/trk/ad-engine-request.gif?bcid=5c6c7f1c17e0e151b5b9cb66&bid=56bcd17de4b0a5976ac0da12&pid=59947c0544a64b1a49e52a48&pt=o2unit&pv=10.2.59&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&s=true&sid=d852b6e4-f455-4f04-80e0-d58f8aa289d6&vvuid=95293cf8-fd73-485a-8eb1-947b338634ea&orgId=28230&plcid=1206795&vrid=2f180f54-42c7-4d69-ab74-0c70596da56b&at=preroll&adIdx=-1&pbl=true&ps=html5-vpaid&seq=-1&spaceid=793604934&v=593fb311c214e33ec50202f0&w=480&p.vw.active=1&p.vw.sound=0&vwa=100&vwm=-1&h=270&cb=0.6311079508859283
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.157.226.24 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:49:07 GMT
rid
match.adsrvr.org/track/
109 B
546 B
XHR
General
Full URL
https://match.adsrvr.org/track/rid?ttd_pid=v5zyp9g&fmt=json
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.50.156.162 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
3f86e833ad19bda0ba1f7a461bc8dabaed15de2037eefa058c00c9bcdbdb9293

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
x-aspnet-version
4.0.30319
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Content-Length, Content-Encoding, Vary, Cache-Control, Accept
content-length
109
expires
Thu, 14 Jan 2021 12:49:07 GMT
showad.js
ads.pubmatic.com/AdServer/js/ Frame D5CA
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.33 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-33.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
ads.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Last-Modified
Wed, 21 Oct 2020 18:57:52 GMT
ETag
"13006b6-94f8-5b232eca8cf5e"
Server
Apache/2.2.15 (CentOS)
Accept-Ranges
bytes
Content-Encoding
gzip
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
13837
Content-Type
text/html; charset=UTF-8
Cache-Control
public, max-age=91831
Expires
Wed, 16 Dec 2020 14:19:40 GMT
Date
Tue, 15 Dec 2020 12:49:09 GMT
Connection
keep-alive
Vary
Accept-Encoding
ixmatch.html
js-sec.indexww.com/um/ Frame E22F
0
0
Document
General
Full URL
https://js-sec.indexww.com/um/ixmatch.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.92 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-37-92.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

Host
js-sec.indexww.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache
Last-Modified
Tue, 06 Oct 2020 14:04:48 GMT
ETag
"e20015-8f4-5b10114f2003a"
Accept-Ranges
bytes
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR DEVa TAIa OUR BUS UNI"
Content-Type
text/html; charset=UTF-8
Vary
Accept-Encoding
Content-Encoding
gzip
Content-Length
1136
Date
Tue, 15 Dec 2020 12:49:14 GMT
Connection
keep-alive
async_usersync.html
acdn.adnxs.com/dmp/ Frame 8B07
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.13.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:49:07 GMT
Age
56349
X-Served-By
cache-lga21927-LGA, cache-fra19140-FRA
X-Cache
HIT, HIT
X-Cache-Hits
1, 292300
X-Timer
S1608036547.496848,VS0,VE0
Vary
Accept-Encoding
async_usersync.html
acdn.adnxs.com/dmp/ Frame CA92
0
0
Document
General
Full URL
https://acdn.adnxs.com/dmp/async_usersync.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.13.108 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash

Request headers

Host
acdn.adnxs.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Connection
keep-alive
Content-Length
17053
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Wed, 02 Dec 2020 20:56:47 GMT
ETag
W/"5fc7ff8f-cf34"
Expires
Thu, 03 Dec 2020 21:09:36 GMT
Cache-Control
max-age=86402
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 15 Dec 2020 12:49:07 GMT
Age
56349
X-Served-By
cache-lga21927-LGA, cache-fra19140-FRA
X-Cache
HIT, HIT
X-Cache-Hits
1, 292302
X-Timer
S1608036548.611723,VS0,VE0
Vary
Accept-Encoding
pd
u.openx.net/w/1.0/ Frame 9EC8
0
0
Document
General
Full URL
https://u.openx.net/w/1.0/pd
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
u.openx.net
:scheme
https
:path
/w/1.0/pd
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=060d5142-9f70-0098-0ff6-27d383812dcf|1608036545
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=060d5142-9f70-0098-0ff6-27d383812dcf|1608036545; Version=1; Expires=Wed, 15-Dec-2021 12:49:07 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036547|gekin0vNiygu; Version=1; Expires=Wed, 30-Dec-2020 12:49:07 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:49:07 GMT
content-type
text/html
content-length
420
content-encoding
gzip
via
1.1 google
alt-svc
clear
pd
u.openx.net/w/1.0/ Frame 3658
0
0
Document
General
Full URL
https://u.openx.net/w/1.0/pd
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash

Request headers

:method
GET
:authority
u.openx.net
:scheme
https
:path
/w/1.0/pd
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
cookie
i=060d5142-9f70-0098-0ff6-27d383812dcf|1608036545
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

vary
Accept, Accept-Encoding
set-cookie
i=060d5142-9f70-0098-0ff6-27d383812dcf|1608036545; Version=1; Expires=Wed, 15-Dec-2021 12:49:07 GMT; Max-Age=31536000; Secure; Domain=.openx.net; Path=/; SameSite=None pd=v2|1608036547|gekin0vNiygu; Version=1; Expires=Wed, 30-Dec-2020 12:49:07 GMT; Max-Age=1296000; Secure; Domain=.openx.net; Path=/; SameSite=None
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 15 Dec 2020 12:49:07 GMT
content-type
text/html
content-length
420
content-encoding
gzip
via
1.1 google
alt-svc
clear
usync.html
eus.rubiconproject.com/ Frame 0C50
0
0
Document
General
Full URL
https://eus.rubiconproject.com/usync.html
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.108.50.124 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-108-50-124.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
eus.rubiconproject.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
gzip, deflate, br
Accept-Language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

Server
Apache/2.2.15 (CentOS)
Last-Modified
Mon, 28 Sep 2020 17:02:39 GMT
ETag
"4000c-123-5b062a240e9c0"
Accept-Ranges
bytes
Content-Encoding
gzip
Content-Length
238
Content-Type
text/html; charset=UTF-8
Date
Tue, 15 Dec 2020 12:49:07 GMT
Connection
keep-alive
Vary
Accept-Encoding
sync
pixel.advertising.com/ups/55953/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=adaptv&ttd_tpi=1
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=adaptv&ttd_tpi=1
  • https://pixel.advertising.com/ups/55953/sync?uid=e8feca8b-7df7-47ac-9429-9f6b961e7756&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=e8feca8b-7df7-47ac-9429-9f6b961e7756
0
124 B
Image
General
Full URL
https://pixel.advertising.com/ups/55953/sync?uid=e8feca8b-7df7-47ac-9429-9f6b961e7756&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=e8feca8b-7df7-47ac-9429-9f6b961e7756
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.124.119.192 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:07 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://pixel.advertising.com/ups/55953/sync?uid=e8feca8b-7df7-47ac-9429-9f6b961e7756&_origin=1&gdpr=1&gdpr_consent=&piggybackCookie=e8feca8b-7df7-47ac-9429-9f6b961e7756
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
369
sync
ups.analytics.yahoo.com/ups/57304/
Redirect Chain
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true
  • https://pixel.advertising.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&verify=true
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
  • https://ups.analytics.yahoo.com/ups/57304/sync?gdpr=&gdpr_consent=&_origin=0&redir=true&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e&verify=true
  • https://cm.g.doubleclick.net/pixel?google_nid=adaptv_dbm&google_cm&google_hm=VVBlYjdmYmE2OS0zZWQzLTExZWItYTExMS0wNjViY2NjN2U4OWU%3D
  • https://pixel.advertising.com/ups/57304/sync?uid=CAESEGMi23x308itW04Onv7Ii9w&google_cver=1
  • https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEGMi23x308itW04Onv7Ii9w&google_cver=1&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
0
976 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEGMi23x308itW04Onv7Ii9w&google_cver=1&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:49:07 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/57304/sync?uid=CAESEGMi23x308itW04Onv7Ii9w&google_cver=1&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
date
Tue, 15 Dec 2020 12:49:07 GMT
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
sync
ups.analytics.yahoo.com/ups/55986/
Redirect Chain
  • https://sync-tm.everesttech.net/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=
  • https://sync-tm.everesttech.net/ct/upi/pid/m7y5t93k?gdpr=0&gdpr_consent=&redir=https%3A%2F%2Fpixel.advertising.com%2Fups%2F55986%2Fsync%3Fuid%3D%24%7BUSER_ID%7D%26_origin%3D0&gdpr=0&gdpr_consent=&_...
  • https://pixel.advertising.com/ups/55986/sync?uid=X9iwwwAAAIX6IToG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwwwAAAIX6IToG
  • https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwwwAAAIX6IToG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwwwAAAIX6IToG&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
0
964 B
Image
General
Full URL
https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwwwAAAIX6IToG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwwwAAAIX6IToG&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
18.156.0.31 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
ATS/7.1.2.128 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:49:07 GMT
Server
ATS/7.1.2.128
Connection
keep-alive
Age
0
Strict-Transport-Security
max-age=31536000
P3P
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV

Redirect headers

location
https://ups.analytics.yahoo.com/ups/55986/sync?uid=X9iwwwAAAIX6IToG&_origin=0&gdpr=0&gdpr_consent=&_test=X9iwwwAAAIX6IToG&apid=UPeb7fba69-3ed3-11eb-a111-065bccc7e89e
date
Tue, 15 Dec 2020 12:49:07 GMT
content-length
0
strict-transport-security
max-age=31536000
p3p
CP=NOI DSP COR LAW CURa DEVa TAIa PSAa PSDa OUR BUS UNI COM NAV
ads
securepubads.g.doubleclick.net/gampad/
42 KB
11 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=301895128690214&correlator=968299714921998&output=ldjh&impl=fif&adsid=NT&hxva=1&scor=1237536699736358&eid=21067994%2C21069136%2C21064365%2C21067257&vrg=2020120801&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20201215&iu_parts=5765%2Cdailymail.uk%2Cdm_dmsciencetech_sciencetechart%2Cmpu_player&enc_prev_ius=%2F0%2F1%2F2%2F3&prev_iu_szs=300x250&prev_scp=pos%3Dmpu_player%26adx_channel%3D17%26nobids%3Dfalse%26refreshCount%3D0%26offset%3D0%26amznbid%3D2%26amznsz%3D0x0%26amznp%3D2&eri=4&cust_params=page%3Dart%26article%3D9050821%26area%3Dsciencetech%26subarea%3Dsciencetech%26environment%3Dproduction%26country%3Dde%26abv%3Dmol-22070%252F19a28e0b%26bot%3Dfalse%26random%3D3914be93-8d9c-4fbc-bb9b-1c1cae37551c%26impid%3D3f1d50f8-c1bc-4818-92f7-6e4353f3e475%26browserResolution%3Dmin_1244px%26device%3Dother%26device_features%3D%26articlewithvideo%3Dtrue%26style%3Dwide%26session%3D1%26session_page_ID%3Dnone%26utm_source%3Dnone%26watershed%3Dfalse%26location%3Ddailymail_co_uk%26id5%3Dtrue%26permutive%3D10277%252C31736%252Crts%26puid%3D8ae168bc-50cf-4fd5-aa08-6b927e71518c%26ptime%3D1608036526016&cookie_enabled=1&cdm=www.dailymail.co.uk&bc=31&abxe=1&dt=1608036547419&dlt=1608036523894&idt=1430&frm=20&biw=1600&bih=1200&oid=3&adxs=1223&adys=945&adks=3432249630&ucis=h&ifi=17&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=www.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html&loc=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&vis=1&dmc=8&scr_x=0&scr_y=0&psz=445x-1&msz=445x-1&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H_S_JiAPTCyLnMXW-8Gme6kBHd_2URHTKn6UxAt4OXnVhd4HbWzUCtAHwDLVusbgx2bo6bmjazmc9v6aTx04RKP4lYsb2jmbZQu4kgEE9dO%2CAGkb-H_u2rhcq2eyu3egZcbj8dURn95XJjputWUBai9BFigYSdmhIaqyJAhwg6KNQ9pjRGHQZDqe-xk_QRiBRTfz2bi5nh_As6oweLXIPw%2CAGkb-H-uMrLNKXTs-hRPWBx2zwC_USTq2e7VmLk2hFofoUPxHZEgFeF3mZVo2D5qrFqi2f8q-oFtFA8TEpBmo41dL2gSnVGVCFOAz1RVUQ%2CAGkb-H8DivnnHBMmqJ7nFxiA5jiKyWlvBrKy0iQsA5wcQNMjDdGfO-4RdmMdCNYJw-G_QED8f7AMXvQJJIC64Uggcg%2CAGkb-H_RL5E7JsgzlS14x5s12oFLmAw98o5FTCGiFhaw1FIvL7B1FinjVPaSh2583MFAOfVbrtOPvLtjiGH8FAFwwg%2CAGkb-H_ikEHuq1ahXuqVuAtyt7YIj8sjRajCRvidSdAEDDYgt-t5i-BGKnW8D_umOayQeNVMVFHRrGJpYS7z4osNeMBWFjX6JBU%2CAGkb-H-OoqSEExEm60pQM0BiNkgZJjxOKoTIRPBprqYnI2Rp2YRH8401MFCe7_rbhbEInk7QNDHdGpXY-T_c6EvYQ-N4D4xOyvQ&ga_vid=1453141251.1608036525&ga_sid=1608036525&ga_hid=1653325603&fws=516&ohw=445&btvi=0&tt_state=W3siaXNzdWVyT3JpZ2luIjoiaHR0cHM6Ly9hZHNlcnZpY2UuZ29vZ2xlLmNvbSIsInN0YXRlIjowfSx7Imlzc3Vlck9yaWdpbiI6Imh0dHBzOi8vYXR0ZXN0YXRpb24uYW5kcm9pZC5jb20iLCJzdGF0ZSI6MH1d
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
cafe /
Resource Hash
2da63b01e2730f1c8f8770c33662ca54d327409c6fe39844ce7f3bc454151fea
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
10575
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
x-google-amp-ad-validated-version
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel.gif
px.moatads.com/
43 B
253 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=0&ac=1&bq=7&i=AOL_VIDIBLE_API1&t=1608036547476&de=53317696220&d=273%3A-%3A-%3A-&bo=dailymail.co.uk&bd=dailymail.co.uk&f=0&cs=0
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2.21.38.40 , France, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
a2-21-38-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:07 GMT
last-modified
Fri, 20 May 2016 15:16:00 GMT
server
Apache
etag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type
image/gif
cache-control
max-age=0, no-cache, no-store
accept-ranges
bytes
content-length
43
expires
Tue, 15 Dec 2020 12:49:07 GMT
unip
trc-events.taboola.com/1125455/log/3/
0
295 B
XHR
General
Full URL
https://trc-events.taboola.com/1125455/log/3/unip?en=pre_d_eng_tb&tos=22589&scd=18&ssd=1&est=1608036524900&ver=27&isls=true&src=i&invt=12000&tim=1608036547489&vi=1608036524897&ri=33989576fd58a84e73b3f9a0b11cec49&sd=v2_bf71d5d1fc71f64880fa94a010aa143c_5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c_1608036524_1608036524_CNawjgYQz9hEGOHGyLPmLiABKAEwrgE47qgMQO3xK0jp2dgDUP___________wFYAWAAaOKmqpGyrZficA&ui=5d5cbf1f-1cf5-40f6-900d-71de32af01a3-tuct6d2362c&ref=null&cv=20201123-29-RELEASE
Requested by
Host: cdn.taboola.com
URL: https://cdn.taboola.com/libtrc/unip/1125455/tfa.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:07 GMT
server
nginx
x-fastly-to-nlb-rtt
28230
p3p
policyref="http://trc.taboola.com/p3p.xml", CP="NOI DSP COR LAW NID CURa ADMa DEVa PSAa PSDa OUR BUS IND UNI COM NAV INT DEM"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache
access-control-allow-credentials
true
tbl-x-upstream
10.41.30.18:10213
metrics
api.permutive.com/v2.0/internal/
2 B
87 B
XHR
General
Full URL
https://api.permutive.com/v2.0/internal/metrics?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
2689367b205c16ce32ed4200942b8b8b1e262dfc70d9bc9fbc77c49699a4f1df

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:49:07 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
22
via
1.1 google
amp4ads-v0.mjs
cdn.ampproject.org/rtv/012010270040000/ Frame 4D49
180 KB
50 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b2ab9ac436910017b9a2ca7db0e981bad3638db97f576d713eaa9b302e06c094
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
398164
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
51478
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 22:13:03 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"0305d7d21a7fe4a1"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 22:13:03 GMT
amp-ad-exit-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 4D49
13 KB
5 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-ad-exit-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
ebab910fdc7c7e9e079caa9f7321177b135b2e1542f86ce36937ceb41865086d
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
285675
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4850
x-xss-protection
0
server
sffe
date
Sat, 12 Dec 2020 05:27:52 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"77bd676d834aaa8d"
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 12 Dec 2021 05:27:52 GMT
amp-analytics-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 4D49
90 KB
27 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-analytics-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
477549a4d5fb644cda6bf64af01631b8411022d88e608bbd8e5a06e327b391cb
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
475845
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27668
x-xss-protection
0
server
sffe
date
Thu, 10 Dec 2020 00:38:22 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1304c1c0caf7ca3c"
accept-ranges
bytes
timing-allow-origin
*
expires
Fri, 10 Dec 2021 00:38:22 GMT
amp-fit-text-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 4D49
3 KB
1 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-fit-text-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a86753d4effe5e607d4eaf03fe37eccb8cac743a528f874f736f4d7f35e094b1
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
355767
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1350
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 09:59:40 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"12c034eb739190af"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 09:59:40 GMT
amp-form-0.1.mjs
cdn.ampproject.org/rtv/012010270040000/v0/ Frame 4D49
41 KB
13 KB
Script
General
Full URL
https://cdn.ampproject.org/rtv/012010270040000/v0/amp-form-0.1.mjs
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b61eb57ae77f31b91b04781da33023ecd897fda21f6c817e6c27623204046f42
Security Headers
Name Value
Content-Security-Policy default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
default-src * blob: data:; script-src blob: https://cdn.ampproject.org/esm/ https://cdn.ampproject.org/lts/ https://cdn.ampproject.org/mp/ https://cdn.ampproject.org/rtv/ https://cdn.ampproject.org/sp/ https://cdn.ampproject.org/sw/ https://cdn.ampproject.org/v0.js https://cdn.ampproject.org/v0.mjs https://cdn.ampproject.org/v0/ https://cdn.ampproject.org/viewer/; object-src 'none'; style-src 'unsafe-inline' https://cdn.ampproject.org/rtv/ https://cdn.materialdesignicons.com https://cloud.typography.com https://fast.fonts.net https://fonts.googleapis.com https://maxcdn.bootstrapcdn.com https://p.typekit.net https://pro.fontawesome.com https://use.fontawesome.com https://use.typekit.net; report-uri https://csp.withgoogle.com/csp/amp
content-encoding
br
x-content-type-options
nosniff
age
353879
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13075
x-xss-protection
0
server
sffe
date
Fri, 11 Dec 2020 10:31:08 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/javascript
access-control-allow-origin
*
vary
Accept-Encoding
cache-control
public, max-age=31536000
etag
"1e8a1dae72af56cd"
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 11 Dec 2021 10:31:08 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 4D49
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47680
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 4D49
295 B
587 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020120801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53746
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
truncated
/ Frame 4D49
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
51dd2df6b7678dc2c30bf9ab6565a2b0cbdef449782db9b790df9c694a2932d4

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
18134932572154338480
tpc.googlesyndication.com/daca_images/simgad/ Frame 4D49
37 KB
37 KB
Image
General
Full URL
https://tpc.googlesyndication.com/daca_images/simgad/18134932572154338480
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c61f8f9095f9bf3b783491ed9a4def68b38985a9b213e4165d590d76085d4a02
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 23:04:39 GMT
x-content-type-options
nosniff
age
49468
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37550
x-xss-protection
0
last-modified
Tue, 24 Nov 2020 06:41:35 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 23:04:39 GMT
l
www.google.com/ads/measurement/ Frame 4D49
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaSdNslR_1fw_fZvCIJYwbP0b9gPyQ2pqfk2ilhRlPGNNtO6lV7N31zeGD2yU5CzeoBCP0Z9Oqk-mxz-yk4G2MOb3G-9-g
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

adview
securepubads.g.doubleclick.net/pagead/ Frame 4D49
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=C8_tOw7DYX9KkIY2F-gaSu56YCO7nmIZgwerey_wMvuOaigQQASCs2bgiYOnkyYXYGqABtK365gLIAQKpAt7KoUUOVZI-4AIAqAMByAMIqgTDAk_Qz0xvQy-mFIZJ4aGXC8OZAPkiPWUXOjWykNaOwlJG2AHNZEkta0rSp_m3tOJdoZgpqOxTVfr6qbj5Z4CrhlLCPRC9WICIUJi28STes7enkLzy8gwk7Keh0y_akHE6yGzsf5wPq1kLtRmBGerApu8G9vQWgP2gOZBId5HxtB1f0aiLFSU0OFfSyWRlBBM6s_IdO-8IGbixy8jFBPBA1h8PP7G57xrryrDYpeUAPd8A2aG2vzcfgw9qWnOBzk1eMn2dt8QrRCxt_0gjzKYPoNhFT5FPlIAV9SGMmsmsgFeOK3bYwrjyiz28L8NazAIyfj3Riw1Ocu7_guX9j7HcExSGn3elBys0yxTBbSSoegpkpw5WPZAgwovEAw63yKVKA-1B7QRdHUWZI05BIN0P_eXw7hCDl_BNNZZNp_oo_OphS-zYwATv18GRnQPgBAGgBgKAB7yX-cMBqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQ6aUG0ggJCIDhgBAQARgdgAoDyAsB2BMDmBYBshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=ue4TKPrCVZE&tpd=AGWhJmst38opmYvDlmeQg9rCwg7FJzDIbPRcGbjqVI-z-fE6hg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

si
googleads.g.doubleclick.net/pagead/drt/ Frame 4D49
Redirect Chain
  • https://www.google.com/pagead/drt/ui
  • https://googleads.g.doubleclick.net/pagead/drt/si
0
0
Image
General
Full URL
https://googleads.g.doubleclick.net/pagead/drt/si
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Redirect headers

date
Tue, 15 Dec 2020 12:49:07 GMT
x-content-type-options
nosniff
server
safe
content-type
text/html; charset=UTF-8
location
https://googleads.g.doubleclick.net/pagead/drt/si
cache-control
private
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
246
x-xss-protection
0
18134932572154338480
tpc.googlesyndication.com/daca_images/simgad/ Frame 4D49
37 KB
37 KB
Image
General
Full URL
https://tpc.googlesyndication.com/daca_images/simgad/18134932572154338480
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
c61f8f9095f9bf3b783491ed9a4def68b38985a9b213e4165d590d76085d4a02
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 14 Dec 2020 23:04:39 GMT
x-content-type-options
nosniff
age
49469
x-dns-prefetch-control
off
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37550
x-xss-protection
0
last-modified
Tue, 24 Nov 2020 06:41:35 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 14 Dec 2021 23:04:39 GMT
en.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 4D49
2 KB
3 KB
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/en.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
36133ca07927c88a7cc578fddbaed3c668ab75087834d0ca13dca5de4ec856c1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 23:34:27 GMT
x-content-type-options
nosniff
server
cafe
age
47681
etag
14819457070020093239
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2502
x-xss-protection
0
expires
Tue, 15 Dec 2020 23:34:27 GMT
icon.png
tpc.googlesyndication.com/pagead/images/adchoices/ Frame 4D49
295 B
325 B
Image
General
Full URL
https://tpc.googlesyndication.com/pagead/images/adchoices/icon.png
Requested by
Host: cdn.ampproject.org
URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:81d::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7fd59024b6ca83f11f7a3448ec148309a13b705725716df134f699e60a96eb1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 14 Dec 2020 21:53:21 GMT
x-content-type-options
nosniff
server
cafe
age
53747
etag
426692510519060060
vary
Accept-Encoding
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
public, max-age=86400
cross-origin-resource-policy
cross-origin
content-type
image/png
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
295
x-xss-protection
0
expires
Tue, 15 Dec 2020 21:53:21 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=11&_fw_gdpr=0&_fw_gdpr_consent=
  • https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDM1ZWZmNzNhODRjYjQwZDc4OWRmZjRmNDg0YWFi&gdpr=0&gdpr_consent=
170 B
213 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDM1ZWZmNzNhODRjYjQwZDc4OWRmZjRmNDg0YWFi&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:08 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:08 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://cm.g.doubleclick.net/pixel?google_nid=stickyxchange_dbm&google_hm=ZDM1ZWZmNzNhODRjYjQwZDc4OWRmZjRmNDg0YWFi&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036548283093-27
Expires
Tue, 15 Dec 2020 12:49:08 GMT
ecm3
s.amazon-adsystem.com/
Redirect Chain
  • https://ads.stickyadstv.com/user-matching?id=2545&_fw_gdpr=0&_fw_gdpr_consent=
  • https://s.amazon-adsystem.com/ecm3?id=d35eff73a84cb40d789dff4f484aab&ex=freewheel.tv&gdpr=0&gdpr_consent=
43 B
344 B
Image
General
Full URL
https://s.amazon-adsystem.com/ecm3?id=d35eff73a84cb40d789dff4f484aab&ex=freewheel.tv&gdpr=0&gdpr_consent=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.239.17.112 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Server /
Resource Hash
c21e2c1246fe45a6750ae6208db2b5965ff6ed63eb80d2ecec3be9c83813428e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:09 GMT
Server
Server
Vary
User-Agent
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store, private, must-revalidate, s-maxage=0
Connection
keep-alive
Content-Length
43
Expires
Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:08 GMT
Server
nginx
Access-Control-Allow-Origin
*
Location
https://s.amazon-adsystem.com/ecm3?id=d35eff73a84cb40d789dff4f484aab&ex=freewheel.tv&gdpr=0&gdpr_consent=
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
0
x-sticky-vk
1608036548310057-136
Expires
Tue, 15 Dec 2020 12:49:08 GMT
/
crta.dailymail.co.uk/
8 B
449 B
Other
General
Full URL
https://crta.dailymail.co.uk/
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:2be::16c2 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
http-to-kafka/0.8.10 /
Resource Hash
a00fb0c50741f81bb51d35b4475a4357f8039aabd896a21036bc516839401595

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:08 GMT
server
http-to-kafka/0.8.10
etag
W/"8-YaBXLEiT7zQxEyDYTILfiL6oPhE"
content-type
text/plain; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
8
expires
Tue, 15 Dec 2020 12:49:08 GMT
adview
securepubads.g.doubleclick.net/pagead/ Frame 4D49
0
0
Image
General
Full URL
https://securepubads.g.doubleclick.net/pagead/adview?ai=CTZbww7DYX9KkIY2F-gaSu56YCO7nmIZgwerey_wMvuOaigQQASCs2bgiYOnkyYXYGqABtK365gLIAQKpAt7KoUUOVZI-4AIAqAMBqgTDAk_Qz0xvQy-mFIZJ4aGXC8OZAPkiPWUXOjWykNaOwlJG2AHNZEkta0rSp_m3tOJdoZgpqOxTVfr6qbj5Z4CrhlLCPRC9WICIUJi28STes7enkLzy8gwk7Keh0y_akHE6yGzsf5wPq1kLtRmBGerApu8G9vQWgP2gOZBId5HxtB1f0aiLFSU0OFfSyWRlBBM6s_IdO-8IGbixy8jFBPBA1h8PP7G57xrryrDYpeUAPd8A2aG2vzcfgw9qWnOBzk1eMn2dt8QrRCxt_0gjzKYPoNhFT5FPlIAV9SGMmsmsgFeOK3bYwrjyiz28L8NazAIyfj3Riw1Ocu7_guX9j7HcExSGn3elBys0yxTBbSSoegpkpw5WPZAgwovEAw63yKVKA-1B7QRdHUWZI05BIN0P_eXw7hCDl_BNNZZNp_oo_OphS-zYwATv18GRnQPgBAGgBgKAB7yX-cMBqAfVyRuoB_DZG6gH8tkbqAeUmLECqAel3xuoB47OG6gHk9gbqAe6BqgH7paxAqgHpr4bqAfs1RvYBwHyBwQQ6aUG0ggJCIDhgBAQARgdgAoDyAsB2BMDmBYBshcaChgIARIUcHViLTQxODA4MzU2OTQxNjYyNTU&sigh=EDmTq_BijyQ&vt=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
172.217.22.2 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s14-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

activeview
pagead2.googlesyndication.com/pcs/ Frame 4D49
42 B
108 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssvRO3UdCJIaafW5-YCY_G5A4hpORp1vBH1RsHsxudXxMdWZBsgrJ2IWxxleh9_v99PsaXEUYLoz-wA5geLDTPOPCFw_BFIMZsytu8cB5v3gv1WKV27b2THBqJ7h3vclSEZeuHK_aKLOqcZ3uGYq2dQ&sai=AMfl-YTjbfckq3W3eqHjL9y9lLK1H1zcbfib1YKibFyU81PWxhqoYXtuBbuy9zUB5rIeQN4kU0_2mz2Dpzt3Urkn36EQMJVtF-A8Fc3zvem4bbcFEeWgDiDE5_kBX4qF&sig=Cg0ArKJSzIi5YrhkzR4lEAE&cid=CAASF-RoTcyOAjkbedk6JZDxMJxWBygKL8l6&id=ampim&o=1223,945&d=300,250&ss=1600,1200&bs=1600,1200&mcvt=1000&mtos=0,0,1000,1000,1000&tos=0,0,1000,0,0&tfs=118&tls=1118&g=100&h=100&tt=1118&r=v&avms=ampa&adk=3432249630
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:09 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
events
api.permutive.com/v2.0/batch/
101 B
180 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
0bc1acc332cf6042315858f450f21185727f1842cb56bb812c8c4635c22208de

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:49:09 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
112
via
1.1 google
track
track1.aniview.com/
0
93 B
XHR
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=PL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=96641&t=1608036538&cip=194.99.105.99&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036538232-938474427970-020635-011-004656&imid=c8c4b999f5891c593a8ff8248e57f7b521443856872172315192&cha=0.7&cb=74377213301&d9=1000&AV_WIDTH=480&AV_HEIGHT=270
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.81.198.99 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
*
date
Tue, 15 Dec 2020 12:49:11 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
metrics
api.permutive.com/v2.0/internal/
2 B
87 B
XHR
General
Full URL
https://api.permutive.com/v2.0/internal/metrics?k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
2689367b205c16ce32ed4200942b8b8b1e262dfc70d9bc9fbc77c49699a4f1df

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:49:12 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
text/plain;charset=utf-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
22
via
1.1 google
480x270_MP4_1225476966369939162.mp4
video.dailymail.co.uk/video/mol/2020/10/09/1225476966369939162/
2 MB
2 MB
Media
General
Full URL
https://video.dailymail.co.uk/video/mol/2020/10/09/1225476966369939162/480x270_MP4_1225476966369939162.mp4
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:6c00:297::11ae , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
1383eca76078bf18ffcb8304e0148c76b5aee1e99d23fd6c13333f3565eca4cc

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Accept-Encoding
identity;q=1, *;q=0
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Range
bytes=0-

Response headers

date
Tue, 15 Dec 2020 12:49:12 GMT
last-modified
Fri, 09 Oct 2020 09:54:05 GMT
server
AkamaiNetStorage
etag
"ca85077d6ba1579f077d6d790b182b5c:1602237245.871325"
content-type
video/mp4
Content-Range
bytes 0-1997031/1997032
accept-ranges
bytes
Content-Length
1997032
sync
am-match.taboola.com/ Frame 8047
0
0
Document
General
Full URL
https://am-match.taboola.com/sync?dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&excid=22&docw=0&cijs=1&nlb=true
Requested by
Host: vidstat.taboola.com
URL: https://vidstat.taboola.com/lite-unit/2.4.6/UnitFeedManagerDesktop.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
141.226.228.48 , Netherlands, ASN200478 (TABOOLA-AS, IL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

:method
GET
:authority
am-match.taboola.com
:scheme
https
:path
/sync?dast=V7BnoCFgNBPFozdqe0rwRBPFozdqe0rwUAAAAGBvQHHTackFaLxWi4Ge12i8VkthstlrvNargaDidD4LDhhLRaLEbDzWi3Wywms91mM5ysJpvdcDCFDWO5TAa1QOTyfE1_w1vE8nxNf8Nb1zS53KCGptPhc93rdb_fXeRwmp1vh9Ns1_jtqq9f83G67B6X6eUx-hWW09NjdrmVg9VgOFnsJS23yeV52p6Wt8Rld9mcHqfD7BY8TE-X3fR5i_we09_yeUtetpfDbBea3mY7AAAAADwAKC2HQPwAAgBEAAAAAEgAAAAAUARU_FsIXAAAAABgABSINmgAqHIYrOXh9fv-AQDwUAACADCgQAIwoHZUAlBRdnsCAAAAAAAAAMDy____HwOgx_8rA5BxONcD8OAD8EBUUFnECAAAAEB4LG3saFInVBZVAAAE6VYAVwAAAXZmciisYQAAAANjC_Sw-P1mh13jd7sMAAAAAAAAAMDs_-wfTQgpij0tyLN-WO0XEABg7RcQAIBN3QAA3gTggo6gFYPB6gZospgdAAAAwN3___-_HkjZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzni6smee6VQdeXwWxPF_T3_DWNU0ug_igYVhOBsH8JmwxWk0mm-VwtlxMBsPRcDTanwBuBjhBw-FgsRssdovFcLKYjAbLwQIFYjDBCRmONpPVaLfaTZbDyWg020w2SNGq1Wy0GQxXs8lst1sNB8PlaIQUrVnMJpPFbLTcbQbLyWgwnAyHCFMj18Zic8zcio3NtRYNZra1cjAYuXWLkcszWdgMi4VnLXp9TLeRZTObbLwoGFC2F8FFOhE5nGbn2-E0uyV_30Us0Zws0onssm_ZNoPJyjFzbAaL5XIxWDiXu5VtOJhtDJPVbjnzt0aujcXmmLkVG5trLRrMbGvlYDBy6xYjl2eysBkWC89a9PqYbiPLZjbZ-BuzwXCwma0mq31jNhgONrPVZLXv0Bm-q8_ZaIt2zx2fyGOeCW0z00HhMhi9y89F2i1-bkafM_wSpobLyGdiFfr9fr_f7_f7_X7vxmzwGAyGn8t2HH7My7Xm9DgoYongdJFORC_j6SKWSJ4W6USw2hhmI9vIZNtYVh6bZ2OcOCy2hXFiMZmMg9lqIpYoTRfpRK_5OF12j8v08hj9Csvp6TG73MrBajCcLPaSl9vk8jxtT8tb4rK7bE6P02F2Cx6mp8tu-rxFfo_pb_m8JS_by2G2C01vs0X9x4ZYjubK5VwxWM2Vy1UCAAAAAAAAAFjCnHkTAAAAgNNAJpvhYrVcgAejPd0faUQfUKffwF0XbE62yzMjk-LGjxvI4TQ73w6n2S35-64M8GB0x7zZM0Gs1WpZAwAAEGADAAAEcOvmLRCTkQM!&excid=22&docw=0&cijs=1&nlb=true
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4

Response headers

server
nginx
date
Tue, 15 Dec 2020 12:49:13 GMT
content-type
text/html;charset=ISO-8859-1
machineid
3404
video_info
context.iris.tv/
113 B
455 B
XHR
General
Full URL
https://context.iris.tv/video_info?access_token=1d9f05c8b00daddfbffcf5afa8a0691bf6370c0cd9dfc8bc6fb38e13c4474dab&global=GlobalIrisPlayer&client_token=W491AUI45FTTFWD&platform_id=1724715945520447388
Requested by
Host: ovp.iris.tv
URL: https://ovp.iris.tv/libs/context/iris-context.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.91 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Zer01ne /
Resource Hash
136410fd77fc6607b3c1c54b8212855f622ec18255a8ebca45366b9a4fa0c129

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:18:07 GMT
via
1.1 bf5caee39117de5337c47c748b716e80.cloudfront.net (CloudFront)
server
Zer01ne
age
1866
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, stale-while-revalidate=600, stale-if-error=600
x-amz-cf-pop
AMS1-C1
x-robots-tag
noindex, follow
x-amz-cf-id
zkci5AqiybNeLQdkF-BMJ1yh9LjZTRmAv9gP1UlYtgLbv3vFdL_jqw==
video_info
context.iris.tv/
113 B
446 B
XHR
General
Full URL
https://context.iris.tv/video_info?access_token=1d9f05c8b00daddfbffcf5afa8a0691bf6370c0cd9dfc8bc6fb38e13c4474dab&global=GlobalIrisPlayer&client_token=W491AUI45FTTFWD&platform_id=1724715945520447388
Requested by
Host: ovp.iris.tv
URL: https://ovp.iris.tv/libs/context/iris-context.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.73.91 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
Zer01ne /
Resource Hash
136410fd77fc6607b3c1c54b8212855f622ec18255a8ebca45366b9a4fa0c129

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:18:07 GMT
via
1.1 bf5caee39117de5337c47c748b716e80.cloudfront.net (CloudFront)
server
Zer01ne
age
1866
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, stale-while-revalidate=600, stale-if-error=600
x-amz-cf-pop
AMS1-C1
x-robots-tag
noindex, follow
x-amz-cf-id
3H7feuh4rABCeQpw4HDYqhu7eQnyHjJ06Q-hN_4qkayGY_1MQiHCcg==
partner
sync.search.spotxchange.com/
Redirect Chain
  • https://sync.search.spotxchange.com/partner?source=dados
  • https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=eef7087d-3ed3-11eb-a9da-1ce730eb0606
0
587 B
Image
General
Full URL
https://sync.search.spotxchange.com/partner?source=dados&__user_check__=1&sync_id=eef7087d-3ed3-11eb-a9da-1ce730eb0606
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.94.180.125 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-spotx-halt-type
Audience Dsp sync Priority Sync endpoint Source ID is not on enabled source whitelist
Date
Tue, 15 Dec 2020 12:49:13 GMT
Server
nginx
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
4
Connection
keep-alive
Content-Length
0

Redirect headers

Date
Tue, 15 Dec 2020 12:49:13 GMT
Server
nginx
Location
/partner?source=dados&__user_check__=1&sync_id=eef7087d-3ed3-11eb-a9da-1ce730eb0606
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
Access-Control-Allow-Credentials
false
X-fe
140
Connection
keep-alive
Content-Length
0
bid
c.amazon-adsystem.com/e/dtb/
24 B
375 B
XHR
General
Full URL
https://c.amazon-adsystem.com/e/dtb/bid?src=3065&u=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&pid=j9cJFKJ4NYZyi&cb=19&ws=1600x1200&v=7.58.01&t=2000&slots=%5B%7B%22id%22%3A%22jw_video_desktop%22%2C%22mt%22%3A%22v%22%2C%22kv%22%3A%7B%22pubcid%22%3A%223093687966%22%7D%7D%5D&gdprl=%7B%22status%22%3A%22no-cmp%22%7D
Requested by
Host: c.amazon-adsystem.com
URL: https://c.amazon-adsystem.com/aax2/apstag.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.84.88.20 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-84-88-20.muc50.r.cloudfront.net
Software
Server /
Resource Hash
09cdbf90e836b623c22eb7f0a7f2e3765e7635ac989caf88229b29b54ec691be

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:13 GMT
via
1.1 ac90d46be219b2aa8a23e6982405715d.cloudfront.net (CloudFront)
server
Server
x-amz-cf-pop
MUC50-C1
vary
User-Agent
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
timing-allow-origin
*
content-length
24
x-amz-cf-id
Om7YW_jwFFW0mSGhDDOFGKq97yJW-84jf2v78Mkb7TkvTdqrFlZF8Q==
auction
prebid.adnxs.com/pbs/v1/openrtb2/
150 B
499 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
8e98cdc1845feca87a8593bdab2fe7f7c409d4e2687411dddca177ecbcddc00d

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:13 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
150
Expires
0
avjp
mailonline-uk-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://mailonline-uk-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=false&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=8a89e2aa-85ba-419c-876a-2b260de125f4&nocache=1608036553181&id5id=ID5-ZHMO6tA3QNYViPdwxqXlM7pRwmnB91HmAtL0p2oNRg&pubcid=3093687966&ttduuid=756bd07b-da9f-4519-81af-bb93a5ce71b6&auid=540675388&vwd=401&vht=225
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:13 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
714 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:13 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.73:80
AN-X-Request-Uuid
1cdb0a0d-811c-4247-aab4-e8956c83770a
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cygnus
htlb.casalemedia.com/
26 B
376 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=293354&v=8.1&r=%7B%22id%22%3A%22261cafd7654280e7%22%2C%22imp%22%3A%5B%7B%22id%22%3A%22262a42bf905bc6bd%22%2C%22ext%22%3A%7B%22siteID%22%3A%22293354%22%2C%22sid%22%3A%22401x225%22%7D%2C%22video%22%3A%7B%22startdelay%22%3A0%2C%22mimes%22%3A%5B%22video%2Fmp4%22%2C%22video%2Fwebm%22%2C%22application%2Fjavascript%22%5D%2C%22minduration%22%3A0%2C%22maxduration%22%3A30%2C%22protocols%22%3A%5B1%2C2%2C3%2C4%2C5%2C6%5D%2C%22api%22%3A%5B1%2C2%5D%2C%22w%22%3A401%2C%22h%22%3A225%2C%22placement%22%3A1%7D%7D%5D%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%7D%7D&ac=j&sd=1&nf=1
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.215.135 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-215-135.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
15e367d0c6e69060570aecb1e2df3639df04a7c45f0965dd5c12a16daec40f4b

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:13 GMT
content-encoding
gzip
x-ak-initial-geo
CC:[PL], RC:[], CN:[EU], CIP:[194.99.105.99], XFF:[]
server
Apache
vary
Is-Traffic-Invalid,Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
x-cs-client-geo
09
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
46
x-ak-client-geo
09
expires
Tue, 15 Dec 2020 12:49:13 GMT
openrtb
ads.adaptv.advertising.com/rtb/
0
220 B
XHR
General
Full URL
https://ads.adaptv.advertising.com/rtb/openrtb?ext_id=MailOnline
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.28.189.33 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
adaptv/1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.dailymail.co.uk
access-control-allow-credentials
true
server
adaptv/1.0
Connection
keep-alive
content-length
0
content-type
application/json
ad-engine-response.gif
trk.vidible.tv/trk/ Frame 3F16
43 B
245 B
Image
General
Full URL
https://trk.vidible.tv/trk/ad-engine-response.gif?bcid=5c6c7f1c17e0e151b5b9cb66&bid=56bcd17de4b0a5976ac0da12&pid=59947c0544a64b1a49e52a48&pt=o2unit&pv=10.2.59&r=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&s=true&sid=d852b6e4-f455-4f04-80e0-d58f8aa289d6&vvuid=95293cf8-fd73-485a-8eb1-947b338634ea&orgId=28230&plcid=1206795&vrid=2f180f54-42c7-4d69-ab74-0c70596da56b&at=preroll&adIdx=-1&pbl=true&ps=html5-vpaid&seq=-1&spaceid=793604934&v=593fb311c214e33ec50202f0&w=480&aert=6254&ar=no&fo=0&ft=0&h=270&cb=0.8238677434201527
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.157.226.24 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
nginx/1.19.4 /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:13 GMT
cache-control
max-age=0, no-cache, no-store, must-revalidate
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
nginx/1.19.4
content-type
image/gif
content-length
43
expires
Tue, 15 Dec 2020 12:49:13 GMT
7197697
ads.stickyadstv.com/vast/vpaid-adapter/
1 KB
2 KB
XHR
General
Full URL
https://ads.stickyadstv.com/vast/vpaid-adapter/7197697?_fw_gdpr=1&_fw_gdpr_consent=&schain=1.0,1!selectmedia.asia,5e3a966128a06134f417790e,1,,Mail%20Metro%20Media,mailonline.co.uk&_fw_us_privacy=1---&cbb=8036553382
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/AVmanager.js?v=1.0&type=s&pid=5e3a966128a06134f417790e
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.234.233 , Ascension Island, ASN16625 (AKAMAI-AS, US),
Reverse DNS
Software
nginx /
Resource Hash
0a02fe2315b3aa42cad0f40ac793af98a8d1a7f438e8a73d020d79ce776200b8

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:13 GMT
Server
nginx
Content-Type
application/xml;charset=ISO-8859-1
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
1340
x-sticky-vk
1608036553498045-101
Expires
Tue, 15 Dec 2020 12:49:13 GMT
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=PL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=96641&t=1608036538&cip=194.99.105.99&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036538232-938474427970-020635-011-004656&imid=c8c4b999f5891c593a8ff8248e57f7b521443856872172315192&cha=0.7&cb=74377213301&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=request&cb=1608036553382&asid=5c249de6073ef47e0c19572b%2C5eeb836e0cb48833c651eaeb%2C5f5f7e84e602f721885bf507%2C5eb7e6462559631ad84a9a98&ofpr=%2C3%2C2.65%2C1.25&fpo=%2C%2C%2C
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.81.198.99 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:13 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
auction
prebid-server.rubiconproject.com/openrtb2/
173 B
385 B
XHR
General
Full URL
https://prebid-server.rubiconproject.com/openrtb2/auction
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.156.233.67 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash
330d7988452a56d6ddc6fc5fbbaa7da4969b0567d7da9d34c82717892664f71e

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:14 GMT
content-encoding
gzip
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
167
expires
0
avjp
select-d.openx.net/v/1.0/
92 B
282 B
XHR
General
Full URL
https://select-d.openx.net/v/1.0/avjp?ju=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-60&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=1d7d57e8-8ffa-4903-9e77-e3dcfca10d03&nocache=1608036553387&ttduuid=1728bdaa-6079-4772-9ec7-6c90876566af&schain=1.0%2C1!selectmedia.asia%2C5e3a966128a06134f417790e%2C1%2C%2CMail%20Metro%20Media%2Cmailonline.co.uk&openrtb=%7B%22imp%22%3A%5B%7B%22video%22%3A%7B%22mimes%22%3A%5B%22video%2Fx-ms-wmv%22%2C%22video%2Fmp4%22%2C%22application%2Fjavascript%22%5D%2C%22w%22%3A480%2C%22h%22%3A270%7D%7D%5D%2C%22w%22%3A480%2C%22v%22%3A270%7D&auid=541066210&vwd=480&vht=270&vos=101
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
OXGW/16.199.0 /
Resource Hash
004e5faf0bf890f61697daeede9f21826affd1137fb2cb58eaf4719937a04a14

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:13 GMT
via
1.1 google
server
OXGW/16.199.0
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.dailymail.co.uk
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
92
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
138 B
834 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.aniview.com
URL: https://player.aniview.com/script/6.1/avpb3.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.242 , Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
724.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
6fb8903b787212ca122f338fe05e5052861310001db20dbb0cf6cb2577977583
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 15 Dec 2020 12:49:13 GMT
X-Proxy-Origin
194.99.105.99; 194.99.105.99; 724.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.54:80
AN-X-Request-Uuid
9cc2b962-583d-4b0f-9ba9-30fe0c66be90
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
138
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
csi
csi.gstatic.com/ Frame 19E7
0
54 B
Other
General
Full URL
https://csi.gstatic.com/csi?v=2&s=pagead&action=csi_pagead&dmc=8&puid=2~kipzfm3r&ctx=2&qqid=CIvmu--C0O0CFSWIOAodrnQAbA&met.8=8.1_20000.2_100.3_100.4_true
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/js/rum.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:401a:805::2003 , Ireland, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

pragma
no-cache
date
Tue, 15 Dec 2020 12:49:13 GMT
last-modified
Wed, 21 Jan 2004 19:51:30 GMT
server
Golfe2
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
events
api.permutive.com/v2.0/batch/
201 B
210 B
XHR
General
Full URL
https://api.permutive.com/v2.0/batch/events?enrich=false&k=ed45e86d-a09e-4d2b-85c0-fbbd6857373e
Requested by
Host: cdn.permutive.com
URL: https://cdn.permutive.com/5f42864d-a421-4f37-9478-00266f871d68-web.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.254.252 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Permutive /
Resource Hash
4c895710e2e3e8e81021dca23eb547727f22bb2814936e2cb9c450da5c181cb5

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 15 Dec 2020 12:49:13 GMT
content-encoding
gzip
server
Permutive
vary
Origin,Access-Control-Request-Method
access-control-allow-methods
POST
content-type
application/json
access-control-allow-origin
https://www.dailymail.co.uk
access-control-expose-headers
*
access-control-allow-credentials
true
access-control-max-age
86400
alt-svc
clear
content-length
142
via
1.1 google
225114
search.spotxchange.com/openrtb/2.3/dados/
0
988 B
XHR
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Requested by
Host: js.spotx.tv
URL: https://js.spotx.tv/directsdk/v1/234272.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
x-openrtb-version
2.3
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 15 Dec 2020 12:49:14 GMT
X-SpotX-Timing-Transform
0.000267
X-SpotX-Timing-SpotMarket
0.009577
X-SpotX-Timing-Page-Mux
0.001125
X-SpotX-Timing-Page-Require
0.000400
X-fe
123
Connection
keep-alive
X-SpotX-Timing-Page-Cookie
0.000005
X-SpotX-Timing-Page
0.013493
Pragma
no-cache
X-SpotX-Timing-Page-Context
0.000448
Last-Modified
Tue, 15 Dec 2020 12:49:14 GMT
Server
nginx
Cache-Control
no-cache, must-revalidate, post-check=0, pre-check=0
X-SpotX-Timing-SpotMarket-Primary
0.009577
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Content-Type
application/json
Access-Control-Allow-Origin
https://www.dailymail.co.uk
X-SpotX-Timing-Page-Misc
0.001658
X-SpotX-Timing-Page-Exception
0.000000
X-SpotX-Timing-SpotMarket-Secondary
0.000000
X-SpotX-Timing-Page-URI
0.000013
Access-Control-Allow-Credentials
true
Access-Control-Allow-Headers
Expires
Thu, 01 Jan 1970 00:00:00 GMT
225114
search.spotxchange.com/openrtb/2.3/dados/ Frame
0
0
Other
General
Full URL
https://search.spotxchange.com/openrtb/2.3/dados/225114
Protocol
HTTP/1.1
Server
185.94.180.123 , Netherlands, ASN35220 (SPOTX-AMS, NL),
Reverse DNS
Software
nginx /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type,x-openrtb-version
Origin
https://www.dailymail.co.uk
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Server
nginx
Date
Tue, 15 Dec 2020 12:49:13 GMT
Content-Type
text/plain;charset=UTF-8
Content-Length
0
Connection
keep-alive
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Tue, 15 Dec 2020 12:49:13 GMT
Cache-Control
no-cache, must-revalidate post-check=0, pre-check=0
Pragma
no-cache
Access-Control-Allow-Origin
https://www.dailymail.co.uk
Access-Control-Allow-Methods
POST, GET, PATCH, DELETE, OPTIONS
Access-Control-Allow-Headers
content-type,x-openrtb-version
Access-Control-Allow-Credentials
true
Access-Control-Max-Age
2592000
MLb0HSdlHb2mq1M%252BB1xNYl5%252FV%252BogCZUvvQ5KxE8qFpg%253D-resultThumbUrl.jpg
i.newzit.com/i/newzit/ Frame 1FE6
18 KB
19 KB
Image
General
Full URL
https://i.newzit.com/i/newzit/MLb0HSdlHb2mq1M%252BB1xNYl5%252FV%252BogCZUvvQ5KxE8qFpg%253D-resultThumbUrl.jpg
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:b::b856:675f , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5120d36c487dd1543323f292d3567e8b95e5f7391d256289edd3a34a7603feb8

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:49:13 GMT
Last-Modified
Tue, 15 Dec 2020 12:15:31 GMT
Server
AmazonS3
x-amz-request-id
E52F4CF023649EB7
ETag
"e043c14159e04ae82d915bced3de44c7"
Content-Type
image/jpeg
Cache-Control
max-age=2006
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
18895
x-amz-id-2
URBkfYRIDWrbZpW9U2xhUNhgliCUPaAmB2Mfb4/AVL/pq7ycDwtIB+17yGFnwvt7FN7HQ8KSAAs=
Expires
Tue, 15 Dec 2020 13:22:39 GMT
dailymail.co.uk.ico
i.newzit.com/favicons/ Frame 1FE6
15 KB
15 KB
Image
General
Full URL
https://i.newzit.com/favicons/dailymail.co.uk.ico
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:1700:b::b856:675f , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
fa071812ff258cb3621dce21b3ff409d05378b42dfb776838035b784711fdb5e

Request headers

Referer
https://scripts.dailymail.co.uk/static/mol-fe/static/mol-fe-xpmodule-news-search/1.13.0/mpuCarousel.html?forceIto=Mol-Carousel&startTab=entertainment&clickUrl=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsuatl4weNdGbIhVewoMX0U4Lg2SPGvrepyp_IrBOVaBJOsayJckE7D1KrX74zaUC1v6U67k4v90iXmlsY_AE3kBqSpihu3dPhj1chAvOAtCRe_h9uVKfxRZmXCxUNn3FCPjsX1YQmEhYHgXva_rhAHKIizg9pO92FevBJvZxaBixb_H3CO045rxi_kWP0kC4r1ctAwzMixR8OH3es31PKR_utRG0YNfIMtF0svN7FcljeeAJlSpdrLXpPmiLddBfnjQvm4cOEFI9siA_4y75GMUOxa81Kqw1o4S_c6uJilE-OZczsZRbstDYqUNF3htc-Ev9g%2526sai%253DAMfl-YSjqs1n42sWB7HakInfY_AMQB-ZMf-zsoFif3Ijm97S0HW1LxCer09qoZQ79HiHLPBFLhfv-gKePTXLhVXOnyqtcxBgOAqOO_jhjOioOjehYgsFLGT25XWsUK44AO7m%2526sig%253DCg0ArKJSzIkWN8kfQBGGEAE%2526urlfix%253D1%2526adurl%253D
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Tue, 15 Dec 2020 12:49:13 GMT
Last-Modified
Fri, 13 Sep 2019 09:44:23 GMT
Server
AkamaiNetStorage
ETag
"3caad4661bebf96fe90a0cc19bc27e46:1568367863.4734"
Content-Type
image/x-icon
Cache-Control
max-age=391
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
15086
Expires
Tue, 15 Dec 2020 12:55:44 GMT
track
track1.aniview.com/
0
70 B
Image
General
Full URL
https://track1.aniview.com/track?d=Chrome&cou=PL&cos=OSX&r=www.dailymail.co.uk&rs=www.dailymail.co.uk&sid=96641&t=1608036538&cip=194.99.105.99&sn=&tgt=0&osv=10.14.5&bv=83.0&brn=Chrome&wi=480&he=270&app=&AV_PUBLISHERID=5e3a966128a06134f417790e&test=&aafaid=&proto=https&uid=1608036538232-938474427970-020635-011-004656&imid=c8c4b999f5891c593a8ff8248e57f7b521443856872172315192&cha=0.7&cb=74377213301&d9=1000&AV_WIDTH=480&AV_HEIGHT=270&ppid=5e3a966128a06134f417790e&nid=58fcbed1073ef420086c9d08&pcid=5e3a987528a0611c3444f80c&ncid=5ebbaa0fd5dbd82f9b0f9a69&pasid=5ebbaa68f985a05cae268384&e=bid&cb=1608036554572&asid=5c249de6073ef47e0c19572b&ofpr=&fpo=
Requested by
Host: www.dailymail.co.uk
URL: https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.81.198.99 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Tue, 15 Dec 2020 12:49:14 GMT
cache-control
max-age=0, no-cache, no-store
content-length
0
vpaid-adapter.min.js
cdn.stickyadstv.com/mustang/ Frame 4B1C
0
0

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
pixel.rubiconproject.com
URL
https://pixel.rubiconproject.com/exchange/sync.php?p=16698
Domain
api.skimlinks.mgr.consensu.org
URL
https://api.skimlinks.mgr.consensu.org/iab?nocache=1608036527045
Domain
cdn.stickyadstv.com
URL
https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js
Domain
ib.adnxs.com
URL
https://ib.adnxs.com/ut/v3/prebid
Domain
prebid-eu.creativecdn.com
URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Domain
fastlane.rubiconproject.com
URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=20598&site_id=345700&zone_id=1828452&size_id=15&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&tk_flint=pbjs_lite_v4.15.0-pre&x_source.tid=33d7de36-03d2-4103-8f39-9bd3aa31583c&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.5873248148880046
Domain
prebid-server.rubiconproject.com
URL
https://prebid-server.rubiconproject.com/openrtb2/auction
Domain
prebid.adnxs.com
URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Domain
mfad.inskinad.com
URL
https://mfad.inskinad.com/api/v2
Domain
bidder.criteo.com
URL
https://bidder.criteo.com/cdb?ptv=100&profileId=185&av=32&wv=4.13.0-mol-1&cb=9821198548
Domain
c2shb.ssp.yahoo.com
URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_billboard&cmd=bid&secure=1
Domain
fastlane.rubiconproject.com
URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=587732&size_id=2&alt_size_ids=57&p_pos=atf&tpid_tdid=756bd07b-da9f-4519-81af-bb93a5ce71b6&eid_pubcid.org=3093687966%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=3bebd531-886d-45bf-acb2-eecb6db98fa0&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.9625343738159677
Domain
ib.adnxs.com
URL
https://ib.adnxs.com/ut/v3/prebid
Domain
c2shb.ssp.yahoo.com
URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9691510171713aaede3c85d0ab0026&pos=desktop_mpu_player&cmd=bid&secure=1
Domain
fastlane.rubiconproject.com
URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=8625&site_id=124374&zone_id=1694080&size_id=15&tpid_tdid=756bd07b-da9f-4519-81af-bb93a5ce71b6&eid_pubcid.org=3093687966%5E1&rf=https%3A%2F%2Fwww.dailymail.co.uk%2Fsciencetech%2Farticle-9050821%2FRemdesivir-beneficial-patients-doctors-reveal.html%3F_hsmi%3D88974744%26_hsenc%3Dp2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4&tg_i.area=sciencetech&tk_flint=pbjs_lite_v4.13.0-mol-1&x_source.tid=2a549085-f90b-40f4-be84-96469883a52b&p_screen_res=1600x1200&rp_floor=0.01&rp_secure=1&slots=1&rand=0.32302082768773976
Domain
cdn.stickyadstv.com
URL
https://cdn.stickyadstv.com/mustang/bandwidth-test-25ko?cachebuster=1608036546689
Domain
cdn.stickyadstv.com
URL
https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js

Verdicts & Comments Add Verdict or Comment

292 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| 8 object| 9 object| 10 object| 11 object| 12 object| 13 object| 14 object| 15 object| 16 object| 17 object| 18 object| 19 object| 20 object| 21 object| 22 object| 23 object| 24 object| 25 object| 26 object| 27 object| 28 object| 29 object| 30 object| 31 object| 32 object| 33 object| 34 object| 35 object| 36 object| 37 object| 38 object| 39 object| 40 object| 41 object| 42 object| 43 object| 44 object| 45 object| 46 object| 47 object| 48 object| 49 object| 50 object| 51 object| 52 object| ontransitionrun object| ontransitionstart object| ontransitioncancel object| cookieStore function| showDirectoryPicker function| showOpenFilePicker function| showSaveFilePicker object| trustedTypes boolean| crossOriginIsolated boolean| disableAds object| PageCriteria string| PUSHLY_DOMAIN_KEY boolean| useGpt object| adTrackingConfig boolean| ANDDebugOn string| s_account string| s_account15 boolean| haveRenderedSponsoredPollOnPage boolean| useRtp string| twitterVia string| adReferrer string| adType string| dartSiteId string| adAreaSiteId string| adAreaId string| adSubareaId string| adPageType string| adContent string| adSection string| adArticleId string| adEnvironment boolean| enableAds object| webVitals object| RTA function| setImmediate function| clearImmediate object| regeneratorRuntime number| s_objectID number| s_giq function| AppMeasurement function| AppMeasurement_Module_Media function| s_gi function| s_pgicq object| s_c_il number| s_c_in object| DM object| _ object| MobileUtils string| searchTerms object| dm string| refererHost undefined| docReferrerHostMatches undefined| docReferrerHost object| pagemeta object| s_i_anddailymailprod string| molMVTest object| adListLoader object| adsDescriptions object| adsRenderer object| DfpServer object| adsTrackers object| AdIntegrator object| AdBehaviour object| AdImpression function| AdEvents function| require function| openAdsControlPanel object| permutive object| googletag object| pubcid_options object| _tfa object| __gcp function| pbjsChunk object| pbjs object| _pbjsGlobals object| Criteo string| currentChannelTwitterFollow string| inlineModules object| BOOMR_mq string| BOOMR_API_key object| BOOMR object| _gaq object| ggeac object| google_js_reporting_queue object| Ext string| id function| $ function| jQuery object| PublisherCommonId object| _google_rum_ns_ object| google_persistent_state_async number| google_global_correlator number| google_srt function| mb function| Goog_AdSense_Lidar_sendVastEvent function| Goog_AdSense_Lidar_getViewability function| Goog_AdSense_Lidar_getUrlSignalsArray function| Goog_AdSense_Lidar_getUrlSignalsList object| module$contents$ima$CompanionAdSelectionSettings_CompanionAdSelectionSettings object| ima object| module$contents$ima$AdsRenderingSettings_AdsRenderingSettings object| module$contents$ima$AdCuePoints_AdCuePoints object| module$contents$ima$AdError_AdError object| module$contents$ima$AdErrorEvent_AdErrorEvent object| module$contents$ima$AdEvent_AdEvent object| module$contents$ima$AdsManagerLoadedEvent_AdsManagerLoadedEvent object| google string| articleShortUrl object| _taboola function| BOOMR_check_doc_domain object| ErrorStackParser object| UserTimingCompression object| hulk object| TFASC object| TRC number| taboola_view_id object| TRCImpl function| __trcError function| IrisContextAPI object| IrisContextGlobal object| _gat object| gaGlobal object| _fbq boolean| DotMetricsInitScript boolean| apstagLOADED object| apstag object| _tblConsole undefined| msg boolean| CLOSURE_NO_DEPS object| SpotX function| __trcCopyProps function| __trcFromError function| __trcClientTimestamp function| __trcLog function| __trcDebug function| __trcInfo function| __trcWarn function| __trcDOMWalker function| __trcJSONify function| __trcUnJSONify function| __trcTrim function| __trcGetElementsByClass function| __trcToArray function| __trcObjectCreate function| PageManager function| addHashParam number| trc_debug_level string| trc_article_id function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter undefined| google_measure_js_timing object| FFF object| adBlockQueue object| ABE object| DMS function| emailArticle function| postToDiggit function| postToFark function| postToFB function| postToLinkedIn function| postToPinterest function| postToReddit function| postToTWTTR function| ArticlePage object| DMArticleDefer object| DMDefer function| videojs number| vdata1608036525471 object| pkcs7 object| Mustache object| TINY object| FFFOverlayHelpers object| s object| closure_lm_191496 function| submitReportAbuseFunction undefined| initialData object| DotMetricsSettings object| closure_lm_591348 function| get_real_link object| __SKIM_JS_GLOBAL__ object| skimlinksAPI object| audienceProjectLayer object| _urq object| __sak object| DotmetricsJSON object| CryptoJS object| DotMetricsObj object| _bvt object| $__BPN function| $__Protocol object| googleToken object| googleIMState function| processGoogleToken number| __google_ad_urls_id number| google_unique_id string| nam object| placementData object| ampInaboxPositionObserver object| ampInaboxFrameOverlayManager object| __google_ad_urls boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| ampInaboxIframes object| ampInaboxPendingMessages object| _moatApi94421227 object| closure_lm_253728 object| cmTag object| _cm_wfCounters object| aniplayerPos object| criteo_pubtag string| lastWfUrl function| avPlayer undefined| GLOBAL_VAR undefined| ct undefined| et undefined| hourElapsed undefined| pixelDomain undefined| isDomless undefined| documentReferrer undefined| isBeta undefined| viewHash undefined| pxSrc undefined| moat_px object| Moat#G26 object| MoatSuperV26 object| Moat#PML#26#1.2 boolean| Moat#EVA object| storageAni undefined| define function| startCMTagMain object| yhmgIfram undefined| moatApiInit1608036547061 undefined| px string| prop object| callbacks object| time

0 Cookies

16 Console Messages

Source Level URL
Text
console-api debug URL: https://info.silobreaker.com/e2t/tc/VVpSyK2RnDPVW30YyJ824wQCXVNrtzX4kD20cN3Z5rbf2-HwLV1-WJV7CgR2WW3spyL14pq9bYN4Y8PRgc9Lq8W5pTDsr8zZfJYW2gNZ4w8btlMNW44RRM18Z-mJyW2z-vXx4NwMfYW2KvmFd1m0m89W4fz0mg1kd5_GW6sqL9380MmjDN4Pvkqvtvp87W6ZdBhc31lK36W2kyPYF66sKVqW5HWj4x61zlDPW8RY5JY7z_0q-W3XqszP6hGsgqW4DTSJw6ZnMxwW2RlF3l41jN_CM2Dv-4YpPGTW7l8-XL4w3YvLW4hCnJs79fQpFW4N-Vlx8DYP0jW5hY_lM664kpSW1w2NCj8S5KD-W38ntZR50Bsm8W96BYGG3m7Nr7W7S96zD1j0h3_W5tcQrH3P9tzZVMm4545YkSMM3jrp1(Line 13)
Message:
toS
console-api info URL: https://www.dailymail.co.uk/static/mol-fe/static/mol-fe-sync-bundle/5.9.0/desktop.js(Line 1)
Message:
Current log level: ERROR
console-api log URL: https://ovp.iris.tv/libs/context/iris-context.min.js(Line 1)
Message:
[Iris Context API] v1.0.5
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
console-api error URL: https://www.dailymail.co.uk/static/mol-adverts/demo/mol-22070/19a28e0b/mol-adverts.js(Line 1)
Message:
video tags cached ctp [object Object] TypeError: Cannot convert undefined or null to object
console-api warning URL: https://player.hb.selectmedia.asia/prebidlink/446676/hb_310028_7816.js(Line 3)
Message:
fun-hooks: referenced 'registerAdserver' but it was never created
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
console-api error URL: https://www.dailymail.co.uk/static/videoplayer/6.11.0-pr-503.2312/scripts/mol-fe-videoplayer.min.js(Line 6)
Message:
### Video ads error [object Object]
console-api warning URL: https://cdn.stickyadstv.com/mustang/vpaid-adapter.min.js(Line 61)
Message:
13:49:06,687 com.stickyadstv.utils.Browser GDPR 2.0 - TCFAPI function cannot be found. _fw_gdpr: null, _fw_gdpr_consent: null
console-api info URL: https://cdn.ampproject.org/rtv/012010270040000/amp4ads-v0.mjs(Line 9)
Message:
Powered by AMP ⚡ HTML – Version 2010270040000 https://www.dailymail.co.uk/sciencetech/article-9050821/Remdesivir-beneficial-patients-doctors-reveal.html?_hsmi=88974744&_hsenc=p2ANqtz--BeiWlt68nLgIISU2qFWmBbzh0iBiyBx9HNDe3E_RcKtJuK0wleZVbn4zzMEMoCnOiE2GoQ3u8LokHAwYe2v8nzuXvl-WHEj-KopTl5at9wf2f3c4
console-api error URL: https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js(Line 55)
Message:
13:49:13.375 [ERROR] EventBus: TypeError: Cannot read property 'length' of undefined event [object Object]
console-api error URL: https://cdn-ssl.vidible.tv/prod/ad-client/js/10.2.59/0.js(Line 55)
Message:
13:49:13.376 [ERROR] EventBus: TypeError: Cannot read property 'length' of undefined event [object Object]

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

15.taboola.com
45a2b82d2f192dabbef5e097155e0a61.safeframe.googlesyndication.com
a.teads.tv
aa.agkn.com
acdn.adnxs.com
acds.prod.vidible.tv
ads.adaptv.advertising.com
ads.avct.cloud
ads.avocet.io
ads.creative-serving.com
ads.pubmatic.com
ads.stickyadstv.com
adservice.google.com
adservice.google.de
adservice.google.pl
aka.spotxcdn.com
am-match.taboola.com
am-vid-events.taboola.com
api.permutive.com
api.skimlinks.mgr.consensu.org
aud.pubmatic.com
audex.userreport.com
bh.contextweb.com
bidder.criteo.com
bttrack.com
c.amazon-adsystem.com
c.go-mpulse.net
c2shb.ssp.yahoo.com
c3.taboola.com
cdn-ssl.vidible.tv
cdn.ampproject.org
cdn.jsdelivr.net
cdn.permutive.com
cdn.stickyadstv.com
cdn.taboola.com
cdn.userreport.com
cds.taboola.com
cdw-dcl.userreport.com
ce.lijit.com
cm.g.doubleclick.net
cm.smadex.com
connect.facebook.net
context.iris.tv
creative.dailymail.co.uk
crta.dailymail.co.uk
csi.gstatic.com
d3tsytm1wtjqo2.cloudfront.net
dis.criteo.com
dmp.adform.net
dsp.adkernel.com
e.serverbid.com
e1.emxdgt.com
eb2.3lift.com
ee12f6ec35b2c173a5233b824c7d979b.safeframe.googlesyndication.com
eu-u.openx.net
eus.rubiconproject.com
fastlane.rubiconproject.com
fff.dailymail.co.uk
go1.aniview.com
google-analytics.com
googleads.g.doubleclick.net
googlesync.permutive.com
hb.hb.selectmedia.asia
hbopenbid.pubmatic.com
htlb.casalemedia.com
hulkprod.anm.co.uk
i.dailymail.co.uk
i.liadm.com
i.newzit.com
i6.liadm.com
ib.adnxs.com
ice.360yield.com
id5-sync.com
idsync.rlcdn.com
image2.pubmatic.com
images.taboola.com
imasdk.googleapis.com
imprammp.taboola.com
info.silobreaker.com
js-sec.indexww.com
js.spotx.tv
loadm.exelator.com
mailonline-uk-d.openx.net
match.adsrvr.org
match.taboola.com
mfad.inskinad.com
ml314.com
mwzeom.zeotap.com
odr.mookie1.com
ovp.iris.tv
p.skimresources.com
pagead2.googlesyndication.com
pixel.advertising.com
pixel.onaudience.com
pixel.quantserve.com
pixel.rubiconproject.com
pixel.tapad.com
play.selectmedia.asia
player.adtelligent.com
player.aniview.com
player.hb.selectmedia.asia
pr-bh.ybp.yahoo.com
pre.ads.justpremium.com
prebid-eu.creativecdn.com
prebid-server.rubiconproject.com
prebid.adnxs.com
pub.admanmedia.com
px.moatads.com
r.skimresources.com
relay.userreport.com
rtb-csync.smartadserver.com
rtb.mfadsrvr.com
s.adtelli.com
s.amazon-adsystem.com
s.c.appier.net
s.go-mpulse.net
s.skimresources.com
s0.2mdn.net
sak.userreport.com
sb.scorecardresearch.com
scripts.dailymail.co.uk
search.spotxchange.com
secured.dailymail.co.uk
securepubads.g.doubleclick.net
select-d.openx.net
simage2.pubmatic.com
ssl.google-analytics.com
ssum-sec.casalemedia.com
ssum.casalemedia.com
static.criteo.net
stats.g.doubleclick.net
swa.and.co.uk
sync-t1.taboola.com
sync-tm.everesttech.net
sync.1dmp.io
sync.ads.152media.com
sync.crwdcntrl.net
sync.search.spotxchange.com
sync.sxp.smartclip.net
sync.taboola.com
t.dailymail.co.uk
t.skimresources.com
tag.userreport.com
tags.bluekai.com
ted.dailymail.co.uk
tlx.3lift.com
tpc.googlesyndication.com
track1.aniview.com
trc-events.taboola.com
trc.taboola.com
trk.vidible.tv
u.openx.net
uk-script.dotmetrics.net
ups.analytics.yahoo.com
video.dailymail.co.uk
vidstat.taboola.com
visitanalytics.userreport.com
wf.taboola.com
www.dailymail.co.uk
www.facebook.com
www.google.com
www.googletagservices.com
www.newzit.com
www.storygize.net
x.bidswitch.net
z.moatads.com
api.skimlinks.mgr.consensu.org
bidder.criteo.com
c2shb.ssp.yahoo.com
cdn.stickyadstv.com
fastlane.rubiconproject.com
ib.adnxs.com
mfad.inskinad.com
pixel.rubiconproject.com
prebid-eu.creativecdn.com
prebid-server.rubiconproject.com
prebid.adnxs.com
104.108.50.124
104.111.215.135
104.111.238.139
104.111.246.202
104.19.149.54
109.206.182.43
13.227.156.93
134.209.131.220
139.162.84.221
141.226.224.32
141.226.228.48
147.75.102.200
15.237.76.117
151.101.113.44
151.101.114.49
151.101.13.108
151.101.13.44
151.139.128.11
172.217.22.2
172.217.23.162
174.137.133.49
178.250.0.165
178.250.2.151
18.156.0.31
18.185.197.81
18.195.155.181
18.196.214.144
185.33.220.242
185.64.189.112
185.64.189.249
185.64.190.80
185.86.139.115
185.94.180.123
185.94.180.125
185.94.180.128
192.132.33.46
198.148.27.139
199.232.57.44
199.60.103.2
2.18.232.7
2.18.234.233
2.21.36.138
2.21.37.33
2.21.37.92
2.21.38.40
2001:4de0:ac19::1:b:3b
213.174.135.1
23.227.137.155
2600:1f18:444a:4602:fff0:3de7:a67e:fe5f
2600:9000:20eb:4600:15:d134:4e40:93a1
2600:9000:2104:6200:11:af01:b40:93a1
2600:9000:2104:9c00:19:d208:7940:93a1
2600:9000:2104:c000:1:91d6:b080:21
2606:4700:10::6816:1857
2620:116:800d:21:51e4:db4b:4436:b305
2a00:1288:110:c305::8000
2a00:1288:f03d:1fa::2000
2a00:1450:4001:801::2001
2a00:1450:4001:809::2008
2a00:1450:4001:817::2004
2a00:1450:4001:817::200a
2a00:1450:4001:818::2006
2a00:1450:4001:81a::2004
2a00:1450:4001:81b::2002
2a00:1450:4001:81d::2001
2a00:1450:4001:820::2001
2a00:1450:4001:825::2002
2a00:1450:400c:c0c::9c
2a00:1450:401a:805::2003
2a02:2638::3
2a02:26f0:10c:48b::2c79
2a02:26f0:1700:11::b856:679b
2a02:26f0:1700:b::b856:675f
2a02:26f0:6c00:19a::11a6
2a02:26f0:6c00:287::11a6
2a02:26f0:6c00:289::11ae
2a02:26f0:6c00:297::11ae
2a02:26f0:6c00:2be::16c2
2a02:26f0:6c00::210:bb21
2a02:26f0:6c00::210:bb28
2a02:26f0:eb:3a5::11ae
2a02:26f0:eb:3b5::11ae
2a03:2880:f02d:12:face:b00c:0:3
2a03:2880:f12d:83:face:b00c:0:25de
2a04:4e42:3::621
2a0c:5c81:5160::2
3.124.119.192
3.81.198.99
34.107.254.252
34.120.207.148
34.213.170.153
34.240.2.137
34.245.253.34
34.250.60.119
34.98.64.218
34.98.67.61
35.156.233.67
35.157.226.24
35.159.48.82
35.171.145.49
35.190.59.101
35.190.91.160
35.201.67.47
35.227.248.159
37.157.3.29
37.252.161.190
51.210.112.66
51.89.20.87
52.1.33.51
52.18.215.87
52.28.106.210
52.28.189.33
52.28.203.152
52.29.22.19
52.29.85.133
52.50.156.162
52.57.190.156
54.195.94.143
54.225.161.250
54.239.17.112
54.80.202.86
54.93.211.166
62.149.0.72
65.9.68.93
65.9.73.118
65.9.73.31
65.9.73.91
69.173.144.143
72.251.249.9
88.99.214.77
99.84.88.20
99.84.89.98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